0001683168-22-005495.txt : 20220810 0001683168-22-005495.hdr.sgml : 20220810 20220810094110 ACCESSION NUMBER: 0001683168-22-005495 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 53 CONFORMED PERIOD OF REPORT: 20220630 FILED AS OF DATE: 20220810 DATE AS OF CHANGE: 20220810 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Paysign, Inc. CENTRAL INDEX KEY: 0001496443 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389] IRS NUMBER: 954550154 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-38623 FILM NUMBER: 221150656 BUSINESS ADDRESS: STREET 1: 2615 ST. ROSE PARKWAY CITY: HENDERSON STATE: NV ZIP: 89052 BUSINESS PHONE: 702-453-2221 MAIL ADDRESS: STREET 1: 2615 ST. ROSE PARKWAY CITY: HENDERSON STATE: NV ZIP: 89052 FORMER COMPANY: FORMER CONFORMED NAME: 3PEA INTERNATIONAL, INC. DATE OF NAME CHANGE: 20100713 10-Q 1 paysign_i10q-063022.htm FORM 10-Q
0001496443 false --12-31 2022 Q2 0001496443 2022-01-01 2022-06-30 0001496443 2022-08-05 0001496443 2022-06-30 0001496443 2021-12-31 0001496443 2022-04-01 2022-06-30 0001496443 2021-04-01 2021-06-30 0001496443 2021-01-01 2021-06-30 0001496443 PAYS:PlasmaIndustryMember 2022-04-01 2022-06-30 0001496443 PAYS:PlasmaIndustryMember 2021-04-01 2021-06-30 0001496443 PAYS:PlasmaIndustryMember 2022-01-01 2022-06-30 0001496443 PAYS:PlasmaIndustryMember 2021-01-01 2021-06-30 0001496443 PAYS:PharmaceuticalIndustryMember 2022-04-01 2022-06-30 0001496443 PAYS:PharmaceuticalIndustryMember 2021-04-01 2021-06-30 0001496443 PAYS:PharmaceuticalIndustryMember 2022-01-01 2022-06-30 0001496443 PAYS:PharmaceuticalIndustryMember 2021-01-01 2021-06-30 0001496443 PAYS:OtherRevenueMember 2022-04-01 2022-06-30 0001496443 PAYS:OtherRevenueMember 2021-04-01 2021-06-30 0001496443 PAYS:OtherRevenueMember 2022-01-01 2022-06-30 0001496443 PAYS:OtherRevenueMember 2021-01-01 2021-06-30 0001496443 us-gaap:CommonStockMember 2021-12-31 0001496443 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001496443 us-gaap:TreasuryStockMember 2021-12-31 0001496443 us-gaap:RetainedEarningsMember 2021-12-31 0001496443 us-gaap:CommonStockMember 2022-03-31 0001496443 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001496443 us-gaap:TreasuryStockMember 2022-03-31 0001496443 us-gaap:RetainedEarningsMember 2022-03-31 0001496443 2022-03-31 0001496443 us-gaap:CommonStockMember 2020-12-31 0001496443 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001496443 us-gaap:TreasuryStockMember 2020-12-31 0001496443 us-gaap:RetainedEarningsMember 2020-12-31 0001496443 2020-12-31 0001496443 us-gaap:CommonStockMember 2021-03-31 0001496443 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001496443 us-gaap:TreasuryStockMember 2021-03-31 0001496443 us-gaap:RetainedEarningsMember 2021-03-31 0001496443 2021-03-31 0001496443 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001496443 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001496443 us-gaap:TreasuryStockMember 2022-01-01 2022-03-31 0001496443 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001496443 2022-01-01 2022-03-31 0001496443 us-gaap:CommonStockMember 2022-04-01 2022-06-30 0001496443 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0001496443 us-gaap:TreasuryStockMember 2022-04-01 2022-06-30 0001496443 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001496443 us-gaap:CommonStockMember 2021-01-01 2021-03-31 0001496443 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0001496443 us-gaap:TreasuryStockMember 2021-01-01 2021-03-31 0001496443 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001496443 2021-01-01 2021-03-31 0001496443 us-gaap:CommonStockMember 2021-04-01 2021-06-30 0001496443 us-gaap:AdditionalPaidInCapitalMember 2021-04-01 2021-06-30 0001496443 us-gaap:TreasuryStockMember 2021-04-01 2021-06-30 0001496443 us-gaap:RetainedEarningsMember 2021-04-01 2021-06-30 0001496443 us-gaap:CommonStockMember 2022-06-30 0001496443 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001496443 us-gaap:TreasuryStockMember 2022-06-30 0001496443 us-gaap:RetainedEarningsMember 2022-06-30 0001496443 us-gaap:CommonStockMember 2021-06-30 0001496443 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001496443 us-gaap:TreasuryStockMember 2021-06-30 0001496443 us-gaap:RetainedEarningsMember 2021-06-30 0001496443 2021-06-30 0001496443 PAYS:OtherReceivableMember 2022-06-30 0001496443 PAYS:OtherReceivableMember 2021-12-31 0001496443 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember PAYS:OneCustomerMember 2022-01-01 2022-06-30 0001496443 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember PAYS:AnotherCustomerMember 2022-01-01 2022-06-30 0001496443 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember PAYS:OneCustomerMember 2021-01-01 2021-12-31 0001496443 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember PAYS:AnotherCustomerMember 2021-01-01 2021-12-31 0001496443 PAYS:IntangibleAssetsMember 2022-01-01 2022-06-30 0001496443 PAYS:ComputerSoftwareMember 2022-01-01 2022-06-30 0001496443 us-gaap:EquipmentMember 2022-06-30 0001496443 us-gaap:EquipmentMember 2021-12-31 0001496443 us-gaap:SoftwareDevelopmentMember 2022-06-30 0001496443 us-gaap:SoftwareDevelopmentMember 2021-12-31 0001496443 us-gaap:FurnitureAndFixturesMember 2022-06-30 0001496443 us-gaap:FurnitureAndFixturesMember 2021-12-31 0001496443 PAYS:WebsiteCostsMember 2022-06-30 0001496443 PAYS:WebsiteCostsMember 2021-12-31 0001496443 us-gaap:LeaseholdImprovementsMember 2022-06-30 0001496443 us-gaap:LeaseholdImprovementsMember 2021-12-31 0001496443 us-gaap:TrademarksAndTradeNamesMember 2022-06-30 0001496443 us-gaap:TrademarksAndTradeNamesMember 2021-12-31 0001496443 PAYS:PlatformMember 2022-06-30 0001496443 PAYS:PlatformMember 2021-12-31 0001496443 PAYS:CustomerListsAndContractsMember 2022-06-30 0001496443 PAYS:CustomerListsAndContractsMember 2021-12-31 0001496443 PAYS:LicensesMember 2022-06-30 0001496443 PAYS:LicensesMember 2021-12-31 0001496443 PAYS:StockOptionsMember 2022-04-01 2022-06-30 0001496443 PAYS:StockOptionsMember 2022-01-01 2022-06-30 0001496443 PAYS:UnvestedRestrictedStockAwardsMember 2022-04-01 2022-06-30 0001496443 PAYS:UnvestedRestrictedStockAwardsMember 2022-01-01 2022-06-30 0001496443 PAYS:StockOptionsMember 2021-04-01 2021-06-30 0001496443 PAYS:StockOptionsMember 2021-01-01 2021-06-30 0001496443 PAYS:UnvestedRestrictedStockAwardsMember 2021-04-01 2021-06-30 0001496443 PAYS:UnvestedRestrictedStockAwardsMember 2021-01-01 2021-06-30 0001496443 PAYS:RelatedPartyLawFirmMember 2022-04-01 2022-06-30 0001496443 PAYS:RelatedPartyLawFirmMember 2022-01-01 2022-06-30 0001496443 PAYS:RelatedPartyLawFirmMember 2021-04-01 2021-06-30 0001496443 PAYS:RelatedPartyLawFirmMember 2021-01-01 2021-06-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

Table of Contents

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended June 30, 2022

 

or

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ___________ to __________

 

Commission file number 001-38623

 

PAYSIGN, INC.

(Exact name of registrant as specified in its charter)

 

Nevada 95-4550154
(State or other jurisdiction of incorporation or organization) (IRS Employer Identification No.)

 

2615 St. Rose Parkway,

Henderson, Nevada 89052

(Address of principal executive offices)

 

(702) 453-2221

(Registrant’s telephone number, including area code)

 

                           N/A                           

(Former name, former address and former fiscal year, if changed since last report)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each Class Trading Symbol Name of each exchange on which registered
Common Stock, $0.001 par value per share PAYS

The Nasdaq Stock Market LLC

  

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated Filer ☐ Accelerated Filer ☐
Non-accelerated Filer Smaller reporting company
  Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date: 52,151,932 shares as of August 5, 2022.

 

   

 

 

PAYSIGN, INC.

 

FORM 10-Q REPORT

INDEX

 

PART I. FINANCIAL INFORMATION.  
   
Item 1. Financial Statements. 3
   
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations. 15
   
Item 3. Quantitative and Qualitative Disclosures about Market Risk. 23
   
Item 4. Controls and Procedures. 23
   
PART II. OTHER INFORMATION.  
   
Item 1. Legal Proceedings. 24
   
Item 1A. Risk Factors. 24
   
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds. 24
   
Item 6. Exhibits. 25
   
SIGNATURES 26

 

 

 

 

 

 

 

 2 

 

 

PART I. FINANCIAL INFORMATION

 

Item 1. Financial Statements

 

PAYSIGN, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

 

                 
   

June 30,
2022

(Unaudited)

   

December 31,
2021

(Audited)

 
ASSETS                
Current assets                
Cash   $ 6,527,476     $ 7,387,156  
Restricted cash     76,967,850       61,283,914  
Accounts receivable     3,488,759       3,393,940  
Other receivables     1,439,251       1,019,218  
Prepaid expenses and other current assets     1,754,140       1,242,967  
Total current assets     90,177,476       74,327,195  
                 
Fixed assets, net     1,410,947       1,642,981  
Intangible assets, net     4,501,854       4,086,962  
Operating lease right-of-use asset     3,806,793       3,993,655  
                 
Total assets   $ 99,897,070     $ 84,050,793  
                 
LIABILITIES AND STOCKHOLDERS' EQUITY                
Current liabilities                
Accounts payable and accrued liabilities   $ 5,575,119     $ 5,765,478  
Operating lease liability, current portion     350,753       340,412  
Customer card funding     76,967,850       61,283,914  
Total current liabilities     82,893,722       67,389,804  
                 
Operating lease liability, long term portion     3,495,185       3,673,186  
                 
Total liabilities     86,388,907       71,062,990  
                 
Commitments and contingencies (Note 8)            
                 
Stockholders' equity                
Preferred stock: $0.001 par value; 25,000,000 shares authorized; none issued and outstanding            
Common stock; $0.001 par value; 150,000,000 shares authorized, 52,323,382 and 52,095,382 issued at June 30, 2022 and December 31, 2021, respectively     52,323       52,095  
Additional paid-in capital     17,917,680       16,860,119  
Treasury stock at cost, 303,450 shares     (150,000 )     (150,000 )
Accumulated deficit     (4,311,840 )     (3,774,411 )
Total stockholders' equity     13,508,163       12,987,803  
                 
Total liabilities and stockholders' equity   $ 99,897,070     $ 84,050,793  

 

 

See accompanying notes to unaudited condensed consolidated financial statements.

 

 

 3 

 

 

PAYSIGN, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(UNAUDITED)

 

                         
    Three Months Ended
June 30,
   

Six Months Ended

June 30,

 
    2022     2021     2022     2021  
Revenues                        
Plasma industry   $ 7,806,201     $ 5,947,313     $ 15,200,565     $ 11,330,464  
Pharma industry     773,311       641,037       1,579,879       1,523,867  
Other     19,264       62,940       38,971       76,387  
Total revenues     8,598,776       6,651,290       16,819,415       12,930,718  
                                 
Cost of revenues     3,900,965       3,498,723       7,123,355       6,946,345  
                                 
Gross profit     4,697,811       3,152,567       9,696,060       5,984,373  
                                 
Operating expenses                                
Selling, general and administrative     4,255,976       3,474,562       8,896,888       7,339,548  
Depreciation and amortization     713,180       614,182       1,392,351       1,210,030  
Total operating expenses     4,969,156       4,088,744       10,289,239       8,549,578  
                                 
Loss from operations     (271,345 )     (936,177 )     (593,179 )     (2,565,205
                                 
Other income                                
Interest income, net     70,227       5,010       84,563       12,111  
                                 
Loss before income tax provision     (201,118 )     (931,167 )     (508,616 )     (2,553,094
Income tax provision     26,916       800       28,813       2,400  
                                 
Net loss   $ (228,034 )   $ (931,967 )   $ (537,429 )   $ (2,555,494
                                 
Net loss per share                                
Basic   $ (0.00 )   $ (0.02   $ (0.01 )   $ (0.05
Diluted   $ (0.00 )   $ (0.02   $ (0.01 )   $ (0.05
                                 
Weighted average common shares                                
Basic     51,993,031       50,748,437       51,906,335       50,551,299  
Diluted     51,993,031       50,748,437       51,906,335       50,551,299  

 

 

See accompanying notes to unaudited condensed consolidated financial statements.

 

 

 4 

 

 

PAYSIGN, INC.

CONDENSED CONSOLIDATED STATEMENTS OF EQUITY

(UNAUDITED)

 

                         
   Common Stock   Additional
Paid-in
   Treasury
Stock
   Accumulated   Total Stockholders’ 
   Shares   Amount   Capital   Amount   Deficit   Equity 
Balance, December 31, 2021   52,095,382   $52,095   $16,860,119   $(150,000)  $(3,774,411)  $12,987,803 
                               
Stock issued upon vesting of restricted stock   123,000    123    (123)            
Stock-based compensation           569,502            569,502 
Net loss                   (309,395)   (309,395)
                               
Balance, March 31, 2022   52,218,382   $52,218   $17,429,498   $(150,000)  $(4,083,806)  $13,247,910 
                               
Stock issued upon vesting of restricted stock   105,000    105    (105)            
Stock-based compensation           488,287             
Net loss                  $(228,034)  $(228,034)
                               
Balance, June 30, 2022   52,323,382   $52,323   $17,917,680   $(150,000)  $(4,311,840)  $13,508,163 

 

 

                         
   Common Stock   Additional
Paid-in
   Treasury
Stock
   Accumulated   Total Stockholders’ 
   Shares   Amount   Capital   Amount   Deficit   Equity 
Balance, December 31, 2020   50,251,607   $50,252   $14,388,890   $(150,000)  $(1,053,077)  $13,236,065 
                               
Stock issued upon vesting of restricted stock   466,689    467    (467)            
Exercise of stock options   32,586    32    110,434            110,466 
Stock-based compensation           636,214            636,214 
Net loss                   (1,623,527)   (1,623,527)
                               
Balance, March 31, 2021   50,750,882    50,751    15,135,071    (150,000)   (2,676,604)   12,359,218 
                               
Stock issued upon vesting of restricted stock   390,000    390    (390)            
Exercise of stock options   2,500    2    9,673            9,675 
Stock-based compensation           540,921            540,921 
Net loss                   (931,967)   (931,967)
                               
Balance, June 30, 2021   51,143,382   $51,143   $15,685,275   $(150,000)  $(3,608,571)  $11,977,847 

 

 

See accompanying notes to unaudited condensed consolidated financial statements.

 

 

 5 

 

 

PAYSIGN, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(UNAUDITED)

 

         
   Six Months Ended
June 30,
 
   2022   2021 
Cash flows from operating activities:          
Net loss  $(537,429)  $(2,555,494)
Adjustments to reconcile net loss to net cash provided by operating activities:          
Stock-based compensation expense   1,057,789    1,210,030 
Depreciation and amortization   1,392,351    1,177,135 
Noncash lease expense   186,862    211,407 
Changes in operating assets and liabilities:          
Accounts receivable   (94,819)   (293,095)
Other receivable   (420,033)    
Prepaid expenses and other current assets   (511,173)   (366,502)
Accounts payable and accrued liabilities   (190,359)   701,581 
Operating lease liability   (167,660)   (157,920)
Customer card funding   15,683,936    17,654,611 
Net cash provided by operating activities   16,399,465    17,581,753 
           
Cash flows from investing activities:          
Purchase of fixed assets   (38,188)   (173,479)
Capitalization of internally developed software   (1,537,021)   (1,048,364)
Purchase of intangible assets       (39,713)
Net cash used in investing activities   (1,575,209)   (1,261,556)
           
Cash flows from financing activities:          
Proceeds from exercise of stock options       120,141 
Net cash provided by financing activities       120,141 
           
Net change in cash and restricted cash   14,824,256    16,440,338 
Cash and restricted cash, beginning of period   68,671,070    55,930,404 
           
Cash and restricted cash, end of period  $83,495,326   $72,370,742 
           
Cash and restricted cash reconciliation:          
Cash   6,527,476    6,615,180 
Restricted cash   76,967,850    65,755,562 
Total cash and restricted cash  $83,495,326   $72,370,742 
           
Supplemental cash flow information:          
Non-cash financing activities          
Cash paid for taxes  $8,700   $2,400 
Interest paid  $821   $2,173 

 

 

See accompanying notes to unaudited condensed consolidated financial statements.

 

 

 6 

 

 

PAYSIGN, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

 

1.     BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT POLICIES

 

The foregoing unaudited interim condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions for Form 10-Q and Regulation S-X as promulgated by the Securities and Exchange Commission (“SEC”). Accordingly, these financial statements do not include all of the disclosures required by GAAP for complete financial statements. These unaudited interim condensed consolidated financial statements should be read in conjunction with the audited financial statements and the notes thereto included on Form 10-K for the year ended December 31, 2021. In the opinion of management, the unaudited interim condensed consolidated financial statements furnished herein include all adjustments, all of which are of a normal recurring nature, necessary for a fair statement of the results for the interim period presented.

 

The preparation of financial statements in accordance with GAAP requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities known to exist as of the date the financial statements are published, and the reported amounts of revenues and expenses during the reporting period. Uncertainties with respect to such estimates and assumptions are inherent in the preparation of the Company’s financial statements; accordingly, it is possible that the actual results could differ from these estimates and assumptions that could have a material effect on the reported amounts of the Company’s financial position and results of operations.

 

Operating results for the six months ended June 30, 2022 are not necessarily indicative of the results that may be expected for the year ending December 31, 2022.

 

Impact of COVID-19 Pandemic

 

The coronavirus (“COVID-19”) pandemic, which started in late 2019 and reached the United States in early 2020, continues to significantly impact the economy of the United States and the rest of the world. While the direct disruption appears to have significantly mitigated due to the availability of vaccines and other factors, the ultimate duration and severity of the pandemic remain uncertain, particularly given the development of new variants that continue to spread, and the economic repercussions are still manifesting themselves. The COVID-19 outbreak caused plasma center closures, and the stimulus packages signed into law during 2020 and 2021 reduced the incentive for individuals to donate plasma for supplementary income. Additionally, labor shortages at plasma donation centers and restrictions preventing Mexican nationals with tourist visas from being compensated for donating plasma, have further impacted donations. Those developments have had, and are expected to continue to have, an adverse impact on the Company’s results of operations. Offsetting those headwinds, inflationary pressures for food, gasoline, and other products and services appear to be driving individuals back into the plasma donation centers based upon the increase we experienced in the number of loads per average donation center in the second quarter of 2022 versus the first quarter of 2022. While we remain cautiously optimistic and have seen improvements in our operating results on an aggregated basis, we cannot foresee how long it may take the Company to attain pre-pandemic operating levels on a per plasma donation center basis. Given the uncertainty around the extent and timing of the potential future spread or mitigation of COVID-19 and variants and around the imposition or relaxation of protective measures, management cannot at this time estimate with reasonable accuracy COVID-19’s further impact on the Company’s results of operations, cash flows or financial condition.

 

Under the provisions of the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”) signed into law in 2020 and the subsequent extension of the CARES Act through September 30, 2021, the Company was eligible for a refundable employee retention credit subject to certain criteria. The Company has elected an accounting policy to recognize the government assistance when it is probable that the Company is eligible to receive the assistance and present the credit be as a reduction of the related expense. During the quarter ended June 30, 2022 the Company filed for a refund and recorded $459,755 related to the employee retention credit. As of June 30, 2022 and December 31, 2021, the Company has $1,296,488 and $876,456, respectively in other receivables on the condensed consolidated balance sheet related to refunds.

 

 

 

 7 

 

 

About Paysign, Inc.

 

Paysign, Inc. (the “Company,” “Paysign,” “we” or “our”) was incorporated on August 24, 1995, and trades under the symbol PAYS on The Nasdaq Stock Market LLC. Paysign. is a provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services and integrated payment processing designed   for businesses, consumers and government institutions. Headquartered in Nevada, the company creates customized, innovative payment solutions for clients across all industries, including pharmaceutical, healthcare, hospitality and retail.

 

Principles of Consolidation – The condensed consolidated financial statements include the accounts of the Company and its subsidiaries. All significant intercompany balances and transactions have been eliminated.

 

Reclassifications – In our cash flows statement, certain accounts related to the lease accounting captions in the prior periods have been reclassified to conform to the current period financial statement presentations.  

 

Use of Estimates – The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect (i) the reported amounts of assets and liabilities, (ii) the disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and (iii) the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.

 

Cash and Cash Equivalents – The Company considers all highly liquid investments purchased with an original maturity of six months or less at the time of purchase to be cash equivalents for the purposes of the statement of cash flows. The Company had no cash equivalents at June 30, 2022 and December 31, 2021.

 

Restricted Cash – At June 30, 2022 and December 31, 2021, restricted cash consisted of funds held specifically for our card product programs that are contractually restricted to use. The Company includes changes in restricted cash balances with cash and cash equivalents when reconciling the beginning and ending total amounts in our condensed consolidated statements of cash flows.

 

Concentrations of Credit Risk – Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents and restricted cash. Paysign maintains its cash and cash equivalents and restricted cash in various bank accounts that, at times, may exceed federally insured limits. Paysign has not experienced, nor does it anticipate, any losses with respect to such accounts. At June 30, 2022 and December 31, 2021, the Company had approximately $37,047,586 and $31,828,826 in excess of federally insured bank account limits, respectively.

 

The Company also has a concentration of accounts receivable risk at June 30, 2022 as two Pharma program customers associated with our Pharma copay programs each individually represent 51% and 11% of our accounts receivable balance. Two Pharma program customers each individually represented 52% and 17% of our accounts receivable balance at December 31, 2021.

 

Fixed Assets – Fixed assets are stated at cost less accumulated depreciation. Depreciation is principally recorded on the straight-line method over the estimated useful life of the asset, which is generally 3 to 10 years. The cost of repairs and maintenance is charged to expense as incurred. Leasehold improvements are capitalized and depreciated over the shorter of the remaining lease term or the estimated useful life of the improvements. Expenditures for property betterments and renewals are capitalized. Upon sale or other disposition of a depreciable asset, cost and accumulated depreciation are removed from the accounts and any gain or loss is reflected in other income (expense).

 

The Company periodically evaluates whether events and circumstances have occurred that may warrant revision of the estimated useful life of fixed assets or whether the remaining balance of fixed assets should be evaluated for possible impairment. The Company uses an estimate of the related undiscounted cash flows over the remaining life of the fixed assets in measuring their recoverability.

 

 

 

 8 

 

 

Intangible Assets – For intangible assets, the Company recognizes an impairment loss if the carrying amount of the intangible asset is not recoverable and exceeds fair value. The carrying amount of the intangible asset is considered not recoverable if it exceeds the sum of the undiscounted cash flows expected to result from the use of the asset.

 

Intangible assets with a finite life are amortized on a straight-line basis over its estimated useful life, which is generally 3 to 15 years.

 

Internally Developed Software Costs - Computer software development costs are expensed as incurred, except for internal use software or website development costs that qualify for capitalization as described below, and include compensation and related expenses, costs of hardware and software, and costs incurred in developing features and functionality.

 

For computer software developed or obtained for internal use, costs that are incurred in the preliminary project and post implementation stages of software development are expensed as incurred. Costs incurred during the application and development stage are capitalized. Capitalized costs are amortized using the straight-line method over a 3three year estimated useful life, beginning in the period in which the software is available for use.

 

Customer Card Funding – At June 30, 2022 and December 31, 2021, customer card funding represents funds loaded or available to be loaded on cards for our prepaid card programs.

 

Earnings Per Share – Basic earnings per share exclude any dilutive effects of options, warrants and convertible securities. Basic earnings per share is computed using the weighted-average number of common shares outstanding during the applicable period. Diluted earnings per share is computed using the weighted average number of common and common stock equivalent shares outstanding during the period, using the treasury stock method. Common stock equivalent shares are excluded from the computation if their effect on the diluted earnings per share calculation is anti-dilutive.

 

Revenue and Expense Recognition – In determining when and how revenue is recognized from contracts with customers, the Company performs the following five-step analysis: (i) identification of contracts with customers; (ii) determination of performance obligations; (iii) measurement of the transaction price; (iv) allocation of the transaction price to the performance obligations; and (v) recognition of revenue when (or as) the Company satisfies each performance obligation.

 

The Company generates revenues from Plasma card programs through fees generated from cardholder fees and interchange fees. Revenues from Pharma card programs are generated through card program management fees, transaction claims processing fees, interchange fees, and settlement income.

 

Plasma and Pharma card program revenues include both fixed and variable components. Cardholder fees represent an obligation to the cardholder based on a per transaction basis and are recognized at a point in time when the performance obligation is fulfilled. Card program management fees and transaction claims processing fees include an obligation to our card program sponsors and are generally recognized when earned on a monthly basis and are typically due within 30 days pursuant to the contract terms which are generally multi-year contracts. The Company uses the output method to recognize card program management fee revenue at the amount of consideration to which an entity has a right to invoice. The performance obligation is satisfied when the services are transferred to the customer which the Company determined to be monthly, as the customer simultaneously receives and consumes the benefit from the Company’s performance. Interchange fees are earned when customer-issued cards are processed through card payment networks as the nature of our promise to the customer is that we stand ready to process transactions at the customer’s requests on a daily basis over the contract term. Since the timing and quantity of transactions to be processed by us are not determinable, we view interchange fees to comprise an obligation to stand ready to process as many transactions as the customer requests. Accordingly, the promise to stand ready is accounted for as a single series performance obligation. The Company uses the right to invoice practical expedient and recognizes interchange fee revenue concurrent with the processing of card transactions. Interchange fees are settled in accordance with the card payment network terms and conditions, which is typically within a few days.

 

 

 

 9 

 

 

The Company utilizes the remote method of revenue recognition for settlement income whereby the unspent balances will be recognized as revenue at the expiration of the cards and the respective program. The Company records all revenue on a gross basis since it is the primary obligor and establishes the price in the contract arrangement with its customers. The Company is currently under no obligation for refunding any fees, and the Company does not currently have any obligations for disputed claim settlements. Given the nature of the Company’s services and contracts, it has no contract assets.

 

Cost of revenues is comprised of transaction processing fees, data connectivity and data center expenses, network fees, bank fees, card production and postage costs, customer service, program management, application integration setup, and sales and commission expense. 

 

Operating leases – The Company determines if a contract is or contains a leasing element at contract inception or the date in which a modification of an existing contract occurs. In order for a contract to be considered a lease, the contract must transfer the right to control the use of an identified asset for a period of time in exchange for consideration. Control is determined to have occurred if the lessee has the right to (i) obtain substantially all of the economic benefits from the use of the identified asset throughout the period of use and (ii) direct the use of the identified asset.

  

In determining the present value of lease payments at lease commencement date, the Company utilizes its incremental borrowing rate based on the information available, unless the rate implicit in the lease is readily determinable. The liability for operating leases is based on the present value of future lease payments. Operating lease expenses are recorded as rent expense, which is included within selling, general and administrative expenses within the consolidated statements of operations and presented as operating cash outflows within the consolidated statements of cash flows.

 

Leases with an initial term of 12 months or less are not recorded on the balance sheet, with lease expense for these leases recognized on a straight-line basis over the lease term.

 

Stock-Based Compensation – The Company recognizes compensation expense for all restricted stock awards and stock options. The fair value of restricted stock awards is measured using the grant date trading price of our stock. The fair value of stock options is estimated at the grant date using the Black-Scholes option-pricing model, and the portion that is ultimately expected to vest is recognized as compensation cost over the requisite service period. We have elected to recognize compensation expense for all options with graded vesting on a straight-line basis over the vesting period of the entire option. The determination of fair value using the Black-Scholes pricing model is affected by our stock price as well as assumptions regarding a number of complex and subjective variables, including expected stock price volatility and the risk-free interest rate.

 

Recently Issued Accounting Pronouncements – In June 2016, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2016-13, Financial Instruments–Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which provides updated guidance on how an entity should measure credit losses on all financial instruments carried at amortized cost (including loans held for investment and held-to-maturity debt securities, as well as trade receivables, reinsurance recoverables, and receivables that relate to repurchase agreements and securities lending agreements), a lessor’s net investments in leases, and off-balance sheet credit exposures not accounted for as insurance or as derivatives, including loan commitments, standby letters of credit, and financial guarantees. Subsequently, in November 2018 the FASB issued ASU No. 2018-19, Codification Improvements to Topic 326, Financial Instruments–Credit Losses, which clarified that receivables arising from operating leases are not within the scope of Subtopic 326-20, but instead should be accounted for in accordance with Topic 842, Leases. In March 2022 the FASB issued ASU No. 2022-02, Financial Instruments—Credit Losses: Troubled Debt Restructurings and Vintage Disclosures which clarified accounting treatment required for trouble debt restructurings by creditors and enhanced disclosures for write-offs. The new standard and related amendments are effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. We are currently evaluating the impact of adopting this guidance on our Financial Statements; however, we do not expect it to have a material impact on the Company’s consolidated financial statements.

 

In October 2021, the FASB issued ASU No. 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. This ASU requires contract assets and contract liabilities acquired in a business combination to be recognized and measured by the acquirer on the acquisition date in accordance with ASU No. 2016-10, Revenue from Contracts with Customers (Topic 606). This guidance is effective for the Company beginning on January 1, 2023 and is not expected to have a material impact on the Company’s consolidated financial statements.

 

 

 

 10 

 

 

2.     FIXED ASSETS, NET

 

Fixed assets consist of the following:

        
   June 30,
2022
   December 31,
2021
 
Equipment  $2,098,522   $2,067,834 
Software   323,355    315,855 
Furniture and fixtures   757,662    757,662 
Website costs   69,881    69,881 
Leasehold improvements   229,772    229,772 
    3,479,192    3,441,004 
Less: accumulated depreciation   2,068,245    1,798,023 
Fixed assets, net  $1,410,947   $1,642,981 

 

Depreciation expense for the three months ended June 30, 2022 and 2021 was $134,253 and $133,174, respectively. Depreciation expense for the six months ended June 30, 2022 and 2021 was $270,222 and $265,125, respectively.

 

3.     INTANGIBLE ASSETS, NET

  

Intangible assets consist of the following:

        
   June 30,
2022
   December 31,
2021
 
Patents and trademarks  $38,186   $38,186 
Platform   11,391,538    9,853,823 
Customer lists and contracts   1,177,200    1,177,200 
Licenses   209,282    209,282 
    12,816,206    11,278,491 
Less: accumulated amortization   8,314,352    7,191,529 
Intangible assets, net  $4,501,854   $4,086,962 

 

Intangible assets are amortized over their useful lives ranging from periods of 3 to 15 years. Amortization expense for the three months ended June 30, 2022 and 2021 was $578,927 and $481,008, respectively. Amortization expense for the six months ended June 30, 2022 and 2021 was $1,122,129 and $944,905, respectively.

 

4.     LEASE

 

The Company entered into an operating lease for office space which became effective in June 2020. The lease term is 10 years from the effective date and allows for two optional extensions of five years each. The two optional extensions are not recognized as part of the right-of-use asset or lease liability since it is not reasonably certain that the Company will extend this lease. As of June 30, 2022, the remaining lease term was 7.9 years and the discount rate was 6%.

 

Operating lease cost included in selling, general and administrative expenses was $184,329 and $367,550 for the three and six months ended June 30, 2022, respectively. Operating lease cost included in selling, general and administrative expenses was $209,056 and $424,200 for the three and six months ended June 30, 2021, respectively.

 

 

 

 11 

 

 

The following is the lease maturity analysis of our operating lease as of June 30, 2022:

 

Year ending December 31,

    
2022 (excluding the six months ended June 30, 2022)  $285,984 
2023   571,968 
2024   571,968 
2025   612,006 
2026   640,604 
Thereafter   2,188,731 
Total lease payments   4,871,261 
Less: Imputed interest   (1,025,323)
Present value of future lease payments   3,845,938 
Less: current portion of lease liability   (350,753)
Long-term portion of lease liability  $3,495,185 

 

5.     CUSTOMER CARD FUNDING LIABILITY

 

The Company issues prepaid cards with various provisions for cardholder fees or expiration. Revenue generated from cardholder transactions and interchange fees are recognized when the Company’s performance obligation is fulfilled. Unspent balances left on Pharma   cards are recognized as settlement income at the expiration of the cards and the program. Contract liabilities related to prepaid cards represent funds on card and client funds held to be loaded to card before the amounts are ultimately spent by the cardholders or recognized as revenue by the Company. Contract liabilities related to prepaid cards are reported as Customer card funding liability on the condensed consolidated balance sheet.

 

The opening and closing balances of the Company's contract liabilities are as follows:

        
  

Six Months Ended

June 30,

 
   2022   2021 
Beginning balance  $61,283,914   $48,100,951 
Increase, net   15,683,936    17,654,611 
Ending balance  $76,967,850   $65,755,562 

 

The amount of revenue recognized during the six months ended June 30, 2022 and 2021 that was included in the opening contract liability for prepaid cards was $1,485,005 and $1,023,055, respectively.

  

6.     COMMON STOCK

 

At June 30, 2022, the Company's authorized capital stock was 150,000,000 shares of common stock, par value $0.001 per share, and 25,000,000 shares of preferred stock, par value $0.001 per share. On that date, the Company had 52,323,382 shares of common stock issued and 52,019,932 shares of common stock outstanding, and no shares of preferred stock outstanding.

 

Stock-based compensation expense related to Company grants for the three and six months ended June 30, 2022 was $488,287 and $1,057,789, respectively. Stock-based compensation expense for the three and six months ended June 30, 2021 was $540,921 and $1,777,135, respectively.

 

 

 

 12 

 

 

2022 Transactions: During the three and six months ended June 30, 2022 the Company issued 105,000 and 228,000 shares, respectively, of common stock for vested stock awards and the exercise of stock options and received proceeds of $0 and $0, respectively.

 

2021 Transactions: During the three and six months ended June 30, 2021 the Company issued 392,500 and 891,775 shares, respectively, of common stock for vested stock awards and the exercise of stock options and received proceeds of $9,675 and $120,141, respectively.

 

7.        BASIC AND FULLY DILUTED NET LOSS PER COMMON SHARE

 

The following table sets forth the computation of basic and fully diluted net loss per common share for the three and six months ended June 30, 2022 and 2021: 

                
   Three Months Ended June 30,   Six Months Ended June 30, 
   2022   2021   2022   2021 
Numerator:                
Net loss  $(228,034)  $(931,967)  $(537,429)  $(2,555,494)
Denominator:                    
Weighted average common shares:                    
Denominator for basic calculation   51,993,031    50,748,437    51,906,335    50,551,299 
Weighted average effects of potentially diluted common stock:                    
Stock options (calculated using the treasury method)                
Unvested restricted stock grants                
Denominator for fully diluted calculation   51,993,031    50,748,437    51,906,335    50,551,299 
Net loss per common share:                    
Basic  $(0.00)  $(0.02)  $(0.01)  $(0.05)
Fully diluted  $(0.00)  $(0.02)  $(0.01)  $(0.05)

 

Due to the net loss for the three and six months ended June 30, 2022, the effect of all potential common share equivalents was anti-dilutive, and therefore, all such shares were excluded from the computation of diluted weighted average shares outstanding for both periods. For the three and six months ended June 30, 2022, the amount of potential common share equivalents excluded were 1,884,400 for stock options and 1,064,000 for unvested restricted stock awards. Due to the net loss for the three and six months ended June 30, 2021, the effect of all potential common share equivalents was anti-dilutive, and therefore, all such shares were excluded from the computation of diluted weighted average shares outstanding for both periods. For the three and six months ended June 30, 2021, the amount of potential common share equivalents excluded were 1,997,350 for stock options and 1,868,000 for unvested restricted stock awards.

 

8.        COMMITMENTS AND CONTINGENCIES

 

From time to time, we may become involved in various lawsuits and legal proceedings which arise in the ordinary course of business. However, litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our business.

 

 

 

 13 

 

 

The Company has been named as a defendant in three complaints filed in the United States District Court for the District of Nevada: Yilan Shi v. Paysign, Inc. et. al., filed on March 19, 2020 (“Shi”), Lorna Chase v. Paysign, Inc. et. al., filed on March 25, 2020 (“Chase”), and Smith & Duvall v. Paysign, Inc. et. al., filed on April 2, 2020 (collectively, the “Complaints” or “Securities Class Action”). Smith & Duvall v. Paysign, Inc. et. al. was voluntarily dismissed on May 21, 2020. On May 18, 2020, the Shi plaintiffs and another entity called the Paysign Investor Group each filed a motion to consolidate the remaining Shi and Chase actions and to be appointed lead plaintiff. The Complaints are putative class actions filed on behalf of a class of persons who acquired the Company’s common stock from March 19, 2019 through March 31, 2020, inclusive. The Complaints generally allege that the Company, Mark Newcomer, and Mark Attinger violated Section 10(b) of the Securities Exchange Act of 1934 (the “Exchange Act”), and that Messrs. Newcomer and Attinger violated Section 20(a) of the Exchange Act, by making materially false or misleading statements, or failing to disclose material facts, regarding the Company’s internal control over financial reporting and its financial statements. The Complaints seek class action certification, compensatory damages, and attorney’s fees and costs. On December 2, 2020, the Court consolidated Shi and Chase as In re Paysign, Inc. Securities Litigation and appointed the Paysign Investor Group as lead plaintiff. On January 12, 2021, Plaintiffs filed an Amended Complaint in the consolidated action. Defendants filed a Motion to Dismiss the Amended Complaint on March 15, 2021, which Plaintiffs opposed via an opposition brief filed on April 29, 2021, to which Defendants replied on June 1, 2021. Thus, the motion is now fully briefed. The Court has not set a hearing date on the motion, or informed the parties whether it intends to entertain oral argument or rule upon the papers filed. As of the date of this filing, Paysign cannot give any meaningful estimate of likely outcome or damages.

 

The Company has also been named as a nominal defendant in two stockholder derivative actions in the United States District Court for the District of Nevada. The first derivative action is entitled Andrzej Toczek, derivatively on behalf of Paysign, Inc. v. Mark R. Newcomer, et al. and was filed on September 17, 2020. This action alleges violations of Section 14(a) of the Exchange Act, breach of fiduciary duty, unjust enrichment, and waste, largely in connection with the failure to correct information technology controls over financial reporting alleged in the Securities Class Action, thereby causing the Company to face exposure in the Securities Class Action. The complaint also alleges insider trading violations against certain individual defendants. On December 16, 2020, the Court approved a stipulation staying the action until the Court in the consolidated Securities Class Action issues a ruling on the Motion to Dismiss. The second derivative action is entitled John K. Gray, derivatively on behalf of Paysign, Inc. v. Mark Attinger, et al. and was filed on May 9, 2022. This action involves the same alleged conduct raised in the Toczek action and asserts claims for breach of fiduciary duty in connection with financial reporting, breach of fiduciary duty in connection with alleged insider trading against certain individual defendants, and unjust enrichment. On June 3, 2022, the Court approved a stipulation staying the action until the Court in the consolidated Securities Class Action issues a ruling on the Motion to Dismiss. As of the date of this filing, Paysign cannot give any meaningful estimate of likely outcome or damages.

 

9.        RELATED PARTY

 

A member of our Board of Directors is also a partner in a law firm that the Company engages for services to review regulatory filings and for various other legal matters. The Company incurred legal expense of $41,019 and $81,753 during the three and six months ended June 30, 2022, respectively, with the related party law firm. During the three and six months ended June 30, 2021 the Company incurred legal expense of $390,172 and $410,884, respectively, with the related party law firm.

 

10.        INCOME TAX PROVISION

 

The effective tax rate (income tax provision as a percentage of loss before income tax provision) was (13.4%) for the three months ended June 30, 2022, as compared to (0.1%) for the three months ended June 30, 2021. The effective tax rate was (5.7%) and (0.1%) for the six months ended June 30, 2022 and 2021, respectively. The effective tax rates vary, primarily as a result of the full valuation on our deferred tax asset in the current year and the tax benefit related to our stock-based compensation and a pretax loss in the prior year period.

 

 

 

 14 

 

 

Item 2. Management’s discussion and analysis of financial condition and results of operations.

 

Disclosure Regarding Forward-Looking Statements

 

This Quarterly Report on Form 10-Q includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (“Forward-Looking Statements”). All statements other than statements of historical fact included in this report are Forward-Looking Statements. These Forward-Looking Statements are based on our current expectations, assumptions, estimates and projections about our business and our industry. Words such as "believe," "anticipate," "expect," "intend," "plan," “propose,” "may," and other similar expressions identify Forward-Looking statements. In the normal course of our business, we, in an effort to help keep our shareholders and the public informed about our operations, may from time-to-time issue certain statements, either in writing or orally, that contain, or may contain, Forward-Looking Statements. Although we believe that the expectations reflected in such Forward-Looking Statements are reasonable, we can give no assurance that such expectations will prove to have been correct. In addition, any statements that refer to expectations, projections, estimates, forecasts, or other characterizations of future events or circumstances are Forward-Looking Statements. These Forward-Looking Statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those reflected in the Forward-Looking Statements. Such important factors (“Important Factors”) and other factors are disclosed in this report, including those factors discussed in “Part II - Item 1A. Risk Factors.” All prior and subsequent written and oral Forward-Looking Statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by the Important Factors described below that could cause actual results to differ materially from our expectations as set forth in any Forward-Looking Statement made by or on behalf of us. You are cautioned not to place undue reliance on these Forward-Looking Statements, which relate only to events as of the date on which the statements are made. We undertake no obligation to publicly revise these Forward-Looking Statements to reflect events or circumstances that arise after the date hereof. You should refer to and carefully review the information in future documents we file with the Securities and Exchange Commission.

 

Overview

 

Paysign, Inc. (the “Company,” “Paysign,” “we” or “our”), headquartered in Nevada, was incorporated on August 24, 1995, and trades under the symbol PAYS on The Nasdaq Stock Market LLC. Paysign is a vertically integrated provider of prepaid card products and processing services for corporate, consumer and government applications. Our payment solutions are utilized by our corporate customers as a means to increase customer loyalty, increase patient adherence rates, reduce administration costs and streamline operations. Public sector organizations can utilize our payment solutions to disburse public benefits or for internal payments. We market our prepaid card solutions under our Paysign® brand. As we are a payment processor and prepaid card program manager, we derive our revenue from all stages of the prepaid card lifecycle.

 

We provide a card processing platform consisting of proprietary systems and software applications based on the unique needs of our clients. We have extended our processing business capabilities through our proprietary Paysign platform. Through the Paysign platform, we provide a variety of services including transaction processing, cardholder enrollment, value loading, cardholder account management, reporting, and customer service. The Paysign platform was built on modern cross-platform architecture and designed to be highly flexible, scalable and customizable. The platform’s flexibility and ease of customization has allowed us to expand our operational capabilities by facilitating our entry into new markets within the payments space. The Paysign platform delivers cost benefits and revenue building opportunities to our partners.

 

We have developed prepaid card programs for corporate incentive and rewards including, but not limited to, consumer rebates and rewards, donor compensation, clinical trials, healthcare reimbursement payments and pharmaceutical payment assistance. We have expanded our product offerings to include additional corporate incentive products and demand deposit accounts accessible with a debit card. In the future, we expect to further expand our product offerings into other prepaid card offerings such as payroll cards, travel cards, and expense reimbursement cards. Our cards are sponsored by our issuing bank partners.

 

Our revenues include fees generated from cardholder fees, interchange, card program management fees, transaction claims processing fees, and settlement income. Revenue from cardholder fees, interchange, card program management fees, and transaction claims processing fees is recorded when the performance obligation is fulfilled. Settlement income is recorded at the expiration of the card program.

 

 

 

 15 

 

 

We have two categories for our prepaid debit cards: (1) corporate and consumer reloadable cards, and (2) non-reloadable cards.

 

Reloadable Cards: These types of cards are generally classified as payroll or considered general purpose reloadable (“GPR”) cards. Payroll cards are issued by an employer to an employee in order to allow the employee to access payroll amounts that are deposited into an account linked to their card. GPR cards can also be issued to a consumer at a retail location or mailed to a consumer after completing an on-line application. GPR cards can be reloaded multiple times with a consumer’s payroll, government benefit, a federal or state tax refund or through cash reload networks located at retail locations. Reloadable cards are generally open-loop cards as described below.

  

Non-Reloadable Cards: These are generally one-time use cards that are only active until the funds initially loaded to the card are spent. These types of cards are generally used as gift or incentive cards. Normally these types of cards are used for purchase of goods or services at retail locations and cannot be used to receive cash.

 

Both reloadable and non-reloadable cards may be open-loop, closed-loop, or restricted-loop. Open-loop cards can be used to receive cash at ATM locations by PIN; or purchase goods or services by PIN or signature at retail locations virtually anywhere that the network brand (American Express, Discover, MasterCard, Visa, etc.) is accepted. Closed-loop cards can only be used at a specific merchant. Restricted-loop cards can be used at several merchants, or a defined group of merchants, such as all merchants at a specific shopping mall.

 

The prepaid card market in the U.S. has experienced significant growth in recent years due to consumers and merchants embracing improved technology, greater convenience, more product choices and greater flexibility. Prepaid cards have also proven to be an attractive alternative to traditional bank accounts for certain segments of the population, particularly those without, or who could not qualify for, a checking or savings account.

 

We manage all aspects of the prepaid card lifecycle, from managing the card design and approval processes with partners and networks, to production, packaging, distribution, and personalization. We also oversee inventory and security controls, renewals, lost and stolen card management, and replacement. We deploy a fully staffed, in-house customer service department which utilizes bilingual customer service representatives, Interactive Voice Response, and two-way short message service messaging and text alerts.

 

Currently, we are focusing our marketing efforts on corporate incentive and expense prepaid card products in various market verticals including but not limited to general corporate expense, healthcare related markets including co-pay assistance, clinical trials and donor compensation, loyalty rewards, and incentive cards.

 

As part of our continuing platform expansion process, we evaluate current and emerging technologies for applicability to our existing and future software platform. To this end, we engage with various hardware and software vendors in evaluation of various infrastructure components. Where appropriate, we use third-party technology components in the development of our software applications and service offerings. Third-party software may be used for highly specialized business functions, which we may not be able to develop internally within time and budget constraints. Our principal target markets for processing services include prepaid card issuers, retail and private-label issuers, small third-party processors, and small and mid-size financial institutions in the United States and Mexico.

  

We have devoted more extensive resources to sales and marketing activities as we have added essential personnel to our marketing and sales team. We market our Paysign payment solutions through direct marketing by the Company’s sales team. Our primary market focus is on companies and municipalities that require a streamlined payment solution for rewards, rebates, payment assistance, and other payments to their customers, employees, agents and others. To reach these markets, we focus our sales efforts on direct contact with our target market and attendance at various industry specific conferences. We may, at times, utilize independent contractors who make direct sales and are paid on a commission basis only. We market our Paysign Premier product through existing communication channels to a targeted segment of our existing cardholders, as well as to a broad group of individuals, ranging from non-banked to fully banked consumers with a focus on long term users of our product.

 

 

 

 16 

 

 

In 2022, we plan to continue to invest additional funds in technology improvements, sales and marketing, fraud and disputes, customer service, and regulatory compliance. From time to time, we evaluate raising capital to enable us to diversify into new market verticals. If we do not raise new capital, we believe that we will still be able to expand into new markets using internally generated funds.

 

The coronavirus (“COVID-19”) pandemic, which started in late 2019 and reached the United States in early 2020, continues to significantly impact the economy of the United States and the rest of the world. While the direct disruption appears to have significantly mitigated due to the availability of vaccines and other factors, the ultimate duration and severity of the pandemic remain uncertain, particularly given the development of new variants that continue to spread, and the economic repercussions are still manifesting themselves. The COVID-19 outbreak caused plasma center closures, and the stimulus packages signed into law during 2020 and 2021 reduced the incentive for individuals to donate plasma for supplementary income. Additionally, labor shortages at plasma donation centers and restrictions preventing Mexican nationals with tourist visas from being compensated for donating plasma, have further impacted donations. Those developments have had, and are expected to continue to have, an adverse impact on the Company’s results of operations. Offsetting those headwinds, inflationary pressures for food, gasoline, and other products and services appear to be driving individuals back into the plasma donation centers based upon the increase we experienced in the number of loads per average donation center in the second quarter of 2022 versus the first quarter of 2022. While we remain cautiously optimistic and have seen improvements in our operating results on an aggregated basis, we cannot foresee how long it may take the Company to attain pre-pandemic operating levels on a per plasma donation center basis. Given the uncertainty around the extent and timing of the potential future spread or mitigation of COVID-19 and variants and around the imposition or relaxation of protective measures, management cannot at this time estimate with reasonable accuracy COVID-19’s further impact on the Company’s results of operations, cash flows or financial condition.

 

Results of Operations

 

Three Months Ended June 30, 2022 and 2021

 

The following table summarizes our consolidated financial results:

 

  

Three Months Ended

June 30,

(unaudited)

   Variance 
   2022   2021   $   % 
Revenues                
Plasma industry  $7,806,201   $5,947,313   $1,858,888    31.3% 
Pharma industry   773,311    641,037    132,274    20.6% 
Other   19,264    62,940    (43,676)   (69.4%)
Total revenues   8,598,776    6,651,290    1,947,486    29.3% 
Cost of revenues   3,900,965    3,498,723    402,242    11.5% 
Gross profit   4,697,811    3,152,567    1,545,244    49.0% 
Gross margin %   54.6%    47.4%           
                     
Operating expenses                    
Selling, general and administrative   4,255,976    3,474,562    781,414    22.5% 
Depreciation and amortization   713,180    614,182    98,998    16,1% 
Total operating expenses   4,969,156    4,088,744    880,412    21.5% 
Loss from operations  $(271,345)  $(936,177)  $664,832    (71.0%)
                     
Net loss  $(228,034)  $(931,967)  $703,933    (75.5%)
Net margin %   (2.7%)   (14.0%)          

 

 

 

 17 

 

 

The increase in total revenues of $1,947,486 for the three months ended June 30, 2022 compared to the same period in the prior year consisted primarily of a $1,858,888 increase in Plasma revenue and a $132,274 increase in Pharma revenue, offset by a $43,676 decrease in Other revenue. The increase in Plasma revenue was primarily due to an increase in the number of plasma centers and donations, and, consequently, dollars loaded to cards, cardholder fees, and interchange, as COVID-19 restrictions such as donation center closures, mobility restrictions and Federal government stimulus measures were relaxed compared to the prior year period. The increase in Pharma revenue was primarily due to the launch of new Pharma copay programs offset by the end of a number of Pharma prepaid programs. The decrease in Other revenue was primarily due to the recognition of settlement income from a rewards program that terminated in the second quarter of 2021.

 

Cost of revenues for the three months ended June 30, 2022 increased $402,242 compared to the same period in the prior year. Cost of revenues is comprised of transaction processing fees, data connectivity and data center expenses, network fees, bank fees, card production and postage costs, customer service, program management, application integration setup, and sales and commission expense. Cost of revenues increased during the second quarter of 2022 primarily due to the increase in cardholder usage activity, the increase in plastics, collateral and postage related to upfront costs associated with new openings and competitive conversion of 62 plasma donation centers, the increase in network expenses related to our Pharma copay business, and the increase in customer service expenses, offset by a decline in sales commissions related to the restructuring of an agreement in the first quarter of 2022.

 

Gross profit for the three months ended June 30, 2022 increased $1,545,244 compared to the same period in the prior year resulting from the increase in Plasma revenue, the restructuring of an agreement mentioned above, and the beneficial impact of a variable cost structure as many of the Plasma transaction costs are variable in nature which are provided by third parties who charge us based on the number of transactions that occurred during the period. The increase in gross profit was offset by the upfront costs associated with the 62 new plasma donation centers that were added during the quarter and the increase in customer service expenses relating to the overall growth of our business. The increase in gross margin resulted from the aforementioned factors.

 

Selling, general and administrative expenses (“SG&A”) for the three months ended June 30, 2022 increased $781,414 or 22.5% compared to the same period in the prior year and consisted primarily of an increase in compensation and benefits of $890,000, a decrease in stock-based compensation of $52,600, a decrease in outside professional services for legal, tax, accounting and consultants of $151,400, a decrease in insurance of $15,000, an increase in technologies and telecom of $237,000, a decrease in rent, utilities, and maintenance of $14,100, an increase in travel and entertainment of $57,200, and an increase in other operating expenses of $210,000. The remainder of the difference is primarily related to an increase in capitalized software development costs.

 

Depreciation and amortization expense for the three months ended June 30, 2022 increased $98,998 compared to the same period in the prior year. The increase in depreciation and amortization expense was primarily due to continued capitalization of new software and equipment, and continued enhancements to our platform.

 

For the three months ended June 30, 2022 we recorded a loss from operations of $271,345 representing a net increase of $664,832 compared to the same period last year related to the aforementioned factors.

 

Other income for the three months ended June 30, 2022 increased $65,217 related to an increase in interest rates and the associated interest income received on higher bank account balances at our sponsor bank and lower interest expense related to the financing of insurance premiums.

 

We recorded an income tax expense of $26,916 for the three months ended June 30, 2022, which equates to an effective tax rate of (13.4%) primarily as a result of the full valuation on our deferred tax asset in both the current and prior period and the tax benefit related to our stock-based compensation and a pretax loss in the prior period. We recorded an income tax expense of $800 for the three months ended June 30, 2021 due to estimated state tax payments.

 

The net loss for the three months ended June 30, 2022 was $228,034, an improvement of $703,933 compared to the net loss of $931,967 for the three months ended June 30, 2021. The overall change in net loss relates to the aforementioned factors.

 

 

 

 18 

 

 

Six Months Ended June 30, 2022 and 2021

 

The following table summarizes our consolidated financial results:

 

  

Six Months Ended

June 30,

(unaudited)

   Variance 
   2022   2021   $   % 
Revenues                
Plasma industry  $15,200,565   $11,330,464   $3,870,101    34.2% 
Pharma industry   1,579,879    1,523,867    56,012    3.7% 
Other   38,971    76,387    (37,416)   (49.0%)
Total revenues   16,819,415    12,930,718    3,888,697    30.1% 
Cost of revenues   7,123,355    6,946,345    177,010    2.5% 
Gross profit   9,696,060    5,984,373    3,711,687    62.0% 
Gross margin %   57.6%    46.3%           
                     
Operating expenses                    
Selling, general and administrative   8,896,888    7,339,548    1,557,340    21.2% 
Depreciation and amortization   1,392,351    1,210,030    182,321    15.1% 
Total operating expenses   10,289,239    8,549,578    1,739,661    20.3% 
Loss from operations  $(593,179)  $(2,565,205)  $1,972,026    (76.9%)
                     
Net loss  $(537,429)  $(2,555,494)  $2,018,065    (79.0%)
Net margin %   (3.2%)   (19.8%)          

 

The increase in total revenues of $3,888,697 for the six months ended June 30, 2022 compared to the same period in the prior year consisted primarily of a $3,870,101 increase in Plasma revenue and a $56,012 increase in Pharma revenue, offset by a $37,416 decrease in Other revenue. The increase in Plasma revenue was primarily due to an increase in the number of plasma centers and donations, and, consequently, dollars loaded to cards, cardholder fees, and interchange, as COVID-19 restrictions such as donation center closures, mobility restrictions and Federal government stimulus measures were relaxed compared to the prior year period. The increase in Pharma revenue was primarily due to the launch of new Pharma copay programs offset by the end of a number of Pharma prepaid programs. The decrease in Other revenue was primarily driven by the recognition of settlement income from a rewards program that ended during the second quarter of 2021.

 

Cost of revenues for the six months ended June 30, 2022 increased $177,010 compared to the same period in the prior year. Cost of revenues is comprised of transaction processing fees, data connectivity and data center expenses, network fees, bank fees, card production and postage costs, customer service, program management, application integration setup, and sales and commission expense. Cost of revenues increased during the six months of 2022 primarily due to the increase in cardholder usage activity, the increase in plastics, collateral and postage related to upfront costs associated with the de novo opening or competitive conversion of 71 plasma donation centers that we service, the increase in network expenses related to our Pharma copay business, and the increase in customer service expenses, offset by a decline in sales commissions related to the restructuring of an agreement in the first quarter of 2022.

 

Gross profit for the six months ended June 30, 2022 increased $3,711,687 compared to the same period in the prior year resulting from the increase in Plasma revenue, the restructuring of an agreement mentioned above, and the beneficial impact of a variable cost structure as many of the Plasma transaction costs are provided by third parties who charge us based on the number of transactions that occurred during the period, with a lower per-transaction cost at larger numbers of transactions. The increase in Gross profit was offset by the upfront costs associated with the 71 new plasma donation centers that were added during the six month period and the increase in customer service expenses relating to the overall growth of our business. The increase in gross margin resulted from the aforementioned factors.

 

 

 

 19 

 

 

SG&A for the six months ended June 30, 2022 increased $1,557,340 or 21.2% compared to the same period in the prior year and consisted primarily of an increase in compensation and benefits of $1,294,200, a decrease in stock-based compensation of $119,300, a decrease in outside professional services for legal, tax, accounting and consultants of $245,800, an increase in legal settlements of $354,000, an increase in insurance of $95,800, an increase in technologies and telecom of $415,100, a decrease in rent, utilities, and maintenance of $43,900, an increase in travel and entertainment of $131,800, and an increase in other operating expenses of $375,100. The remainder of the difference is primarily related to an increase in capitalized software development costs.

 

Depreciation and amortization expense for the six months ended June 30, 2022 increased $182,300 compared to the same period in the prior year. The increase in depreciation and amortization expense was primarily due to continued capitalization of new software and equipment and continued enhancements to our platform.

 

For the six months ended June 30, 2022 we recorded a loss from operations of $593,179 representing a net increase of $1,972,026 compared to the same period last year related to the aforementioned factors.

 

Other income for the six months ended June 30, 2022 increased $72,452 related to an increase in interest rates and the associated interest income received on higher bank account balances at our sponsor bank and lower interest expense related to the financing of insurance premiums.

 

We recorded an income tax expense of $28,813 for the six months ended June 30, 2022, which equates to an effective tax rate of (5.7%) percent primarily as a result of the full valuation on our deferred tax asset in both the current and prior period and the tax benefit related to our stock-based compensation and a pretax loss in the prior period. We recorded an income tax expense of $2,400 for the six months ended June 30, 2021 due to estimated state tax payments.

 

The net loss for the six months ended June 30, 2022 was $537,429, an improvement of $2,018,065 compared to the net loss of $2,555,494 for the six months ended June 30, 2021. The overall change in net loss relates to the aforementioned factors.

 

Key Performance Indicators and Non-GAAP Measures

 

Management reviews a number of metrics to help us monitor the performance of and identify trends affecting our business. We believe the following measures are the primary indicators of our quarterly and annual revenues:

 

Gross Dollar Volume Loaded on Cards – Represents the total dollar volume of funds loaded to all of our prepaid card programs. Our gross dollar volume loaded on cards was $376 million and $267 million for the three months ended June 30, 2022 and 2021, respectively. That gross dollar volume was $699 million and $546 million for the six months ended June 30, 2022 and 2021, respectively. We use this metric to analyze the total amount of money moving into our prepaid card programs.

 

Conversion Rates on Gross Dollar Volume Loaded on Cards – Equals revenues, gross profit or net income conversion rates of gross dollar volume loaded on cards which are calculated by taking our total revenues, gross profit or net income (loss), respectively, as a numerator and dividing by the gross dollar volume loaded on cards as a denominator. As we derive a number of our financial results from cardholder fees, we utilize these metrics as an indication of the amount of money that is added to cards and will eventually be converted to revenues, gross profit and net income. Our total revenue conversion rates for the three months ended June 30, 2022 and 2021 were 2.29% or 229 basis points (“bps”), and 2.49% or 249 bps, respectively, of gross dollar volume loaded on cards. Our total gross profit conversion rates for the three months ended June 30, 2022 and 2021 were 1.25% or 125 bps, and 1.18% or 118 bps, respectively, of gross dollar volume loaded on cards. Our net income conversion rates for the three months ended June 30, 2022 and 2021 were (0.06)% or (6) bps, and (0.35)% or (35) bps, respectively, of gross dollar volume loaded on cards. Our total revenue conversion rates for the six months ended June 30, 2022 and 2021 were 2.41% or 241 bps, and 2.37% or 237 bps, respectively, of gross dollar volume loaded on cards. Our total gross profit conversion rates for the six months ended June 30, 2022 and 2021 were 1.39% or 139 bps, and 1.10% or 110 bps, respectively, of gross dollar volume loaded on cards. Our net income conversion rates for the six months ended June 30, 2022 and 2021 were (0.08)% or (8) bps, and (0.47)% or (47) bps, respectively, of gross dollar volume loaded on cards.

 

Management also reviews key performance indicators, such as revenues, gross profit, operational expenses as a percent of revenues, and cardholder participation. In addition, we consider certain non-GAAP (or "adjusted") measures to be useful to management and investors evaluating our operating performance for the periods presented, and provide a financial tool for evaluating our ongoing operations, liquidity and management of assets. This information can assist investors in assessing our financial performance and measures our ability to generate capital for deployment and investment in new card programs. These adjusted metrics are consistent with how management views our business and are used to make financial, operating and planning decisions. These metrics, however, are not measures of financial performance under GAAP and should not be considered a substitute for revenue, operating income, net income (loss), earnings (loss) per share (basic and diluted) or net cash from operating activities as determined in accordance with GAAP. We consider the following non-GAAP measures, which may not be comparable to similarly titled measures reported by other companies, to be key performance indicators:

 

 

 

 20 

 

 

“EBITDA” is defined as earnings before interest, income taxes, and depreciation and amortization expense and "Adjusted EBITDA" reflects the adjustment to EBITDA to exclude stock-based compensation expense. A reconciliation of net loss to Adjusted EBITDA is provided in the table below.

  

   Three Months Ended
June 30,
   Six Months Ended
June 30,
 
   2022   2021   2022   2021 
Reconciliation of Adjusted EBITDA to net loss:                
Net loss  $(228,034)  $(931,967)  $(537,429)  $(2,555,494)
Income tax provision   26,916    800    28,813    2,400 
Interest income   (70,227)   (5,010)   (84,563)   (12,111)
Depreciation and amortization   713,180    614,182    1,392,351    1,210,030 
EBITDA   441,835    (321,995)   799,172    (1,355,175)
Stock-based compensation   488,287    540,921    1,057,789    1,177,135 
Adjusted EBITDA  $930,122   $218,926   $1,856,961   $(178,040)

 

Liquidity and Capital Resources

 

The following table sets forth the major sources and uses of cash:

 

  

Six Months Ended June 30,

(unaudited)

 
   2022   2021 
Net cash provided by operating activities  $16,399,465   $17,581,753 
Net cash used in investing activities   (1,575,209)   (1,261,556)
Net cash provided by financing activities       120,141 
Net increase in cash and restricted cash  $14,824,256   $16,440,338 

  

Comparison of Six Months Ended June 30, 2022 and 2021

 

During the six months ended June 30, 2022 and 2021, we financed our operations through internally generated funds.

 

Cash provided by operating activities decreased $1,182,288 for the six months ended June 30, 2022, as compared to the same period in the prior year. The decrease is primarily due to changes in cash flows from operating assets and liabilities, particularly decreases in cash flows from other receivables of $420,033 related to employee retention credits recorded in the current year, accounts payable and accrued liabilities of $891,940 associated with the timing of a payment due to a third-party service provider, and customer card funding of $1,970,675 primarily related to the return of restricted cash associated with the end of a number of Pharma prepaid programs. These decreases were partially offset by an improvement in net loss from operations of $2,018,065, a decrease in cash flows from stock-based compensation of $119,346 and an increase in cash flows from depreciation and amortization of $182,321.

 

 

 

 21 

 

 

Cash used in investing activities increased $313,653 for the six months ended June 30, 2022 as compared to the six months ended June 30, 2021. The change between periods was primarily attributed to an increase in the capitalization of internally developed software as we continue to invest in our technology platform.

 

Cash provided by financing activities was zero for the six months ended June 30, 2022 as compared to cash provided by financing activities of $120,141 for the six months ended June 30, 2021. Cash provided by financing activities in the 2021 period consisted of cash received from the exercise of employee stock options totaling $120,141.

  

Sources of Liquidity

 

We believe that our available cash on hand, excluding restricted cash, at June 30, 2022 of $6,527,476, along with our forecast for revenues and cash flows for the remainder of the year and for 2023, will be sufficient to sustain our operations for the next twelve months.

 

Off-Balance Sheet Arrangements

 

We do not have any off-balance sheet arrangements that are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to investors.

 

Critical Accounting Policies and Estimates

 

Our significant accounting policies are described in Note 1 of the Notes to Consolidated Financial Statements and our Annual Report on Form 10-K for the fiscal year ended December 31, 2021.

 

The preparation of consolidated financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.

 

Our estimates are based on our experience and our interpretation of economic, political, regulatory, and other factors that affect our business prospects. Actual results may differ significantly from our estimates.

 

 

 

 22 

 

 

Item 3. Quantitative and Qualitative Disclosures about Market Risk.

 

Because we are a smaller reporting company, we are not required to provide the information called for by this Item.

  

Item 4. Controls and Procedures.

 

Disclosure Controls and Procedures.

 

Disclosure controls and procedures means controls and other procedures that are designed to ensure that the information we are required to disclose in the reports that we file or submit under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms, and to ensure that information required to be disclosed by us in those reports is accumulated and communicated to our management, including our principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. Our chief executive officer and chief financial officer evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934) as of June 30, 2022. Based on that evaluation, our chief executive officer and chief financial officer have concluded that our disclosure controls and procedures were effective as of June 30, 2022, the end of the period covered by this Quarterly Report on Form 10-Q.

  

Changes in Internal Control over Financial Reporting

 

During the quarter ended June 30, 2022, there have been no changes in our internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

 

 

 

 

 

 

 

 

 

 

 

 23 

 

 

PART II. OTHER INFORMATION

 

Item 1. Legal Proceedings.

 

From time to time, we may become involved in various lawsuits and legal proceedings which arise in the ordinary course of business. However, litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our business.

  

The Company has been named as a defendant in three complaints filed in the United States District Court for the District of Nevada: Yilan Shi v. Paysign, Inc. et. al., filed on March 19, 2020 (“Shi”), Lorna Chase v. Paysign, Inc. et. al., filed on March 25, 2020 (“Chase”), and Smith & Duvall v. Paysign, Inc. et. al., filed on April 2, 2020 (collectively, the “Complaints” or “Securities Class Action”). Smith & Duvall v. Paysign, Inc. et. al. was voluntarily dismissed on May 21, 2020. On May 18, 2020, the Shi plaintiffs and another entity called the Paysign Investor Group each filed a motion to consolidate the remaining Shi and Chase actions and to be appointed lead plaintiff. The Complaints are putative class actions filed on behalf of a class of persons who acquired the Company’s common stock from March 19, 2019 through March 31, 2020, inclusive. The Complaints generally allege that the Company, Mark R. Newcomer, and Mark Attinger violated Section 10(b) of the Exchange Act, and that Messrs. Newcomer and Attinger violated Section 20(a) of the Exchange Act, by making materially false or misleading statements, or failing to disclose material facts, regarding the Company’s internal control over financial reporting and its financial statements. The Complaints seek class action certification, compensatory damages, and attorney’s fees and costs. On December 2, 2020, the Court consolidated Shi and Chase as In re Paysign, Inc. Securities Litigation and appointed the Paysign Investor Group as lead plaintiff. On January 12, 2021, Plaintiffs filed an Amended Complaint in the consolidated action. Defendants filed a Motion to Dismiss the Amended Complaint on March 15, 2021, which Plaintiffs opposed via an opposition brief filed on April 29, 2021, to which Defendants replied on June 1, 2021. Thus, the motion is now fully briefed. The Court has not set a hearing date on the motion, or informed the parties whether it intends to entertain oral argument or rule upon the papers filed.

 

The Company has also been named as a nominal defendant in two stockholder derivative actions in the United States District Court for the District of Nevada. The first derivative action is entitled Andrzej Toczek, derivatively on behalf of Paysign, Inc. v. Mark R. Newcomer, et al. and was filed on September 17, 2020. This action alleges violations of Section 14(a) of the Exchange Act, breach of fiduciary duty, unjust enrichment, and waste, largely in connection with the failure to correct information technology controls over financial reporting alleged in the Securities Class Action, thereby causing the Company to face exposure in the Securities Class Action. The complaint also alleges insider trading violations against certain individual defendants. On December 16, 2020, the Court approved a stipulation staying the action until the Court in the consolidated Securities Class Action issues a ruling on the Motion to Dismiss. The second derivative action is entitled John K. Gray, derivatively on behalf of Paysign, Inc. v. Mark Attinger, et al. and was filed on May 9, 2022. This action involves the same alleged conduct raised in the Toczek action and asserts claims for breach of fiduciary duty in connection with financial reporting, breach of fiduciary duty in connection with alleged insider trading against certain individual defendants, and unjust enrichment. On June 3, 2022, the Court approved a stipulation staying the action until the Court in the consolidated Securities Class Action issues a ruling on the Motion to Dismiss.

 

Item 1A. Risk Factors.

 

Because we are a smaller reporting company, we are not required to provide the information called for by this Item. 

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

 

During the quarter ended June 30, 2022, we issued, pursuant to an exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, a total of 105,000 shares of common stock for restricted stock awards previously earned and vested to certain directors, consultants and employees.

 

 

 

 24 

 

 

Item 6. Exhibits.

 

31.1 Rule 13a-14(a)/15d-14(a) Certifications
31.2 Rule 13a-14(a)/15d-14(a) Certifications
32.1 Section 1350 Certifications
32.2 Section 1350 Certifications
101.INS Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document)
101.SCH Inline XBRL Taxonomy Extension Schema Document
101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document
104 Cover Page Interactive Data File (formatted in iXBRL, and included in exhibit 101).

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 25 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  PAYSIGN, INC.
   
   
Date: August 10, 2022 /s/ Mark Newcomer
 

By: Mark Newcomer, Chief Executive Officer

(principal executive officer)

   
   
Date: August 10, 2022 /s/ Jeff Baker
 

By: Jeff Baker, Chief Financial Officer

(principal financial and accounting officer)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 26 

 

EX-31.1 2 paysign_ex3101.htm CERTIFICATION

Exhibit 31.1

 

CERTIFICATION

 

I, Mark Newcomer, certify that:

 

(1) I have reviewed this quarterly report on Form 10-Q for the period ended June 30, 2022 (the “report”) of Paysign, Inc.;

 

(2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

(3) Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

(4) The registrant's other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

(5) The registrant's other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

 

Date: August 10, 2022 /s/ Mark Newcomer
 

Mark Newcomer

Chief Executive Officer

(principal executive officer)

 

EX-31.2 3 paysign_ex3102.htm CERTIFICATION

Exhibit 31.2

 

CERTIFICATION

 

I, Jeff Baker, certify that:

 

(1) I have reviewed this quarterly report on Form 10-Q for the period ended June 30, 2022 (the “report”) of Paysign, Inc.;

 

(2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

(3) Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

(4) The registrant's other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

(5) The registrant's other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

 

Date: August 10, 2022 /s/ Jeff Baker
 

Jeff Baker

Chief Financial Officer

(principal financial and accounting officer)

 

EX-32.1 4 paysign_ex3201.htm SECTION 1350 CERTIFICATION

Exhibit 32.1

 

SECTION 1350 CERTIFICATIONS

 

Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, I, Mark Newcomer, the Chief Executive Officer of Paysign, Inc., a Nevada corporation (the "Company"), does hereby certify, to the best of my knowledge, that:

 

1. The Quarterly Report on Form 10-Q for the period ended June 30, 2022 (the "Report") of the Company fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

/s/ Mark Newcomer                     

Mark Newcomer

Chief Executive Officer

(principal executive officer)

 

Date: August 10, 2022 

 

EX-32.2 5 paysign_ex3202.htm SECTION 1350 CERTIFICATION

Exhibit 32.2

 

SECTION 1350 CERTIFICATIONS

 

Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, I, Jeff Baker, the Chief Financial Officer of Paysign, Inc., a Nevada corporation (the "Company"), does hereby certify, to the best of my knowledge, that:

 

1. The Quarterly Report on Form 10-Q for the period ended June 30, 2022 (the "Report") of the Company fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

/s/ Jeff Baker                     

Jeff Baker

Chief Financial Officer

(principal financial and accounting officer)

 

Date: August 10, 2022

EX-101.SCH 6 pays-20220630.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS EQUITY (DEFICIT) (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT POLICIES link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - FIXED ASSETS, NET link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - INTANGIBLE ASSETS, NET link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - LEASE link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - CUSTOMER CARD FUNDING LIABILITY link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - COMMON STOCK link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - BASIC AND FULLY DILUTED NET LOSS PER COMMON SHARE link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - COMMITMENTS AND CONTINGENCIES link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - RELATED PARTY link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - INCOME TAX PROVISION link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - FIXED ASSETS, NET (Tables) link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - INTANGIBLE ASSETS, NET (Tables) link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - LEASE (Tables) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - CUSTOMER CARD FUNDING LIABILITY (Tables) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - BASIC AND FULLY DILUTED NET LOSS PER COMMON SHARE (Tables) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT POLICIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - FIXED ASSETS, NET (Details) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - FIXED ASSETS, NET (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - INTANGIBLE ASSETS, NET (Details) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - INTANGIBLE ASSETS, NET (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - LEASE (Details) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - LEASE (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - CUSTOMER CARD FUNDING LIABILITY (Details) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - CUSTOMER CARD FUNDING LIABILITY (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - COMMON STOCK (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - BASIC AND FULLY DILUTED NET LOSS PER COMMON SHARE (Details) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - BASIC AND FULLY DILUTED NET LOSS PER COMMON SHARE (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - RELATED PARTY (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - INCOME TAX PROVISION (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 pays-20220630_cal.xml XBRL CALCULATION FILE EX-101.DEF 8 pays-20220630_def.xml XBRL DEFINITION FILE EX-101.LAB 9 pays-20220630_lab.xml XBRL LABEL FILE Product and Service [Axis] Plasma Industry [Member] Pharmaceutical industry [Member] Other Revenue [Member] Equity Components [Axis] Common Stock [Member] Additional Paid-in Capital [Member] Treasury Stock [Member] Retained Earnings [Member] Balance Sheet Location [Axis] Other Receivable [Member] Concentration Risk Benchmark [Axis] Accounts Receivable [Member] Concentration Risk Type [Axis] Customer Concentration Risk [Member] Customer [Axis] One Customer [Member] Another Customer [Member] Finite-Lived Intangible Assets by Major Class [Axis] Intangible Assets [Member] Computer Software [Member] Long-Lived Tangible Asset [Axis] Equipment [Member] Software Development [Member] Furniture and Fixtures [Member] Website Costs [Member] Leasehold Improvements [Member] Trademarks and Trade Names [Member] Platform [Member] Customer lists and contracts [Member] Licenses [Member] Antidilutive Securities [Axis] Stock Options [Member] Unvested Restricted Stock Awards [Member] Related Party [Axis] Related Party Law Firm [Member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Statement of Financial Position [Abstract] ASSETS Current assets Cash Restricted cash Accounts receivable Other receivables Prepaid expenses and other current assets Total current assets Fixed assets, net Intangible assets, net Operating lease right-of-use asset Total assets LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities Accounts payable and accrued liabilities Operating lease liability, current portion Customer card funding Total current liabilities Operating lease liability, long term portion Total liabilities Commitments and contingencies (Note 8) Stockholders' equity Preferred stock: $ 0.001 par value; 25,000,000 shares authorized; none issued and outstanding Common stock; $ 0.001 par value; 150,000,000 shares authorized, 52,323,382 and 52,095,382 issued at June 30, 2022 and December 31, 2021, respectively Additional paid-in capital Treasury stock at cost, 303,450 shares Accumulated deficit Total stockholders' equity Total liabilities and stockholders' equity Preferred stock, par value Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Common stock, par value Common stock, shares authorized Common stock, shares issued Treasury stock shares Statement [Table] Statement [Line Items] Revenues Total revenues Cost of revenues Gross profit Operating expenses Selling, general and administrative Depreciation and amortization Total operating expenses Loss from operations Other income Interest income, net Loss before income tax provision Income tax provision Net loss Net loss per share Basic Diluted Weighted average common shares Basic Diluted Beginning balance, value Beginning balance, shares Stock issued upon vesting of restricted stock Stock issued upon vesting of restricted stock, shares Exercise of stock options Exercise of stock options, shares Stock-based compensation Net loss Ending balance, value Ending balance, shares Statement of Cash Flows [Abstract] Cash flows from operating activities: Net loss Adjustments to reconcile net loss to net cash provided by operating activities: Stock-based compensation expense Depreciation and amortization Noncash lease expense Changes in operating assets and liabilities: Accounts receivable Other receivable Prepaid expenses and other current assets Accounts payable and accrued liabilities Operating lease liability Customer card funding Net cash provided by operating activities Cash flows from investing activities: Purchase of fixed assets Capitalization of internally developed software Purchase of intangible assets Net cash used in investing activities Cash flows from financing activities: Proceeds from exercise of stock options Net cash provided by financing activities Net change in cash and restricted cash Cash and restricted cash, beginning of period Cash and restricted cash, end of period Cash and restricted cash reconciliation: Cash Restricted cash Total cash and restricted cash Supplemental cash flow information: Non-cash financing activities Cash paid for taxes Interest paid Accounting Policies [Abstract] BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT POLICIES Property, Plant and Equipment [Abstract] FIXED ASSETS, NET Goodwill and Intangible Assets Disclosure [Abstract] INTANGIBLE ASSETS, NET Leases [Abstract] LEASE Revenue from Contract with Customer [Abstract] CUSTOMER CARD FUNDING LIABILITY Equity [Abstract] COMMON STOCK Earnings Per Share [Abstract] BASIC AND FULLY DILUTED NET LOSS PER COMMON SHARE Commitments and Contingencies Disclosure [Abstract] COMMITMENTS AND CONTINGENCIES Related Party Transactions [Abstract] RELATED PARTY Income Tax Disclosure [Abstract] INCOME TAX PROVISION Impact of COVID-19 Pandemic About Paysign, Inc Principles of Consolidation Reclassifications Use of Estimates Cash and Cash Equivalents Restricted Cash Concentrations of Credit Risk Fixed Assets Intangible Assets Customer Card Funding Earnings Per Share Revenue and Expense Recognition Operating leases Stock-Based Compensation Recently Issued Accounting Pronouncements Schedule of fixed assets Schedule of intangible assets Schedule of operating lease liabilities Schedule of contract liabilities Schedule of computation of earnings per share Schedule of Product Information [Table] Product Information [Line Items] Employee related cost Other receivable Cash equivalents Fdic insured Concentration Risk, Percentage Property, Plant and Equipment, Estimated Useful Lives [custom:FiniteLivedIntangibleAssetUsefulLife1] Property, Plant and Equipment [Table] Property, Plant and Equipment [Line Items] Property, Plant and Equipment, Gross Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Property, Plant and Equipment, Net Depreciation expense Schedule of Finite-Lived Intangible Assets [Table] Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets, Gross Finite-Lived Intangible Assets, Accumulated Amortization Intangible Assets, Net (Excluding Goodwill) Amortization 2022 (excluding the six months ended June 30, 2022) 2023 2024 2025 2026 Thereafter Total lease payments Less: Imputed interest Present value of future lease payments Less: current portion of lease liability Long-term portion of lease liability Lease term Lease term option to extend Remaining lease term Discount rate Operating lease cost Beginning balance Increase (decrease), net Ending balance Revenue recognized in current year previously included in contract liabilities Common Stock, Shares Authorized Common Stock, Par or Stated Value Per Share Preferred Stock, Shares Authorized Preferred Stock, Par or Stated Value Per Share Common Stock, Shares, Issued Common Stock, Shares, Outstanding Share-based Payment Arrangement, Noncash Expense Number of shares vested Proceeds Form Vested Stock Awards And Stock Options Numerator: Denominator: Weighted average common shares: Denominator for basic calculation Weighted average effects of potentially diluted common stock: Stock options (calculated using the treasury method) Unvested restricted stock grants Denominator for fully diluted calculation Net loss per common share: Fully diluted Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Potential common share equivalents excluded from computation Schedule of Related Party Transactions, by Related Party [Table] Related Party Transaction [Line Items] Legal Fees Effective income tax rate Net income per common share [Abstract] Assets, Current Assets Liabilities, Current Liabilities Treasury Stock, Value Stockholders' Equity Attributable to Parent Liabilities and Equity Gross Profit Operating Expenses Operating Income (Loss) Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Net Income (Loss) Available to Common Stockholders, Basic Shares, Outstanding Depreciation, Depletion and Amortization, Nonproduction Increase (Decrease) in Accounts Receivable Increase (Decrease) in Other Receivables Increase (Decrease) in Prepaid Expense and Other Assets Increase (Decrease) in Accounts Payable and Accrued Liabilities Net Cash Provided by (Used in) Operating Activities Payments to Acquire Property, Plant, and Equipment Payments to Develop Software Payments to Acquire Intangible Assets Net Cash Provided by (Used in) Investing Activities Net Cash Provided by (Used in) Financing Activities Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Restricted Cash and Cash Equivalents Operating Leases, Future Minimum Payments Due LessImputedInterest Contract with Customer, Liability EX-101.PRE 10 pays-20220630_pre.xml XBRL PRESENTATION FILE XML 11 R1.htm IDEA: XBRL DOCUMENT v3.22.2
Cover - shares
6 Months Ended
Jun. 30, 2022
Aug. 05, 2022
Cover [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Jun. 30, 2022  
Document Fiscal Period Focus Q2  
Document Fiscal Year Focus 2022  
Current Fiscal Year End Date --12-31  
Entity File Number 001-38623  
Entity Registrant Name PAYSIGN, INC.  
Entity Central Index Key 0001496443  
Entity Tax Identification Number 95-4550154  
Entity Incorporation, State or Country Code NV  
Entity Address, Address Line One 2615 St. Rose Parkway  
Entity Address, City or Town Henderson  
Entity Address, State or Province NV  
Entity Address, Postal Zip Code 89052  
City Area Code (702)  
Local Phone Number 453-2221  
Title of 12(b) Security Common Stock, $0.001 par value per share  
Trading Symbol PAYS  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company true  
Elected Not To Use the Extended Transition Period false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   52,151,932
XML 12 R2.htm IDEA: XBRL DOCUMENT v3.22.2
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($)
Jun. 30, 2022
Dec. 31, 2021
Current assets    
Cash $ 6,527,476 $ 7,387,156
Restricted cash 76,967,850 61,283,914
Accounts receivable 3,488,759 3,393,940
Other receivables 1,439,251 1,019,218
Prepaid expenses and other current assets 1,754,140 1,242,967
Total current assets 90,177,476 74,327,195
Fixed assets, net 1,410,947 1,642,981
Intangible assets, net 4,501,854 4,086,962
Operating lease right-of-use asset 3,806,793 3,993,655
Total assets 99,897,070 84,050,793
Current liabilities    
Accounts payable and accrued liabilities 5,575,119 5,765,478
Operating lease liability, current portion 350,753 340,412
Customer card funding 76,967,850 61,283,914
Total current liabilities 82,893,722 67,389,804
Operating lease liability, long term portion 3,495,185 3,673,186
Total liabilities 86,388,907 71,062,990
Commitments and contingencies (Note 8)
Stockholders' equity    
Preferred stock: $ 0.001 par value; 25,000,000 shares authorized; none issued and outstanding 0 0
Common stock; $ 0.001 par value; 150,000,000 shares authorized, 52,323,382 and 52,095,382 issued at June 30, 2022 and December 31, 2021, respectively 52,323 52,095
Additional paid-in capital 17,917,680 16,860,119
Treasury stock at cost, 303,450 shares (150,000) (150,000)
Accumulated deficit (4,311,840) (3,774,411)
Total stockholders' equity 13,508,163 12,987,803
Total liabilities and stockholders' equity $ 99,897,070 $ 84,050,793
XML 13 R3.htm IDEA: XBRL DOCUMENT v3.22.2
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) - $ / shares
Jun. 30, 2022
Dec. 31, 2021
Statement of Financial Position [Abstract]    
Preferred stock, par value $ 0.001 $ 0.001
Preferred stock, shares authorized 25,000,000 25,000,000
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Common stock, par value $ 0.001 $ 0.001
Common stock, shares authorized 150,000,000 150,000,000
Common stock, shares issued 52,323,382 52,095,382
Treasury stock shares 303,450 303,450
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Revenues        
Total revenues $ 8,598,776 $ 6,651,290 $ 16,819,415 $ 12,930,718
Cost of revenues 3,900,965 3,498,723 7,123,355 6,946,345
Gross profit 4,697,811 3,152,567 9,696,060 5,984,373
Operating expenses        
Selling, general and administrative 4,255,976 3,474,562 8,896,888 7,339,548
Depreciation and amortization 713,180 614,182 1,392,351 1,210,030
Total operating expenses 4,969,156 4,088,744 10,289,239 8,549,578
Loss from operations (271,345) (936,177) (593,179) (2,565,205)
Other income        
Interest income, net 70,227 5,010 84,563 12,111
Loss before income tax provision (201,118) (931,167) (508,616) (2,553,094)
Income tax provision 26,916 800 28,813 2,400
Net loss $ (228,034) $ (931,967) $ (537,429) $ (2,555,494)
Net loss per share        
Basic $ (0.00) $ (0.02) $ (0.01) $ (0.05)
Diluted $ (0.00) $ (0.02) $ (0.01) $ (0.05)
Weighted average common shares        
Basic 51,993,031 50,748,437 51,906,335 50,551,299
Diluted 51,993,031 50,748,437 51,906,335 50,551,299
Plasma Industry [Member]        
Revenues        
Total revenues $ 7,806,201 $ 5,947,313 $ 15,200,565 $ 11,330,464
Pharmaceutical industry [Member]        
Revenues        
Total revenues 773,311 641,037 1,579,879 1,523,867
Other Revenue [Member]        
Revenues        
Total revenues $ 19,264 $ 62,940 $ 38,971 $ 76,387
XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS EQUITY (DEFICIT) (UNAUDITED) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Treasury Stock [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Dec. 31, 2020 $ 50,252 $ 14,388,890 $ (150,000) $ (1,053,077) $ 13,236,065
Beginning balance, shares at Dec. 31, 2020 50,251,607        
Stock issued upon vesting of restricted stock $ 467 (467)
Stock issued upon vesting of restricted stock, shares 466,689        
Exercise of stock options $ 32 110,434 110,466
Exercise of stock options, shares 32,586        
Stock-based compensation 636,214 636,214
Net loss (1,623,527) (1,623,527)
Ending balance, value at Mar. 31, 2021 $ 50,751 15,135,071 (150,000) (2,676,604) 12,359,218
Ending balance, shares at Mar. 31, 2021 50,750,882        
Stock issued upon vesting of restricted stock $ 390 (390)
Stock issued upon vesting of restricted stock, shares 390,000        
Exercise of stock options $ 2 9,673 9,675
Exercise of stock options, shares 2,500        
Stock-based compensation 540,921 540,921
Net loss (931,967) (931,967)
Ending balance, value at Jun. 30, 2021 $ 51,143 15,685,275 (150,000) (3,608,571) 11,977,847
Ending balance, shares at Jun. 30, 2021 51,143,382        
Beginning balance, value at Dec. 31, 2021 $ 52,095 16,860,119 (150,000) (3,774,411) 12,987,803
Beginning balance, shares at Dec. 31, 2021 52,095,382        
Stock issued upon vesting of restricted stock $ 123 (123)
Stock issued upon vesting of restricted stock, shares 123,000        
Stock-based compensation 569,502 569,502
Net loss (309,395) (309,395)
Ending balance, value at Mar. 31, 2022 $ 52,218 17,429,498 (150,000) (4,083,806) 13,247,910
Ending balance, shares at Mar. 31, 2022 52,218,382        
Stock issued upon vesting of restricted stock $ 105 (105)
Stock issued upon vesting of restricted stock, shares 105,000        
Stock-based compensation 488,287
Net loss (228,034) (228,034)
Ending balance, value at Jun. 30, 2022 $ 52,323 $ 17,917,680 $ (150,000) $ (4,311,840) $ 13,508,163
Ending balance, shares at Jun. 30, 2022 52,323,382        
XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Cash flows from operating activities:    
Net loss $ (537,429) $ (2,555,494)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Stock-based compensation expense 1,057,789 1,210,030
Depreciation and amortization 1,392,351 1,177,135
Noncash lease expense 186,862 211,407
Changes in operating assets and liabilities:    
Accounts receivable (94,819) (293,095)
Other receivable (420,033) 0
Prepaid expenses and other current assets (511,173) (366,502)
Accounts payable and accrued liabilities (190,359) 701,581
Operating lease liability (167,660) (157,920)
Customer card funding 15,683,936 17,654,611
Net cash provided by operating activities 16,399,465 17,581,753
Cash flows from investing activities:    
Purchase of fixed assets (38,188) (173,479)
Capitalization of internally developed software (1,537,021) (1,048,364)
Purchase of intangible assets 0 (39,713)
Net cash used in investing activities (1,575,209) (1,261,556)
Cash flows from financing activities:    
Proceeds from exercise of stock options 0 120,141
Net cash provided by financing activities 0 120,141
Net change in cash and restricted cash 14,824,256 16,440,338
Cash and restricted cash, beginning of period 68,671,070 55,930,404
Cash and restricted cash, end of period 83,495,326 72,370,742
Cash and restricted cash reconciliation:    
Cash 6,527,476 6,615,180
Restricted cash 76,967,850 65,755,562
Total cash and restricted cash 83,495,326 72,370,742
Non-cash financing activities    
Cash paid for taxes 8,700 2,400
Interest paid $ 821 $ 2,173
XML 17 R7.htm IDEA: XBRL DOCUMENT v3.22.2
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT POLICIES
6 Months Ended
Jun. 30, 2022
Accounting Policies [Abstract]  
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT POLICIES

1.     BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT POLICIES

 

The foregoing unaudited interim condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions for Form 10-Q and Regulation S-X as promulgated by the Securities and Exchange Commission (“SEC”). Accordingly, these financial statements do not include all of the disclosures required by GAAP for complete financial statements. These unaudited interim condensed consolidated financial statements should be read in conjunction with the audited financial statements and the notes thereto included on Form 10-K for the year ended December 31, 2021. In the opinion of management, the unaudited interim condensed consolidated financial statements furnished herein include all adjustments, all of which are of a normal recurring nature, necessary for a fair statement of the results for the interim period presented.

 

The preparation of financial statements in accordance with GAAP requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities known to exist as of the date the financial statements are published, and the reported amounts of revenues and expenses during the reporting period. Uncertainties with respect to such estimates and assumptions are inherent in the preparation of the Company’s financial statements; accordingly, it is possible that the actual results could differ from these estimates and assumptions that could have a material effect on the reported amounts of the Company’s financial position and results of operations.

 

Operating results for the six months ended June 30, 2022 are not necessarily indicative of the results that may be expected for the year ending December 31, 2022.

 

Impact of COVID-19 Pandemic

 

The coronavirus (“COVID-19”) pandemic, which started in late 2019 and reached the United States in early 2020, continues to significantly impact the economy of the United States and the rest of the world. While the direct disruption appears to have significantly mitigated due to the availability of vaccines and other factors, the ultimate duration and severity of the pandemic remain uncertain, particularly given the development of new variants that continue to spread, and the economic repercussions are still manifesting themselves. The COVID-19 outbreak caused plasma center closures, and the stimulus packages signed into law during 2020 and 2021 reduced the incentive for individuals to donate plasma for supplementary income. Additionally, labor shortages at plasma donation centers and restrictions preventing Mexican nationals with tourist visas from being compensated for donating plasma, have further impacted donations. Those developments have had, and are expected to continue to have, an adverse impact on the Company’s results of operations. Offsetting those headwinds, inflationary pressures for food, gasoline, and other products and services appear to be driving individuals back into the plasma donation centers based upon the increase we experienced in the number of loads per average donation center in the second quarter of 2022 versus the first quarter of 2022. While we remain cautiously optimistic and have seen improvements in our operating results on an aggregated basis, we cannot foresee how long it may take the Company to attain pre-pandemic operating levels on a per plasma donation center basis. Given the uncertainty around the extent and timing of the potential future spread or mitigation of COVID-19 and variants and around the imposition or relaxation of protective measures, management cannot at this time estimate with reasonable accuracy COVID-19’s further impact on the Company’s results of operations, cash flows or financial condition.

 

Under the provisions of the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”) signed into law in 2020 and the subsequent extension of the CARES Act through September 30, 2021, the Company was eligible for a refundable employee retention credit subject to certain criteria. The Company has elected an accounting policy to recognize the government assistance when it is probable that the Company is eligible to receive the assistance and present the credit be as a reduction of the related expense. During the quarter ended June 30, 2022 the Company filed for a refund and recorded $459,755 related to the employee retention credit. As of June 30, 2022 and December 31, 2021, the Company has $1,296,488 and $876,456, respectively in other receivables on the condensed consolidated balance sheet related to refunds.

 

About Paysign, Inc.

 

Paysign, Inc. (the “Company,” “Paysign,” “we” or “our”) was incorporated on August 24, 1995, and trades under the symbol PAYS on The Nasdaq Stock Market LLC. Paysign. is a provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services and integrated payment processing designed   for businesses, consumers and government institutions. Headquartered in Nevada, the company creates customized, innovative payment solutions for clients across all industries, including pharmaceutical, healthcare, hospitality and retail.

 

Principles of Consolidation – The condensed consolidated financial statements include the accounts of the Company and its subsidiaries. All significant intercompany balances and transactions have been eliminated.

 

Reclassifications – In our cash flows statement, certain accounts related to the lease accounting captions in the prior periods have been reclassified to conform to the current period financial statement presentations.  

 

Use of Estimates – The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect (i) the reported amounts of assets and liabilities, (ii) the disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and (iii) the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.

 

Cash and Cash Equivalents – The Company considers all highly liquid investments purchased with an original maturity of six months or less at the time of purchase to be cash equivalents for the purposes of the statement of cash flows. The Company had no cash equivalents at June 30, 2022 and December 31, 2021.

 

Restricted Cash – At June 30, 2022 and December 31, 2021, restricted cash consisted of funds held specifically for our card product programs that are contractually restricted to use. The Company includes changes in restricted cash balances with cash and cash equivalents when reconciling the beginning and ending total amounts in our condensed consolidated statements of cash flows.

 

Concentrations of Credit Risk – Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents and restricted cash. Paysign maintains its cash and cash equivalents and restricted cash in various bank accounts that, at times, may exceed federally insured limits. Paysign has not experienced, nor does it anticipate, any losses with respect to such accounts. At June 30, 2022 and December 31, 2021, the Company had approximately $37,047,586 and $31,828,826 in excess of federally insured bank account limits, respectively.

 

The Company also has a concentration of accounts receivable risk at June 30, 2022 as two Pharma program customers associated with our Pharma copay programs each individually represent 51% and 11% of our accounts receivable balance. Two Pharma program customers each individually represented 52% and 17% of our accounts receivable balance at December 31, 2021.

 

Fixed Assets – Fixed assets are stated at cost less accumulated depreciation. Depreciation is principally recorded on the straight-line method over the estimated useful life of the asset, which is generally 3 to 10 years. The cost of repairs and maintenance is charged to expense as incurred. Leasehold improvements are capitalized and depreciated over the shorter of the remaining lease term or the estimated useful life of the improvements. Expenditures for property betterments and renewals are capitalized. Upon sale or other disposition of a depreciable asset, cost and accumulated depreciation are removed from the accounts and any gain or loss is reflected in other income (expense).

 

The Company periodically evaluates whether events and circumstances have occurred that may warrant revision of the estimated useful life of fixed assets or whether the remaining balance of fixed assets should be evaluated for possible impairment. The Company uses an estimate of the related undiscounted cash flows over the remaining life of the fixed assets in measuring their recoverability.

 

Intangible Assets – For intangible assets, the Company recognizes an impairment loss if the carrying amount of the intangible asset is not recoverable and exceeds fair value. The carrying amount of the intangible asset is considered not recoverable if it exceeds the sum of the undiscounted cash flows expected to result from the use of the asset.

 

Intangible assets with a finite life are amortized on a straight-line basis over its estimated useful life, which is generally 3 to 15 years.

 

Internally Developed Software Costs - Computer software development costs are expensed as incurred, except for internal use software or website development costs that qualify for capitalization as described below, and include compensation and related expenses, costs of hardware and software, and costs incurred in developing features and functionality.

 

For computer software developed or obtained for internal use, costs that are incurred in the preliminary project and post implementation stages of software development are expensed as incurred. Costs incurred during the application and development stage are capitalized. Capitalized costs are amortized using the straight-line method over a 3three year estimated useful life, beginning in the period in which the software is available for use.

 

Customer Card Funding – At June 30, 2022 and December 31, 2021, customer card funding represents funds loaded or available to be loaded on cards for our prepaid card programs.

 

Earnings Per Share – Basic earnings per share exclude any dilutive effects of options, warrants and convertible securities. Basic earnings per share is computed using the weighted-average number of common shares outstanding during the applicable period. Diluted earnings per share is computed using the weighted average number of common and common stock equivalent shares outstanding during the period, using the treasury stock method. Common stock equivalent shares are excluded from the computation if their effect on the diluted earnings per share calculation is anti-dilutive.

 

Revenue and Expense Recognition – In determining when and how revenue is recognized from contracts with customers, the Company performs the following five-step analysis: (i) identification of contracts with customers; (ii) determination of performance obligations; (iii) measurement of the transaction price; (iv) allocation of the transaction price to the performance obligations; and (v) recognition of revenue when (or as) the Company satisfies each performance obligation.

 

The Company generates revenues from Plasma card programs through fees generated from cardholder fees and interchange fees. Revenues from Pharma card programs are generated through card program management fees, transaction claims processing fees, interchange fees, and settlement income.

 

Plasma and Pharma card program revenues include both fixed and variable components. Cardholder fees represent an obligation to the cardholder based on a per transaction basis and are recognized at a point in time when the performance obligation is fulfilled. Card program management fees and transaction claims processing fees include an obligation to our card program sponsors and are generally recognized when earned on a monthly basis and are typically due within 30 days pursuant to the contract terms which are generally multi-year contracts. The Company uses the output method to recognize card program management fee revenue at the amount of consideration to which an entity has a right to invoice. The performance obligation is satisfied when the services are transferred to the customer which the Company determined to be monthly, as the customer simultaneously receives and consumes the benefit from the Company’s performance. Interchange fees are earned when customer-issued cards are processed through card payment networks as the nature of our promise to the customer is that we stand ready to process transactions at the customer’s requests on a daily basis over the contract term. Since the timing and quantity of transactions to be processed by us are not determinable, we view interchange fees to comprise an obligation to stand ready to process as many transactions as the customer requests. Accordingly, the promise to stand ready is accounted for as a single series performance obligation. The Company uses the right to invoice practical expedient and recognizes interchange fee revenue concurrent with the processing of card transactions. Interchange fees are settled in accordance with the card payment network terms and conditions, which is typically within a few days.

 

The Company utilizes the remote method of revenue recognition for settlement income whereby the unspent balances will be recognized as revenue at the expiration of the cards and the respective program. The Company records all revenue on a gross basis since it is the primary obligor and establishes the price in the contract arrangement with its customers. The Company is currently under no obligation for refunding any fees, and the Company does not currently have any obligations for disputed claim settlements. Given the nature of the Company’s services and contracts, it has no contract assets.

 

Cost of revenues is comprised of transaction processing fees, data connectivity and data center expenses, network fees, bank fees, card production and postage costs, customer service, program management, application integration setup, and sales and commission expense. 

 

Operating leases – The Company determines if a contract is or contains a leasing element at contract inception or the date in which a modification of an existing contract occurs. In order for a contract to be considered a lease, the contract must transfer the right to control the use of an identified asset for a period of time in exchange for consideration. Control is determined to have occurred if the lessee has the right to (i) obtain substantially all of the economic benefits from the use of the identified asset throughout the period of use and (ii) direct the use of the identified asset.

  

In determining the present value of lease payments at lease commencement date, the Company utilizes its incremental borrowing rate based on the information available, unless the rate implicit in the lease is readily determinable. The liability for operating leases is based on the present value of future lease payments. Operating lease expenses are recorded as rent expense, which is included within selling, general and administrative expenses within the consolidated statements of operations and presented as operating cash outflows within the consolidated statements of cash flows.

 

Leases with an initial term of 12 months or less are not recorded on the balance sheet, with lease expense for these leases recognized on a straight-line basis over the lease term.

 

Stock-Based Compensation – The Company recognizes compensation expense for all restricted stock awards and stock options. The fair value of restricted stock awards is measured using the grant date trading price of our stock. The fair value of stock options is estimated at the grant date using the Black-Scholes option-pricing model, and the portion that is ultimately expected to vest is recognized as compensation cost over the requisite service period. We have elected to recognize compensation expense for all options with graded vesting on a straight-line basis over the vesting period of the entire option. The determination of fair value using the Black-Scholes pricing model is affected by our stock price as well as assumptions regarding a number of complex and subjective variables, including expected stock price volatility and the risk-free interest rate.

 

Recently Issued Accounting Pronouncements – In June 2016, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2016-13, Financial Instruments–Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which provides updated guidance on how an entity should measure credit losses on all financial instruments carried at amortized cost (including loans held for investment and held-to-maturity debt securities, as well as trade receivables, reinsurance recoverables, and receivables that relate to repurchase agreements and securities lending agreements), a lessor’s net investments in leases, and off-balance sheet credit exposures not accounted for as insurance or as derivatives, including loan commitments, standby letters of credit, and financial guarantees. Subsequently, in November 2018 the FASB issued ASU No. 2018-19, Codification Improvements to Topic 326, Financial Instruments–Credit Losses, which clarified that receivables arising from operating leases are not within the scope of Subtopic 326-20, but instead should be accounted for in accordance with Topic 842, Leases. In March 2022 the FASB issued ASU No. 2022-02, Financial Instruments—Credit Losses: Troubled Debt Restructurings and Vintage Disclosures which clarified accounting treatment required for trouble debt restructurings by creditors and enhanced disclosures for write-offs. The new standard and related amendments are effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. We are currently evaluating the impact of adopting this guidance on our Financial Statements; however, we do not expect it to have a material impact on the Company’s consolidated financial statements.

 

In October 2021, the FASB issued ASU No. 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. This ASU requires contract assets and contract liabilities acquired in a business combination to be recognized and measured by the acquirer on the acquisition date in accordance with ASU No. 2016-10, Revenue from Contracts with Customers (Topic 606). This guidance is effective for the Company beginning on January 1, 2023 and is not expected to have a material impact on the Company’s consolidated financial statements.

 

XML 18 R8.htm IDEA: XBRL DOCUMENT v3.22.2
FIXED ASSETS, NET
6 Months Ended
Jun. 30, 2022
Property, Plant and Equipment [Abstract]  
FIXED ASSETS, NET

2.     FIXED ASSETS, NET

 

Fixed assets consist of the following:

        
   June 30,
2022
   December 31,
2021
 
Equipment  $2,098,522   $2,067,834 
Software   323,355    315,855 
Furniture and fixtures   757,662    757,662 
Website costs   69,881    69,881 
Leasehold improvements   229,772    229,772 
    3,479,192    3,441,004 
Less: accumulated depreciation   2,068,245    1,798,023 
Fixed assets, net  $1,410,947   $1,642,981 

 

Depreciation expense for the three months ended June 30, 2022 and 2021 was $134,253 and $133,174, respectively. Depreciation expense for the six months ended June 30, 2022 and 2021 was $270,222 and $265,125, respectively.

 

XML 19 R9.htm IDEA: XBRL DOCUMENT v3.22.2
INTANGIBLE ASSETS, NET
6 Months Ended
Jun. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract]  
INTANGIBLE ASSETS, NET

3.     INTANGIBLE ASSETS, NET

  

Intangible assets consist of the following:

        
   June 30,
2022
   December 31,
2021
 
Patents and trademarks  $38,186   $38,186 
Platform   11,391,538    9,853,823 
Customer lists and contracts   1,177,200    1,177,200 
Licenses   209,282    209,282 
    12,816,206    11,278,491 
Less: accumulated amortization   8,314,352    7,191,529 
Intangible assets, net  $4,501,854   $4,086,962 

 

Intangible assets are amortized over their useful lives ranging from periods of 3 to 15 years. Amortization expense for the three months ended June 30, 2022 and 2021 was $578,927 and $481,008, respectively. Amortization expense for the six months ended June 30, 2022 and 2021 was $1,122,129 and $944,905, respectively.

 

XML 20 R10.htm IDEA: XBRL DOCUMENT v3.22.2
LEASE
6 Months Ended
Jun. 30, 2022
Leases [Abstract]  
LEASE

4.     LEASE

 

The Company entered into an operating lease for office space which became effective in June 2020. The lease term is 10 years from the effective date and allows for two optional extensions of five years each. The two optional extensions are not recognized as part of the right-of-use asset or lease liability since it is not reasonably certain that the Company will extend this lease. As of June 30, 2022, the remaining lease term was 7.9 years and the discount rate was 6%.

 

Operating lease cost included in selling, general and administrative expenses was $184,329 and $367,550 for the three and six months ended June 30, 2022, respectively. Operating lease cost included in selling, general and administrative expenses was $209,056 and $424,200 for the three and six months ended June 30, 2021, respectively.

 

 

The following is the lease maturity analysis of our operating lease as of June 30, 2022:

 

Year ending December 31,

    
2022 (excluding the six months ended June 30, 2022)  $285,984 
2023   571,968 
2024   571,968 
2025   612,006 
2026   640,604 
Thereafter   2,188,731 
Total lease payments   4,871,261 
Less: Imputed interest   (1,025,323)
Present value of future lease payments   3,845,938 
Less: current portion of lease liability   (350,753)
Long-term portion of lease liability  $3,495,185 

 

XML 21 R11.htm IDEA: XBRL DOCUMENT v3.22.2
CUSTOMER CARD FUNDING LIABILITY
6 Months Ended
Jun. 30, 2022
Revenue from Contract with Customer [Abstract]  
CUSTOMER CARD FUNDING LIABILITY

5.     CUSTOMER CARD FUNDING LIABILITY

 

The Company issues prepaid cards with various provisions for cardholder fees or expiration. Revenue generated from cardholder transactions and interchange fees are recognized when the Company’s performance obligation is fulfilled. Unspent balances left on Pharma   cards are recognized as settlement income at the expiration of the cards and the program. Contract liabilities related to prepaid cards represent funds on card and client funds held to be loaded to card before the amounts are ultimately spent by the cardholders or recognized as revenue by the Company. Contract liabilities related to prepaid cards are reported as Customer card funding liability on the condensed consolidated balance sheet.

 

The opening and closing balances of the Company's contract liabilities are as follows:

        
  

Six Months Ended

June 30,

 
   2022   2021 
Beginning balance  $61,283,914   $48,100,951 
Increase, net   15,683,936    17,654,611 
Ending balance  $76,967,850   $65,755,562 

 

The amount of revenue recognized during the six months ended June 30, 2022 and 2021 that was included in the opening contract liability for prepaid cards was $1,485,005 and $1,023,055, respectively.

  

XML 22 R12.htm IDEA: XBRL DOCUMENT v3.22.2
COMMON STOCK
6 Months Ended
Jun. 30, 2022
Equity [Abstract]  
COMMON STOCK

6.     COMMON STOCK

 

At June 30, 2022, the Company's authorized capital stock was 150,000,000 shares of common stock, par value $0.001 per share, and 25,000,000 shares of preferred stock, par value $0.001 per share. On that date, the Company had 52,323,382 shares of common stock issued and 52,019,932 shares of common stock outstanding, and no shares of preferred stock outstanding.

 

Stock-based compensation expense related to Company grants for the three and six months ended June 30, 2022 was $488,287 and $1,057,789, respectively. Stock-based compensation expense for the three and six months ended June 30, 2021 was $540,921 and $1,777,135, respectively.

 

2022 Transactions: During the three and six months ended June 30, 2022 the Company issued 105,000 and 228,000 shares, respectively, of common stock for vested stock awards and the exercise of stock options and received proceeds of $0 and $0, respectively.

 

2021 Transactions: During the three and six months ended June 30, 2021 the Company issued 392,500 and 891,775 shares, respectively, of common stock for vested stock awards and the exercise of stock options and received proceeds of $9,675 and $120,141, respectively.

 

XML 23 R13.htm IDEA: XBRL DOCUMENT v3.22.2
BASIC AND FULLY DILUTED NET LOSS PER COMMON SHARE
6 Months Ended
Jun. 30, 2022
Earnings Per Share [Abstract]  
BASIC AND FULLY DILUTED NET LOSS PER COMMON SHARE

7.        BASIC AND FULLY DILUTED NET LOSS PER COMMON SHARE

 

The following table sets forth the computation of basic and fully diluted net loss per common share for the three and six months ended June 30, 2022 and 2021: 

                
   Three Months Ended June 30,   Six Months Ended June 30, 
   2022   2021   2022   2021 
Numerator:                
Net loss  $(228,034)  $(931,967)  $(537,429)  $(2,555,494)
Denominator:                    
Weighted average common shares:                    
Denominator for basic calculation   51,993,031    50,748,437    51,906,335    50,551,299 
Weighted average effects of potentially diluted common stock:                    
Stock options (calculated using the treasury method)                
Unvested restricted stock grants                
Denominator for fully diluted calculation   51,993,031    50,748,437    51,906,335    50,551,299 
Net loss per common share:                    
Basic  $(0.00)  $(0.02)  $(0.01)  $(0.05)
Fully diluted  $(0.00)  $(0.02)  $(0.01)  $(0.05)

 

Due to the net loss for the three and six months ended June 30, 2022, the effect of all potential common share equivalents was anti-dilutive, and therefore, all such shares were excluded from the computation of diluted weighted average shares outstanding for both periods. For the three and six months ended June 30, 2022, the amount of potential common share equivalents excluded were 1,884,400 for stock options and 1,064,000 for unvested restricted stock awards. Due to the net loss for the three and six months ended June 30, 2021, the effect of all potential common share equivalents was anti-dilutive, and therefore, all such shares were excluded from the computation of diluted weighted average shares outstanding for both periods. For the three and six months ended June 30, 2021, the amount of potential common share equivalents excluded were 1,997,350 for stock options and 1,868,000 for unvested restricted stock awards.

 

XML 24 R14.htm IDEA: XBRL DOCUMENT v3.22.2
COMMITMENTS AND CONTINGENCIES
6 Months Ended
Jun. 30, 2022
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS AND CONTINGENCIES

8.        COMMITMENTS AND CONTINGENCIES

 

From time to time, we may become involved in various lawsuits and legal proceedings which arise in the ordinary course of business. However, litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our business.

 

The Company has been named as a defendant in three complaints filed in the United States District Court for the District of Nevada: Yilan Shi v. Paysign, Inc. et. al., filed on March 19, 2020 (“Shi”), Lorna Chase v. Paysign, Inc. et. al., filed on March 25, 2020 (“Chase”), and Smith & Duvall v. Paysign, Inc. et. al., filed on April 2, 2020 (collectively, the “Complaints” or “Securities Class Action”). Smith & Duvall v. Paysign, Inc. et. al. was voluntarily dismissed on May 21, 2020. On May 18, 2020, the Shi plaintiffs and another entity called the Paysign Investor Group each filed a motion to consolidate the remaining Shi and Chase actions and to be appointed lead plaintiff. The Complaints are putative class actions filed on behalf of a class of persons who acquired the Company’s common stock from March 19, 2019 through March 31, 2020, inclusive. The Complaints generally allege that the Company, Mark Newcomer, and Mark Attinger violated Section 10(b) of the Securities Exchange Act of 1934 (the “Exchange Act”), and that Messrs. Newcomer and Attinger violated Section 20(a) of the Exchange Act, by making materially false or misleading statements, or failing to disclose material facts, regarding the Company’s internal control over financial reporting and its financial statements. The Complaints seek class action certification, compensatory damages, and attorney’s fees and costs. On December 2, 2020, the Court consolidated Shi and Chase as In re Paysign, Inc. Securities Litigation and appointed the Paysign Investor Group as lead plaintiff. On January 12, 2021, Plaintiffs filed an Amended Complaint in the consolidated action. Defendants filed a Motion to Dismiss the Amended Complaint on March 15, 2021, which Plaintiffs opposed via an opposition brief filed on April 29, 2021, to which Defendants replied on June 1, 2021. Thus, the motion is now fully briefed. The Court has not set a hearing date on the motion, or informed the parties whether it intends to entertain oral argument or rule upon the papers filed. As of the date of this filing, Paysign cannot give any meaningful estimate of likely outcome or damages.

 

The Company has also been named as a nominal defendant in two stockholder derivative actions in the United States District Court for the District of Nevada. The first derivative action is entitled Andrzej Toczek, derivatively on behalf of Paysign, Inc. v. Mark R. Newcomer, et al. and was filed on September 17, 2020. This action alleges violations of Section 14(a) of the Exchange Act, breach of fiduciary duty, unjust enrichment, and waste, largely in connection with the failure to correct information technology controls over financial reporting alleged in the Securities Class Action, thereby causing the Company to face exposure in the Securities Class Action. The complaint also alleges insider trading violations against certain individual defendants. On December 16, 2020, the Court approved a stipulation staying the action until the Court in the consolidated Securities Class Action issues a ruling on the Motion to Dismiss. The second derivative action is entitled John K. Gray, derivatively on behalf of Paysign, Inc. v. Mark Attinger, et al. and was filed on May 9, 2022. This action involves the same alleged conduct raised in the Toczek action and asserts claims for breach of fiduciary duty in connection with financial reporting, breach of fiduciary duty in connection with alleged insider trading against certain individual defendants, and unjust enrichment. On June 3, 2022, the Court approved a stipulation staying the action until the Court in the consolidated Securities Class Action issues a ruling on the Motion to Dismiss. As of the date of this filing, Paysign cannot give any meaningful estimate of likely outcome or damages.

 

XML 25 R15.htm IDEA: XBRL DOCUMENT v3.22.2
RELATED PARTY
6 Months Ended
Jun. 30, 2022
Related Party Transactions [Abstract]  
RELATED PARTY

9.        RELATED PARTY

 

A member of our Board of Directors is also a partner in a law firm that the Company engages for services to review regulatory filings and for various other legal matters. The Company incurred legal expense of $41,019 and $81,753 during the three and six months ended June 30, 2022, respectively, with the related party law firm. During the three and six months ended June 30, 2021 the Company incurred legal expense of $390,172 and $410,884, respectively, with the related party law firm.

 

XML 26 R16.htm IDEA: XBRL DOCUMENT v3.22.2
INCOME TAX PROVISION
6 Months Ended
Jun. 30, 2022
Income Tax Disclosure [Abstract]  
INCOME TAX PROVISION

10.        INCOME TAX PROVISION

 

The effective tax rate (income tax provision as a percentage of loss before income tax provision) was (13.4%) for the three months ended June 30, 2022, as compared to (0.1%) for the three months ended June 30, 2021. The effective tax rate was (5.7%) and (0.1%) for the six months ended June 30, 2022 and 2021, respectively. The effective tax rates vary, primarily as a result of the full valuation on our deferred tax asset in the current year and the tax benefit related to our stock-based compensation and a pretax loss in the prior year period.

 

XML 27 R17.htm IDEA: XBRL DOCUMENT v3.22.2
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT POLICIES (Policies)
6 Months Ended
Jun. 30, 2022
Accounting Policies [Abstract]  
Impact of COVID-19 Pandemic

Impact of COVID-19 Pandemic

 

The coronavirus (“COVID-19”) pandemic, which started in late 2019 and reached the United States in early 2020, continues to significantly impact the economy of the United States and the rest of the world. While the direct disruption appears to have significantly mitigated due to the availability of vaccines and other factors, the ultimate duration and severity of the pandemic remain uncertain, particularly given the development of new variants that continue to spread, and the economic repercussions are still manifesting themselves. The COVID-19 outbreak caused plasma center closures, and the stimulus packages signed into law during 2020 and 2021 reduced the incentive for individuals to donate plasma for supplementary income. Additionally, labor shortages at plasma donation centers and restrictions preventing Mexican nationals with tourist visas from being compensated for donating plasma, have further impacted donations. Those developments have had, and are expected to continue to have, an adverse impact on the Company’s results of operations. Offsetting those headwinds, inflationary pressures for food, gasoline, and other products and services appear to be driving individuals back into the plasma donation centers based upon the increase we experienced in the number of loads per average donation center in the second quarter of 2022 versus the first quarter of 2022. While we remain cautiously optimistic and have seen improvements in our operating results on an aggregated basis, we cannot foresee how long it may take the Company to attain pre-pandemic operating levels on a per plasma donation center basis. Given the uncertainty around the extent and timing of the potential future spread or mitigation of COVID-19 and variants and around the imposition or relaxation of protective measures, management cannot at this time estimate with reasonable accuracy COVID-19’s further impact on the Company’s results of operations, cash flows or financial condition.

 

Under the provisions of the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”) signed into law in 2020 and the subsequent extension of the CARES Act through September 30, 2021, the Company was eligible for a refundable employee retention credit subject to certain criteria. The Company has elected an accounting policy to recognize the government assistance when it is probable that the Company is eligible to receive the assistance and present the credit be as a reduction of the related expense. During the quarter ended June 30, 2022 the Company filed for a refund and recorded $459,755 related to the employee retention credit. As of June 30, 2022 and December 31, 2021, the Company has $1,296,488 and $876,456, respectively in other receivables on the condensed consolidated balance sheet related to refunds.

 

About Paysign, Inc

About Paysign, Inc.

 

Paysign, Inc. (the “Company,” “Paysign,” “we” or “our”) was incorporated on August 24, 1995, and trades under the symbol PAYS on The Nasdaq Stock Market LLC. Paysign. is a provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services and integrated payment processing designed   for businesses, consumers and government institutions. Headquartered in Nevada, the company creates customized, innovative payment solutions for clients across all industries, including pharmaceutical, healthcare, hospitality and retail.

 

Principles of Consolidation

Principles of Consolidation – The condensed consolidated financial statements include the accounts of the Company and its subsidiaries. All significant intercompany balances and transactions have been eliminated.

 

Reclassifications

Reclassifications – In our cash flows statement, certain accounts related to the lease accounting captions in the prior periods have been reclassified to conform to the current period financial statement presentations.  

 

Use of Estimates

Use of Estimates – The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect (i) the reported amounts of assets and liabilities, (ii) the disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and (iii) the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.

 

Cash and Cash Equivalents

Cash and Cash Equivalents – The Company considers all highly liquid investments purchased with an original maturity of six months or less at the time of purchase to be cash equivalents for the purposes of the statement of cash flows. The Company had no cash equivalents at June 30, 2022 and December 31, 2021.

 

Restricted Cash

Restricted Cash – At June 30, 2022 and December 31, 2021, restricted cash consisted of funds held specifically for our card product programs that are contractually restricted to use. The Company includes changes in restricted cash balances with cash and cash equivalents when reconciling the beginning and ending total amounts in our condensed consolidated statements of cash flows.

 

Concentrations of Credit Risk

Concentrations of Credit Risk – Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents and restricted cash. Paysign maintains its cash and cash equivalents and restricted cash in various bank accounts that, at times, may exceed federally insured limits. Paysign has not experienced, nor does it anticipate, any losses with respect to such accounts. At June 30, 2022 and December 31, 2021, the Company had approximately $37,047,586 and $31,828,826 in excess of federally insured bank account limits, respectively.

 

The Company also has a concentration of accounts receivable risk at June 30, 2022 as two Pharma program customers associated with our Pharma copay programs each individually represent 51% and 11% of our accounts receivable balance. Two Pharma program customers each individually represented 52% and 17% of our accounts receivable balance at December 31, 2021.

 

Fixed Assets

Fixed Assets – Fixed assets are stated at cost less accumulated depreciation. Depreciation is principally recorded on the straight-line method over the estimated useful life of the asset, which is generally 3 to 10 years. The cost of repairs and maintenance is charged to expense as incurred. Leasehold improvements are capitalized and depreciated over the shorter of the remaining lease term or the estimated useful life of the improvements. Expenditures for property betterments and renewals are capitalized. Upon sale or other disposition of a depreciable asset, cost and accumulated depreciation are removed from the accounts and any gain or loss is reflected in other income (expense).

 

The Company periodically evaluates whether events and circumstances have occurred that may warrant revision of the estimated useful life of fixed assets or whether the remaining balance of fixed assets should be evaluated for possible impairment. The Company uses an estimate of the related undiscounted cash flows over the remaining life of the fixed assets in measuring their recoverability.

 

Intangible Assets

Intangible Assets – For intangible assets, the Company recognizes an impairment loss if the carrying amount of the intangible asset is not recoverable and exceeds fair value. The carrying amount of the intangible asset is considered not recoverable if it exceeds the sum of the undiscounted cash flows expected to result from the use of the asset.

 

Intangible assets with a finite life are amortized on a straight-line basis over its estimated useful life, which is generally 3 to 15 years.

 

Internally Developed Software Costs - Computer software development costs are expensed as incurred, except for internal use software or website development costs that qualify for capitalization as described below, and include compensation and related expenses, costs of hardware and software, and costs incurred in developing features and functionality.

 

For computer software developed or obtained for internal use, costs that are incurred in the preliminary project and post implementation stages of software development are expensed as incurred. Costs incurred during the application and development stage are capitalized. Capitalized costs are amortized using the straight-line method over a 3three year estimated useful life, beginning in the period in which the software is available for use.

 

Customer Card Funding

Customer Card Funding – At June 30, 2022 and December 31, 2021, customer card funding represents funds loaded or available to be loaded on cards for our prepaid card programs.

 

Earnings Per Share

Earnings Per Share – Basic earnings per share exclude any dilutive effects of options, warrants and convertible securities. Basic earnings per share is computed using the weighted-average number of common shares outstanding during the applicable period. Diluted earnings per share is computed using the weighted average number of common and common stock equivalent shares outstanding during the period, using the treasury stock method. Common stock equivalent shares are excluded from the computation if their effect on the diluted earnings per share calculation is anti-dilutive.

 

Revenue and Expense Recognition

Revenue and Expense Recognition – In determining when and how revenue is recognized from contracts with customers, the Company performs the following five-step analysis: (i) identification of contracts with customers; (ii) determination of performance obligations; (iii) measurement of the transaction price; (iv) allocation of the transaction price to the performance obligations; and (v) recognition of revenue when (or as) the Company satisfies each performance obligation.

 

The Company generates revenues from Plasma card programs through fees generated from cardholder fees and interchange fees. Revenues from Pharma card programs are generated through card program management fees, transaction claims processing fees, interchange fees, and settlement income.

 

Plasma and Pharma card program revenues include both fixed and variable components. Cardholder fees represent an obligation to the cardholder based on a per transaction basis and are recognized at a point in time when the performance obligation is fulfilled. Card program management fees and transaction claims processing fees include an obligation to our card program sponsors and are generally recognized when earned on a monthly basis and are typically due within 30 days pursuant to the contract terms which are generally multi-year contracts. The Company uses the output method to recognize card program management fee revenue at the amount of consideration to which an entity has a right to invoice. The performance obligation is satisfied when the services are transferred to the customer which the Company determined to be monthly, as the customer simultaneously receives and consumes the benefit from the Company’s performance. Interchange fees are earned when customer-issued cards are processed through card payment networks as the nature of our promise to the customer is that we stand ready to process transactions at the customer’s requests on a daily basis over the contract term. Since the timing and quantity of transactions to be processed by us are not determinable, we view interchange fees to comprise an obligation to stand ready to process as many transactions as the customer requests. Accordingly, the promise to stand ready is accounted for as a single series performance obligation. The Company uses the right to invoice practical expedient and recognizes interchange fee revenue concurrent with the processing of card transactions. Interchange fees are settled in accordance with the card payment network terms and conditions, which is typically within a few days.

 

The Company utilizes the remote method of revenue recognition for settlement income whereby the unspent balances will be recognized as revenue at the expiration of the cards and the respective program. The Company records all revenue on a gross basis since it is the primary obligor and establishes the price in the contract arrangement with its customers. The Company is currently under no obligation for refunding any fees, and the Company does not currently have any obligations for disputed claim settlements. Given the nature of the Company’s services and contracts, it has no contract assets.

 

Cost of revenues is comprised of transaction processing fees, data connectivity and data center expenses, network fees, bank fees, card production and postage costs, customer service, program management, application integration setup, and sales and commission expense. 

 

Operating leases

Operating leases – The Company determines if a contract is or contains a leasing element at contract inception or the date in which a modification of an existing contract occurs. In order for a contract to be considered a lease, the contract must transfer the right to control the use of an identified asset for a period of time in exchange for consideration. Control is determined to have occurred if the lessee has the right to (i) obtain substantially all of the economic benefits from the use of the identified asset throughout the period of use and (ii) direct the use of the identified asset.

  

In determining the present value of lease payments at lease commencement date, the Company utilizes its incremental borrowing rate based on the information available, unless the rate implicit in the lease is readily determinable. The liability for operating leases is based on the present value of future lease payments. Operating lease expenses are recorded as rent expense, which is included within selling, general and administrative expenses within the consolidated statements of operations and presented as operating cash outflows within the consolidated statements of cash flows.

 

Leases with an initial term of 12 months or less are not recorded on the balance sheet, with lease expense for these leases recognized on a straight-line basis over the lease term.

 

Stock-Based Compensation

Stock-Based Compensation – The Company recognizes compensation expense for all restricted stock awards and stock options. The fair value of restricted stock awards is measured using the grant date trading price of our stock. The fair value of stock options is estimated at the grant date using the Black-Scholes option-pricing model, and the portion that is ultimately expected to vest is recognized as compensation cost over the requisite service period. We have elected to recognize compensation expense for all options with graded vesting on a straight-line basis over the vesting period of the entire option. The determination of fair value using the Black-Scholes pricing model is affected by our stock price as well as assumptions regarding a number of complex and subjective variables, including expected stock price volatility and the risk-free interest rate.

 

Recently Issued Accounting Pronouncements

Recently Issued Accounting Pronouncements – In June 2016, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2016-13, Financial Instruments–Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which provides updated guidance on how an entity should measure credit losses on all financial instruments carried at amortized cost (including loans held for investment and held-to-maturity debt securities, as well as trade receivables, reinsurance recoverables, and receivables that relate to repurchase agreements and securities lending agreements), a lessor’s net investments in leases, and off-balance sheet credit exposures not accounted for as insurance or as derivatives, including loan commitments, standby letters of credit, and financial guarantees. Subsequently, in November 2018 the FASB issued ASU No. 2018-19, Codification Improvements to Topic 326, Financial Instruments–Credit Losses, which clarified that receivables arising from operating leases are not within the scope of Subtopic 326-20, but instead should be accounted for in accordance with Topic 842, Leases. In March 2022 the FASB issued ASU No. 2022-02, Financial Instruments—Credit Losses: Troubled Debt Restructurings and Vintage Disclosures which clarified accounting treatment required for trouble debt restructurings by creditors and enhanced disclosures for write-offs. The new standard and related amendments are effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. We are currently evaluating the impact of adopting this guidance on our Financial Statements; however, we do not expect it to have a material impact on the Company’s consolidated financial statements.

 

In October 2021, the FASB issued ASU No. 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. This ASU requires contract assets and contract liabilities acquired in a business combination to be recognized and measured by the acquirer on the acquisition date in accordance with ASU No. 2016-10, Revenue from Contracts with Customers (Topic 606). This guidance is effective for the Company beginning on January 1, 2023 and is not expected to have a material impact on the Company’s consolidated financial statements.

 

XML 28 R18.htm IDEA: XBRL DOCUMENT v3.22.2
FIXED ASSETS, NET (Tables)
6 Months Ended
Jun. 30, 2022
Property, Plant and Equipment [Abstract]  
Schedule of fixed assets
        
   June 30,
2022
   December 31,
2021
 
Equipment  $2,098,522   $2,067,834 
Software   323,355    315,855 
Furniture and fixtures   757,662    757,662 
Website costs   69,881    69,881 
Leasehold improvements   229,772    229,772 
    3,479,192    3,441,004 
Less: accumulated depreciation   2,068,245    1,798,023 
Fixed assets, net  $1,410,947   $1,642,981 
XML 29 R19.htm IDEA: XBRL DOCUMENT v3.22.2
INTANGIBLE ASSETS, NET (Tables)
6 Months Ended
Jun. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of intangible assets
        
   June 30,
2022
   December 31,
2021
 
Patents and trademarks  $38,186   $38,186 
Platform   11,391,538    9,853,823 
Customer lists and contracts   1,177,200    1,177,200 
Licenses   209,282    209,282 
    12,816,206    11,278,491 
Less: accumulated amortization   8,314,352    7,191,529 
Intangible assets, net  $4,501,854   $4,086,962 
XML 30 R20.htm IDEA: XBRL DOCUMENT v3.22.2
LEASE (Tables)
6 Months Ended
Jun. 30, 2022
Leases [Abstract]  
Schedule of operating lease liabilities
    
2022 (excluding the six months ended June 30, 2022)  $285,984 
2023   571,968 
2024   571,968 
2025   612,006 
2026   640,604 
Thereafter   2,188,731 
Total lease payments   4,871,261 
Less: Imputed interest   (1,025,323)
Present value of future lease payments   3,845,938 
Less: current portion of lease liability   (350,753)
Long-term portion of lease liability  $3,495,185 
XML 31 R21.htm IDEA: XBRL DOCUMENT v3.22.2
CUSTOMER CARD FUNDING LIABILITY (Tables)
6 Months Ended
Jun. 30, 2022
Revenue from Contract with Customer [Abstract]  
Schedule of contract liabilities
        
  

Six Months Ended

June 30,

 
   2022   2021 
Beginning balance  $61,283,914   $48,100,951 
Increase, net   15,683,936    17,654,611 
Ending balance  $76,967,850   $65,755,562 
XML 32 R22.htm IDEA: XBRL DOCUMENT v3.22.2
BASIC AND FULLY DILUTED NET LOSS PER COMMON SHARE (Tables)
6 Months Ended
Jun. 30, 2022
Earnings Per Share [Abstract]  
Schedule of computation of earnings per share
                
   Three Months Ended June 30,   Six Months Ended June 30, 
   2022   2021   2022   2021 
Numerator:                
Net loss  $(228,034)  $(931,967)  $(537,429)  $(2,555,494)
Denominator:                    
Weighted average common shares:                    
Denominator for basic calculation   51,993,031    50,748,437    51,906,335    50,551,299 
Weighted average effects of potentially diluted common stock:                    
Stock options (calculated using the treasury method)                
Unvested restricted stock grants                
Denominator for fully diluted calculation   51,993,031    50,748,437    51,906,335    50,551,299 
Net loss per common share:                    
Basic  $(0.00)  $(0.02)  $(0.01)  $(0.05)
Fully diluted  $(0.00)  $(0.02)  $(0.01)  $(0.05)
XML 33 R23.htm IDEA: XBRL DOCUMENT v3.22.2
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT POLICIES (Details Narrative) - USD ($)
6 Months Ended 12 Months Ended
Jun. 30, 2022
Dec. 31, 2021
Product Information [Line Items]    
Employee related cost $ 459,755  
Cash equivalents 0 $ 0
Fdic insured $ 37,047,586 $ 31,828,826
Property, Plant and Equipment, Estimated Useful Lives 3 to 10 years  
Intangible Assets [Member]    
Product Information [Line Items]    
[custom:FiniteLivedIntangibleAssetUsefulLife1] 3 to 15 years  
Computer Software [Member]    
Product Information [Line Items]    
[custom:FiniteLivedIntangibleAssetUsefulLife1] 3  
Accounts Receivable [Member] | Customer Concentration Risk [Member] | One Customer [Member]    
Product Information [Line Items]    
Concentration Risk, Percentage 51.00% 52.00%
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Another Customer [Member]    
Product Information [Line Items]    
Concentration Risk, Percentage 11.00% 17.00%
Other Receivable [Member]    
Product Information [Line Items]    
Other receivable $ 1,296,488 $ 876,456
XML 34 R24.htm IDEA: XBRL DOCUMENT v3.22.2
FIXED ASSETS, NET (Details) - USD ($)
Jun. 30, 2022
Dec. 31, 2021
Property, Plant and Equipment [Line Items]    
Property, Plant and Equipment, Gross $ 3,479,192 $ 3,441,004
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment 2,068,245 1,798,023
Property, Plant and Equipment, Net 1,410,947 1,642,981
Equipment [Member]    
Property, Plant and Equipment [Line Items]    
Property, Plant and Equipment, Gross 2,098,522 2,067,834
Software Development [Member]    
Property, Plant and Equipment [Line Items]    
Property, Plant and Equipment, Gross 323,355 315,855
Furniture and Fixtures [Member]    
Property, Plant and Equipment [Line Items]    
Property, Plant and Equipment, Gross 757,662 757,662
Website Costs [Member]    
Property, Plant and Equipment [Line Items]    
Property, Plant and Equipment, Gross 69,881 69,881
Leasehold Improvements [Member]    
Property, Plant and Equipment [Line Items]    
Property, Plant and Equipment, Gross $ 229,772 $ 229,772
XML 35 R25.htm IDEA: XBRL DOCUMENT v3.22.2
FIXED ASSETS, NET (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Property, Plant and Equipment [Abstract]        
Depreciation expense $ 134,253 $ 133,174 $ 270,222 $ 265,125
XML 36 R26.htm IDEA: XBRL DOCUMENT v3.22.2
INTANGIBLE ASSETS, NET (Details) - USD ($)
Jun. 30, 2022
Dec. 31, 2021
Finite-Lived Intangible Assets [Line Items]    
Finite-Lived Intangible Assets, Gross $ 12,816,206 $ 11,278,491
Finite-Lived Intangible Assets, Accumulated Amortization 8,314,352 7,191,529
Intangible Assets, Net (Excluding Goodwill) 4,501,854 4,086,962
Trademarks and Trade Names [Member]    
Finite-Lived Intangible Assets [Line Items]    
Finite-Lived Intangible Assets, Gross 38,186 38,186
Platform [Member]    
Finite-Lived Intangible Assets [Line Items]    
Finite-Lived Intangible Assets, Gross 11,391,538 9,853,823
Customer lists and contracts [Member]    
Finite-Lived Intangible Assets [Line Items]    
Finite-Lived Intangible Assets, Gross 1,177,200 1,177,200
Licenses [Member]    
Finite-Lived Intangible Assets [Line Items]    
Finite-Lived Intangible Assets, Gross $ 209,282 $ 209,282
XML 37 R27.htm IDEA: XBRL DOCUMENT v3.22.2
INTANGIBLE ASSETS, NET (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Finite-Lived Intangible Assets [Line Items]        
Amortization $ 578,927 $ 481,008 $ 1,122,129 $ 944,905
Intangible Assets [Member]        
Finite-Lived Intangible Assets [Line Items]        
[custom:FiniteLivedIntangibleAssetUsefulLife1]     3 to 15 years  
XML 38 R28.htm IDEA: XBRL DOCUMENT v3.22.2
LEASE (Details) - USD ($)
Jun. 30, 2022
Dec. 31, 2021
Leases [Abstract]    
2022 (excluding the six months ended June 30, 2022) $ 285,984  
2023 571,968  
2024 571,968  
2025 612,006  
2026 640,604  
Thereafter 2,188,731  
Total lease payments 4,871,261  
Less: Imputed interest 1,025,323  
Present value of future lease payments 3,845,938  
Less: current portion of lease liability (350,753) $ (340,412)
Long-term portion of lease liability $ 3,495,185 $ 3,673,186
XML 39 R29.htm IDEA: XBRL DOCUMENT v3.22.2
LEASE (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Leases [Abstract]        
Lease term 10 years   10 years  
Lease term option to extend     two optional extensions of five years each  
Remaining lease term 7 years 10 months 24 days   7 years 10 months 24 days  
Discount rate 6.00%   6.00%  
Operating lease cost $ 184,329 $ 209,056 $ 367,550 $ 424,200
XML 40 R30.htm IDEA: XBRL DOCUMENT v3.22.2
CUSTOMER CARD FUNDING LIABILITY (Details) - USD ($)
6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Revenue from Contract with Customer [Abstract]    
Beginning balance $ 61,283,914 $ 48,100,951
Increase (decrease), net 15,683,936 17,654,611
Ending balance $ 76,967,850 $ 65,755,562
XML 41 R31.htm IDEA: XBRL DOCUMENT v3.22.2
CUSTOMER CARD FUNDING LIABILITY (Details Narrative) - USD ($)
6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Revenue from Contract with Customer [Abstract]    
Revenue recognized in current year previously included in contract liabilities $ 1,485,005 $ 1,023,055
XML 42 R32.htm IDEA: XBRL DOCUMENT v3.22.2
COMMON STOCK (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Dec. 31, 2021
Equity [Abstract]          
Common Stock, Shares Authorized 150,000,000   150,000,000   150,000,000
Common Stock, Par or Stated Value Per Share $ 0.001   $ 0.001   $ 0.001
Preferred Stock, Shares Authorized 25,000,000   25,000,000   25,000,000
Preferred Stock, Par or Stated Value Per Share $ 0.001   $ 0.001   $ 0.001
Common Stock, Shares, Issued 52,323,382   52,323,382   52,095,382
Common Stock, Shares, Outstanding 52,019,932   52,019,932    
Share-based Payment Arrangement, Noncash Expense $ 488,287 $ 540,921 $ 1,057,789 $ 1,777,135  
Number of shares vested 105,000 392,500 228,000 891,775  
Proceeds Form Vested Stock Awards And Stock Options $ 0 $ 9,675 $ 0 $ 120,141  
XML 43 R33.htm IDEA: XBRL DOCUMENT v3.22.2
BASIC AND FULLY DILUTED NET LOSS PER COMMON SHARE (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Numerator:        
Net loss $ (228,034) $ (931,967) $ (537,429) $ (2,555,494)
Weighted average common shares:        
Denominator for basic calculation 51,993,031 50,748,437 51,906,335 50,551,299
Weighted average effects of potentially diluted common stock:        
Stock options (calculated using the treasury method) 0 0 0 0
Unvested restricted stock grants 0 0 0 0
Denominator for fully diluted calculation 51,993,031 50,748,437 51,906,335 50,551,299
Basic $ (0.00) $ (0.02) $ (0.01) $ (0.05)
Fully diluted $ (0.00) $ (0.02) $ (0.01) $ (0.05)
XML 44 R34.htm IDEA: XBRL DOCUMENT v3.22.2
BASIC AND FULLY DILUTED NET LOSS PER COMMON SHARE (Details Narrative) - shares
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Stock Options [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Potential common share equivalents excluded from computation 1,884,400 1,997,350 1,884,400 1,997,350
Unvested Restricted Stock Awards [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Potential common share equivalents excluded from computation 1,064,000 1,868,000 1,064,000 1,868,000
XML 45 R35.htm IDEA: XBRL DOCUMENT v3.22.2
RELATED PARTY (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Related Party Law Firm [Member]        
Related Party Transaction [Line Items]        
Legal Fees $ 41,019 $ 390,172 $ 81,753 $ 410,884
XML 46 R36.htm IDEA: XBRL DOCUMENT v3.22.2
INCOME TAX PROVISION (Details Narrative)
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Income Tax Disclosure [Abstract]        
Effective income tax rate 13.40% 0.10% 5.70% 0.10%
XML 47 paysign_i10q-063022_htm.xml IDEA: XBRL DOCUMENT 0001496443 2022-01-01 2022-06-30 0001496443 2022-08-05 0001496443 2022-06-30 0001496443 2021-12-31 0001496443 2022-04-01 2022-06-30 0001496443 2021-04-01 2021-06-30 0001496443 2021-01-01 2021-06-30 0001496443 PAYS:PlasmaIndustryMember 2022-04-01 2022-06-30 0001496443 PAYS:PlasmaIndustryMember 2021-04-01 2021-06-30 0001496443 PAYS:PlasmaIndustryMember 2022-01-01 2022-06-30 0001496443 PAYS:PlasmaIndustryMember 2021-01-01 2021-06-30 0001496443 PAYS:PharmaceuticalIndustryMember 2022-04-01 2022-06-30 0001496443 PAYS:PharmaceuticalIndustryMember 2021-04-01 2021-06-30 0001496443 PAYS:PharmaceuticalIndustryMember 2022-01-01 2022-06-30 0001496443 PAYS:PharmaceuticalIndustryMember 2021-01-01 2021-06-30 0001496443 PAYS:OtherRevenueMember 2022-04-01 2022-06-30 0001496443 PAYS:OtherRevenueMember 2021-04-01 2021-06-30 0001496443 PAYS:OtherRevenueMember 2022-01-01 2022-06-30 0001496443 PAYS:OtherRevenueMember 2021-01-01 2021-06-30 0001496443 us-gaap:CommonStockMember 2021-12-31 0001496443 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001496443 us-gaap:TreasuryStockMember 2021-12-31 0001496443 us-gaap:RetainedEarningsMember 2021-12-31 0001496443 us-gaap:CommonStockMember 2022-03-31 0001496443 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001496443 us-gaap:TreasuryStockMember 2022-03-31 0001496443 us-gaap:RetainedEarningsMember 2022-03-31 0001496443 2022-03-31 0001496443 us-gaap:CommonStockMember 2020-12-31 0001496443 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001496443 us-gaap:TreasuryStockMember 2020-12-31 0001496443 us-gaap:RetainedEarningsMember 2020-12-31 0001496443 2020-12-31 0001496443 us-gaap:CommonStockMember 2021-03-31 0001496443 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001496443 us-gaap:TreasuryStockMember 2021-03-31 0001496443 us-gaap:RetainedEarningsMember 2021-03-31 0001496443 2021-03-31 0001496443 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001496443 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001496443 us-gaap:TreasuryStockMember 2022-01-01 2022-03-31 0001496443 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001496443 2022-01-01 2022-03-31 0001496443 us-gaap:CommonStockMember 2022-04-01 2022-06-30 0001496443 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0001496443 us-gaap:TreasuryStockMember 2022-04-01 2022-06-30 0001496443 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001496443 us-gaap:CommonStockMember 2021-01-01 2021-03-31 0001496443 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0001496443 us-gaap:TreasuryStockMember 2021-01-01 2021-03-31 0001496443 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001496443 2021-01-01 2021-03-31 0001496443 us-gaap:CommonStockMember 2021-04-01 2021-06-30 0001496443 us-gaap:AdditionalPaidInCapitalMember 2021-04-01 2021-06-30 0001496443 us-gaap:TreasuryStockMember 2021-04-01 2021-06-30 0001496443 us-gaap:RetainedEarningsMember 2021-04-01 2021-06-30 0001496443 us-gaap:CommonStockMember 2022-06-30 0001496443 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001496443 us-gaap:TreasuryStockMember 2022-06-30 0001496443 us-gaap:RetainedEarningsMember 2022-06-30 0001496443 us-gaap:CommonStockMember 2021-06-30 0001496443 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001496443 us-gaap:TreasuryStockMember 2021-06-30 0001496443 us-gaap:RetainedEarningsMember 2021-06-30 0001496443 2021-06-30 0001496443 PAYS:OtherReceivableMember 2022-06-30 0001496443 PAYS:OtherReceivableMember 2021-12-31 0001496443 PAYS:OneCustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-06-30 0001496443 PAYS:AnotherCustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-06-30 0001496443 PAYS:OneCustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0001496443 PAYS:AnotherCustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0001496443 PAYS:IntangibleAssetsMember 2022-01-01 2022-06-30 0001496443 PAYS:ComputerSoftwareMember 2022-01-01 2022-06-30 0001496443 us-gaap:EquipmentMember 2022-06-30 0001496443 us-gaap:EquipmentMember 2021-12-31 0001496443 us-gaap:SoftwareDevelopmentMember 2022-06-30 0001496443 us-gaap:SoftwareDevelopmentMember 2021-12-31 0001496443 us-gaap:FurnitureAndFixturesMember 2022-06-30 0001496443 us-gaap:FurnitureAndFixturesMember 2021-12-31 0001496443 PAYS:WebsiteCostsMember 2022-06-30 0001496443 PAYS:WebsiteCostsMember 2021-12-31 0001496443 us-gaap:LeaseholdImprovementsMember 2022-06-30 0001496443 us-gaap:LeaseholdImprovementsMember 2021-12-31 0001496443 us-gaap:TrademarksAndTradeNamesMember 2022-06-30 0001496443 us-gaap:TrademarksAndTradeNamesMember 2021-12-31 0001496443 PAYS:PlatformMember 2022-06-30 0001496443 PAYS:PlatformMember 2021-12-31 0001496443 PAYS:CustomerListsAndContractsMember 2022-06-30 0001496443 PAYS:CustomerListsAndContractsMember 2021-12-31 0001496443 PAYS:LicensesMember 2022-06-30 0001496443 PAYS:LicensesMember 2021-12-31 0001496443 PAYS:StockOptionsMember 2022-04-01 2022-06-30 0001496443 PAYS:StockOptionsMember 2022-01-01 2022-06-30 0001496443 PAYS:UnvestedRestrictedStockAwardsMember 2022-04-01 2022-06-30 0001496443 PAYS:UnvestedRestrictedStockAwardsMember 2022-01-01 2022-06-30 0001496443 PAYS:StockOptionsMember 2021-04-01 2021-06-30 0001496443 PAYS:StockOptionsMember 2021-01-01 2021-06-30 0001496443 PAYS:UnvestedRestrictedStockAwardsMember 2021-04-01 2021-06-30 0001496443 PAYS:UnvestedRestrictedStockAwardsMember 2021-01-01 2021-06-30 0001496443 PAYS:RelatedPartyLawFirmMember 2022-04-01 2022-06-30 0001496443 PAYS:RelatedPartyLawFirmMember 2022-01-01 2022-06-30 0001496443 PAYS:RelatedPartyLawFirmMember 2021-04-01 2021-06-30 0001496443 PAYS:RelatedPartyLawFirmMember 2021-01-01 2021-06-30 iso4217:USD shares iso4217:USD shares pure 0001496443 false --12-31 2022 Q2 10-Q true 2022-06-30 false 001-38623 PAYSIGN, INC. NV 95-4550154 2615 St. Rose Parkway Henderson NV 89052 (702) 453-2221 Common Stock, $0.001 par value per share PAYS NASDAQ Yes Yes Non-accelerated Filer true true false false 52151932 6527476 7387156 76967850 61283914 3488759 3393940 1439251 1019218 1754140 1242967 90177476 74327195 1410947 1642981 4501854 4086962 3806793 3993655 99897070 84050793 5575119 5765478 350753 340412 76967850 61283914 82893722 67389804 3495185 3673186 86388907 71062990 0.001 0.001 25000000 25000000 0 0 0 0 0 0 0.001 0.001 150000000 150000000 52323382 52095382 52323 52095 17917680 16860119 303450 303450 150000 150000 -4311840 -3774411 13508163 12987803 99897070 84050793 7806201 5947313 15200565 11330464 773311 641037 1579879 1523867 19264 62940 38971 76387 8598776 6651290 16819415 12930718 3900965 3498723 7123355 6946345 4697811 3152567 9696060 5984373 4255976 3474562 8896888 7339548 713180 614182 1392351 1210030 4969156 4088744 10289239 8549578 -271345 -936177 -593179 -2565205 70227 5010 84563 12111 -201118 -931167 -508616 -2553094 26916 800 28813 2400 -228034 -931967 -537429 -2555494 -0.00 -0.02 -0.01 -0.05 -0.00 -0.02 -0.01 -0.05 51993031 50748437 51906335 50551299 51993031 50748437 51906335 50551299 52095382 52095 16860119 -150000 -3774411 12987803 123000 123 -123 569502 569502 -309395 -309395 52218382 52218 17429498 -150000 -4083806 13247910 105000 105 -105 488287 -228034 -228034 52323382 52323 17917680 -150000 -4311840 13508163 50251607 50252 14388890 -150000 -1053077 13236065 466689 467 -467 32586 32 110434 110466 636214 636214 -1623527 -1623527 50750882 50751 15135071 -150000 -2676604 12359218 390000 390 -390 2500 2 9673 9675 540921 540921 -931967 -931967 51143382 51143 15685275 -150000 -3608571 11977847 -537429 -2555494 1057789 1210030 1392351 1177135 186862 211407 94819 293095 420033 -0 511173 366502 -190359 701581 -167660 -157920 15683936 17654611 16399465 17581753 38188 173479 1537021 1048364 -0 39713 -1575209 -1261556 0 120141 0 120141 14824256 16440338 68671070 55930404 83495326 72370742 6527476 6615180 76967850 65755562 83495326 72370742 8700 2400 821 2173 <p id="xdx_80C_eus-gaap--BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_znxRsMVm9AL" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">1.     <span style="text-decoration: underline"><span id="xdx_829_zEPgMhQo0YO3">BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT POLICIES</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The foregoing unaudited interim condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions for Form 10-Q and Regulation S-X as promulgated by the Securities and Exchange Commission (“SEC”). Accordingly, these financial statements do not include all of the disclosures required by GAAP for complete financial statements. These unaudited interim condensed consolidated financial statements should be read in conjunction with the audited financial statements and the notes thereto included on Form 10-K for the year ended December 31, 2021. In the opinion of management, the unaudited interim condensed consolidated financial statements furnished herein include all adjustments, all of which are of a normal recurring nature, necessary for a fair statement of the results for the interim period presented.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in accordance with GAAP requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities known to exist as of the date the financial statements are published, and the reported amounts of revenues and expenses during the reporting period. Uncertainties with respect to such estimates and assumptions are inherent in the preparation of the Company’s financial statements; accordingly, it is possible that the actual results could differ from these estimates and assumptions that could have a material effect on the reported amounts of the Company’s financial position and results of operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Operating results for the six months ended June 30, 2022 are not necessarily indicative of the results that may be expected for the year ending December 31, 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_846_ecustom--ImpactOfCovid19PandemicPoliciesTextBlock_zGtfOS69Q7td" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_863_zgmhf30F4poa">Impact of COVID-19 Pandemic</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The coronavirus (“COVID-19”) pandemic, which started in late 2019 and reached the United States in early 2020, continues to significantly impact the economy of the United States and the rest of the world. While the direct disruption appears to have significantly mitigated due to the availability of vaccines and other factors, the ultimate duration and severity of the pandemic remain uncertain, particularly given the development of new variants that continue to spread, and the economic repercussions are still manifesting themselves. The COVID-19 outbreak caused plasma center closures, and the stimulus packages signed into law during 2020 and 2021 reduced the incentive for individuals to donate plasma for supplementary income. Additionally, labor shortages at plasma donation centers and restrictions preventing Mexican nationals with tourist visas from being compensated for donating plasma, have further impacted donations. Those developments have had, and are expected to continue to have, an adverse impact on the Company’s results of operations. Offsetting those headwinds, inflationary pressures for food, gasoline, and other products and services appear to be driving individuals back into the plasma donation centers based upon the increase we experienced in the number of loads per average donation center in the second quarter of 2022 versus the first quarter of 2022. While we remain cautiously optimistic and have seen improvements in our operating results on an aggregated basis, we cannot foresee how long it may take the Company to attain pre-pandemic operating levels on a per plasma donation center basis. Given the uncertainty around the extent and timing of the potential future spread or mitigation of COVID-19 and variants and around the imposition or relaxation of protective measures, management cannot at this time estimate with reasonable accuracy COVID-19’s further impact on the Company’s results of operations, cash flows or financial condition.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under the provisions of the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”) signed into law in 2020 and the subsequent extension of the CARES Act through September 30, 2021, the Company was eligible for a refundable employee retention credit subject to certain criteria. The Company has elected an accounting policy to recognize the government assistance when it is probable that the Company is eligible to receive the assistance and present the credit be as a reduction of the related expense. During the quarter ended June 30, 2022 the Company filed for a refund and recorded $<span id="xdx_90C_eus-gaap--EmployeeRelatedLiabilitiesCurrent_iI_c20220630_zufJKUQrkLgk" title="Employee related cost">459,755</span> related to the employee retention credit. As of June 30, 2022 and December 31, 2021, the Company has $<span id="xdx_90B_ecustom--RefundReceivable_iI_c20220630__us-gaap--BalanceSheetLocationAxis__custom--OtherReceivableMember_zAStctYWmcS" title="Other receivable">1,296,488</span> and $<span id="xdx_90F_ecustom--RefundReceivable_iI_c20211231__us-gaap--BalanceSheetLocationAxis__custom--OtherReceivableMember_zFzSpxd58be7">876,456</span>, respectively in other receivables on the condensed consolidated balance sheet related to refunds.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_84C_eus-gaap--BusinessDescriptionAndAccountingPoliciesTextBlock_zm6qFtajyIzd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_86B_zFB9YLE1aBz6">About Paysign, Inc</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Paysign, Inc. (the “Company,” “Paysign,” “we” or “our”) was incorporated on August 24, 1995, and trades under the symbol PAYS on The Nasdaq Stock Market LLC. Paysign. is a provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services and integrated payment processing designed</span>   <span style="font-family: Times New Roman, Times, Serif">for businesses, consumers and government institutions. Headquartered in Nevada, the company creates customized, innovative payment solutions for clients across all industries, including pharmaceutical, healthcare, hospitality and retail.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_842_eus-gaap--ConsolidationPolicyTextBlock_zrVqx5j4k4Kl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_868_zU9fJDbPeiB5">Principles of Consolidation</span></span> – The condensed consolidated financial statements include the accounts of the Company and its subsidiaries. All significant intercompany balances and transactions have been eliminated.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_849_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zttdQEX9KFzh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_868_zfNt5UGoKUsg">Reclassifications</span></span> – In our cash flows statement, certain accounts related to the lease accounting captions in the prior periods have been reclassified to conform to the current period financial statement presentations.</span>  </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_84E_eus-gaap--UseOfEstimates_zTQTVxI9Lg4f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_86E_z2KAjPN7xKZ2">Use of Estimates</span></span> – The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect (i) the reported amounts of assets and liabilities, (ii) the disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and (iii) the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_842_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_z0Ecqs3ugN5a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_864_zzMUhl8sHilj">Cash and Cash Equivalents</span></span> – The Company considers all highly liquid investments purchased with an original maturity of six months or less at the time of purchase to be cash equivalents for the purposes of the statement of cash flows. The Company had <span id="xdx_901_eus-gaap--CashEquivalentsAtCarryingValue_iI_pp0p0_do_c20220630_zRHxCiiivfrk" title="Cash equivalents"><span id="xdx_901_eus-gaap--CashEquivalentsAtCarryingValue_iI_pp0p0_do_c20211231_zq7ND84JtRu3" title="Cash equivalents">no</span></span> cash equivalents at June 30, 2022 and December 31, 2021.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_84E_eus-gaap--CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_zRdU03qtG3k2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_861_zdYlAIOxLdPa">Restricted Cash</span></span> – At June 30, 2022 and December 31, 2021, restricted cash consisted of funds held specifically for our card product programs that are contractually restricted to use. The Company includes changes in restricted cash balances with cash and cash equivalents when reconciling the beginning and ending total amounts in our condensed consolidated statements of cash flows.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_849_eus-gaap--ConcentrationRiskCreditRisk_zrx4myTEWPT4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_865_zkfVAdkoufZ7">Concentrations of Credit Risk</span></span> – Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents and restricted cash. Paysign maintains its cash and cash equivalents and restricted cash in various bank accounts that, at times, may exceed federally insured limits. Paysign has not experienced, nor does it anticipate, any losses with respect to such accounts. At June 30, 2022 and December 31, 2021, the Company had approximately $<span id="xdx_902_eus-gaap--CashUninsuredAmount_c20220630_pp0p0" title="Fdic insured">37,047,586</span> and $<span id="xdx_907_eus-gaap--CashUninsuredAmount_c20211231_pp0p0" title="Fdic insured">31,828,826</span> in excess of federally insured bank account limits, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company also has a concentration of accounts receivable risk at June 30, 2022 as two Pharma program customers associated with our Pharma copay programs each individually represent <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneCustomerMember_zNVEmM1cOvX7" title="Concentration Risk, Percentage">51</span>% and <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--AnotherCustomerMember_zAZUekDWBqgk" title="Concentration Risk, Percentage">11</span>% of our accounts receivable balance. Two Pharma program customers each individually represented <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneCustomerMember_zI0dsdtVNWjl" title="Concentration Risk, Percentage">52</span>% and <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--AnotherCustomerMember_zeFlltaFU81h" title="Concentration Risk, Percentage">17</span>% of our accounts receivable balance at December 31, 2021.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_842_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zd0kb0l63mOc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_861_z1ywoyXyg9Tf">Fixed Assets</span></span> – Fixed assets are stated at cost less accumulated depreciation. Depreciation is principally recorded on the straight-line method over the estimated useful life of the asset, which is generally <span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentEstimatedUsefulLives_c20220101__20220630_z3Ibo7SNTWl4">3 to 10 years</span>. The cost of repairs and maintenance is charged to expense as incurred. Leasehold improvements are capitalized and depreciated over the shorter of the remaining lease term or the estimated useful life of the improvements. Expenditures for property betterments and renewals are capitalized. Upon sale or other disposition of a depreciable asset, cost and accumulated depreciation are removed from the accounts and any gain or loss is reflected in other income (expense).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company periodically evaluates whether events and circumstances have occurred that may warrant revision of the estimated useful life of fixed assets or whether the remaining balance of fixed assets should be evaluated for possible impairment. The Company uses an estimate of the related undiscounted cash flows over the remaining life of the fixed assets in measuring their recoverability.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_848_eus-gaap--IntangibleAssetsFiniteLivedPolicy_zX1WBdJZTT68" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_863_zwCF8kZAHqNi">Intangible Assets</span></span> – For intangible assets, the Company recognizes an impairment loss if the carrying amount of the intangible asset is not recoverable and exceeds fair value. The carrying amount of the intangible asset is considered not recoverable if it exceeds the sum of the undiscounted cash flows expected to result from the use of the asset.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Intangible assets with a finite life are amortized on a straight-line basis over its estimated useful life, which is generally <span id="xdx_90E_ecustom--FiniteLivedIntangibleAssetUsefulLife1_c20220101__20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--IntangibleAssetsMember_zj767k3sK3ta">3 to 15 years</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Internally Developed Software Costs - </i>Computer software development costs are expensed as incurred, except for internal use software or website development costs that qualify for capitalization as described below, and include compensation and related expenses, costs of hardware and software, and costs incurred in developing features and functionality.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For computer software developed or obtained for internal use, costs that are incurred in the preliminary project and post implementation stages of software development are expensed as incurred. Costs incurred during the application and development stage are capitalized. Capitalized costs are amortized using the straight-line method over a <span id="xdx_904_ecustom--FiniteLivedIntangibleAssetUsefulLife1_c20220101__20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ComputerSoftwareMember_z8hZVwFJ6yWl" style="color: White">3</span>three year estimated useful life, beginning in the period in which the software is available for use.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_849_ecustom--CustomerCardFundingPolicyTextBlock_z3qbQf5bGeqb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_86C_z5G0C3xYiOG6">Customer Card Funding</span></span> – At June 30, 2022 and December 31, 2021, customer card funding represents funds loaded or available to be loaded on cards for our prepaid card programs.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_846_eus-gaap--EarningsPerSharePolicyTextBlock_z6QVlkdeaABa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_862_zrxdElDjCZF9">Earnings Per Share</span></span> – Basic earnings per share exclude any dilutive effects of options, warrants and convertible securities. Basic earnings per share is computed using the weighted-average number of common shares outstanding during the applicable period. Diluted earnings per share is computed using the weighted average number of common and common stock equivalent shares outstanding during the period, using the treasury stock method. Common stock equivalent shares are excluded from the computation if their effect on the diluted earnings per share calculation is anti-dilutive.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_844_eus-gaap--RevenueRecognitionPolicyTextBlock_zxQunrfZ0yM6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_861_zntMgD9CT6h8">Revenue and Expense Recognition</span></span> – In determining when and how revenue is recognized from contracts with customers, the Company performs the following five-step analysis: (i) identification of contracts with customers; (ii) determination of performance obligations; (iii) measurement of the transaction price; (iv) allocation of the transaction price to the performance obligations; and (v) recognition of revenue when (or as) the Company satisfies each performance obligation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company generates revenues from Plasma card programs through fees generated from cardholder fees and interchange fees. Revenues from Pharma card programs are generated through card program management fees, transaction claims processing fees, interchange fees, and settlement income.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Plasma and Pharma card program revenues include both fixed and variable components. Cardholder fees represent an obligation to the cardholder based on a per transaction basis and are recognized at a point in time when the performance obligation is fulfilled. Card program management fees and transaction claims processing fees include an obligation to our card program sponsors and are generally recognized when earned on a monthly basis and are typically due within 30 days pursuant to the contract terms which are generally multi-year contracts. The Company uses the output method to recognize card program management fee revenue at the amount of consideration to which an entity has a right to invoice. The performance obligation is satisfied when the services are transferred to the customer which the Company determined to be monthly, as the customer simultaneously receives and consumes the benefit from the Company’s performance. Interchange fees are earned when customer-issued cards are processed through card payment networks as the nature of our promise to the customer is that we stand ready to process transactions at the customer’s requests on a daily basis over the contract term. Since the timing and quantity of transactions to be processed by us are not determinable, we view interchange fees to comprise an obligation to stand ready to process as many transactions as the customer requests. Accordingly, the promise to stand ready is accounted for as a single series performance obligation. The Company uses the right to invoice practical expedient and recognizes interchange fee revenue concurrent with the processing of card transactions. Interchange fees are settled in accordance with the card payment network terms and conditions, which is typically within a few days.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company utilizes the remote method of revenue recognition for settlement income whereby the unspent balances will be recognized as revenue at the expiration of the cards and the respective program. The Company records all revenue on a gross basis since it is the primary obligor and establishes the price in the contract arrangement with its customers. The Company is currently under no obligation for refunding any fees, and the Company does not currently have any obligations for disputed claim settlements. Given the nature of the Company’s services and contracts, it has no contract assets.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Cost of revenues is comprised of transaction processing fees, data connectivity and data center expenses, network fees, bank fees, card production and postage costs, customer service, program management, application integration setup, and sales and commission expense. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_849_eus-gaap--LesseeLeasesPolicyTextBlock_zZzLT1pBpeC8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_864_zLC5a2gTm5md">Operating leases</span></span> – The Company determines if a contract is or contains a leasing element at contract inception or the date in which a modification of an existing contract occurs. In order for a contract to be considered a lease, the contract must transfer the right to control the use of an identified asset for a period of time in exchange for consideration. Control is determined to have occurred if the lessee has the right to (i) obtain substantially all of the economic benefits from the use of the identified asset throughout the period of use and (ii) direct the use of the identified asset.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">  </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In determining the present value of lease payments at lease commencement date, the Company utilizes its incremental borrowing rate based on the information available, unless the rate implicit in the lease is readily determinable. The liability for operating leases is based on the present value of future lease payments. Operating lease expenses are recorded as rent expense, which is included within selling, general and administrative expenses within the consolidated statements of operations and presented as operating cash outflows within the consolidated statements of cash flows.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Leases with an initial term of 12 months or less are not recorded on the balance sheet, with lease expense for these leases recognized on a straight-line basis over the lease term</span><span style="font-family: Times New Roman, Times, Serif">.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_842_eus-gaap--CompensationRelatedCostsPolicyTextBlock_zgaHTqShThf6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_864_zlustcQTQSm2">Stock-Based Compensation</span></span> – The Company recognizes compensation expense for all restricted stock awards and stock options. The fair value of restricted stock awards is measured using the grant date trading price of our stock. The fair value of stock options is estimated at the grant date using the Black-Scholes option-pricing model, and the portion that is ultimately expected to vest is recognized as compensation cost over the requisite service period. We have elected to recognize compensation expense for all options with graded vesting on a straight-line basis over the vesting period of the entire option. The determination of fair value using the Black-Scholes pricing model is affected by our stock price as well as assumptions regarding a number of complex and subjective variables, including expected stock price volatility and the risk-free interest rate.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_841_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zLmVtGDWe3vj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_86D_zbWTghn4osa">Recently Issued Accounting Pronouncements</span></span> – In June 2016, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2016-13, <i>Financial Instruments–Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, </i>which provides updated guidance on how an entity should measure credit losses on all financial instruments carried at amortized cost (including loans held for investment and held-to-maturity debt securities, as well as trade receivables, reinsurance recoverables, and receivables that relate to repurchase agreements and securities lending agreements), a lessor’s net investments in leases, and off-balance sheet credit exposures not accounted for as insurance or as derivatives, including loan commitments, standby letters of credit, and financial guarantees. Subsequently, in November 2018 the FASB issued ASU No. 2018-19, <i>Codification Improvements to Topic 326, Financial Instruments–Credit Losses, </i>which clarified that receivables arising from operating leases are not within the scope of Subtopic 326-20, but instead should be accounted for in accordance with Topic 842, Leases. In March 2022 the FASB issued ASU No. 2022-02, <i>Financial Instruments—Credit Losses: Troubled Debt Restructurings and Vintage Disclosures </i>which clarified accounting treatment required for trouble debt restructurings by creditors and enhanced disclosures for write-offs. The new standard and related amendments are effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. We are currently evaluating the impact of adopting this guidance on our Financial Statements; however, we do not expect it to have a material impact on the Company’s consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In October 2021, the FASB issued ASU No. 2021-08, <i>Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers</i>. This ASU requires contract assets and contract liabilities acquired in a business combination to be recognized and measured by the acquirer on the acquisition date in accordance with ASU No. 2016-10, <i>Revenue from Contracts with Customers (Topic 606)</i>. This guidance is effective for the Company beginning on January 1, 2023 and is not expected to have a material impact on the Company’s consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_846_ecustom--ImpactOfCovid19PandemicPoliciesTextBlock_zGtfOS69Q7td" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_863_zgmhf30F4poa">Impact of COVID-19 Pandemic</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The coronavirus (“COVID-19”) pandemic, which started in late 2019 and reached the United States in early 2020, continues to significantly impact the economy of the United States and the rest of the world. While the direct disruption appears to have significantly mitigated due to the availability of vaccines and other factors, the ultimate duration and severity of the pandemic remain uncertain, particularly given the development of new variants that continue to spread, and the economic repercussions are still manifesting themselves. The COVID-19 outbreak caused plasma center closures, and the stimulus packages signed into law during 2020 and 2021 reduced the incentive for individuals to donate plasma for supplementary income. Additionally, labor shortages at plasma donation centers and restrictions preventing Mexican nationals with tourist visas from being compensated for donating plasma, have further impacted donations. Those developments have had, and are expected to continue to have, an adverse impact on the Company’s results of operations. Offsetting those headwinds, inflationary pressures for food, gasoline, and other products and services appear to be driving individuals back into the plasma donation centers based upon the increase we experienced in the number of loads per average donation center in the second quarter of 2022 versus the first quarter of 2022. While we remain cautiously optimistic and have seen improvements in our operating results on an aggregated basis, we cannot foresee how long it may take the Company to attain pre-pandemic operating levels on a per plasma donation center basis. Given the uncertainty around the extent and timing of the potential future spread or mitigation of COVID-19 and variants and around the imposition or relaxation of protective measures, management cannot at this time estimate with reasonable accuracy COVID-19’s further impact on the Company’s results of operations, cash flows or financial condition.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under the provisions of the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”) signed into law in 2020 and the subsequent extension of the CARES Act through September 30, 2021, the Company was eligible for a refundable employee retention credit subject to certain criteria. The Company has elected an accounting policy to recognize the government assistance when it is probable that the Company is eligible to receive the assistance and present the credit be as a reduction of the related expense. During the quarter ended June 30, 2022 the Company filed for a refund and recorded $<span id="xdx_90C_eus-gaap--EmployeeRelatedLiabilitiesCurrent_iI_c20220630_zufJKUQrkLgk" title="Employee related cost">459,755</span> related to the employee retention credit. As of June 30, 2022 and December 31, 2021, the Company has $<span id="xdx_90B_ecustom--RefundReceivable_iI_c20220630__us-gaap--BalanceSheetLocationAxis__custom--OtherReceivableMember_zAStctYWmcS" title="Other receivable">1,296,488</span> and $<span id="xdx_90F_ecustom--RefundReceivable_iI_c20211231__us-gaap--BalanceSheetLocationAxis__custom--OtherReceivableMember_zFzSpxd58be7">876,456</span>, respectively in other receivables on the condensed consolidated balance sheet related to refunds.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 459755 1296488 876456 <p id="xdx_84C_eus-gaap--BusinessDescriptionAndAccountingPoliciesTextBlock_zm6qFtajyIzd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_86B_zFB9YLE1aBz6">About Paysign, Inc</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Paysign, Inc. (the “Company,” “Paysign,” “we” or “our”) was incorporated on August 24, 1995, and trades under the symbol PAYS on The Nasdaq Stock Market LLC. Paysign. is a provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services and integrated payment processing designed</span>   <span style="font-family: Times New Roman, Times, Serif">for businesses, consumers and government institutions. Headquartered in Nevada, the company creates customized, innovative payment solutions for clients across all industries, including pharmaceutical, healthcare, hospitality and retail.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_842_eus-gaap--ConsolidationPolicyTextBlock_zrVqx5j4k4Kl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_868_zU9fJDbPeiB5">Principles of Consolidation</span></span> – The condensed consolidated financial statements include the accounts of the Company and its subsidiaries. All significant intercompany balances and transactions have been eliminated.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_849_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zttdQEX9KFzh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_868_zfNt5UGoKUsg">Reclassifications</span></span> – In our cash flows statement, certain accounts related to the lease accounting captions in the prior periods have been reclassified to conform to the current period financial statement presentations.</span>  </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_84E_eus-gaap--UseOfEstimates_zTQTVxI9Lg4f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_86E_z2KAjPN7xKZ2">Use of Estimates</span></span> – The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect (i) the reported amounts of assets and liabilities, (ii) the disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and (iii) the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_842_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_z0Ecqs3ugN5a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_864_zzMUhl8sHilj">Cash and Cash Equivalents</span></span> – The Company considers all highly liquid investments purchased with an original maturity of six months or less at the time of purchase to be cash equivalents for the purposes of the statement of cash flows. The Company had <span id="xdx_901_eus-gaap--CashEquivalentsAtCarryingValue_iI_pp0p0_do_c20220630_zRHxCiiivfrk" title="Cash equivalents"><span id="xdx_901_eus-gaap--CashEquivalentsAtCarryingValue_iI_pp0p0_do_c20211231_zq7ND84JtRu3" title="Cash equivalents">no</span></span> cash equivalents at June 30, 2022 and December 31, 2021.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 0 0 <p id="xdx_84E_eus-gaap--CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_zRdU03qtG3k2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_861_zdYlAIOxLdPa">Restricted Cash</span></span> – At June 30, 2022 and December 31, 2021, restricted cash consisted of funds held specifically for our card product programs that are contractually restricted to use. The Company includes changes in restricted cash balances with cash and cash equivalents when reconciling the beginning and ending total amounts in our condensed consolidated statements of cash flows.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_849_eus-gaap--ConcentrationRiskCreditRisk_zrx4myTEWPT4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_865_zkfVAdkoufZ7">Concentrations of Credit Risk</span></span> – Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents and restricted cash. Paysign maintains its cash and cash equivalents and restricted cash in various bank accounts that, at times, may exceed federally insured limits. Paysign has not experienced, nor does it anticipate, any losses with respect to such accounts. At June 30, 2022 and December 31, 2021, the Company had approximately $<span id="xdx_902_eus-gaap--CashUninsuredAmount_c20220630_pp0p0" title="Fdic insured">37,047,586</span> and $<span id="xdx_907_eus-gaap--CashUninsuredAmount_c20211231_pp0p0" title="Fdic insured">31,828,826</span> in excess of federally insured bank account limits, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company also has a concentration of accounts receivable risk at June 30, 2022 as two Pharma program customers associated with our Pharma copay programs each individually represent <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneCustomerMember_zNVEmM1cOvX7" title="Concentration Risk, Percentage">51</span>% and <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--AnotherCustomerMember_zAZUekDWBqgk" title="Concentration Risk, Percentage">11</span>% of our accounts receivable balance. Two Pharma program customers each individually represented <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneCustomerMember_zI0dsdtVNWjl" title="Concentration Risk, Percentage">52</span>% and <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--AnotherCustomerMember_zeFlltaFU81h" title="Concentration Risk, Percentage">17</span>% of our accounts receivable balance at December 31, 2021.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 37047586 31828826 0.51 0.11 0.52 0.17 <p id="xdx_842_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zd0kb0l63mOc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_861_z1ywoyXyg9Tf">Fixed Assets</span></span> – Fixed assets are stated at cost less accumulated depreciation. Depreciation is principally recorded on the straight-line method over the estimated useful life of the asset, which is generally <span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentEstimatedUsefulLives_c20220101__20220630_z3Ibo7SNTWl4">3 to 10 years</span>. The cost of repairs and maintenance is charged to expense as incurred. Leasehold improvements are capitalized and depreciated over the shorter of the remaining lease term or the estimated useful life of the improvements. Expenditures for property betterments and renewals are capitalized. Upon sale or other disposition of a depreciable asset, cost and accumulated depreciation are removed from the accounts and any gain or loss is reflected in other income (expense).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company periodically evaluates whether events and circumstances have occurred that may warrant revision of the estimated useful life of fixed assets or whether the remaining balance of fixed assets should be evaluated for possible impairment. The Company uses an estimate of the related undiscounted cash flows over the remaining life of the fixed assets in measuring their recoverability.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 3 to 10 years <p id="xdx_848_eus-gaap--IntangibleAssetsFiniteLivedPolicy_zX1WBdJZTT68" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_863_zwCF8kZAHqNi">Intangible Assets</span></span> – For intangible assets, the Company recognizes an impairment loss if the carrying amount of the intangible asset is not recoverable and exceeds fair value. The carrying amount of the intangible asset is considered not recoverable if it exceeds the sum of the undiscounted cash flows expected to result from the use of the asset.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Intangible assets with a finite life are amortized on a straight-line basis over its estimated useful life, which is generally <span id="xdx_90E_ecustom--FiniteLivedIntangibleAssetUsefulLife1_c20220101__20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--IntangibleAssetsMember_zj767k3sK3ta">3 to 15 years</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Internally Developed Software Costs - </i>Computer software development costs are expensed as incurred, except for internal use software or website development costs that qualify for capitalization as described below, and include compensation and related expenses, costs of hardware and software, and costs incurred in developing features and functionality.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For computer software developed or obtained for internal use, costs that are incurred in the preliminary project and post implementation stages of software development are expensed as incurred. Costs incurred during the application and development stage are capitalized. Capitalized costs are amortized using the straight-line method over a <span id="xdx_904_ecustom--FiniteLivedIntangibleAssetUsefulLife1_c20220101__20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ComputerSoftwareMember_z8hZVwFJ6yWl" style="color: White">3</span>three year estimated useful life, beginning in the period in which the software is available for use.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 3 to 15 years 3 <p id="xdx_849_ecustom--CustomerCardFundingPolicyTextBlock_z3qbQf5bGeqb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_86C_z5G0C3xYiOG6">Customer Card Funding</span></span> – At June 30, 2022 and December 31, 2021, customer card funding represents funds loaded or available to be loaded on cards for our prepaid card programs.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_846_eus-gaap--EarningsPerSharePolicyTextBlock_z6QVlkdeaABa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_862_zrxdElDjCZF9">Earnings Per Share</span></span> – Basic earnings per share exclude any dilutive effects of options, warrants and convertible securities. Basic earnings per share is computed using the weighted-average number of common shares outstanding during the applicable period. Diluted earnings per share is computed using the weighted average number of common and common stock equivalent shares outstanding during the period, using the treasury stock method. Common stock equivalent shares are excluded from the computation if their effect on the diluted earnings per share calculation is anti-dilutive.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_844_eus-gaap--RevenueRecognitionPolicyTextBlock_zxQunrfZ0yM6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_861_zntMgD9CT6h8">Revenue and Expense Recognition</span></span> – In determining when and how revenue is recognized from contracts with customers, the Company performs the following five-step analysis: (i) identification of contracts with customers; (ii) determination of performance obligations; (iii) measurement of the transaction price; (iv) allocation of the transaction price to the performance obligations; and (v) recognition of revenue when (or as) the Company satisfies each performance obligation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company generates revenues from Plasma card programs through fees generated from cardholder fees and interchange fees. Revenues from Pharma card programs are generated through card program management fees, transaction claims processing fees, interchange fees, and settlement income.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Plasma and Pharma card program revenues include both fixed and variable components. Cardholder fees represent an obligation to the cardholder based on a per transaction basis and are recognized at a point in time when the performance obligation is fulfilled. Card program management fees and transaction claims processing fees include an obligation to our card program sponsors and are generally recognized when earned on a monthly basis and are typically due within 30 days pursuant to the contract terms which are generally multi-year contracts. The Company uses the output method to recognize card program management fee revenue at the amount of consideration to which an entity has a right to invoice. The performance obligation is satisfied when the services are transferred to the customer which the Company determined to be monthly, as the customer simultaneously receives and consumes the benefit from the Company’s performance. Interchange fees are earned when customer-issued cards are processed through card payment networks as the nature of our promise to the customer is that we stand ready to process transactions at the customer’s requests on a daily basis over the contract term. Since the timing and quantity of transactions to be processed by us are not determinable, we view interchange fees to comprise an obligation to stand ready to process as many transactions as the customer requests. Accordingly, the promise to stand ready is accounted for as a single series performance obligation. The Company uses the right to invoice practical expedient and recognizes interchange fee revenue concurrent with the processing of card transactions. Interchange fees are settled in accordance with the card payment network terms and conditions, which is typically within a few days.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company utilizes the remote method of revenue recognition for settlement income whereby the unspent balances will be recognized as revenue at the expiration of the cards and the respective program. The Company records all revenue on a gross basis since it is the primary obligor and establishes the price in the contract arrangement with its customers. The Company is currently under no obligation for refunding any fees, and the Company does not currently have any obligations for disputed claim settlements. Given the nature of the Company’s services and contracts, it has no contract assets.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Cost of revenues is comprised of transaction processing fees, data connectivity and data center expenses, network fees, bank fees, card production and postage costs, customer service, program management, application integration setup, and sales and commission expense. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_849_eus-gaap--LesseeLeasesPolicyTextBlock_zZzLT1pBpeC8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_864_zLC5a2gTm5md">Operating leases</span></span> – The Company determines if a contract is or contains a leasing element at contract inception or the date in which a modification of an existing contract occurs. In order for a contract to be considered a lease, the contract must transfer the right to control the use of an identified asset for a period of time in exchange for consideration. Control is determined to have occurred if the lessee has the right to (i) obtain substantially all of the economic benefits from the use of the identified asset throughout the period of use and (ii) direct the use of the identified asset.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">  </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In determining the present value of lease payments at lease commencement date, the Company utilizes its incremental borrowing rate based on the information available, unless the rate implicit in the lease is readily determinable. The liability for operating leases is based on the present value of future lease payments. Operating lease expenses are recorded as rent expense, which is included within selling, general and administrative expenses within the consolidated statements of operations and presented as operating cash outflows within the consolidated statements of cash flows.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Leases with an initial term of 12 months or less are not recorded on the balance sheet, with lease expense for these leases recognized on a straight-line basis over the lease term</span><span style="font-family: Times New Roman, Times, Serif">.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_842_eus-gaap--CompensationRelatedCostsPolicyTextBlock_zgaHTqShThf6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_864_zlustcQTQSm2">Stock-Based Compensation</span></span> – The Company recognizes compensation expense for all restricted stock awards and stock options. The fair value of restricted stock awards is measured using the grant date trading price of our stock. The fair value of stock options is estimated at the grant date using the Black-Scholes option-pricing model, and the portion that is ultimately expected to vest is recognized as compensation cost over the requisite service period. We have elected to recognize compensation expense for all options with graded vesting on a straight-line basis over the vesting period of the entire option. The determination of fair value using the Black-Scholes pricing model is affected by our stock price as well as assumptions regarding a number of complex and subjective variables, including expected stock price volatility and the risk-free interest rate.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_841_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zLmVtGDWe3vj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_86D_zbWTghn4osa">Recently Issued Accounting Pronouncements</span></span> – In June 2016, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2016-13, <i>Financial Instruments–Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, </i>which provides updated guidance on how an entity should measure credit losses on all financial instruments carried at amortized cost (including loans held for investment and held-to-maturity debt securities, as well as trade receivables, reinsurance recoverables, and receivables that relate to repurchase agreements and securities lending agreements), a lessor’s net investments in leases, and off-balance sheet credit exposures not accounted for as insurance or as derivatives, including loan commitments, standby letters of credit, and financial guarantees. Subsequently, in November 2018 the FASB issued ASU No. 2018-19, <i>Codification Improvements to Topic 326, Financial Instruments–Credit Losses, </i>which clarified that receivables arising from operating leases are not within the scope of Subtopic 326-20, but instead should be accounted for in accordance with Topic 842, Leases. In March 2022 the FASB issued ASU No. 2022-02, <i>Financial Instruments—Credit Losses: Troubled Debt Restructurings and Vintage Disclosures </i>which clarified accounting treatment required for trouble debt restructurings by creditors and enhanced disclosures for write-offs. The new standard and related amendments are effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. We are currently evaluating the impact of adopting this guidance on our Financial Statements; however, we do not expect it to have a material impact on the Company’s consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In October 2021, the FASB issued ASU No. 2021-08, <i>Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers</i>. This ASU requires contract assets and contract liabilities acquired in a business combination to be recognized and measured by the acquirer on the acquisition date in accordance with ASU No. 2016-10, <i>Revenue from Contracts with Customers (Topic 606)</i>. This guidance is effective for the Company beginning on January 1, 2023 and is not expected to have a material impact on the Company’s consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_804_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zjliiHEEEb4e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">2.     <span style="text-decoration: underline"><span id="xdx_823_zZfHOgdTJAIh">FIXED ASSETS, NET</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Fixed assets consist of the following:</p> <table cellpadding="0" cellspacing="0" id="xdx_88D_eus-gaap--PropertyPlantAndEquipmentTextBlock_z4yqAeWCTVU" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - FIXED ASSETS, NET (Details)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8BF_zeAwPFtAqz22" style="display: none">Schedule of fixed assets</span></td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, <br/> 2022</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br/> 2021</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 68%">Equipment</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_pp0p0" style="width: 13%; text-align: right" title="Property, Plant and Equipment, Gross">2,098,522</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_pp0p0" style="width: 13%; text-align: right" title="Property, Plant and Equipment, Gross">2,067,834</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Software</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentGross_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--SoftwareDevelopmentMember_pp0p0" style="text-align: right" title="Property, Plant and Equipment, Gross">323,355</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--SoftwareDevelopmentMember_pp0p0" style="text-align: right" title="Property, Plant and Equipment, Gross">315,855</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Furniture and fixtures</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" style="text-align: right" title="Property, Plant and Equipment, Gross">757,662</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" style="text-align: right" title="Property, Plant and Equipment, Gross">757,662</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Website costs</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--WebsiteCostsMember_pp0p0" style="text-align: right" title="Property, Plant and Equipment, Gross">69,881</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--WebsiteCostsMember_pp0p0" style="text-align: right" title="Property, Plant and Equipment, Gross">69,881</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Leasehold improvements</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Property, Plant and Equipment, Gross">229,772</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Property, Plant and Equipment, Gross">229,772</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_c20220630_pp0p0" style="text-align: right" title="Property, Plant and Equipment, Gross">3,479,192</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_c20211231_pp0p0" style="text-align: right" title="Property, Plant and Equipment, Gross">3,441,004</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Less: accumulated depreciation</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c20220630_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment">2,068,245</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c20211231_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment">1,798,023</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Fixed assets, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentNet_c20220630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Property, Plant and Equipment, Net">1,410,947</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentNet_c20211231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Property, Plant and Equipment, Net">1,642,981</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Depreciation expense for the three months ended June 30, 2022 and 2021 was $<span id="xdx_90C_eus-gaap--Depreciation_pp0p0_c20220401__20220630_zByRsQNWcwR1" title="Depreciation expense">134,253</span> and $<span id="xdx_909_eus-gaap--Depreciation_pp0p0_c20210401__20210630_zMhrtdu3pte3" title="Depreciation expense">133,174</span>, respectively. Depreciation expense for the six months ended June 30, 2022 and 2021 was $<span id="xdx_90D_eus-gaap--Depreciation_c20220101__20220630_pp0p0" title="Depreciation expense">270,222</span> and $<span id="xdx_90F_eus-gaap--Depreciation_c20210101__20210630_pp0p0" title="Depreciation expense">265,125</span>, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_88D_eus-gaap--PropertyPlantAndEquipmentTextBlock_z4yqAeWCTVU" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - FIXED ASSETS, NET (Details)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8BF_zeAwPFtAqz22" style="display: none">Schedule of fixed assets</span></td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, <br/> 2022</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br/> 2021</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 68%">Equipment</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_pp0p0" style="width: 13%; text-align: right" title="Property, Plant and Equipment, Gross">2,098,522</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_pp0p0" style="width: 13%; text-align: right" title="Property, Plant and Equipment, Gross">2,067,834</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Software</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentGross_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--SoftwareDevelopmentMember_pp0p0" style="text-align: right" title="Property, Plant and Equipment, Gross">323,355</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--SoftwareDevelopmentMember_pp0p0" style="text-align: right" title="Property, Plant and Equipment, Gross">315,855</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Furniture and fixtures</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" style="text-align: right" title="Property, Plant and Equipment, Gross">757,662</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" style="text-align: right" title="Property, Plant and Equipment, Gross">757,662</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Website costs</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--WebsiteCostsMember_pp0p0" style="text-align: right" title="Property, Plant and Equipment, Gross">69,881</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--WebsiteCostsMember_pp0p0" style="text-align: right" title="Property, Plant and Equipment, Gross">69,881</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Leasehold improvements</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Property, Plant and Equipment, Gross">229,772</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Property, Plant and Equipment, Gross">229,772</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_c20220630_pp0p0" style="text-align: right" title="Property, Plant and Equipment, Gross">3,479,192</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_c20211231_pp0p0" style="text-align: right" title="Property, Plant and Equipment, Gross">3,441,004</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Less: accumulated depreciation</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c20220630_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment">2,068,245</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c20211231_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment">1,798,023</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Fixed assets, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentNet_c20220630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Property, Plant and Equipment, Net">1,410,947</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentNet_c20211231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Property, Plant and Equipment, Net">1,642,981</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 2098522 2067834 323355 315855 757662 757662 69881 69881 229772 229772 3479192 3441004 2068245 1798023 1410947 1642981 134253 133174 270222 265125 <p id="xdx_80B_eus-gaap--IntangibleAssetsDisclosureTextBlock_zcCj96z7Q1Ka" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">3.     <span style="text-decoration: underline"><span id="xdx_823_zFQuVLMqjKq1">INTANGIBLE ASSETS, NET</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">  </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Intangible assets consist of the following:</p> <table cellpadding="0" cellspacing="0" id="xdx_882_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zAdRX2MY2gje" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INTANGIBLE ASSETS, NET (Details)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8BA_zL4Cns7WsHg5" style="display: none">Schedule of intangible assets</span></td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, <br/> 2022</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br/> 2021</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 68%; text-align: left">Patents and trademarks</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_pp0p0" style="width: 13%; text-align: right" title="Finite-Lived Intangible Assets, Gross">38,186</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsGross_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_pp0p0" style="width: 13%; text-align: right" title="Finite-Lived Intangible Assets, Gross">38,186</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Platform</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PlatformMember_pp0p0" style="text-align: right" title="Finite-Lived Intangible Assets, Gross">11,391,538</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsGross_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PlatformMember_pp0p0" style="text-align: right" title="Finite-Lived Intangible Assets, Gross">9,853,823</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Customer lists and contracts</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CustomerListsAndContractsMember_pp0p0" style="text-align: right" title="Finite-Lived Intangible Assets, Gross">1,177,200</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CustomerListsAndContractsMember_pp0p0" style="text-align: right" title="Finite-Lived Intangible Assets, Gross">1,177,200</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">Licenses</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--LicensesMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Finite-Lived Intangible Assets, Gross">209,282</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsGross_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--LicensesMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Finite-Lived Intangible Assets, Gross">209,282</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630_pp0p0" style="text-align: right" title="Finite-Lived Intangible Assets, Gross">12,816,206</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsGross_c20211231_pp0p0" style="text-align: right" title="Finite-Lived Intangible Assets, Gross">11,278,491</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Less: accumulated amortization</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20220630_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Finite-Lived Intangible Assets, Accumulated Amortization">8,314,352</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20211231_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Finite-Lived Intangible Assets, Accumulated Amortization">7,191,529</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 2.5pt">Intangible assets, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20220630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Intangible Assets, Net (Excluding Goodwill)">4,501,854</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20211231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Intangible Assets, Net (Excluding Goodwill)">4,086,962</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Intangible assets are amortized over their useful lives ranging from periods of <span id="xdx_90E_ecustom--FiniteLivedIntangibleAssetUsefulLife1_c20220101__20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--IntangibleAssetsMember_zwLlz8BKZjW">3 to 15 years</span>. Amortization expense for the three months ended June 30, 2022 and 2021 was $<span id="xdx_909_eus-gaap--AdjustmentForAmortization_pp0p0_c20220401__20220630_z2XZAitS6Zo5">578,927 </span>and $<span id="xdx_90D_eus-gaap--AdjustmentForAmortization_pp0p0_c20210401__20210630_zc26PZgYQuKg">481,008</span>, respectively. Amortization expense for the six months ended June 30, 2022 and 2021 was $<span id="xdx_900_eus-gaap--AdjustmentForAmortization_c20220101__20220630_pp0p0">1,122,129 </span>and $<span id="xdx_902_eus-gaap--AdjustmentForAmortization_c20210101__20210630_pp0p0">944,905</span>, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <table cellpadding="0" cellspacing="0" id="xdx_882_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zAdRX2MY2gje" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INTANGIBLE ASSETS, NET (Details)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8BA_zL4Cns7WsHg5" style="display: none">Schedule of intangible assets</span></td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, <br/> 2022</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br/> 2021</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 68%; text-align: left">Patents and trademarks</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_pp0p0" style="width: 13%; text-align: right" title="Finite-Lived Intangible Assets, Gross">38,186</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsGross_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_pp0p0" style="width: 13%; text-align: right" title="Finite-Lived Intangible Assets, Gross">38,186</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Platform</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PlatformMember_pp0p0" style="text-align: right" title="Finite-Lived Intangible Assets, Gross">11,391,538</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsGross_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PlatformMember_pp0p0" style="text-align: right" title="Finite-Lived Intangible Assets, Gross">9,853,823</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Customer lists and contracts</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CustomerListsAndContractsMember_pp0p0" style="text-align: right" title="Finite-Lived Intangible Assets, Gross">1,177,200</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CustomerListsAndContractsMember_pp0p0" style="text-align: right" title="Finite-Lived Intangible Assets, Gross">1,177,200</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">Licenses</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--LicensesMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Finite-Lived Intangible Assets, Gross">209,282</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsGross_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--LicensesMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Finite-Lived Intangible Assets, Gross">209,282</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630_pp0p0" style="text-align: right" title="Finite-Lived Intangible Assets, Gross">12,816,206</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsGross_c20211231_pp0p0" style="text-align: right" title="Finite-Lived Intangible Assets, Gross">11,278,491</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Less: accumulated amortization</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20220630_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Finite-Lived Intangible Assets, Accumulated Amortization">8,314,352</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20211231_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Finite-Lived Intangible Assets, Accumulated Amortization">7,191,529</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 2.5pt">Intangible assets, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20220630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Intangible Assets, Net (Excluding Goodwill)">4,501,854</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20211231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Intangible Assets, Net (Excluding Goodwill)">4,086,962</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 38186 38186 11391538 9853823 1177200 1177200 209282 209282 12816206 11278491 8314352 7191529 4501854 4086962 3 to 15 years 578927 481008 1122129 944905 <p id="xdx_809_eus-gaap--LeasesOfLessorDisclosureTextBlock_zry6I8CWHUPb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">4.     <span style="text-decoration: underline"><span id="xdx_826_zwahJrPD7pb8">LEASE</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company entered into an operating lease for office space which became effective in June 2020. The lease term is <span id="xdx_902_eus-gaap--LessorOperatingLeaseTermOfContract_iI_dtY_c20220630_zsr0S7DHRNVb" title="Lease term">10</span> years from the effective date and allows for <span id="xdx_90F_eus-gaap--LessorOperatingLeaseOptionToExtend_c20220101__20220630" title="Lease term option to extend">two optional extensions of five years each</span>. The two optional extensions are not recognized as part of the right-of-use asset or lease liability since it is not reasonably certain that the Company will extend this lease. As of June 30, 2022, the remaining lease term was <span id="xdx_90F_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20220630_z4n9p2SXaEAl" title="Remaining lease term">7.9</span> years and the discount rate was <span id="xdx_906_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_c20220630_zPxBWrKaKUGk" title="Discount rate">6</span>%.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Operating lease cost included in selling, general and administrative expenses was $<span id="xdx_90B_eus-gaap--OperatingLeaseCost_pp0p0_c20220401__20220630_zqMbvB5rgT83" title="Operating lease cost">184,329</span> and $<span id="xdx_90F_eus-gaap--OperatingLeaseCost_pp0p0_c20220101__20220630_zFAdesjDg1O6" title="Operating lease cost">367,550</span> for the three and six months ended June 30, 2022, respectively. Operating lease cost included in selling, general and administrative expenses was $<span id="xdx_905_eus-gaap--OperatingLeaseCost_pp0p0_c20210401__20210630_zVyDvYo2gQfi" title="Operating lease cost">209,056</span> and $<span id="xdx_905_eus-gaap--OperatingLeaseCost_pp0p0_c20210101__20210630_zki8PQypGUyb" title="Operating lease cost">424,200</span> for the three and six months ended June 30, 2021, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following is the lease maturity analysis of our operating lease as of June 30, 2022:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Year ending December 31,</p> <table cellpadding="0" cellspacing="0" id="xdx_88C_eus-gaap--LeaseCostTableTextBlock_zN8pDQLWmVCk" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - LEASE (Details)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B4_zxkG37MOyZG" style="display: none">Schedule of operating lease liabilities</span></td><td> </td> <td colspan="2" id="xdx_49F_20220630_zxwFKIK37Lkl" style="text-align: center"> </td><td> </td></tr> <tr id="xdx_402_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueCurrent_iI_pp0p0_maOLFMPzjk0_zUvCfkoypvId" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt; width: 84%">2022 (excluding the six months ended June 30, 2022)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">285,984</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInTwoYears_iI_pp0p0_maOLFMPzjk0_zfTSPTgtIVl5" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">2023</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">571,968</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInThreeYears_iI_pp0p0_maOLFMPzjk0_zzidJvx2ZRr4" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt; text-align: left">2024</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">571,968</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInFourYears_iI_pp0p0_maOLFMPzjk0_zIQU3TFpcekb" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">2025</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">612,006</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInFiveYears_iI_pp0p0_maOLFMPzjk0_zAwfPs223Jgl" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt; text-align: left">2026</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">640,604</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueThereafter_iI_pp0p0_maOLFMPzjk0_zY5V5d2o0fRi" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; padding-bottom: 1pt">Thereafter</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">2,188,731</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--OperatingLeasesFutureMinimumPaymentsDue_iTI_pp0p0_mtOLFMPzjk0_z8sRqUgSrHB1" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Total lease payments</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,871,261</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_ecustom--LessImputedInterest_iNI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Less: Imputed interest</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(1,025,323</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_40F_eus-gaap--OperatingLeaseLiability_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Present value of future lease payments</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,845,938</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--OperatingLeaseLiabilityCurrent_iNI_pp0p0_di_zrxfgBbceuG1" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Less: current portion of lease liability</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(350,753</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_40C_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 2.5pt">Long-term portion of lease liability</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,495,185</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> P10Y two optional extensions of five years each P7Y10M24D 0.06 184329 367550 209056 424200 <table cellpadding="0" cellspacing="0" id="xdx_88C_eus-gaap--LeaseCostTableTextBlock_zN8pDQLWmVCk" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - LEASE (Details)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B4_zxkG37MOyZG" style="display: none">Schedule of operating lease liabilities</span></td><td> </td> <td colspan="2" id="xdx_49F_20220630_zxwFKIK37Lkl" style="text-align: center"> </td><td> </td></tr> <tr id="xdx_402_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueCurrent_iI_pp0p0_maOLFMPzjk0_zUvCfkoypvId" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt; width: 84%">2022 (excluding the six months ended June 30, 2022)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">285,984</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInTwoYears_iI_pp0p0_maOLFMPzjk0_zfTSPTgtIVl5" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">2023</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">571,968</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInThreeYears_iI_pp0p0_maOLFMPzjk0_zzidJvx2ZRr4" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt; text-align: left">2024</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">571,968</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInFourYears_iI_pp0p0_maOLFMPzjk0_zIQU3TFpcekb" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">2025</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">612,006</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInFiveYears_iI_pp0p0_maOLFMPzjk0_zAwfPs223Jgl" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt; text-align: left">2026</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">640,604</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueThereafter_iI_pp0p0_maOLFMPzjk0_zY5V5d2o0fRi" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; padding-bottom: 1pt">Thereafter</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">2,188,731</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--OperatingLeasesFutureMinimumPaymentsDue_iTI_pp0p0_mtOLFMPzjk0_z8sRqUgSrHB1" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Total lease payments</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,871,261</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_ecustom--LessImputedInterest_iNI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Less: Imputed interest</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(1,025,323</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_40F_eus-gaap--OperatingLeaseLiability_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Present value of future lease payments</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,845,938</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--OperatingLeaseLiabilityCurrent_iNI_pp0p0_di_zrxfgBbceuG1" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Less: current portion of lease liability</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(350,753</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_40C_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 2.5pt">Long-term portion of lease liability</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,495,185</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 285984 571968 571968 612006 640604 2188731 4871261 -1025323 3845938 350753 3495185 <p id="xdx_800_eus-gaap--RevenueFromContractWithCustomerTextBlock_zz3BcvFhCi37" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">5.     <span style="text-decoration: underline"><span id="xdx_82D_zyXovhctk4t5">CUSTOMER CARD FUNDING LIABILITY</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The Company issues prepaid cards with various provisions for cardholder fees or expiration. Revenue generated from cardholder transactions and interchange fees are recognized when the Company’s performance obligation is fulfilled. Unspent balances left on Pharma</span>   <span style="font-family: Times New Roman, Times, Serif">cards are recognized as settlement income at the expiration of the cards and the program. Contract liabilities related to prepaid cards represent funds on card and client funds held to be loaded to card before the amounts are ultimately spent by the cardholders or recognized as revenue by the Company. Contract liabilities related to prepaid cards are reported as Customer card funding liability on the condensed consolidated balance sheet.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The opening and closing balances of the Company's contract liabilities are as follows:</p> <table cellpadding="0" cellspacing="0" id="xdx_886_eus-gaap--ContractWithCustomerAssetAndLiabilityTableTextBlock_zgxTcG5ktrgk" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - CUSTOMER CARD FUNDING LIABILITY (Details)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8BB_zm3CBahub2sk" style="display: none">Schedule of contract liabilities</span></td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Six Months Ended</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>June 30, </b></p></td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 68%; text-align: left">Beginning balance</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--ContractWithCustomerLiability_iS_pp0p0_c20220101__20220630_z1EXy1xMaAw7" style="width: 13%; text-align: right" title="Beginning balance">61,283,914</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--ContractWithCustomerLiability_iS_pp0p0_c20210101__20210630_zR7Ooe0CGCX6" style="width: 13%; text-align: right" title="Beginning balance">48,100,951</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Increase, net</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--IncreaseDecreaseInContractWithCustomerLiability_c20220101__20220630_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Increase (decrease), net">15,683,936</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--IncreaseDecreaseInContractWithCustomerLiability_c20210101__20210630_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Increase (decrease), net">17,654,611</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt">Ending balance</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--ContractWithCustomerLiability_iE_pp0p0_c20220101__20220630_zjJvyOi1itI3" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance">76,967,850</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--ContractWithCustomerLiability_iE_pdp0_c20210101__20210630_zIZdPWwjZmKb" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance">65,755,562</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The amount of revenue recognized during the six months ended June 30, 2022 and 2021 that was included in the opening contract liability for prepaid cards was $<span id="xdx_90A_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20220101__20220630_pp0p0" title="Revenue recognized in current year previously included in contract liabilities">1,485,005</span> and $<span id="xdx_908_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20210101__20210630_pp0p0" title="Revenue recognized in current year previously included in contract liabilities">1,023,055</span>, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">  </p> <table cellpadding="0" cellspacing="0" id="xdx_886_eus-gaap--ContractWithCustomerAssetAndLiabilityTableTextBlock_zgxTcG5ktrgk" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - CUSTOMER CARD FUNDING LIABILITY (Details)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8BB_zm3CBahub2sk" style="display: none">Schedule of contract liabilities</span></td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Six Months Ended</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>June 30, </b></p></td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 68%; text-align: left">Beginning balance</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--ContractWithCustomerLiability_iS_pp0p0_c20220101__20220630_z1EXy1xMaAw7" style="width: 13%; text-align: right" title="Beginning balance">61,283,914</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--ContractWithCustomerLiability_iS_pp0p0_c20210101__20210630_zR7Ooe0CGCX6" style="width: 13%; text-align: right" title="Beginning balance">48,100,951</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Increase, net</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--IncreaseDecreaseInContractWithCustomerLiability_c20220101__20220630_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Increase (decrease), net">15,683,936</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--IncreaseDecreaseInContractWithCustomerLiability_c20210101__20210630_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Increase (decrease), net">17,654,611</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt">Ending balance</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--ContractWithCustomerLiability_iE_pp0p0_c20220101__20220630_zjJvyOi1itI3" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance">76,967,850</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--ContractWithCustomerLiability_iE_pdp0_c20210101__20210630_zIZdPWwjZmKb" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance">65,755,562</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 61283914 48100951 15683936 17654611 76967850 65755562 1485005 1023055 <p id="xdx_80E_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zVgBOHRn9mb7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">6.     <span style="text-decoration: underline"><span id="xdx_82F_z95qRJuTr7Ph">COMMON STOCK</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At June 30, 2022, the Company's authorized capital stock was <span id="xdx_90B_eus-gaap--CommonStockSharesAuthorized_iI_c20220630_zqNQM17I9Vij">150,000,000</span> shares of common stock, par value $<span id="xdx_909_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20220630_zAK2m5YZmeEd">0.001</span> per share, and <span id="xdx_904_eus-gaap--PreferredStockSharesAuthorized_iI_c20220630_zCUWuiTW2gi5">25,000,000</span> shares of preferred stock, par value $<span id="xdx_903_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20220630_zgRtVU3nDXY9">0.001</span> per share. On that date, the Company had <span id="xdx_90B_eus-gaap--CommonStockSharesIssued_iI_c20220630_zl9W4jFJ8p2d">52,323,382</span> shares of common stock issued and <span id="xdx_905_eus-gaap--CommonStockSharesOutstanding_iI_c20220630_zieaDARXHmW9">52,019,932</span> shares of common stock outstanding, and no shares of preferred stock outstanding.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Stock-based compensation expense related to Company grants for the three and six months ended June 30, 2022 was $<span id="xdx_902_eus-gaap--ShareBasedCompensation_pp0p0_c20220401__20220630_zHttVhkzAX9c" title="Share-based Payment Arrangement, Noncash Expense">488,287</span> and $<span id="xdx_906_eus-gaap--ShareBasedCompensation_c20220101__20220630_pp0p0" title="Share-based Payment Arrangement, Noncash Expense">1,057,789</span>, respectively. Stock-based compensation expense for the three and six months ended June 30, 2021 was $<span id="xdx_90A_eus-gaap--ShareBasedCompensation_pp0p0_c20210401__20210630_zpXPG9XkGTTb" title="Share-based Payment Arrangement, Noncash Expense">540,921</span> and $<span id="xdx_90E_eus-gaap--ShareBasedCompensation_pp0p0_c20210101__20210630_zN2HKCIAWo4i">1,777,135</span>, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>2022 Transactions: </i>During the three and six months ended June 30, 2022 the Company issued <span id="xdx_908_ecustom--StockIssuedForVestedStockAwardsAndExerciseOfStockOptionsShares_c20220401__20220630_zNTMZJo0dixh" title="Number of shares vested">105,000</span> and <span id="xdx_905_ecustom--StockIssuedForVestedStockAwardsAndExerciseOfStockOptionsShares_c20220101__20220630_z4sBVKj3aFyd" title="Number of shares vested">228,000</span> shares, respectively, of common stock for vested stock awards and the exercise of stock options and received proceeds of $<span id="xdx_900_ecustom--ProceedsFormVestedStockAwardsAndStockOptions_pp0p0_c20220401__20220630_zvS2AuB34T4g" title="Proceeds Form Vested Stock Awards And Stock Options">0</span> and $<span id="xdx_90A_ecustom--ProceedsFormVestedStockAwardsAndStockOptions_pp0p0_c20220101__20220630_zNczT1zLfjw2" title="Proceeds Form Vested Stock Awards And Stock Options">0</span>, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>2021 Transactions: </i>During the three and six months ended June 30, 2021 the Company issued <span id="xdx_90F_ecustom--StockIssuedForVestedStockAwardsAndExerciseOfStockOptionsShares_c20210401__20210630_zk4bCarrh7F6">392,500</span> and <span id="xdx_901_ecustom--StockIssuedForVestedStockAwardsAndExerciseOfStockOptionsShares_c20210101__20210630_zLypBzQdi5T7">891,775</span> shares, respectively, of common stock for vested stock awards and the exercise of stock options and received proceeds of $<span id="xdx_906_ecustom--ProceedsFormVestedStockAwardsAndStockOptions_pp0p0_c20210401__20210630_zfnh96WhRhy6" title="Proceeds Form Vested Stock Awards And Stock Options">9,675</span> and $<span id="xdx_902_ecustom--ProceedsFormVestedStockAwardsAndStockOptions_c20210101__20210630_pp0p0" title="Proceeds Form Vested Stock Awards And Stock Options">120,141</span>, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> 150000000 0.001 25000000 0.001 52323382 52019932 488287 1057789 540921 1777135 105000 228000 0 0 392500 891775 9675 120141 <p id="xdx_80B_eus-gaap--EarningsPerShareTextBlock_zj7OTht8GcNd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">7.        <span style="text-decoration: underline"><span id="xdx_824_zCn46pz54N65">BASIC AND FULLY DILUTED NET LOSS PER COMMON SHARE</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets forth the computation of basic and fully diluted net loss per common share for the three and six months ended June 30, 2022 and 2021: </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <table cellpadding="0" cellspacing="0" id="xdx_883_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zGBfVd4WZ9bk" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - BASIC AND FULLY DILUTED NET LOSS PER COMMON SHARE (Details)"> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span id="xdx_8B3_z5hnLhiJmUWd" style="display: none">Schedule of computation of earnings per share</span></td><td> </td> <td colspan="2" id="xdx_492_20220401__20220630_zKb6tIOdH0Nd" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" id="xdx_493_20210401__20210630_zmzhySMkE9nj" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" id="xdx_49A_20220101__20220630_zhg5EpfLJMgb" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" id="xdx_49F_20210101__20210630_zSYheHneOvmj" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Three Months Ended June 30,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Six Months Ended June 30,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_40E_eus-gaap--EarningsPerShareReconciliationAbstract_iB" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Numerator:</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr id="xdx_407_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_i01_pp0p0_zlPpYQ1qdlb7" style="vertical-align: bottom; background-color: White"> <td style="width: 44%; text-align: left">Net loss</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">(228,034</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">(931,967</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">(537,429</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">(2,555,494</td><td style="width: 1%; text-align: left">)</td></tr> <tr id="xdx_402_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_iB" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Denominator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--WeightedAverageNumberOfSharesOutstandingAbstract_i01B" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Weighted average common shares:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i02_pdd" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 20pt; text-align: left">Denominator for basic calculation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">51,993,031</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">50,748,437</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">51,906,335</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">50,551,299</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_iB" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -10pt; padding-left: 20pt; text-align: left">Weighted average effects of potentially diluted common stock:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_i01_d0_zUPVVGFzSuUj" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-indent: -10pt; padding-left: 30pt; text-align: left">Stock options (calculated using the treasury method)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_i01_d0_zQb1dW2kEjg5" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -10pt; padding-left: 30pt; text-align: left; padding-bottom: 1pt">Unvested restricted stock grants</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_i01_pdd" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-indent: -10pt; padding-left: 30pt; text-align: left; padding-bottom: 2.5pt">Denominator for fully diluted calculation</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">51,993,031</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">50,748,437</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">51,906,335</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">50,551,299</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr id="xdx_40A_ecustom--NetIncomePerCommonShareAbstract_iB" style="vertical-align: bottom; background-color: White"> <td>Net loss per common share:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--EarningsPerShareBasic_i01_pdd" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt; padding-bottom: 2.5pt">Basic</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.00</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.02</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.01</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.05</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr id="xdx_40D_eus-gaap--EarningsPerShareDiluted_i01_pdd" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Fully diluted</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.00</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.02</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.01</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.05</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">Due to the net loss for the three and six months ended June 30, 2022, the effect of all potential common share equivalents was anti-dilutive, and therefore, all such shares were excluded from the computation of diluted weighted average shares outstanding for both periods. For the three and six months ended June 30, 2022, the amount of potential common share equivalents excluded were <span id="xdx_906_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220401__20220630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionsMember_zGK5UiIvKuje" title="Potential common share equivalents excluded from computation"><span id="xdx_90F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20220630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionsMember_zRv5fyAZdWDj" title="Potential common share equivalents excluded from computation">1,884,400</span></span> for stock options and <span id="xdx_901_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220401__20220630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--UnvestedRestrictedStockAwardsMember_zpIW5ZnX0kN3" title="Potential common share equivalents excluded from computation"><span id="xdx_908_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20220630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--UnvestedRestrictedStockAwardsMember_pdd" title="Potential common share equivalents excluded from computation">1,064,000</span></span> for unvested restricted stock awards. Due to the net loss for the three and six months ended June 30, 2021, the effect of all potential common share equivalents was anti-dilutive, and therefore, all such shares were excluded from the computation of diluted weighted average shares outstanding for both periods. For the three and six months ended June 30, 2021, the amount of potential common share equivalents excluded were <span id="xdx_90A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210401__20210630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionsMember_z9AHzmcOh277" title="Potential common share equivalents excluded from computation"><span id="xdx_90E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20210630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionsMember_zOXJdVE34Kq5" title="Potential common share equivalents excluded from computation">1,997,350</span></span> for stock options and <span id="xdx_902_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210401__20210630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--UnvestedRestrictedStockAwardsMember_zPwJ0StDgeFl" title="Potential common share equivalents excluded from computation"><span id="xdx_905_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20210630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--UnvestedRestrictedStockAwardsMember_zvLGbu9LImub" title="Potential common share equivalents excluded from computation">1,868,000</span></span> for unvested restricted stock awards.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_883_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zGBfVd4WZ9bk" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - BASIC AND FULLY DILUTED NET LOSS PER COMMON SHARE (Details)"> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span id="xdx_8B3_z5hnLhiJmUWd" style="display: none">Schedule of computation of earnings per share</span></td><td> </td> <td colspan="2" id="xdx_492_20220401__20220630_zKb6tIOdH0Nd" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" id="xdx_493_20210401__20210630_zmzhySMkE9nj" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" id="xdx_49A_20220101__20220630_zhg5EpfLJMgb" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" id="xdx_49F_20210101__20210630_zSYheHneOvmj" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Three Months Ended June 30,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Six Months Ended June 30,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_40E_eus-gaap--EarningsPerShareReconciliationAbstract_iB" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Numerator:</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr id="xdx_407_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_i01_pp0p0_zlPpYQ1qdlb7" style="vertical-align: bottom; background-color: White"> <td style="width: 44%; text-align: left">Net loss</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">(228,034</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">(931,967</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">(537,429</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">(2,555,494</td><td style="width: 1%; text-align: left">)</td></tr> <tr id="xdx_402_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_iB" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Denominator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--WeightedAverageNumberOfSharesOutstandingAbstract_i01B" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Weighted average common shares:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i02_pdd" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 20pt; text-align: left">Denominator for basic calculation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">51,993,031</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">50,748,437</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">51,906,335</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">50,551,299</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_iB" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -10pt; padding-left: 20pt; text-align: left">Weighted average effects of potentially diluted common stock:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_i01_d0_zUPVVGFzSuUj" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-indent: -10pt; padding-left: 30pt; text-align: left">Stock options (calculated using the treasury method)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_i01_d0_zQb1dW2kEjg5" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -10pt; padding-left: 30pt; text-align: left; padding-bottom: 1pt">Unvested restricted stock grants</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_i01_pdd" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-indent: -10pt; padding-left: 30pt; text-align: left; padding-bottom: 2.5pt">Denominator for fully diluted calculation</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">51,993,031</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">50,748,437</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">51,906,335</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">50,551,299</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr id="xdx_40A_ecustom--NetIncomePerCommonShareAbstract_iB" style="vertical-align: bottom; background-color: White"> <td>Net loss per common share:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--EarningsPerShareBasic_i01_pdd" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt; padding-bottom: 2.5pt">Basic</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.00</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.02</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.01</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.05</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr id="xdx_40D_eus-gaap--EarningsPerShareDiluted_i01_pdd" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Fully diluted</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.00</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.02</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.01</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.05</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> -228034 -931967 -537429 -2555494 51993031 50748437 51906335 50551299 0 0 0 0 0 0 0 0 51993031 50748437 51906335 50551299 -0.00 -0.02 -0.01 -0.05 -0.00 -0.02 -0.01 -0.05 1884400 1884400 1064000 1064000 1997350 1997350 1868000 1868000 <p id="xdx_80D_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zzhTxiGI7zna" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">8.        <span style="text-decoration: underline"><span id="xdx_822_z59xpF6USZWf">COMMITMENTS AND CONTINGENCIES</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">From time to time, we may become involved in various lawsuits and legal proceedings which arise in the ordinary course of business. However, litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our business.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has been named as a defendant in three complaints filed in the United States District Court for the District of Nevada: Yilan Shi v. Paysign, Inc. et. al., filed on March 19, 2020 (“Shi”), Lorna Chase v. Paysign, Inc. et. al., filed on March 25, 2020 (“Chase”), and Smith &amp; Duvall v. Paysign, Inc. et. al., filed on April 2, 2020 (collectively, the “Complaints” or “Securities Class Action”). Smith &amp; Duvall v. Paysign, Inc. et. al. was voluntarily dismissed on May 21, 2020. On May 18, 2020, the Shi plaintiffs and another entity called the Paysign Investor Group each filed a motion to consolidate the remaining Shi and Chase actions and to be appointed lead plaintiff. The Complaints are putative class actions filed on behalf of a class of persons who acquired the Company’s common stock from March 19, 2019 through March 31, 2020, inclusive. The Complaints generally allege that the Company, Mark Newcomer, and Mark Attinger violated Section 10(b) of the Securities Exchange Act of 1934 (the “Exchange Act”), and that Messrs. Newcomer and Attinger violated Section 20(a) of the Exchange Act, by making materially false or misleading statements, or failing to disclose material facts, regarding the Company’s internal control over financial reporting and its financial statements. The Complaints seek class action certification, compensatory damages, and attorney’s fees and costs. On December 2, 2020, the Court consolidated Shi and Chase as In re Paysign, Inc. Securities Litigation and appointed the Paysign Investor Group as lead plaintiff. On January 12, 2021, Plaintiffs filed an Amended Complaint in the consolidated action. Defendants filed a Motion to Dismiss the Amended Complaint on March 15, 2021, which Plaintiffs opposed via an opposition brief filed on April 29, 2021, to which Defendants replied on June 1, 2021. Thus, the motion is now fully briefed. The Court has not set a hearing date on the motion, or informed the parties whether it intends to entertain oral argument or rule upon the papers filed. As of the date of this filing, Paysign cannot give any meaningful estimate of likely outcome or damages.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has also been named as a nominal defendant in two stockholder derivative actions in the United States District Court for the District of Nevada. The first derivative action is entitled Andrzej Toczek, derivatively on behalf of Paysign, Inc. v. Mark R. Newcomer, et al. and was filed on September 17, 2020. This action alleges violations of Section 14(a) of the Exchange Act, breach of fiduciary duty, unjust enrichment, and waste, largely in connection with the failure to correct information technology controls over financial reporting alleged in the Securities Class Action, thereby causing the Company to face exposure in the Securities Class Action. The complaint also alleges insider trading violations against certain individual defendants. On December 16, 2020, the Court approved a stipulation staying the action until the Court in the consolidated Securities Class Action issues a ruling on the Motion to Dismiss. The second derivative action is entitled John K. Gray, derivatively on behalf of Paysign, Inc. v. Mark Attinger, et al. and was filed on May 9, 2022. This action involves the same alleged conduct raised in the Toczek action and asserts claims for breach of fiduciary duty in connection with financial reporting, breach of fiduciary duty in connection with alleged insider trading against certain individual defendants, and unjust enrichment. On June 3, 2022, the Court approved a stipulation staying the action until the Court in the consolidated Securities Class Action issues a ruling on the Motion to Dismiss. As of the date of this filing, Paysign cannot give any meaningful estimate of likely outcome or damages.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_809_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_z5fYtlJSZDxa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">9.        <span style="text-decoration: underline"><span id="xdx_82A_zqiWwgBslXTf">RELATED PARTY</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A member of our Board of Directors is also a partner in a law firm that the Company engages for services to review regulatory filings and for various other legal matters. The Company incurred legal expense of $<span id="xdx_90E_eus-gaap--LegalFees_c20220401__20220630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RelatedPartyLawFirmMember_z5d8hpLzyW8f">41,019</span> and $<span id="xdx_905_eus-gaap--LegalFees_c20220101__20220630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RelatedPartyLawFirmMember_zWJlgc74i5k5">81,753</span> during the three and six months ended June 30, 2022, respectively, with the related party law firm. During the three and six months ended June 30, 2021 the Company incurred legal expense of $<span id="xdx_909_eus-gaap--LegalFees_c20210401__20210630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RelatedPartyLawFirmMember_z5MJdWN9MjGg">390,172</span> and $<span id="xdx_904_eus-gaap--LegalFees_c20210101__20210630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RelatedPartyLawFirmMember_znUAilMhokDc">410,884</span>, respectively, with the related party law firm.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> 41019 81753 390172 410884 <p id="xdx_80B_eus-gaap--IncomeTaxDisclosureTextBlock_zo9alnhoDiEe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">10.        <span style="text-decoration: underline"><span id="xdx_82E_zN1jWS5XSMp1">INCOME TAX PROVISION</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The effective tax rate <span style="background-color: white">(income tax provision as a percentage of loss before income tax provision) was (<span id="xdx_90B_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_c20220401__20220630_zKaPJfjc1csb" title="Effective income tax rate">13.4</span>%) for the three months ended June 30, 2022, as compared to (<span id="xdx_904_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_c20210401__20210630_zo9gMZDAZ3lj" title="Effective income tax rate">0.1</span>%) for the three months ended June 30, 2021. The effective tax rate was (<span id="xdx_90E_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_c20220101__20220630_zc8JUXx2xfJ1" title="Effective income tax rate">5.7</span>%) and (<span id="xdx_905_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_c20210101__20210630_zezDArvkjDz8" title="Effective income tax rate">0.1</span>%) for the six months ended June 30, 2022 and 2021, respectively. The effective tax rates vary</span>, primarily as a result of the full valuation on our deferred tax asset in the current year and the tax benefit related to our stock-based compensation and a pretax loss in the prior year period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 0.134 0.001 0.057 0.001 EXCEL 48 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 49 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 50 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 51 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.2 html 103 174 1 false 26 0 false 4 false false R1.htm 00000001 - Document - Cover Sheet http://paysign.com/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) Sheet http://paysign.com/role/CondensedConsolidatedBalanceSheets CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) Statements 2 false false R3.htm 00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) Sheet http://paysign.com/role/CondensedConsolidatedBalanceSheetsParenthetical CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) Sheet http://paysign.com/role/CondensedConsolidatedStatementsOfOperations CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) Statements 4 false false R5.htm 00000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS EQUITY (DEFICIT) (UNAUDITED) Sheet http://paysign.com/role/CondensedConsolidatedStatementsOfStockholdersEquityDeficit CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS EQUITY (DEFICIT) (UNAUDITED) Statements 5 false false R6.htm 00000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) Sheet http://paysign.com/role/CondensedConsolidatedStatementsOfCashFlows CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) Statements 6 false false R7.htm 00000007 - Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT POLICIES Sheet http://paysign.com/role/BasisOfPresentationAndSummaryOfSignificantPolicies BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT POLICIES Notes 7 false false R8.htm 00000008 - Disclosure - FIXED ASSETS, NET Sheet http://paysign.com/role/FixedAssetsNet FIXED ASSETS, NET Notes 8 false false R9.htm 00000009 - Disclosure - INTANGIBLE ASSETS, NET Sheet http://paysign.com/role/IntangibleAssetsNet INTANGIBLE ASSETS, NET Notes 9 false false R10.htm 00000010 - Disclosure - LEASE Sheet http://paysign.com/role/Lease LEASE Notes 10 false false R11.htm 00000011 - Disclosure - CUSTOMER CARD FUNDING LIABILITY Sheet http://paysign.com/role/CustomerCardFundingLiability CUSTOMER CARD FUNDING LIABILITY Notes 11 false false R12.htm 00000012 - Disclosure - COMMON STOCK Sheet http://paysign.com/role/CommonStock COMMON STOCK Notes 12 false false R13.htm 00000013 - Disclosure - BASIC AND FULLY DILUTED NET LOSS PER COMMON SHARE Sheet http://paysign.com/role/BasicAndFullyDilutedNetLossPerCommonShare BASIC AND FULLY DILUTED NET LOSS PER COMMON SHARE Notes 13 false false R14.htm 00000014 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://paysign.com/role/CommitmentsAndContingencies COMMITMENTS AND CONTINGENCIES Notes 14 false false R15.htm 00000015 - Disclosure - RELATED PARTY Sheet http://paysign.com/role/RelatedParty RELATED PARTY Notes 15 false false R16.htm 00000016 - Disclosure - INCOME TAX PROVISION Sheet http://paysign.com/role/IncomeTaxProvision INCOME TAX PROVISION Notes 16 false false R17.htm 00000017 - Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT POLICIES (Policies) Sheet http://paysign.com/role/BasisOfPresentationAndSummaryOfSignificantPoliciesPolicies BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT POLICIES (Policies) Policies 17 false false R18.htm 00000018 - Disclosure - FIXED ASSETS, NET (Tables) Sheet http://paysign.com/role/FixedAssetsNetTables FIXED ASSETS, NET (Tables) Tables http://paysign.com/role/FixedAssetsNet 18 false false R19.htm 00000019 - Disclosure - INTANGIBLE ASSETS, NET (Tables) Sheet http://paysign.com/role/IntangibleAssetsNetTables INTANGIBLE ASSETS, NET (Tables) Tables http://paysign.com/role/IntangibleAssetsNet 19 false false R20.htm 00000020 - Disclosure - LEASE (Tables) Sheet http://paysign.com/role/LeaseTables LEASE (Tables) Tables http://paysign.com/role/Lease 20 false false R21.htm 00000021 - Disclosure - CUSTOMER CARD FUNDING LIABILITY (Tables) Sheet http://paysign.com/role/CustomerCardFundingLiabilityTables CUSTOMER CARD FUNDING LIABILITY (Tables) Tables http://paysign.com/role/CustomerCardFundingLiability 21 false false R22.htm 00000022 - Disclosure - BASIC AND FULLY DILUTED NET LOSS PER COMMON SHARE (Tables) Sheet http://paysign.com/role/BasicAndFullyDilutedNetLossPerCommonShareTables BASIC AND FULLY DILUTED NET LOSS PER COMMON SHARE (Tables) Tables http://paysign.com/role/BasicAndFullyDilutedNetLossPerCommonShare 22 false false R23.htm 00000023 - Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT POLICIES (Details Narrative) Sheet http://paysign.com/role/BasisOfPresentationAndSummaryOfSignificantPoliciesDetailsNarrative BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT POLICIES (Details Narrative) Details http://paysign.com/role/BasisOfPresentationAndSummaryOfSignificantPoliciesPolicies 23 false false R24.htm 00000024 - Disclosure - FIXED ASSETS, NET (Details) Sheet http://paysign.com/role/FixedAssetsNetDetails FIXED ASSETS, NET (Details) Details http://paysign.com/role/FixedAssetsNetTables 24 false false R25.htm 00000025 - Disclosure - FIXED ASSETS, NET (Details Narrative) Sheet http://paysign.com/role/FixedAssetsNetDetailsNarrative FIXED ASSETS, NET (Details Narrative) Details http://paysign.com/role/FixedAssetsNetTables 25 false false R26.htm 00000026 - Disclosure - INTANGIBLE ASSETS, NET (Details) Sheet http://paysign.com/role/IntangibleAssetsNetDetails INTANGIBLE ASSETS, NET (Details) Details http://paysign.com/role/IntangibleAssetsNetTables 26 false false R27.htm 00000027 - Disclosure - INTANGIBLE ASSETS, NET (Details Narrative) Sheet http://paysign.com/role/IntangibleAssetsNetDetailsNarrative INTANGIBLE ASSETS, NET (Details Narrative) Details http://paysign.com/role/IntangibleAssetsNetTables 27 false false R28.htm 00000028 - Disclosure - LEASE (Details) Sheet http://paysign.com/role/LeaseDetails LEASE (Details) Details http://paysign.com/role/LeaseTables 28 false false R29.htm 00000029 - Disclosure - LEASE (Details Narrative) Sheet http://paysign.com/role/LeaseDetailsNarrative LEASE (Details Narrative) Details http://paysign.com/role/LeaseTables 29 false false R30.htm 00000030 - Disclosure - CUSTOMER CARD FUNDING LIABILITY (Details) Sheet http://paysign.com/role/CustomerCardFundingLiabilityDetails CUSTOMER CARD FUNDING LIABILITY (Details) Details http://paysign.com/role/CustomerCardFundingLiabilityTables 30 false false R31.htm 00000031 - Disclosure - CUSTOMER CARD FUNDING LIABILITY (Details Narrative) Sheet http://paysign.com/role/CustomerCardFundingLiabilityDetailsNarrative CUSTOMER CARD FUNDING LIABILITY (Details Narrative) Details http://paysign.com/role/CustomerCardFundingLiabilityTables 31 false false R32.htm 00000032 - Disclosure - COMMON STOCK (Details Narrative) Sheet http://paysign.com/role/CommonStockDetailsNarrative COMMON STOCK (Details Narrative) Details http://paysign.com/role/CommonStock 32 false false R33.htm 00000033 - Disclosure - BASIC AND FULLY DILUTED NET LOSS PER COMMON SHARE (Details) Sheet http://paysign.com/role/BasicAndFullyDilutedNetLossPerCommonShareDetails BASIC AND FULLY DILUTED NET LOSS PER COMMON SHARE (Details) Details http://paysign.com/role/BasicAndFullyDilutedNetLossPerCommonShareTables 33 false false R34.htm 00000034 - Disclosure - BASIC AND FULLY DILUTED NET LOSS PER COMMON SHARE (Details Narrative) Sheet http://paysign.com/role/BasicAndFullyDilutedNetLossPerCommonShareDetailsNarrative BASIC AND FULLY DILUTED NET LOSS PER COMMON SHARE (Details Narrative) Details http://paysign.com/role/BasicAndFullyDilutedNetLossPerCommonShareTables 34 false false R35.htm 00000035 - Disclosure - RELATED PARTY (Details Narrative) Sheet http://paysign.com/role/RelatedPartyDetailsNarrative RELATED PARTY (Details Narrative) Details http://paysign.com/role/RelatedParty 35 false false R36.htm 00000036 - Disclosure - INCOME TAX PROVISION (Details Narrative) Sheet http://paysign.com/role/IncomeTaxProvisionDetailsNarrative INCOME TAX PROVISION (Details Narrative) Details http://paysign.com/role/IncomeTaxProvision 36 false false All Reports Book All Reports paysign_i10q-063022.htm pays-20220630.xsd pays-20220630_cal.xml pays-20220630_def.xml pays-20220630_lab.xml pays-20220630_pre.xml paysign_ex3101.htm paysign_ex3102.htm paysign_ex3201.htm paysign_ex3202.htm http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true JSON 53 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "paysign_i10q-063022.htm": { "axisCustom": 0, "axisStandard": 10, "contextCount": 103, "dts": { "calculationLink": { "local": [ "pays-20220630_cal.xml" ] }, "definitionLink": { "local": [ "pays-20220630_def.xml" ] }, "inline": { "local": [ "paysign_i10q-063022.htm" ] }, "labelLink": { "local": [ "pays-20220630_lab.xml" ] }, "presentationLink": { "local": [ "pays-20220630_pre.xml" ] }, "schema": { "local": [ "pays-20220630.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 298, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2022": 31, "http://paysign.com/20220630": 12, "http://xbrl.sec.gov/dei/2022": 5, "total": 48 }, "keyCustom": 9, "keyStandard": 165, "memberCustom": 15, "memberStandard": 11, "nsprefix": "PAYS", "nsuri": "http://paysign.com/20220630", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "paysign_i10q-063022.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "role": "http://paysign.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "paysign_i10q-063022.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "paysign_i10q-063022.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeasesOfLessorDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000010 - Disclosure - LEASE", "role": "http://paysign.com/role/Lease", "shortName": "LEASE", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "paysign_i10q-063022.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeasesOfLessorDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "paysign_i10q-063022.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000011 - Disclosure - CUSTOMER CARD FUNDING LIABILITY", "role": "http://paysign.com/role/CustomerCardFundingLiability", "shortName": "CUSTOMER CARD FUNDING LIABILITY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "paysign_i10q-063022.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "paysign_i10q-063022.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000012 - Disclosure - COMMON STOCK", "role": "http://paysign.com/role/CommonStock", "shortName": "COMMON STOCK", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "paysign_i10q-063022.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "paysign_i10q-063022.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000013 - Disclosure - BASIC AND FULLY DILUTED NET LOSS PER COMMON SHARE", "role": "http://paysign.com/role/BasicAndFullyDilutedNetLossPerCommonShare", "shortName": "BASIC AND FULLY DILUTED NET LOSS PER COMMON SHARE", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "paysign_i10q-063022.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "paysign_i10q-063022.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000014 - Disclosure - COMMITMENTS AND CONTINGENCIES", "role": "http://paysign.com/role/CommitmentsAndContingencies", "shortName": "COMMITMENTS AND CONTINGENCIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "paysign_i10q-063022.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "paysign_i10q-063022.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000015 - Disclosure - RELATED PARTY", "role": "http://paysign.com/role/RelatedParty", "shortName": "RELATED PARTY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "paysign_i10q-063022.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "paysign_i10q-063022.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000016 - Disclosure - INCOME TAX PROVISION", "role": "http://paysign.com/role/IncomeTaxProvision", "shortName": "INCOME TAX PROVISION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "paysign_i10q-063022.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "paysign_i10q-063022.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "PAYS:ImpactOfCovid19PandemicPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000017 - Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT POLICIES (Policies)", "role": "http://paysign.com/role/BasisOfPresentationAndSummaryOfSignificantPoliciesPolicies", "shortName": "BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT POLICIES (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "paysign_i10q-063022.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "PAYS:ImpactOfCovid19PandemicPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "paysign_i10q-063022.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000018 - Disclosure - FIXED ASSETS, NET (Tables)", "role": "http://paysign.com/role/FixedAssetsNetTables", "shortName": "FIXED ASSETS, NET (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "paysign_i10q-063022.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "paysign_i10q-063022.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000019 - Disclosure - INTANGIBLE ASSETS, NET (Tables)", "role": "http://paysign.com/role/IntangibleAssetsNetTables", "shortName": "INTANGIBLE ASSETS, NET (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "paysign_i10q-063022.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "paysign_i10q-063022.htm", "contextRef": "AsOf2022-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Cash", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)", "role": "http://paysign.com/role/CondensedConsolidatedBalanceSheets", "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "paysign_i10q-063022.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "lang": null, "name": "us-gaap:Cash", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "us-gaap:LeasesOfLessorDisclosureTextBlock", "body", "html" ], "baseRef": "paysign_i10q-063022.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeaseCostTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000020 - Disclosure - LEASE (Tables)", "role": "http://paysign.com/role/LeaseTables", "shortName": "LEASE (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:LeasesOfLessorDisclosureTextBlock", "body", "html" ], "baseRef": "paysign_i10q-063022.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeaseCostTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "us-gaap:RevenueFromContractWithCustomerTextBlock", "body", "html" ], "baseRef": "paysign_i10q-063022.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000021 - Disclosure - CUSTOMER CARD FUNDING LIABILITY (Tables)", "role": "http://paysign.com/role/CustomerCardFundingLiabilityTables", "shortName": "CUSTOMER CARD FUNDING LIABILITY (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:RevenueFromContractWithCustomerTextBlock", "body", "html" ], "baseRef": "paysign_i10q-063022.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "paysign_i10q-063022.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000022 - Disclosure - BASIC AND FULLY DILUTED NET LOSS PER COMMON SHARE (Tables)", "role": "http://paysign.com/role/BasicAndFullyDilutedNetLossPerCommonShareTables", "shortName": "BASIC AND FULLY DILUTED NET LOSS PER COMMON SHARE (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "paysign_i10q-063022.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "span", "p", "PAYS:ImpactOfCovid19PandemicPoliciesTextBlock", "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "paysign_i10q-063022.htm", "contextRef": "AsOf2022-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000023 - Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT POLICIES (Details Narrative)", "role": "http://paysign.com/role/BasisOfPresentationAndSummaryOfSignificantPoliciesDetailsNarrative", "shortName": "BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT POLICIES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "PAYS:ImpactOfCovid19PandemicPoliciesTextBlock", "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "paysign_i10q-063022.htm", "contextRef": "AsOf2022-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "paysign_i10q-063022.htm", "contextRef": "AsOf2022-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000024 - Disclosure - FIXED ASSETS, NET (Details)", "role": "http://paysign.com/role/FixedAssetsNetDetails", "shortName": "FIXED ASSETS, NET (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "paysign_i10q-063022.htm", "contextRef": "AsOf2022-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "paysign_i10q-063022.htm", "contextRef": "From2022-04-012022-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Depreciation", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000025 - Disclosure - FIXED ASSETS, NET (Details Narrative)", "role": "http://paysign.com/role/FixedAssetsNetDetailsNarrative", "shortName": "FIXED ASSETS, NET (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "paysign_i10q-063022.htm", "contextRef": "From2022-04-012022-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Depreciation", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "paysign_i10q-063022.htm", "contextRef": "AsOf2022-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000026 - Disclosure - INTANGIBLE ASSETS, NET (Details)", "role": "http://paysign.com/role/IntangibleAssetsNetDetails", "shortName": "INTANGIBLE ASSETS, NET (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "paysign_i10q-063022.htm", "contextRef": "AsOf2022-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "paysign_i10q-063022.htm", "contextRef": "From2022-04-012022-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AdjustmentForAmortization", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000027 - Disclosure - INTANGIBLE ASSETS, NET (Details Narrative)", "role": "http://paysign.com/role/IntangibleAssetsNetDetailsNarrative", "shortName": "INTANGIBLE ASSETS, NET (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "paysign_i10q-063022.htm", "contextRef": "From2022-04-012022-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AdjustmentForAmortization", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:LeaseCostTableTextBlock", "us-gaap:LeasesOfLessorDisclosureTextBlock", "body", "html" ], "baseRef": "paysign_i10q-063022.htm", "contextRef": "AsOf2022-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000028 - Disclosure - LEASE (Details)", "role": "http://paysign.com/role/LeaseDetails", "shortName": "LEASE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:LeaseCostTableTextBlock", "us-gaap:LeasesOfLessorDisclosureTextBlock", "body", "html" ], "baseRef": "paysign_i10q-063022.htm", "contextRef": "AsOf2022-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:LeasesOfLessorDisclosureTextBlock", "body", "html" ], "baseRef": "paysign_i10q-063022.htm", "contextRef": "AsOf2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LessorOperatingLeaseTermOfContract", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000029 - Disclosure - LEASE (Details Narrative)", "role": "http://paysign.com/role/LeaseDetailsNarrative", "shortName": "LEASE (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:LeasesOfLessorDisclosureTextBlock", "body", "html" ], "baseRef": "paysign_i10q-063022.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "lang": "en-US", "name": "us-gaap:LessorOperatingLeaseOptionToExtend", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "paysign_i10q-063022.htm", "contextRef": "AsOf2022-06-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical)", "role": "http://paysign.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "span", "span", "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "paysign_i10q-063022.htm", "contextRef": "AsOf2022-06-30", "decimals": "INF", "lang": null, "name": "us-gaap:PreferredStockSharesIssued", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock", "us-gaap:RevenueFromContractWithCustomerTextBlock", "body", "html" ], "baseRef": "paysign_i10q-063022.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ContractWithCustomerLiability", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000030 - Disclosure - CUSTOMER CARD FUNDING LIABILITY (Details)", "role": "http://paysign.com/role/CustomerCardFundingLiabilityDetails", "shortName": "CUSTOMER CARD FUNDING LIABILITY (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock", "us-gaap:RevenueFromContractWithCustomerTextBlock", "body", "html" ], "baseRef": "paysign_i10q-063022.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ContractWithCustomerLiability", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:RevenueFromContractWithCustomerTextBlock", "body", "html" ], "baseRef": "paysign_i10q-063022.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ContractWithCustomerLiabilityRevenueRecognized", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000031 - Disclosure - CUSTOMER CARD FUNDING LIABILITY (Details Narrative)", "role": "http://paysign.com/role/CustomerCardFundingLiabilityDetailsNarrative", "shortName": "CUSTOMER CARD FUNDING LIABILITY (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:RevenueFromContractWithCustomerTextBlock", "body", "html" ], "baseRef": "paysign_i10q-063022.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ContractWithCustomerLiabilityRevenueRecognized", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "span", "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "paysign_i10q-063022.htm", "contextRef": "AsOf2022-06-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockSharesAuthorized", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000032 - Disclosure - COMMON STOCK (Details Narrative)", "role": "http://paysign.com/role/CommonStockDetailsNarrative", "shortName": "COMMON STOCK (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "paysign_i10q-063022.htm", "contextRef": "From2022-04-012022-06-30", "decimals": "0", "lang": null, "name": "us-gaap:ShareBasedCompensation", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "paysign_i10q-063022.htm", "contextRef": "From2022-04-012022-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000033 - Disclosure - BASIC AND FULLY DILUTED NET LOSS PER COMMON SHARE (Details)", "role": "http://paysign.com/role/BasicAndFullyDilutedNetLossPerCommonShareDetails", "shortName": "BASIC AND FULLY DILUTED NET LOSS PER COMMON SHARE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "paysign_i10q-063022.htm", "contextRef": "From2022-04-012022-06-30", "decimals": "INF", "lang": null, "name": "us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "span", "span", "span", "p", "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "paysign_i10q-063022.htm", "contextRef": "From2022-04-012022-06-30_custom_StockOptionsMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000034 - Disclosure - BASIC AND FULLY DILUTED NET LOSS PER COMMON SHARE (Details Narrative)", "role": "http://paysign.com/role/BasicAndFullyDilutedNetLossPerCommonShareDetailsNarrative", "shortName": "BASIC AND FULLY DILUTED NET LOSS PER COMMON SHARE (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "span", "p", "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "paysign_i10q-063022.htm", "contextRef": "From2022-04-012022-06-30_custom_StockOptionsMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "paysign_i10q-063022.htm", "contextRef": "From2022-04-012022-06-30_custom_RelatedPartyLawFirmMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LegalFees", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000035 - Disclosure - RELATED PARTY (Details Narrative)", "role": "http://paysign.com/role/RelatedPartyDetailsNarrative", "shortName": "RELATED PARTY (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "paysign_i10q-063022.htm", "contextRef": "From2022-04-012022-06-30_custom_RelatedPartyLawFirmMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LegalFees", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "paysign_i10q-063022.htm", "contextRef": "From2022-04-012022-06-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000036 - Disclosure - INCOME TAX PROVISION (Details Narrative)", "role": "http://paysign.com/role/IncomeTaxProvisionDetailsNarrative", "shortName": "INCOME TAX PROVISION (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "paysign_i10q-063022.htm", "contextRef": "From2022-04-012022-06-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "paysign_i10q-063022.htm", "contextRef": "From2022-04-012022-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)", "role": "http://paysign.com/role/CondensedConsolidatedStatementsOfOperations", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "paysign_i10q-063022.htm", "contextRef": "From2022-04-012022-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "paysign_i10q-063022.htm", "contextRef": "AsOf2020-12-31_us-gaap_CommonStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS EQUITY (DEFICIT) (UNAUDITED)", "role": "http://paysign.com/role/CondensedConsolidatedStatementsOfStockholdersEquityDeficit", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS EQUITY (DEFICIT) (UNAUDITED)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "paysign_i10q-063022.htm", "contextRef": "AsOf2020-12-31_us-gaap_CommonStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "paysign_i10q-063022.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)", "role": "http://paysign.com/role/CondensedConsolidatedStatementsOfCashFlows", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "paysign_i10q-063022.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": "0", "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "paysign_i10q-063022.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000007 - Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT POLICIES", "role": "http://paysign.com/role/BasisOfPresentationAndSummaryOfSignificantPolicies", "shortName": "BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT POLICIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "paysign_i10q-063022.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "paysign_i10q-063022.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000008 - Disclosure - FIXED ASSETS, NET", "role": "http://paysign.com/role/FixedAssetsNet", "shortName": "FIXED ASSETS, NET", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "paysign_i10q-063022.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "paysign_i10q-063022.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000009 - Disclosure - INTANGIBLE ASSETS, NET", "role": "http://paysign.com/role/IntangibleAssetsNet", "shortName": "INTANGIBLE ASSETS, NET", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "paysign_i10q-063022.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 26, "tag": { "PAYS_AnotherCustomerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Another Customer [Member]" } } }, "localname": "AnotherCustomerMember", "nsuri": "http://paysign.com/20220630", "presentation": [ "http://paysign.com/role/BasisOfPresentationAndSummaryOfSignificantPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "PAYS_ComputerSoftwareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Computer Software [Member]" } } }, "localname": "ComputerSoftwareMember", "nsuri": "http://paysign.com/20220630", "presentation": [ "http://paysign.com/role/BasisOfPresentationAndSummaryOfSignificantPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "PAYS_CustomerCardFundingPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Customer Card Funding" } } }, "localname": "CustomerCardFundingPolicyTextBlock", "nsuri": "http://paysign.com/20220630", "presentation": [ "http://paysign.com/role/BasisOfPresentationAndSummaryOfSignificantPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "PAYS_CustomerListsAndContractsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Customer lists and contracts [Member]" } } }, "localname": "CustomerListsAndContractsMember", "nsuri": "http://paysign.com/20220630", "presentation": [ "http://paysign.com/role/IntangibleAssetsNetDetails" ], "xbrltype": "domainItemType" }, "PAYS_FiniteLivedIntangibleAssetUsefulLife1": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "[custom:FiniteLivedIntangibleAssetUsefulLife1]" } } }, "localname": "FiniteLivedIntangibleAssetUsefulLife1", "nsuri": "http://paysign.com/20220630", "presentation": [ "http://paysign.com/role/BasisOfPresentationAndSummaryOfSignificantPoliciesDetailsNarrative", "http://paysign.com/role/IntangibleAssetsNetDetailsNarrative" ], "xbrltype": "stringItemType" }, "PAYS_ImpactOfCovid19PandemicPoliciesTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Impact of COVID-19 Pandemic" } } }, "localname": "ImpactOfCovid19PandemicPoliciesTextBlock", "nsuri": "http://paysign.com/20220630", "presentation": [ "http://paysign.com/role/BasisOfPresentationAndSummaryOfSignificantPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "PAYS_IntangibleAssetsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Intangible Assets [Member]" } } }, "localname": "IntangibleAssetsMember", "nsuri": "http://paysign.com/20220630", "presentation": [ "http://paysign.com/role/BasisOfPresentationAndSummaryOfSignificantPoliciesDetailsNarrative", "http://paysign.com/role/IntangibleAssetsNetDetailsNarrative" ], "xbrltype": "domainItemType" }, "PAYS_LessImputedInterest": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "LessImputedInterest", "negatedLabel": "Less: Imputed interest" } } }, "localname": "LessImputedInterest", "nsuri": "http://paysign.com/20220630", "presentation": [ "http://paysign.com/role/LeaseDetails" ], "xbrltype": "monetaryItemType" }, "PAYS_LicensesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Licenses [Member]" } } }, "localname": "LicensesMember", "nsuri": "http://paysign.com/20220630", "presentation": [ "http://paysign.com/role/IntangibleAssetsNetDetails" ], "xbrltype": "domainItemType" }, "PAYS_NetIncomePerCommonShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Net income per common share [Abstract]", "label": "Net loss per common share:" } } }, "localname": "NetIncomePerCommonShareAbstract", "nsuri": "http://paysign.com/20220630", "presentation": [ "http://paysign.com/role/BasicAndFullyDilutedNetLossPerCommonShareDetails" ], "xbrltype": "stringItemType" }, "PAYS_NetLossPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net loss per share" } } }, "localname": "NetLossPerShareAbstract", "nsuri": "http://paysign.com/20220630", "presentation": [ "http://paysign.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "PAYS_OneCustomerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "One Customer [Member]" } } }, "localname": "OneCustomerMember", "nsuri": "http://paysign.com/20220630", "presentation": [ "http://paysign.com/role/BasisOfPresentationAndSummaryOfSignificantPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "PAYS_OtherReceivableMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Receivable [Member]" } } }, "localname": "OtherReceivableMember", "nsuri": "http://paysign.com/20220630", "presentation": [ "http://paysign.com/role/BasisOfPresentationAndSummaryOfSignificantPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "PAYS_OtherRevenueMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Revenue [Member]" } } }, "localname": "OtherRevenueMember", "nsuri": "http://paysign.com/20220630", "presentation": [ "http://paysign.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "domainItemType" }, "PAYS_PharmaceuticalIndustryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Pharmaceutical industry [Member]" } } }, "localname": "PharmaceuticalIndustryMember", "nsuri": "http://paysign.com/20220630", "presentation": [ "http://paysign.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "domainItemType" }, "PAYS_PlasmaIndustryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Plasma Industry [Member]" } } }, "localname": "PlasmaIndustryMember", "nsuri": "http://paysign.com/20220630", "presentation": [ "http://paysign.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "domainItemType" }, "PAYS_PlatformMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Platform [Member]" } } }, "localname": "PlatformMember", "nsuri": "http://paysign.com/20220630", "presentation": [ "http://paysign.com/role/IntangibleAssetsNetDetails" ], "xbrltype": "domainItemType" }, "PAYS_ProceedsFormVestedStockAwardsAndStockOptions": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Proceeds Form Vested Stock Awards And Stock Options" } } }, "localname": "ProceedsFormVestedStockAwardsAndStockOptions", "nsuri": "http://paysign.com/20220630", "presentation": [ "http://paysign.com/role/CommonStockDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "PAYS_RefundReceivable": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Other receivable" } } }, "localname": "RefundReceivable", "nsuri": "http://paysign.com/20220630", "presentation": [ "http://paysign.com/role/BasisOfPresentationAndSummaryOfSignificantPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "PAYS_RelatedPartyLawFirmMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Law Firm [Member]" } } }, "localname": "RelatedPartyLawFirmMember", "nsuri": "http://paysign.com/20220630", "presentation": [ "http://paysign.com/role/RelatedPartyDetailsNarrative" ], "xbrltype": "domainItemType" }, "PAYS_StockIssuedForVestedStockAwardsAndExerciseOfStockOptionsShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Number of shares vested" } } }, "localname": "StockIssuedForVestedStockAwardsAndExerciseOfStockOptionsShares", "nsuri": "http://paysign.com/20220630", "presentation": [ "http://paysign.com/role/CommonStockDetailsNarrative" ], "xbrltype": "sharesItemType" }, "PAYS_StockIssuedUponVestingOfRestrictedStock": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Stock issued upon vesting of restricted stock" } } }, "localname": "StockIssuedUponVestingOfRestrictedStock", "nsuri": "http://paysign.com/20220630", "presentation": [ "http://paysign.com/role/CondensedConsolidatedStatementsOfStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "PAYS_StockIssuedUponVestingOfRestrictedStockShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stock issued upon vesting of restricted stock, shares" } } }, "localname": "StockIssuedUponVestingOfRestrictedStockShares", "nsuri": "http://paysign.com/20220630", "presentation": [ "http://paysign.com/role/CondensedConsolidatedStatementsOfStockholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "PAYS_StockOptionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stock Options [Member]" } } }, "localname": "StockOptionsMember", "nsuri": "http://paysign.com/20220630", "presentation": [ "http://paysign.com/role/BasicAndFullyDilutedNetLossPerCommonShareDetailsNarrative" ], "xbrltype": "domainItemType" }, "PAYS_UnvestedRestrictedStockAwardsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Unvested Restricted Stock Awards [Member]" } } }, "localname": "UnvestedRestrictedStockAwardsMember", "nsuri": "http://paysign.com/20220630", "presentation": [ "http://paysign.com/role/BasicAndFullyDilutedNetLossPerCommonShareDetailsNarrative" ], "xbrltype": "domainItemType" }, "PAYS_WebsiteCostsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Website Costs [Member]" } } }, "localname": "WebsiteCostsMember", "nsuri": "http://paysign.com/20220630", "presentation": [ "http://paysign.com/role/FixedAssetsNetDetails" ], "xbrltype": "domainItemType" }, "PAYS_WeightedAverageCommonSharesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted average common shares" } } }, "localname": "WeightedAverageCommonSharesAbstract", "nsuri": "http://paysign.com/20220630", "presentation": [ "http://paysign.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://paysign.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://paysign.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r341" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://paysign.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r341" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://paysign.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://paysign.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://paysign.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://paysign.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r340" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://paysign.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r338", "r340", "r341" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://paysign.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://paysign.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://paysign.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://paysign.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://paysign.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r339" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://paysign.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r327" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://paysign.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r340" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://paysign.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r340" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://paysign.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r342" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://paysign.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://paysign.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r330" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://paysign.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://paysign.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://paysign.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://paysign.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://paysign.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://paysign.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://paysign.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://paysign.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r333" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://paysign.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r329" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://paysign.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://paysign.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://paysign.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r329" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://paysign.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r346" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://paysign.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://paysign.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r329" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://paysign.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://paysign.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r343" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://paysign.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r341" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://paysign.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://paysign.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r329" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://paysign.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r329" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://paysign.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r329" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://paysign.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r329" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://paysign.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://paysign.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r344" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://paysign.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://paysign.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://paysign.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://paysign.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r340" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://paysign.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r334" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://paysign.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r335" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://paysign.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r328" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://paysign.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r332" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://paysign.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r331" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://paysign.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r336" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://paysign.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r337" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://paysign.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://paysign.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r345" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://paysign.com/role/Cover" ], "xbrltype": "booleanItemType" }, "srt_MajorCustomersAxis": { "auth_ref": [ "r122", "r189", "r194", "r313" ], "lang": { "en-us": { "role": { "label": "Customer [Axis]" } } }, "localname": "MajorCustomersAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://paysign.com/role/BasisOfPresentationAndSummaryOfSignificantPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_NameOfMajorCustomerDomain": { "auth_ref": [ "r122", "r189", "r194", "r313" ], "localname": "NameOfMajorCustomerDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://paysign.com/role/BasisOfPresentationAndSummaryOfSignificantPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r120", "r146", "r147", "r189", "r193", "r278", "r311", "r312" ], "lang": { "en-us": { "role": { "label": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://paysign.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r120", "r146", "r147", "r189", "r193", "r278", "r311", "r312" ], "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://paysign.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": { "auth_ref": [ "r19" ], "calculation": { "http://paysign.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.", "label": "Accounts payable and accrued liabilities" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableMember": { "auth_ref": [ "r322" ], "lang": { "en-us": { "role": { "documentation": "Due from customers or clients for goods or services that have been delivered or sold.", "label": "Accounts Receivable [Member]" } } }, "localname": "AccountsReceivableMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/BasisOfPresentationAndSummaryOfSignificantPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r123", "r124" ], "calculation": { "http://paysign.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts receivable" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r7", "r140" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/FixedAssetsNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r13", "r273" ], "calculation": { "http://paysign.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r60", "r61", "r62", "r203", "r204", "r205", "r236" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CondensedConsolidatedStatementsOfStockholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentForAmortization": { "auth_ref": [ "r45", "r134" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.", "label": "Amortization" } } }, "localname": "AdjustmentForAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/IntangibleAssetsNetDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "auth_ref": [ "r197", "r206", "r207" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.", "label": "Stock-based compensation" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CondensedConsolidatedStatementsOfStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net loss to net cash provided by operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r201" ], "calculation": { "http://paysign.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "Stock-based compensation expense" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r86" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Potential common share equivalents excluded from computation" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/BasicAndFullyDilutedNetLossPerCommonShareDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "auth_ref": [ "r86" ], "lang": { "en-us": { "role": { "documentation": "Information by type of antidilutive security.", "label": "Antidilutive Securities [Axis]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/BasicAndFullyDilutedNetLossPerCommonShareDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/BasicAndFullyDilutedNetLossPerCommonShareDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "auth_ref": [ "r86" ], "lang": { "en-us": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented." } } }, "localname": "AntidilutiveSecuritiesNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/BasicAndFullyDilutedNetLossPerCommonShareDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r9", "r56", "r109", "r112", "r118", "r126", "r149", "r150", "r151", "r152", "r153", "r154", "r155", "r156", "r157", "r158", "r159", "r224", "r229", "r241", "r271", "r273", "r294", "r302" ], "calculation": { "http://paysign.com/role/CondensedConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r3", "r18", "r56", "r126", "r149", "r150", "r151", "r152", "r153", "r154", "r155", "r156", "r157", "r158", "r159", "r224", "r229", "r241", "r271", "r273" ], "calculation": { "http://paysign.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current assets" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by location on balance sheet (statement of financial position).", "label": "Balance Sheet Location [Axis]" } } }, "localname": "BalanceSheetLocationAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/BasisOfPresentationAndSummaryOfSignificantPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationDomain": { "auth_ref": [ "r233", "r234" ], "lang": { "en-us": { "role": { "documentation": "Location in the balance sheet (statement of financial position)." } } }, "localname": "BalanceSheetLocationDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/BasisOfPresentationAndSummaryOfSignificantPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r59" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.", "label": "BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT POLICIES" } } }, "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/BasisOfPresentationAndSummaryOfSignificantPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock": { "auth_ref": [ "r59", "r104" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the business description and accounting policies concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Accounting policies describe all significant accounting policies of the reporting entity.", "label": "About Paysign, Inc" } } }, "localname": "BusinessDescriptionAndAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/BasisOfPresentationAndSummaryOfSignificantPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_Cash": { "auth_ref": [ "r5", "r273", "r320", "r321" ], "calculation": { "http://paysign.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash", "periodEndLabel": "Cash" } } }, "localname": "Cash", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CondensedConsolidatedBalanceSheets", "http://paysign.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r48" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/BasisOfPresentationAndSummaryOfSignificantPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": { "auth_ref": [ "r48", "r293" ], "lang": { "en-us": { "role": { "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.", "label": "Restricted Cash" } } }, "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/BasisOfPresentationAndSummaryOfSignificantPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r41", "r47", "r50" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "periodEndLabel": "Cash and restricted cash, end of period", "periodStartLabel": "Cash and restricted cash, beginning of period" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": { "auth_ref": [ "r41", "r242" ], "calculation": { "http://paysign.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect", "totalLabel": "Net change in cash and restricted cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashEquivalentsAtCarryingValue": { "auth_ref": [ "r5" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash equivalents" } } }, "localname": "CashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/BasisOfPresentationAndSummaryOfSignificantPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashUninsuredAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of cash as of the balance sheet date that is not insured by the Federal Deposit Insurance Corporation.", "label": "Fdic insured" } } }, "localname": "CashUninsuredAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/BasisOfPresentationAndSummaryOfSignificantPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r23", "r296", "r307" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and contingencies (Note 8)" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r143", "r144", "r145", "r148", "r323" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "COMMITMENTS AND CONTINGENCIES" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r60", "r61", "r236" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CondensedConsolidatedStatementsOfStockholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common stock, par value", "verboseLabel": "Common Stock, Par or Stated Value Per Share" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CommonStockDetailsNarrative", "http://paysign.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common stock, shares authorized", "verboseLabel": "Common Stock, Shares Authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CommonStockDetailsNarrative", "http://paysign.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common stock, shares issued", "verboseLabel": "Common Stock, Shares, Issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CommonStockDetailsNarrative", "http://paysign.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r11", "r173" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CommonStockDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r11", "r273" ], "calculation": { "http://paysign.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common stock; $ 0.001 par value; 150,000,000 shares authorized, 52,323,382 and 52,095,382 issued at June 30, 2022 and December 31, 2021, respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CompensationRelatedCostsPolicyTextBlock": { "auth_ref": [ "r199" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.", "label": "Stock-Based Compensation" } } }, "localname": "CompensationRelatedCostsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/BasisOfPresentationAndSummaryOfSignificantPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r99", "r100", "r122", "r239", "r240", "r322" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage." } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/BasisOfPresentationAndSummaryOfSignificantPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r99", "r100", "r122", "r239", "r240", "r319", "r322" ], "lang": { "en-us": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk Benchmark [Axis]" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/BasisOfPresentationAndSummaryOfSignificantPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskByTypeAxis": { "auth_ref": [ "r99", "r100", "r122", "r239", "r240", "r319", "r322" ], "lang": { "en-us": { "role": { "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.", "label": "Concentration Risk Type [Axis]" } } }, "localname": "ConcentrationRiskByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/BasisOfPresentationAndSummaryOfSignificantPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskCreditRisk": { "auth_ref": [ "r95", "r301" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for credit risk.", "label": "Concentrations of Credit Risk" } } }, "localname": "ConcentrationRiskCreditRisk", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/BasisOfPresentationAndSummaryOfSignificantPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskPercentage1": { "auth_ref": [ "r99", "r100", "r122", "r239", "r240" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.", "label": "Concentration Risk, Percentage" } } }, "localname": "ConcentrationRiskPercentage1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/BasisOfPresentationAndSummaryOfSignificantPoliciesDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_ConcentrationRiskTypeDomain": { "auth_ref": [ "r99", "r100", "r122", "r239", "r240", "r322" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration." } } }, "localname": "ConcentrationRiskTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/BasisOfPresentationAndSummaryOfSignificantPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ConsolidationPolicyTextBlock": { "auth_ref": [ "r51", "r226" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.", "label": "Principles of Consolidation" } } }, "localname": "ConsolidationPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/BasisOfPresentationAndSummaryOfSignificantPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": { "auth_ref": [ "r180" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.", "label": "Schedule of contract liabilities" } } }, "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CustomerCardFundingLiabilityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ContractWithCustomerLiability": { "auth_ref": [ "r178", "r179", "r190" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.", "label": "Contract with Customer, Liability", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance" } } }, "localname": "ContractWithCustomerLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CustomerCardFundingLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityCurrent": { "auth_ref": [ "r178", "r179", "r190" ], "calculation": { "http://paysign.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.", "label": "Customer card funding" } } }, "localname": "ContractWithCustomerLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": { "auth_ref": [ "r191" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.", "label": "Revenue recognized in current year previously included in contract liabilities" } } }, "localname": "ContractWithCustomerLiabilityRevenueRecognized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CustomerCardFundingLiabilityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfGoodsAndServicesSold": { "auth_ref": [ "r34", "r278" ], "calculation": { "http://paysign.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.", "label": "Cost of revenues" } } }, "localname": "CostOfGoodsAndServicesSold", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_CustomerConcentrationRiskMember": { "auth_ref": [ "r98", "r122" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.", "label": "Customer Concentration Risk [Member]" } } }, "localname": "CustomerConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/BasisOfPresentationAndSummaryOfSignificantPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r45", "r138" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation expense" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/FixedAssetsNetDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationAndAmortization": { "auth_ref": [ "r45", "r138" ], "calculation": { "http://paysign.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.", "label": "Depreciation, Depletion and Amortization, Nonproduction", "verboseLabel": "Depreciation and amortization" } } }, "localname": "DepreciationAndAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationDepletionAndAmortization": { "auth_ref": [ "r45", "r107" ], "calculation": { "http://paysign.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Depreciation and amortization" } } }, "localname": "DepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r32", "r65", "r66", "r67", "r68", "r69", "r73", "r76", "r83", "r84", "r85", "r89", "r90", "r237", "r238", "r298", "r309" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Basic" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/BasicAndFullyDilutedNetLossPerCommonShareDetails", "http://paysign.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r32", "r65", "r66", "r67", "r68", "r69", "r76", "r83", "r84", "r85", "r89", "r90", "r237", "r238", "r298", "r309" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Diluted", "verboseLabel": "Fully diluted" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/BasicAndFullyDilutedNetLossPerCommonShareDetails", "http://paysign.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r86", "r87" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Earnings Per Share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/BasisOfPresentationAndSummaryOfSignificantPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EarningsPerShareReconciliationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Numerator:" } } }, "localname": "EarningsPerShareReconciliationAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/BasicAndFullyDilutedNetLossPerCommonShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r86", "r87", "r88", "r91" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "BASIC AND FULLY DILUTED NET LOSS PER COMMON SHARE" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/BasicAndFullyDilutedNetLossPerCommonShare" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "auth_ref": [ "r209" ], "lang": { "en-us": { "role": { "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Effective income tax rate" } } }, "localname": "EffectiveIncomeTaxRateContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/IncomeTaxProvisionDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "auth_ref": [ "r21" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Employee related cost" } } }, "localname": "EmployeeRelatedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/BasisOfPresentationAndSummaryOfSignificantPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tangible personal property used to produce goods and services.", "label": "Equipment [Member]" } } }, "localname": "EquipmentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/FixedAssetsNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r0", "r28", "r29", "r30", "r60", "r61", "r62", "r64", "r70", "r72", "r92", "r127", "r173", "r174", "r203", "r204", "r205", "r213", "r214", "r236", "r243", "r244", "r245", "r246", "r247", "r248", "r262", "r314", "r315", "r316" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CondensedConsolidatedStatementsOfStockholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "auth_ref": [ "r8", "r133" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Accumulated Amortization" } } }, "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/IntangibleAssetsNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r129", "r130", "r133", "r135", "r279", "r280" ], "lang": { "en-us": { "role": { "documentation": "Information by major type or class of finite-lived intangible assets.", "label": "Finite-Lived Intangible Assets by Major Class [Axis]" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/BasisOfPresentationAndSummaryOfSignificantPoliciesDetailsNarrative", "http://paysign.com/role/IntangibleAssetsNetDetails", "http://paysign.com/role/IntangibleAssetsNetDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "auth_ref": [ "r133", "r280" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Gross" } } }, "localname": "FiniteLivedIntangibleAssetsGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/IntangibleAssetsNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Finite-Lived Intangible Assets [Line Items]" } } }, "localname": "FiniteLivedIntangibleAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/IntangibleAssetsNetDetails", "http://paysign.com/role/IntangibleAssetsNetDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r129", "r132" ], "lang": { "en-us": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company." } } }, "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/BasisOfPresentationAndSummaryOfSignificantPoliciesDetailsNarrative", "http://paysign.com/role/IntangibleAssetsNetDetails", "http://paysign.com/role/IntangibleAssetsNetDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_FurnitureAndFixturesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.", "label": "Furniture and Fixtures [Member]" } } }, "localname": "FurnitureAndFixturesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/FixedAssetsNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r33", "r56", "r109", "r111", "r114", "r117", "r119", "r126", "r149", "r150", "r151", "r153", "r154", "r155", "r156", "r157", "r158", "r159", "r241" ], "calculation": { "http://paysign.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "Gross profit" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r57", "r210", "r211", "r212", "r215", "r217", "r219", "r220", "r221" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "INCOME TAX PROVISION" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/IncomeTaxProvision" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r58", "r71", "r72", "r108", "r208", "r216", "r218", "r310" ], "calculation": { "http://paysign.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income tax provision" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxesPaidNet": { "auth_ref": [ "r49" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.", "label": "Cash paid for taxes" } } }, "localname": "IncomeTaxesPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r44" ], "calculation": { "http://paysign.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.", "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities", "verboseLabel": "Accounts payable and accrued liabilities" } } }, "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r44" ], "calculation": { "http://paysign.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": { "auth_ref": [ "r44", "r274" ], "calculation": { "http://paysign.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.", "label": "Increase (decrease), net", "verboseLabel": "Customer card funding" } } }, "localname": "IncreaseDecreaseInContractWithCustomerLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CondensedConsolidatedStatementsOfCashFlows", "http://paysign.com/role/CustomerCardFundingLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": { "auth_ref": [ "r44", "r256" ], "calculation": { "http://paysign.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in obligation for operating lease.", "label": "Operating lease liability" } } }, "localname": "IncreaseDecreaseInOperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Changes in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOtherReceivables": { "auth_ref": [ "r44" ], "calculation": { "http://paysign.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in receivables classified as other.", "label": "Increase (Decrease) in Other Receivables", "negatedLabel": "Other receivable" } } }, "localname": "IncreaseDecreaseInOtherReceivables", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "auth_ref": [ "r44" ], "calculation": { "http://paysign.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "negatedLabel": "Prepaid expenses and other current assets" } } }, "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants": { "auth_ref": [ "r77", "r78", "r79", "r85" ], "lang": { "en-us": { "role": { "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of call options and warrants using the treasury stock method.", "label": "Stock options (calculated using the treasury method)" } } }, "localname": "IncrementalCommonSharesAttributableToCallOptionsAndWarrants", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/BasicAndFullyDilutedNetLossPerCommonShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": { "auth_ref": [ "r77", "r78", "r80", "r85", "r198" ], "lang": { "en-us": { "role": { "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.", "label": "Unvested restricted stock grants" } } }, "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/BasicAndFullyDilutedNetLossPerCommonShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_IntangibleAssetsDisclosureTextBlock": { "auth_ref": [ "r136" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all or part of the information related to intangible assets.", "label": "INTANGIBLE ASSETS, NET" } } }, "localname": "IntangibleAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/IntangibleAssetsNet" ], "xbrltype": "textBlockItemType" }, "us-gaap_IntangibleAssetsFiniteLivedPolicy": { "auth_ref": [ "r52", "r132", "r275", "r276", "r277", "r279" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets.", "label": "Intangible Assets" } } }, "localname": "IntangibleAssetsFiniteLivedPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/BasisOfPresentationAndSummaryOfSignificantPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r128", "r131" ], "calculation": { "http://paysign.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Intangible assets, net", "verboseLabel": "Intangible Assets, Net (Excluding Goodwill)" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CondensedConsolidatedBalanceSheets", "http://paysign.com/role/IntangibleAssetsNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestAndOtherIncome": { "auth_ref": [], "calculation": { "http://paysign.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of interest income and other income recognized during the period. Included in this element is interest derived from investments in debt securities, cash and cash equivalents, and other investments which reflect the time value of money or transactions in which the payments are for the use or forbearance of money and other income from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business).", "label": "Interest income, net" } } }, "localname": "InterestAndOtherIncome", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r39", "r42", "r49" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest paid" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseCostTableTextBlock": { "auth_ref": [ "r259" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.", "label": "Schedule of operating lease liabilities" } } }, "localname": "LeaseCostTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/LeaseTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LeaseholdImprovementsMember": { "auth_ref": [ "r139" ], "lang": { "en-us": { "role": { "documentation": "Additions or improvements to assets held under a lease arrangement.", "label": "Leasehold Improvements [Member]" } } }, "localname": "LeaseholdImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/FixedAssetsNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LeasesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Leases [Abstract]" } } }, "localname": "LeasesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_LeasesOfLessorDisclosureTextBlock": { "auth_ref": [ "r251" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for lessor entity's leasing arrangements for operating, capital and leveraged leases.", "label": "LEASE" } } }, "localname": "LeasesOfLessorDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/Lease" ], "xbrltype": "textBlockItemType" }, "us-gaap_LegalFees": { "auth_ref": [ "r35" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings.", "label": "Legal Fees" } } }, "localname": "LegalFees", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/RelatedPartyDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeLeasesPolicyTextBlock": { "auth_ref": [ "r254" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.", "label": "Operating leases" } } }, "localname": "LesseeLeasesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/BasisOfPresentationAndSummaryOfSignificantPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_LessorOperatingLeaseOptionToExtend": { "auth_ref": [ "r261" ], "lang": { "en-us": { "role": { "documentation": "Description of terms and conditions of option to extend lessor's operating lease.", "label": "Lease term option to extend" } } }, "localname": "LessorOperatingLeaseOptionToExtend", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/LeaseDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_LessorOperatingLeaseTermOfContract": { "auth_ref": [ "r261" ], "lang": { "en-us": { "role": { "documentation": "Term of lessor's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Lease term" } } }, "localname": "LessorOperatingLeaseTermOfContract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/LeaseDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r20", "r56", "r113", "r126", "r149", "r150", "r151", "r153", "r154", "r155", "r156", "r157", "r158", "r159", "r225", "r229", "r230", "r241", "r271", "r272" ], "calculation": { "http://paysign.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r17", "r56", "r126", "r241", "r273", "r295", "r305" ], "calculation": { "http://paysign.com/role/CondensedConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total liabilities and stockholders' equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LIABILITIES AND STOCKHOLDERS' EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r4", "r22", "r56", "r126", "r149", "r150", "r151", "r153", "r154", "r155", "r156", "r157", "r158", "r159", "r225", "r229", "r230", "r241", "r271", "r272", "r273" ], "calculation": { "http://paysign.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current liabilities" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r41" ], "calculation": { "http://paysign.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from financing activities:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r41" ], "calculation": { "http://paysign.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash used in investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from investing activities:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r41", "r43", "r46" ], "calculation": { "http://paysign.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash provided by operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from operating activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r2", "r26", "r27", "r30", "r31", "r46", "r56", "r63", "r65", "r66", "r67", "r68", "r71", "r72", "r81", "r109", "r111", "r114", "r117", "r119", "r126", "r149", "r150", "r151", "r153", "r154", "r155", "r156", "r157", "r158", "r159", "r238", "r241", "r297", "r308" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net loss" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CondensedConsolidatedStatementsOfStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "auth_ref": [ "r65", "r66", "r67", "r68", "r73", "r74", "r82", "r85", "r109", "r111", "r114", "r117", "r119" ], "calculation": { "http://paysign.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://paysign.com/role/CondensedConsolidatedStatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.", "label": "Net Income (Loss) Available to Common Stockholders, Basic", "totalLabel": "Net loss", "verboseLabel": "Net loss" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/BasicAndFullyDilutedNetLossPerCommonShareDetails", "http://paysign.com/role/CondensedConsolidatedStatementsOfCashFlows", "http://paysign.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Denominator:" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersDilutedAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/BasicAndFullyDilutedNetLossPerCommonShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "Recently Issued Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/BasisOfPresentationAndSummaryOfSignificantPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoncashInvestingAndFinancingItemsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Non-cash financing activities" } } }, "localname": "NoncashInvestingAndFinancingItemsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other income" } } }, "localname": "NonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://paysign.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses", "totalLabel": "Total operating expenses" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating expenses" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r109", "r111", "r114", "r117", "r119" ], "calculation": { "http://paysign.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Loss from operations" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseCost": { "auth_ref": [ "r255", "r260" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.", "label": "Operating lease cost" } } }, "localname": "OperatingLeaseCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/LeaseDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r253" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Present value of future lease payments" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/LeaseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r253" ], "calculation": { "http://paysign.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating lease liability, current portion", "negatedLabel": "Less: current portion of lease liability" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CondensedConsolidatedBalanceSheets", "http://paysign.com/role/LeaseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r253" ], "calculation": { "http://paysign.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Operating lease liability, long term portion", "verboseLabel": "Long-term portion of lease liability" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CondensedConsolidatedBalanceSheets", "http://paysign.com/role/LeaseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r252" ], "calculation": { "http://paysign.com/role/CondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating lease right-of-use asset" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r258", "r260" ], "lang": { "en-us": { "role": { "documentation": "Weighted average discount rate for operating lease calculated at point in time.", "label": "Discount rate" } } }, "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/LeaseDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r257", "r260" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Remaining lease term" } } }, "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/LeaseDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDue": { "auth_ref": [ "r249", "r250" ], "calculation": { "http://paysign.com/role/LeaseDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.", "label": "Operating Leases, Future Minimum Payments Due", "totalLabel": "Total lease payments" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/LeaseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent": { "auth_ref": [ "r249", "r250" ], "calculation": { "http://paysign.com/role/LeaseDetails": { "order": 1.0, "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "2022 (excluding the six months ended June 30, 2022)" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/LeaseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears": { "auth_ref": [ "r249", "r250" ], "calculation": { "http://paysign.com/role/LeaseDetails": { "order": 5.0, "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "2026" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueInFiveYears", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/LeaseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears": { "auth_ref": [ "r249", "r250" ], "calculation": { "http://paysign.com/role/LeaseDetails": { "order": 4.0, "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "2025" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueInFourYears", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/LeaseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears": { "auth_ref": [ "r249", "r250" ], "calculation": { "http://paysign.com/role/LeaseDetails": { "order": 3.0, "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "2024" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueInThreeYears", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/LeaseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears": { "auth_ref": [ "r249", "r250" ], "calculation": { "http://paysign.com/role/LeaseDetails": { "order": 2.0, "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "2023" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueInTwoYears", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/LeaseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter": { "auth_ref": [ "r249", "r250" ], "calculation": { "http://paysign.com/role/LeaseDetails": { "order": 6.0, "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Thereafter" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueThereafter", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/LeaseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNoncashExpense": { "auth_ref": [ "r46" ], "calculation": { "http://paysign.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense or loss included in net income that result in no cash flow, classified as other.", "label": "Noncash lease expense" } } }, "localname": "OtherNoncashExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherReceivables": { "auth_ref": [ "r12" ], "calculation": { "http://paysign.com/role/CondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount due from parties in nontrade transactions, classified as other.", "label": "Other receivables" } } }, "localname": "OtherReceivables", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireIntangibleAssets": { "auth_ref": [ "r37" ], "calculation": { "http://paysign.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.", "label": "Payments to Acquire Intangible Assets", "negatedLabel": "Purchase of intangible assets" } } }, "localname": "PaymentsToAcquireIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r37" ], "calculation": { "http://paysign.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Purchase of fixed assets" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToDevelopSoftware": { "auth_ref": [ "r37" ], "calculation": { "http://paysign.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the development or modification of software programs or applications for internal use (that is, not to be sold, leased or otherwise marketed to others) that qualify for capitalization.", "label": "Payments to Develop Software", "negatedLabel": "Capitalization of internally developed software" } } }, "localname": "PaymentsToDevelopSoftware", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r10", "r160" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred stock, par value", "verboseLabel": "Preferred Stock, Par or Stated Value Per Share" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CommonStockDetailsNarrative", "http://paysign.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred stock, shares authorized", "verboseLabel": "Preferred Stock, Shares Authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CommonStockDetailsNarrative", "http://paysign.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r10", "r160" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred stock, shares issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred stock, shares outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r10", "r273" ], "calculation": { "http://paysign.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred stock: $ 0.001 par value; 25,000,000 shares authorized; none issued and outstanding" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r18" ], "calculation": { "http://paysign.com/role/CondensedConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Prepaid expenses and other current assets" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PriorPeriodReclassificationAdjustmentDescription": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.", "label": "Reclassifications" } } }, "localname": "PriorPeriodReclassificationAdjustmentDescription", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/BasisOfPresentationAndSummaryOfSignificantPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ProceedsFromStockOptionsExercised": { "auth_ref": [ "r38", "r202" ], "calculation": { "http://paysign.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.", "label": "Proceeds from exercise of stock options" } } }, "localname": "ProceedsFromStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Product Information [Line Items]" } } }, "localname": "ProductInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/BasisOfPresentationAndSummaryOfSignificantPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r2", "r26", "r27", "r30", "r40", "r56", "r63", "r71", "r72", "r109", "r111", "r114", "r117", "r119", "r126", "r149", "r150", "r151", "r153", "r154", "r155", "r156", "r157", "r158", "r159", "r223", "r227", "r228", "r231", "r232", "r238", "r241", "r299" ], "calculation": { "http://paysign.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "totalLabel": "Loss before income tax provision" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Abstract]" } } }, "localname": "PropertyPlantAndEquipmentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r141" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Long-Lived Tangible Asset [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/FixedAssetsNetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "auth_ref": [ "r142", "r324", "r325", "r326" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "FIXED ASSETS, NET" } } }, "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/FixedAssetsNet" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives": { "auth_ref": [ "r137" ], "lang": { "en-us": { "role": { "documentation": "Describes the periods of time over which an entity anticipates to receive utility from its property, plant and equipment (that is, the periods of time over which an entity allocates the initial cost of its property, plant and equipment).", "label": "Property, Plant and Equipment, Estimated Useful Lives" } } }, "localname": "PropertyPlantAndEquipmentEstimatedUsefulLives", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/BasisOfPresentationAndSummaryOfSignificantPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r6", "r139" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Gross" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/FixedAssetsNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property, Plant and Equipment [Line Items]" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/FixedAssetsNetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r141", "r273", "r300", "r306" ], "calculation": { "http://paysign.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Fixed assets, net", "verboseLabel": "Property, Plant and Equipment, Net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CondensedConsolidatedBalanceSheets", "http://paysign.com/role/FixedAssetsNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "auth_ref": [ "r141", "r324", "r325" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Fixed Assets" } } }, "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/BasisOfPresentationAndSummaryOfSignificantPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "auth_ref": [ "r141" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Schedule of fixed assets" } } }, "localname": "PropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/FixedAssetsNetTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r139" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software." } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/FixedAssetsNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r196", "r265", "r266" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/RelatedPartyDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Related Party Transaction [Line Items]" } } }, "localname": "RelatedPartyTransactionLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/RelatedPartyDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r196", "r265", "r268", "r281", "r282", "r283", "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r292" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/RelatedPartyDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r263", "r264", "r266", "r269", "r270" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "RELATED PARTY" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/RelatedParty" ], "xbrltype": "textBlockItemType" }, "us-gaap_RestrictedCash": { "auth_ref": [ "r5", "r50", "r293", "r303" ], "calculation": { "http://paysign.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.", "label": "Restricted cash", "periodEndLabel": "Restricted cash" } } }, "localname": "RestrictedCash", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CondensedConsolidatedBalanceSheets", "http://paysign.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedCashAndCashEquivalents": { "auth_ref": [ "r5", "r47", "r50", "r293", "r303" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Restricted Cash and Cash Equivalents", "periodEndLabel": "Total cash and restricted cash" } } }, "localname": "RestrictedCashAndCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedCashAndCashEquivalentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash and restricted cash reconciliation:" } } }, "localname": "RestrictedCashAndCashEquivalentsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r14", "r174", "r273", "r304", "r317", "r318" ], "calculation": { "http://paysign.com/role/CondensedConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r0", "r60", "r61", "r62", "r64", "r70", "r72", "r127", "r203", "r204", "r205", "r213", "r214", "r236", "r314", "r316" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CondensedConsolidatedStatementsOfStockholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenue from Contract with Customer [Abstract]" } } }, "localname": "RevenueFromContractWithCustomerAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r105", "r106", "r110", "r115", "r116", "r120", "r121", "r122", "r188", "r189", "r278" ], "calculation": { "http://paysign.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "Total revenues" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerTextBlock": { "auth_ref": [ "r180", "r181", "r182", "r183", "r184", "r185", "r186", "r187", "r192", "r195" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.", "label": "CUSTOMER CARD FUNDING LIABILITY" } } }, "localname": "RevenueFromContractWithCustomerTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CustomerCardFundingLiability" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueRecognitionPolicyTextBlock": { "auth_ref": [ "r53", "r54" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.", "label": "Revenue and Expense Recognition" } } }, "localname": "RevenueRecognitionPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/BasisOfPresentationAndSummaryOfSignificantPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenuesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenues" } } }, "localname": "RevenuesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "auth_ref": [ "r86" ], "lang": { "en-us": { "role": { "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/BasicAndFullyDilutedNetLossPerCommonShareDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r85" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of computation of earnings per share" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/BasicAndFullyDilutedNetLossPerCommonShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": { "auth_ref": [ "r129", "r132", "r279" ], "lang": { "en-us": { "role": { "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Schedule of Finite-Lived Intangible Assets [Table]" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/IntangibleAssetsNetDetails", "http://paysign.com/role/IntangibleAssetsNetDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": { "auth_ref": [ "r129", "r132" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.", "label": "Schedule of intangible assets" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/IntangibleAssetsNetTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfProductInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule detailing quantitative information concerning products or product lines by product or product line.", "label": "Schedule of Product Information [Table]" } } }, "localname": "ScheduleOfProductInformationTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/BasisOfPresentationAndSummaryOfSignificantPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r141" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/FixedAssetsNetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "auth_ref": [ "r267", "r268" ], "lang": { "en-us": { "role": { "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Schedule of Related Party Transactions, by Related Party [Table]" } } }, "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/RelatedPartyDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r36" ], "calculation": { "http://paysign.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.", "label": "Selling, general and administrative" } } }, "localname": "SellingGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r44" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-based Payment Arrangement, Noncash Expense" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CommonStockDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Ending balance, shares", "periodStartLabel": "Beginning balance, shares" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CondensedConsolidatedStatementsOfStockholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_SoftwareDevelopmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Internally developed software for sale, licensing or long-term internal use.", "label": "Software Development [Member]" } } }, "localname": "SoftwareDevelopmentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/FixedAssetsNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r0", "r25", "r28", "r29", "r30", "r60", "r61", "r62", "r64", "r70", "r72", "r92", "r127", "r173", "r174", "r203", "r204", "r205", "r213", "r214", "r236", "r243", "r244", "r245", "r246", "r247", "r248", "r262", "r314", "r315", "r316" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CondensedConsolidatedStatementsOfStockholdersEquityDeficit" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CondensedConsolidatedStatementsOfOperations", "http://paysign.com/role/CondensedConsolidatedStatementsOfStockholdersEquityDeficit" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r60", "r61", "r62", "r92", "r278" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CondensedConsolidatedStatementsOfOperations", "http://paysign.com/role/CondensedConsolidatedStatementsOfStockholdersEquityDeficit" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r10", "r11", "r173", "r174", "r200" ], "lang": { "en-us": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Exercise of stock options, shares" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CondensedConsolidatedStatementsOfStockholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": { "auth_ref": [ "r25", "r173", "r174" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued as a result of the exercise of stock options.", "label": "Exercise of stock options" } } }, "localname": "StockIssuedDuringPeriodValueStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CondensedConsolidatedStatementsOfStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r11", "r15", "r16", "r56", "r125", "r126", "r241", "r273" ], "calculation": { "http://paysign.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Ending balance, value", "periodStartLabel": "Beginning balance, value", "totalLabel": "Total stockholders' equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CondensedConsolidatedBalanceSheets", "http://paysign.com/role/CondensedConsolidatedStatementsOfStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' equity" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r55", "r161", "r162", "r163", "r164", "r165", "r166", "r167", "r168", "r169", "r170", "r171", "r172", "r174", "r177", "r235" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "COMMON STOCK" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CommonStock" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental cash flow information:" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_TrademarksAndTradeNamesMember": { "auth_ref": [ "r222" ], "lang": { "en-us": { "role": { "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style, or rights either acquired through registration of a business name to gain or protect exclusive use thereof.", "label": "Trademarks and Trade Names [Member]" } } }, "localname": "TrademarksAndTradeNamesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/IntangibleAssetsNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TreasuryStockMember": { "auth_ref": [ "r24", "r175" ], "lang": { "en-us": { "role": { "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.", "label": "Treasury Stock [Member]" } } }, "localname": "TreasuryStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CondensedConsolidatedStatementsOfStockholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_TreasuryStockShares": { "auth_ref": [ "r24", "r175" ], "lang": { "en-us": { "role": { "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.", "label": "Treasury stock shares" } } }, "localname": "TreasuryStockShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_TreasuryStockValue": { "auth_ref": [ "r24", "r175", "r176" ], "calculation": { "http://paysign.com/role/CondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.", "label": "Treasury Stock, Value", "negatedLabel": "Treasury stock at cost, 303,450 shares" } } }, "localname": "TreasuryStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r93", "r94", "r96", "r97", "r101", "r102", "r103" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/BasisOfPresentationAndSummaryOfSignificantPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted average effects of potentially diluted common stock:" } } }, "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/BasicAndFullyDilutedNetLossPerCommonShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r75", "r85" ], "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Denominator for fully diluted calculation", "verboseLabel": "Diluted" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/BasicAndFullyDilutedNetLossPerCommonShareDetails", "http://paysign.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted average common shares:" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/BasicAndFullyDilutedNetLossPerCommonShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r73", "r85" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Denominator for basic calculation", "verboseLabel": "Basic" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://paysign.com/role/BasicAndFullyDilutedNetLossPerCommonShareDetails", "http://paysign.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "sharesItemType" } }, "unitCount": 4 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=124429488&loc=d3e326-107755" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r104": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "https://asc.fasb.org/topic&trid=2134479" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r136": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/subtopic&trid=2144471" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=126905813&loc=d3e1205-110223" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r142": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "360", "URI": "https://asc.fasb.org/topic&trid=2155823" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r145": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org/topic&trid=2144648" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751" }, "r148": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org/topic&trid=2127136" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656" }, "r177": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org/topic&trid=2208762" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130531-203044" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130532-203044" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130558-203045" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130550-203045" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046" }, "r195": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "606", "URI": "https://asc.fasb.org/topic&trid=49130388" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126962052&loc=d3e4991-113900" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b),(f(1))", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "2A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331" }, "r221": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "https://asc.fasb.org/topic&trid=2144680" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29,30)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(Note 3)", "Topic": "840", "URI": "https://asc.fasb.org/extlink&oid=123403562&loc=d3e38371-112697" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "840", "URI": "https://asc.fasb.org/extlink&oid=123406913&loc=d3e41502-112717" }, "r251": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "840", "URI": "https://asc.fasb.org/topic&trid=2208923" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918666-209980" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(3)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(4)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=124258985&loc=SL77919359-209981" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580" }, "r270": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "https://asc.fasb.org/topic&trid=2122745" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "912", "URI": "https://asc.fasb.org/extlink&oid=126938201&loc=d3e55415-109406" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "350", "Subparagraph": "(a)", "Topic": "920", "URI": "https://asc.fasb.org/extlink&oid=120155617&loc=SL120155628-234783" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "350", "Subparagraph": "(b)", "Topic": "920", "URI": "https://asc.fasb.org/extlink&oid=120155617&loc=SL120155628-234783" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "350", "Subparagraph": "(a)", "Topic": "920", "URI": "https://asc.fasb.org/extlink&oid=120155617&loc=SL120155638-234783" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(1)(a))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126941378&loc=d3e61044-112788" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(2))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=SL120174063-112916" }, "r327": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12" }, "r328": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r329": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r330": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23" }, "r331": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r332": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g" }, "r333": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d" }, "r334": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r335": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r336": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d" }, "r337": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r338": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310" }, "r339": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r340": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r341": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r342": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r343": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r344": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405" }, "r345": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" }, "r346": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.3)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r59": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org/topic&trid=2122369" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1377-109256" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1707-109256" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1757-109256" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "26", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1828-109256" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(16))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "28A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1500-109256" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258" }, "r91": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "https://asc.fasb.org/topic&trid=2144383" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" } }, "version": "2.1" } ZIP 54 0001683168-22-005495-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001683168-22-005495-xbrl.zip M4$L#!!0 ( "--"E4\GX#=[@D /Y9 1 <&%YID5\41TR_3W<_TT"UY=//;RG64)?89H=YMHWUVWE"P M9U&;>//;QL1LJF9'UQO*;[_^ZY\*_-S\N]E4>@0[]K72I593]V;T%Z6/7'RM M?,0>]A&G_B_*)^0$8H3VB(-]I4/=A8,Y!D(TT[5R==9^BY1FLX3>3]BSJ3\9 MZ1N]3YPOV'6K]?S\?.;1)7JF_E=V9E&WG$*3(QZPC;;SU7G\4T[\@3!K(_R? MW^F"OE^-R);GUY,,R0KQ$Q M7J\K+EB!/$<,;S4 E$G[B,8X\*\5O\XW M+O-5*R*F6$DAZ[N(E22L-L[P,6R=S>FR!03@O[A(& /6G".TV##/$)N&2F-" MBIGY/,\(@UFF)E\O,"MDC4@I 9O[&8%4U(#<$F0A<]X\;S$8\$LX5IUI;:8K$"H1;+WP M,0.YT'@#!F+!F&6/D(4<*W"JR6Q-*12)!Y(@'1:(0+1AUB(X[M.^2( MY#*?,.8LB>E!/GG +R#*8N/#2<0'_:[6-[6NN#('AMY5Q_#A3C74?D=3S'M- M&YO*FTE?G71UH/STBDY1U(?(!U^?,"?@05FHTD)RW"Z_%S?E36JZ5QP32#91 M98/98"%*%[! EFY[!.3XO2V'GSF&_QZT/F WZ"F#H392QSHPO&;@ 2!,3JVO M3]2QH;+4O@6$K^$;DEB$EP1RO[P>0Y_+YNB67P[ENV.@[*CFO=(S!I]KGZ)WB!&(]G#' M(]6SSBIH3FS*$L\#%\N%--/01K M.-), "[<4A6U#UA.'A[4T6.8D_K'O@X9J/;'RA# [NB:64<8>V2%;94QJ$_Z M.-X],V/R\/^<#7]/_P)IHYHF5"3_5?K:N(YAU<$-;TZF#L[$MH@@#_"';(!U M6-+]C_J=H=4]R@8.;UZ(N$:7TDBVS[.1-#35U.H8N$[ .'6QWT&^W0L\<=_/ M(&A*'"B$XJ]9&8<\S.ULF#L3J( >M!%\>XZZ2F_2[^K]CXJAJW>Z ;50+0&@ MKDN]L I-RIKM@#R\%[GP#AX>X LNK#+K&$M145A00_0"QUEWB1- 00C;JD$9 M&\("C@+[!-WPM@ IQR['X;*H[NB$=49O8AB/2ENX\$%_"PU(=,( :GL/.@KUM?2ACD /RMB@Q]'%4NPM8H*X?P\ZC]>M: M[(VP([JE(?*3;3XU(@_O53:\(\T(.Z2A.JKG)JY[<(G':#7TZ9*()UQ)C9<; MEX?V7;[$@[6K*6/U"S0Q@T^Z"1U,'2-#7()/'ONJK6RM42G=6.U"5%5(CE>N-Z[P6KE4A=S M1!S61[YX+KK$QY9=.3URG M[[R/+KWAJ93-W+:%/5UMQ3(H*L80D!RC7BQ=4 M8K&FUW#SXBPZP",'(->M[P>@YBN_H.Q-+7\)70Y!KJO?6QC7.1/VAS>3#F48 MY8#DFO8#>-0\,<(6)94*J1%YK'.M>-RUU'FI[X8OL[B+2?(0Y_KN=(AKOGIE MO5]J49=AE )QF>O0#W:)=@Y&$00Z)]'GV M:_PKWEM);6V5I>1(??\3[WKO?%7A*+BK*>&QTVMQUO&VP8@X^-N( MQYY\/+MM"*":R6G$/\"ULY7K)"Q"M>38:0AL-AKQQ(D*Y%LY+;ECL:"$+K#/ M"6:MQ/A$ 2=LU;$//!5VGH)EQTTK>HRB&#G!_IJ"/TOZB2LOJI.9A;L M#W*ULYWE11V&U*GJ<#K;?I"_W?LH> ;<)SZ7/%RAXME MA\*CX^P&M4)5$A'QJ9G(-<50LWW1O&R?K9B]M;2*$=LP5#,BD3O"B#U'TXOF M9_O8Q46XF,I.NN>(NW320ID6=CA+1HXV8?= _'?8$*JI9,3A4_;[S#DD&7YF M1RT"BP8>]]=5%L*N2/+A.#2VKS(H!T3"'X$@WFYP[+1'K(+\Y'N70/P2A+!H M$^],^&/H(.8BW;,#!L%ZP.Y4O(% F @,Q33B..*A_FV#^X'8*<5K+JYA!R74 M'H<;O1U$QWH;2K3Q;U[K<&U3%Q%/Y]@5G.!?,&6PQP:"^Z-/@\5M(U)'@$5J M-G1F+H0P",]C[S%?SG,*;@SX$_9'>(F] *>-+Z2))&.[A MY-9GQN@"PBD8K$(9 >$L-GH?\10,SSY;3%N^EWH*IHNW+ 4<^R:=\6?D9Y;W M7NHIF/X93QGP="C+1KR0<@HFPQ<,GU'?S7WMI$=/P=0DT0S"-D=I?&1E0WV8 M[12<,8@E#OUG;,^-GH*IX3.0P4+(9_OA77T5U(C$3,S?2T;Q56)\=6H M"EWH>?E@UJ%+8K<_#)%G8Y=8R=\LC_&*WSD[N%;@_X[]A2=J7K!&V/G+BM#: M=8H,LL9UI/B8, MG' ,,L/MQ*VRS'_W+FE@QO2P'1%V8LC1S;9?3#I1<':VL1[U/X7ET$X1!#6T MML*^11B.WS,6EWQ[-\/CM/S=N^/0IQ;&-A.O)RTR?]?H3:-43>;XK[\?NP*@ M](J>'Z?_[J*@0CO ]M>EY$TKNC,+EW\"4$L#!!0 ( "--"E4VM["!T@P M $.; 5 <&%Y&UL[5UM<^(X$OY^5?JF M=F<2D-K=_;2ZI5;+^O+K:N%I3S ($?9O6A=GYRT-^@YVD?]XTYI:;=WJFF9+ M"R/@N\##/KQI^;CUZ[___C>-_/GRCW9;ZR/HN==:#SMMTY_A7[0A6,!K[0[Z M, 1#G[1O@$OII_@/O)@H'7Q8NG!")(OU@^^UCZ>77P 6KO-0?<;]%T<3"?F MENX\BI;A=:?S_/Q\YN,G\(R#/\,S!R_X"%H1B.)P2^U\=9[^67?_XB'_SVOZ MUP,(H4;TY8?7JQ#=M.AST\<^7YWAX+%S>7Y^T?E^/["<.5R -O*IWAS8VO2B M5(KZ77S^_+F3?+MIFFNY>@B\S3.N.AMVMI3)MXC1?H>3$%V'"7L#[( H@;WR M,5II"_I;>].L33]J7URVKR[.5J';VB@_T6" /3B!,XW^2]#;/G4)7D+TZ%.\ M.O2[3A<3>R2,)KWF 9S=M&@;0OSR\OS3U3DE_<],H^AE2>PR1-2L6EKGT,?Z M+O1#Z)(?0NPA%T30O04>59LUAS *JWGBI= 0PV,00#^:PP@YP#N>^T)R]8E" MQR5&H]EH27T),=;#0&"3:D8$*\+.GW/LN<3G&7_%*'KIP1ER4'2T1)64 MFQ&P"\)YW\//QT.4HW02 6Y!B CQ<0!#\IC$!'3?M>+% @0O1(ND,2)J WXT M)DPY"%8*N3,&(2X?U'].!!;FX874["T@"N MHR.3B4RCTPR2.(SP @9=$+C]V*?3J $"#\@C@[)R6'#T/=%(7BRPGWB-ZJ&: M:WJRL>B0L=*//>^EA[R8> !B @,\ Q!(4(GTR"*$F]%GDW< M6$3 (O-F#I_!T?4D+$Z@1]TJB=G5EE?4]D2.@?P(;; :!_@)T:E^M5\HZR$I M!M07"QJ("38@#K:2=5:?NN(#'V>5'4\7*_@8*FA:>]S@XXR?0K,.G(_[ \E) M\@D]& 'DA4,0T)7$$U>0.LT3:O 1Z:/$G,1>I_K8XM8Q7^^ZW!FG$JM[ULP@ MMSH%2)S.!W-JL:CMR9G@UA2S4^W!@5-E B2:8IE;P8?0.O4Z29CGZJ[-AF%. M.SF4GA1AA.+O481/OB(3E8"G;TTK-O'(P4N!Q; #/"?VDJG2@/R>Z0%7$?1= MZ&[H4,8YMQ,B%-&VZ0;/A=:FNT$Q78V3'].6]3'"O3V0X?*2L+;-CE(V1\.> M,;2,'OW)&@W,GFZ37V[U@3[L&IKUU3!L2WLW'>K3GDF^>;_9A]F(Y&$G(X9' M-X+PWI;+9E,MV>Z9@? AV?.)P_8C ,L.1;P#O2CH)<\\8^TW5ZSCA1>:<*YG,7UM_N<[1B&'C@:#EP8W+0N-F1 X&3, M(;]UEK;HA'0=0,FT$<%XTW\6X 5+4:E2< &GN_HB#VEISQ ]SJ.$.3GZG< P M"I!#[)VMZ?UV?#J_E*KS8ME4TK[N.#CVHW "'8B>Z *:!+_J@.16":=1-(?!*[-A.3;YEGQX?)"*1YE\*F$P#N 2(-=8+6FH)G/&A&G.6,;5 MF0^ICU*1$M""2N"M&:R::Z@2RLN\ENI:)O/Z)23KD#&9N4;$-FC)P9+.37?V M<(O&!JN7&H&^=#14"ZP20 6Y.V/E>#'-G-QA[#XCSRL'BJ^W&O&_!# 1!:@$ M7%J:Y#\F.<4)Y68TFX9K*1BS 78W-:8&97,"'I%5PFB3>D2P>CY0U%;N$F , M7NC4BS@Q\DD00U=$'"$BLF-LN6 EJP0!U:ADC]D!M$V,5X)9U4]V1.;&CT\! M*D%&BWX"X$2_HVB^V=S@!XZOM^SXS V?B#)4 G%'0*X H)1'+,'B37N\(?:= M YW>;E>%_)Z8P\O+KQ)H^1KU5O:G C1>_(E0:3CN3,EJX*S"7J>XI>X; *UOY6D$, M,8D3:A'Y& V98G[I[$LY(+]+*RDJ/K.;J2^Z.K:^2'N7>K99-_[HTAD7/4UT9C8Z+;)FD@OZKJ+J!%BP&>L2)&II&L@/<$_1CVR6@L MRO!LMV-HGI_\Y]I@Q8J !Q"3[5<+D,K%PH-UI%)P[.(P&LWHOEKB8&'PA!P8 M6L1ULA9GY7UD!XQJX*HE5FKRN4T8I?472W-GF)C$WKZ-!SYA8 MFO&?J6G_T-[UC+[9->WWF125O$1<_A5N&;D_'2)W5[>^:OW!Z'<%\G#T)!$1 M,3GC2K1V^S(ERC#];!P2Q'?/J1WJ&A6*4[J7T"4# MFYZ-)VS2X;Z@+CI18&4.AK>_ E'L.*S%%*42Q+L)B8-R,@>F8NJKYC@:3 Z5 MJ(1@LI*AM7]$Z,H16=A8=JW'T8@Q5* 24B0F_@II2-J-!2])*M?&NO-7 MC )8^A8,QFZM U%$WX,5/?WG(05IM2!8][UR/B3"$-:54_ M#H1N2*N@DUV1T3*IWS=6,'!0"!E%Q!Q=%8TJ# SSE0Q\ZE%IAD1%IO_3B/<$ M/)AD[W;?DDFB8?:#G99C&"#L[L\3M\7PY(JK$Q6Z#M"F?6%<)65R7+&ZASU.^*NP4SES4_TG>2DFZ8/>YHUO;_7)S^2DB/S;FCVS:X^M+7Q:&!V M3<.JK[JHY*K"C!P_[\O1-[\;/4VW+,.V_J4-#;L^_EB7%V:8_+S/I$GT.[PS M;P=&,YQF;SCWB?)^W@:%;1HTE8SS7&V8XO-CGL#NU[-&],=&Z^J2G]:?# MGCF\TP:F?FL.3/M'G>5N^6L0,ZQ>YE@=W=^38924ZM7'E_CMAQFNKXI\03<9 M^_WI8/!#ZYF#*:W#(S:J#4:6I8VI\E/1ONJ3.LV%XY[$C# ?BB P[77U(!6I M.QK:Q%Z,8;W.J_ RQ0RG'_\V3ZJQM)9Y&V-&L.H0J+U;]Z^1W>HK&C,\ MTC&W-C^]>%943,1>X"/Y82:)KA"G!RD;R<\T:4SG&_9(;_ M7*0O=H W8;Q ^V 1V21UI]!VZN[ZK&)]F4M99A=JC2PG62E!UBKS*I?$K,P)UK_2YQ"&#*:S4;!>=POYQ&'N'C;+.W?"EFEUQV\L-F&'HK)6H)A+8QXN="-0[VY4\DG( MWKAL.M6YOYG))P/7YF:Y*&F0HG\]D A"/OD?4$L#!!0 ( "--"E6$6[(3 M%Q, !$* 0 5 <&%Y&UL[5U;<]NX%7[O3/\# MZ[YD9^K(LI-LDMUTA];%X5265$G.Y4D#D[#-AB)4D/1E?WT!BI)%D;B0(@DH M=2:3R!8.^)WS 3C P2'P^Q^/"\^XASAPD?_IJ/WZY,B OHTK] MWT'X:F)MZKT+PV7PL=5Z>'AX[:-[\(#PC^"UC19R%4Y#$$;!IK:3QY/DSTK\ M=\_U?WRD_UR# !K$7G[P\3%P/QW1YR:/?3A[C?!MZ_3DI-WZ=CF8VG=P 8Y= MG]K-AD=K*5I+GES[PX/@7.TYBDV M-D8>G, ;@_Y/B-X\=0F> O?6I]2VZ'>M#B)-EP"-I>XPO/ET1,N0RD]/3]Z= MG="J_YXJ%#XM21,.7-H"CXQ6V-=OT#L(P$&.2 MK:$AP&. H1_>P="U@;<_^MSJZE.%=F&X($\,1C>C)1UV2&,M1P*_JF94F(;( M_G&'/(<,C[W_1F[XU(4WKNV&>VLDK+D9!3L@N.M[Z&%_BC(U5:+ .0A<4OD8 MPX \)FX"IN],H\4"X"=B15+8)68#?C@FH&P7"A4I7V,E"O7=1^B804"ZYA * MFU%^Z4J 6$1Y_]:]]J T&HY()9 &<.5(N2!2A:KI)%$0H@7$'8"=?N33&=? M!=>N1SJEL%M(R%;4DQ<+Y,>CAKBK9HI6UA=MTE?ZD><]=5TO(B, :0(#% 1C M8H'54^^(OY'I@H4JJLR";AB/5N399!@+"5EDBBTQ9DB(5@)Q CTZK!*?+6YY M>64K&AC(1S@#CV.,[EVZ*A"/"RP)13Z@/E_0@$^8 3+ "J'S9.KR#W+(A(+5 M^0HY0#E%:_<;U5<^8JLJ 8RLC6MV(I[ M#MD:>( !MM>8\PIO0V#L3:RW2.BFQ-L8V1VI MO1-3QV7+( 7RTNDP=M&V53 MB^N'+5*TE91IY590/^[-PXX=M !N0=!9Z080QT\Z7L#%-=VE*00W+5H_5N!Y MQ1#& O7C\E%H%H6VEFFT3<(;$'EAZ4:Y%D]C)K]V?9>NE ;DQQ1N^!A"WX'. M&CFM4'(W,71#6C;9"FX;QW3?.*+!./(Q*5D;#NG-P13(4X)LLS="48Z&W=YP MVNO23]/1P.J:,_+#N3DPAYV>,?WV;[J M&:]23VE87<'&8DK5-W*J3F?DO\O>D*@YZANC<6]BSBQ2(,5IHN):20_9*0."Z[AG1L'Q+0#+%O7A+>B%P?HWL5>/^WKRB_D&/+$DM,C' MC:(>N(9>_-AY4CBO;$LMZCAT)($X*;>+]KDAF7B-.QG.)'W&:@S]:",_)$VO MY\5/(^,PO*4?ULAN,%H(39F8#7$UV+8M 7)D(.Q _.FH??*,Q4.D17\Z"G&4 MH_(>! 4XW"*'_/1,#/EA3N:&3F2'(SR%^-ZUH?GHYC4F4C2_9*7DY$[K1&2D M;8P$>)E4*# ZW7=*P 7=9$K(L7Q>\4K-GYV@[MI>9-:,]=DJ9BDX/3E$#N;M M'-A5T;">DA4=L"K@*=:+1=596:JRJ]2Q^7TZ'WL@6 #+=Z(@Q$^7R9(CPP,M MFU=T_J9R#M*+'[9].0T<28!F&?A-V?&(9> [@!? AE$\-Y,S-$=D_EYW@XO MLPS_OF+#C\A\&$_@/?0CR#5WMN"\G3J&=^M=A=ZC[45T M3X'N,;ES.4+A52'\*,F"9DU=5-D_B4OYM[W%) U@2SH@IHC\? M NC,F:^R\!3T2'6WJQ>K/-*+36=!C$DQT[VR1 M.V$I*7AEO(135?[XAJ0*+ MM0^J6+/\$&(8A&0LCN,I*^QLJO++*^.GF-F1M"J\/3,U1*W6%OS![KG,01*R M"Y])@K+ PB:I+5'JG,Q-N6M8AL!!TL/5A1UT5>:/8/CL,\U[X'ITJW:&MG)R MDY>EX[Q0CG12?E6 M;./WUH[V9&CYH2A/6WQ<4BIM^VV9M.WI;-3YU^?1H-N;3(W>OZ^LV7?C5;?7 MMSK6[)>73.Z73.[#R>0N0]"J6]$C(9$?GW23G]Z]JVV^F*:YWG+@FD M83*3C]?3[/SB#2> %[(UDE& Q4O%V> -$Z-E5GC5Y-63(EY![MDF8L;,N-VD M;>T4G:M9Z/'[QFZJ60YF[48WTW%BDP%O#%S'\CM@Z8; $Q'"%:NA4U7.CE@! M_?949AB"(,)/4ETFI_"\Z3SU$KRP8#/=C\),]9"H 9UU7$U$2'[Y>=[XJQDG M'.1,KZ*,ENQBE3>/WBT[?Z=K!)$/63N_4B!,E(V2:$]"+F+F$%5M"#UN 580 M1-"Y(IWW"PSH-N;H9D(^8->.8S=;I\_NA-$EI?6EH*@2S!%*"2NKEK,?-ZLZ M?@J&ME1A\:0NS_Q9A6Z$"?HQQ"YRXOLQXN]&R_CLBMXCQ+8;\'8."U>E+[E[ M:<3B6-D>,$.-5;.LAF1.78?*LD@E%LW*$M--YS]1L#I"?(88*[]8*7HGBT,G MQ= /XDS["21SK, -8?*JV,H $VBCVQ5)<8OGK9/K?;+V3:@1 [ :G++]\E22 MF&2^G/949M&R[+ZU=:W3/F;VEI34ON6[,ON6'7/ZV>@/1E^;.4)LCPM44KK^ M2D]R(CM QS2/2]NKPT)]_C35KK8FCUK8XY MG!EC8I".U9O6IBKC^I64&N]WU>A;WPA%YG3:FTW_80Q[L]K@\>YC26'\L(O1 M(M8=7ECG@UXC0--WMFQ#:Y_L0AOTS&FOO@/A9.YK20%L[P+L7$UGH\O>A/2[ M2=?H7PV[UO#"&%CFN36P9M]K/,LN>ZU+"NEI!NGH\I+TH#BOH=;AH-AE+BG0 M9WFC0"?N]?VKP>"[T;4&5W3,(^W3&(RF4V-,39]H]MFGR)H\ M:[8:J*E&9!"?D<;2&]8Z:N7>#),"^G87Z*0WB!W+V)S4V((Y]\2DX+W+#E?$ MDCUC9GXCOF'TQ9H2QZ"1?^/ZN79U?LYXM7Y2?=Z=>Z],2B^QXS->K>3K0RN^ M:R8%6=(/UH\[[TJ:;:2G^6ZQ?F %;J1)X2WJ)>O7I.SM-"FU,BZUL'=J1M&* M+JI)Z9[KF4N.6\D3C50)D>6T4N'\0(DQA@9H#G3FH*3R4D>CEAZN[$29N\./\Z1SZ]AV94_[@>R&QY,%Y(UEC:'1F M8Q;R&K!HX!-+JO%0TB2(N,LWA$[^JC[R=/9=-1&LZ9L'IFVCR \#";>WWL9F M2#1^HGW1GH7DU6#Q5/J,^SHPB%[Y9QQ?4QK_E="=46!&FAZMV MJ2"XT>@2_ ?A-5S6F]ZD8%ZYP_%?# 68%#3)P! LB"(I>+P[I3C%&W9/?*,B M&<0-^:*&&-#2[^S-4K,!0!^NG\X/_NV64W&;E[AA(Q%BY@A4\1M!IH]HS%'* MMKEEYV\UMR\;-MT4A<&G0CCK6$DY[PLD6CS]YZ6SDR3U(5%8,5CV 3>1+[S MO ?#Z#R[Q0[!WFS\"GESK146 9GS09A.Z">LBK@ SB'ITI\7/SY:LY($9+ MZ%5U.(0Q(;G)['!66DCT$E@HJPZ)FZS22!@\I2+_BE[R:LP&9>@^E'PEK:?_N M#U,-F>0S*6$]=@9DN)+TBS(Y:6Q5)5*>I(35; 484.21[USUNHF4N>@ M?JUD:YK3MD$JRF';*:CH;/@BO2I[:/\.?NU&T76\NPOOH8>D:&&*J#J'O#Q# M?%680Z4RMOH1)K8DJP9Z!H/[2#\)SR=GRZA* BW/ET 79D"FXKVRK_":'F#8 M08%@HS);4-5I@"5LSE& N?96UC/BPU_H^>G68HG1_>IH0%'7X C-WQ\,3Y+* ML#A[K]\,_@*++GGGR,W;BJY>*+W4EM&GZBW,*MZUBQ91O.W:A4L,;7?UIC9< M>C Y+L=<(!RZ?\:_9^K(IKFJ)QQ>@ZA6<^WFG$R\6V=M%NCU1.KP*!9K([%% MJSJ^+3CL*G,B(CO0O7V(58/GVG'C])D3$YDGVZF-UG.RGS*ML%"&Y$"?B#T' MI73,7ER'-E'[(I0RX_:R-M,^,OS5X-R?[JXALOR?XOR?XOR?X_3;)_ M!5=C @?2XT_H:>'Q#Q2R,+##%5.TC[!GDKJL9E6/Z8P0*%FWA#2EAQO^3!=2 MM3U0P=L!.8I4OCG >B\C>0MSX :;(_,QL 6!9X&4JLA_%2]J2&C6U#[ P+7I MQ31\*M*%5,7_*[!\CB+Z[0-P]!1$E462\[:B S'W6 S*Z:1=;)D#>RLTNAT" M+44KHZZ?C&BNEMJM '."=+U'VXOHI0D7"#D/;AQ689 M(WV(],KKI5?4F!UR M%82.,_>["$*ORB]!> G"O@1A7X*P+T'8ER#L2Q#V)0C[$H35* A;XXDKVDVD M]SQPI;GX:?UO?.H7:&+.FHHII5VXXODN]#["92SB%EUK6;GD) M7?B$G!6_J;-)JI[ON);3AGOG=:/0I>\;Y3:Y_:_#;J 1%E55P&'FD('R.BN/ MK9E^Z#K4(@3"%-H1CD_X6@5 H=,GKFQU>EOL=$8W/8!]TH6IV6*#2<3?JGN" MZAC=GII(Q_&J>8XVL;ZJFQ@S'E@E/]K'#/=4]OPIOP)^C+'6AVH0DZRT!:'F M3*==G#,?K$R,2RRI)I+9!'\R+4;O4&=]O.L@.3ABK& MYH01.E/26;8UFV'@!\#./=\RVP_$DJK#" R$P?E3ZAO9:$&AZK0)"L@2S%SL ME["B]FMZ.9WX2_0B=6BPXBY#(RJML';KY-0(+E@AY955LQ8N87(V9_HN9O&ULW7W[<^-&DN;O%W'_0UW?18PG0G*_QA/K MGIG=8$N4ESMJB2NJ[?4Y+AP04)0P!@$:#TFX-P&F91G-[_[EL=;98O$%% M&:11D&0I_MN;-'OS;__Z/_\'(O_[Z_\Z/447,4ZB3^@\"T\7Z3K["[H*-O@3 M^@&G. _*+/\+^C%(*OJ7[").<([.LLTVP24F'_ O_H2^^_;]GP)T>FIA]T>< M1EG^]6;1VGTHRVWQZ>W;IZ>G;]/L,7C*\M^*;\-L8V=P509E5;36WCV_J__' MU?^:Q.EOG^B_[H("(_*\TN+3_?^[7]]N5R% M#W@3G,8I?6XA?M-H42LRO????__]6_9I(RI(/M_E2?,=']\V<%K+Y--8(]]! M4L2?"@;O,@N#DC6[\6N04H+^=MJ(G=(_G;[_?CL">99@F_P M&C$W/Y6[+:%2$5,FO*G_]I#CM1Q,DN=OJ?[;%-\')8[H%WU/O^C]G^D7_>_Z MSY?!'4[>("I)^*'TZ_N>K5KIK6NP2YS'631/IZ$>:GN"3]Z=O'R! UU]YR[< M9F603 +?U70.^PI/>^)[/?=/FL1Y/.U)=S2/ KL4(8]^O/+GFM _7I*?>A#Q MW83&LVS7/2=]HS,YCHH[ICA(B^)\0\? MWN*D+.AOI_0WYCSYY==EGD556%[G*YP_QB&>/<=%8Y;Y1)ZS4NSM$"95F.4- MUB /#0[7$F_#C'17V_(TX8^6JZ_S;*/[]OJ!9&J97Y.[UAI_<.0+%;![8CDN MLBH/\:AVZV(W/+H:V"8A@C3WPNGIU]6;?ZU%$4F_4"V-?J'R_^^O;_=FIW!C M&^P*UO#O_OSQ'6O\Y>SGU:_+)"@VP2*-JJ+,=U_PY@[G Q>%1A@(/\P( M!9[T5%#LB"_7Y0/.;_ C3BNL9HE,RADWU!!;1H@B,'B@Q#5L?2:(:LF#M;D\ M?ZB*T_L@V'9RB/HO^SRB_L.O=&R--S@MY[]7<;FC(_\L);\6DJ3"4L<%;4;! MIR2R4O!.J3$HAP3CHF@O>Z TY,44(X@V6;HJL_ W:?S1R+FDDA)FESZ"$!C* MJ) -:<+E$!.$$X9F4133J:X@609QM$C/@FU,1O!:OAAT7'+'"GZ71UH%,)RR M03GDUUX'4:73.$6U&ARVW>8X**I\9XY)4DF7S-) [?))(@:&16IL0^XTDM"B MTPTN@SC%T3S(TSB]+[2440F[9(T><)L"X;)9U-!FV6MPEBTR@NSQ2R8)AD@'@D$NU.&+RJ%$X[LQ>/98,",,)*F>TF=(R9]2\B8O?/N\^XS1\V 3Y M;YK@8E9S.^RR"?92*#B&*VCAJ@>:M6@C.IG89A5:5D8XI59W.DX MS0"Z-T13R((AEP&@,#"KQ5]+*+LE7SP(71#[&K$P3#+C-$B8E$- M*,'JK"K*;(-SP3']A*1)RRG-[%SH44VO H=N5C@%RM5:2,*]X\8UP_:,+\$_ MLKQ!)UM'40FYVIJA!MALS! EO)-%"TO)C>..UU+_MK(4EC,U2C/9M?=QU]%F:T9&@N<45@LY:70NT;7FI%(S6UT$3LEHN>W@6 MO#CGN(C3N,27\2..%FE),,R9*@T*VSC[+@,A>9X%HW+QFA M[IV0TS$/F8&<3L'+?C&GJ@CF4J26?!3 ^UC69R,>_L M,6,;LD0DQI&[-;I?I"IQOLK6Y5.0:V:=59+.N*"'VG)!+@:#"UILDJT:3!@U MTG ZMV6>;7%>[I8$<#E+([KY:$LW+!GG;:PT779F(USI=F(6:MXI-Q[KD(*7 M67I?=UFWO;@$96:G=44[DR-(N228 F*73 ,1,,21XY+M/&12<.)3$S'/\2-. M,C-!-/).M[.:8/>VLJJ$P=#'A'!(I+:?ZRC X=1%E9,,OLHQB: 7\3/]2;\3 M2*?@=+AF!-X;G2FEP?#*"%$8>S4*[)A6HW+LU/HG?%>0(=]95NB&6#(I9RFU M&F*;3HLBWGF@QS5L_%H0,4DXX>02!P5^R))HL=GFV2/;[J^/)UH-EP'% GHW MHFC$O5/)'J.0&C<:J*L"AU^W>1!ANF.D(%&2_4*K:>@99M!QN_'9 GY_"[1& M 0S/;%"*VZ(;'=9]L5]9:92C]V!DP%BNLWRC/67GD8]+ #J5SJ M3J@:"Q!AHWAL#EW&(4X+19\BE7#&$#FTEA#]CV&TOQ23D'740G#RC%E:QE&< M5&7\B%%_G_0URYZ.X V&O@/8:QUW!90?DKK?4"4WTE4DYB\!J MB&T4%D6\\TB/2YBP9.<4:\EC][9?TT=&,/=$BD1A/M5>M#L%P93G=_@Q-6'3#(RQT9B:8%230I^S_O MNI]H>N\Q!MR>F1WK6/\MV5BB,D=M[_K(KH,GBYBW9R$1MA9 MG#,";J.;4M([4:S@Z4E!-!!5.4[\*G#X[7WV^#;",0]=Y(=]Q"*__'J6/>)\ M=E>P\?# /VW[Z6&/&?%1FJX#S9&4DA2+KFA0+J MD!H#,5#LD&-3$J05]\L1-C_"ZAH:22**.A]N*, *0X^!'"B>*,"IAR2MO%^F MK!YPDM UIB U!Q29L&NVJ $/^2)*@F*,$IZ2,TP#U2IP:#-_I-DY29,LG>W( M^R2/ %O'GU88+(6&""U9Q-00U?/$I,Z]308."9*NV:. .N3-0 P48^38E%SA MXHC)^R?)/(VL*-+*^2'( *:<'K400'+TD9FH0:1]$N,B+L(@X5@NR-^&J[@& M6=<$4<(=DD00!$44%3HE6;A"PQFFXI4P/^,@MZ-+1](/602HZC5/8Y:U-FBK %LNSZKD -!% ,XUEVTLP+(\XP/<="+]?#SW_'.Z5?@IQ;3BA@]DDQ M$ +$"CDR!2UJ8<2D$1'W0HQE'F^"?+>*0T-7(0JZI88*:)\;0RE Y%! 4["C MED:KQ9G/GN0V>%Y$A*CQ.N;7=AA8HI1W2Q8#[#YG%,* J*-'J& 044)]+9]$ M6J1AEF^SSG:',UI"/]^=99$Z0S%HN265E0M]:FE5 !',!J>"9CW5$[XG!=': MF]P HA:\,&X61>1!%?5_+N,4OU?Z+Y5URRX-W#ZG)(* F*1&I^!/+7G2_("H M#KI.H9#FPPA7/_@GS0=;TGP 39H/4TAS^Y0!(D$?,39?H@ MY2&&R\ C21^8,;AP:9^46&9%&23_-]YJ!^)R82_TD *6DJ0G"8\J,G@FPG = M1)1\#*QKNM(%#>E1LL'G[HX 2V#MCP!W/@1! ADB\0@PGSWA0JZ;F7(TQX$B M(O0_=M;($E!M&W<^@]'$(B"AA=E[361\O,CT$NYD^9"EZ@T"HHBKEE:!:UI[ M^#F(%E> $B^!8'O-J)RGV?CG$J>%/'QW/G/6LP_AM!UY\P&(UAVB$;KIYG/' MK?E3'I?DF\^RS:9*ZU4>V;Y!A9RK5M;";%I<*@2B]77(A KI7!;UA1W38I4E M<1B7<7K_A0P^\SB0>2430O[\.7P@H+#B0()W,2<.\M";@W) 'W$). >]LDX-Y;$M!\+2\10N+2]5T2WP>*XH1::=>DT$ > M\D,B"HHJ:GS*F-&JH+V.ZXJ6K,39(J67.K'OOR _2+Q4R#FK::F#V1:UE F! MX(@.F7AC!RLZUQ%&5-HU+ZHH+G'$P5S$:9"&<9"TY1%E,^)F%6=LL03?$L<@ M#X-#=B %.G&UII9AJ[@O=>EZ*IUOP/@))\G?T^PI7>&@R%(<\;D4V4J17M[M MCAD#[/ZF&84P"#K9(%1LG:%*I[]1+=2HU3-A7ICT8Y94:1GD["QY+HM,"CFW MS%' [#-F( 2(*7)D"H:TPHA+^SF@S:M'M$D6#7C2$C!Z<VI;* M.*,%J#K#7=?\V.?&7,O3$CA:4J9+" * M:0$JST^V.K143-!PREO)F/R,I%KWF6:7^$#*?>$8 :)8.Z85 40/&2Y-!9D< M-;)>N+#:!$GRN2KB%!?JCF@@Y98+4HA]+O1$ '%!ADO!!2:*&EDO7)AO<'Y/ MNKB""9^5I%.0R"NF$G=\ZH@0LW#TB2((@DA&>^AZ25@,U*HY9L).T% #% 1*4JD<<$$9/TTOZ?@_2WO-J6X6Z99R'&=)=5T48KT_R;I;9;SHQR MJ<\F*U5 /!N#5\' O0G4L7'2Z;%\3N;13>.TFEL6_K9Z",@#O*[*@O:@!)AZ M%ERKY'AYP<*!P2*#1@,0]2Q@JA8(*Z..MJ?Q6;&O H@C>NG]&N?T MW,$M?BX_DR_Z33/"L-!U/7JS=FE]$&PY,W%2%LU?]A2M__!KNWOD>MUN*5EF?&)#<:/] M.%47!)WB#.7G&#WO])P 5MBPV*C2K:[['42--OJET??/RUE1X+(P,' HY))K MDQD 0&$/DZ%17NP1, MQSMASH+B0>$5_\@E';I@NJU/_PZFL3M@A+8E'WEOT1M,^!?3I1A-VPZ%7+:R M'&"WO?L28%I>"FO(@;T0"B'0H5Y"*6YPB./'X"[!5[B4SR?9J3CM'RS ][H) MC3P8&EF %+*+6@7EK8YW8M7K, V>X;8>M9A+ JE =DDSE %#% 4P^EJ1PV4K3)8%&N-+EE(4:&)K98Y64!:&:"'/5 M @5IA#)&QQ!6FFO#/8\L,_+)'W/*K R22]O!C^JX,#4"C1/+/-OBO-PM"=22 MT'[^>Q5OZ60/Z8Z5KXI.Q6U<,H/O!R2U/*!(9 0Y9-9%_$PR;HH3E?]VJBYI-L:9+MUL],#0;@38 M(?WVJJ X>$U>HX N&E_BH, W\?U#>;W^6G#_5-FF7L=IUFX#OY?"ZQ3 \,P& MI9#<-SHHH4HHIUJGV?JT*FK*>2<;?VFTV8&/;$J=1D',G[2)$Y"$Z3(.[N(D M+F-KV^NSO__[]>7Y_&;U!S3_SZ^+VY\AL=1N'4RGX(F)%BMB:FF( M;!NW-I;L%;W3J9EZ708[.KE&7AORE[S"D>B=8;[7RH*/V?41KLDFVRW4P5!R M/&;E5/R6FV!S7@$W HJX_6RS\6^GYZI)R=\H0.6 >A@PU !#0BN8IH% 0[7= M23NOQC8*'[B0VJ0]!5G*HOQ/&$:. M "OVV5PSU6"#Q+"K M@[ZYRDJ,_N6/WFDV>AX7RLSMN+G:5S [.WH^MJOP!X29BG<^+7-Z<"O'?'KY MQR"IAF7YM9*.-W>IH XV+TLYQ_XBX]C[[]ZI27:"OOMP\O'#QY./ M__*!<8S\^N[[[]BO#?-*]!\5(>+'=R>(TH")G>,0TPHNZ.-[]E?R;V)XBUDM MS,1_4)Q%$3LQ&"3+((X6Z5FPC4OA*DVCM-/5 3WDWDJ 7!0,=?7XA!G^5AK1 MW:VG<8I"KN"=1K-M>-&Y4( MQ8NQN" /?#1(A5E1GI H]?'D3]\UDTA,EM'^@?+3%I@8I8U5,D"92.((B[IG7;BR,9Z".1[3&DW MEH0UVZ7$)Y_T*B .(TU;E2;N<(*UN6S*IC)85+-$:YQM95D\2"+V1]C+(+_. M65F0B*4#2YRSRDE6PW.ULK]9#Y-#ZHD0E2:8+G047,-TR FEG%IT SK M0;1E%Y]- \DL=6U):RW?'%-4E[14 6 KA>,3.FL-#VM*HQ)YBS4 MP/#0'JMN.0)2#B>4;34F<%H-3WRS2=TTXA#Y99FT]7D%+V,3/-*F:TIIK[Q2 M)VH*4;A\TJ9H4BX!R<]Z"R#<%YNEDD;2VYI3'ZIRT8F+@>&-&IMAO0G(\E); M+_>6'HU2SD[WA;P4/.X!E)8V9A)@F"&%I2Y7_ L3\U^5N$5T&:>8WK2CBAXR M02_$$(!*R=%*P2/($)J&)%24W7]4^&?*#7[$:85-%:Q%,;>KSG*0_37FO@P8 MABB B05,N1@41ER0%I"=3VM+]- "&N3_T6WPK/=\G"4/O)KBJH1Z8\Q 8^<$ M[/*UQ1P*C<^RHKQ>TSI2;(44YX]QB(M5EJ@'8VH%M^,Q$_#^D$PE#89B1HCB MP*Q@-S^ X=(/>584RSQ;*_=I]21P-C"(P(8L8!)HRT2\,Z ] MR%B7:S7E2QIY+\=25;"EQU&'PF BB0FA^OAI4RK7.Y%6.$EH?4.<$F@)+802 M;>(TIF[0/?.U8ZK!AJ6RTQ'<*(=ZHSHK33#D&P57&/UQY1-TS]5Y^9J> >_4 M/,?;'(=Q0#?ADY\3S&YJ(GYNZ 'M?[*_*YZ-G:I+6HYQIDM*&STPE!P!5K@ MKJ/*R=C1\4Y%(=#;=@B>NU>K;A56(J:")Q_>9?!ZU-8!>I/A!E^2K-'D:E?2 M"U]$J%+&[,6 ]!UEBIN&=:HNTQ.3!E,WU'MP1A<5YS6 ![7F)9)@Z*.% M)ZDGSX1KVL"H)L]G1S3]65? \248 V"#*R_J3V%U6@(N:5]UA]=9CFL>H#)X MIC-0CW$!(2OF%+X-GNM ^)F,)=53DDIIM^%$"[D?3Z2B@ **#I\840 2Z J7 M^XQM]AC$"=VN<)MU]DW5Q\ ^!T4"ECM\&N8#1\]^>/[Q@5E[.?5Q0DA=?L(5:DW7I1%Z2R 4N9HY/S'K\L MP*F:'Y'\F^]Q\QZZFO/XC0>Z *60=1F&M'"[P48JZ)TS-NB&I&&?@>/)>9Q4 MI7(#ME+:)U<&D'5LJ47!\J6/3YB#YI\>J9/Y"=,[FW T>\1Y<(_K#I ?,]!T M.%9JSCJ?$4ZT'9&%CG?"C 0Z9$ZCB0*NBL)Z+S^,_=@#QZXJ6B/M>BT"5T-\"=TU/W #?L-V8 MX.FQVB@%H_!,/V8[7?E56'/*6X*B=T8(][)_5+D0XXWGU-*\Y/GV1;& M7BJ%A_R-/0"1M88 ,-G"40LJ:ZQ Y[(9NC69P03G6?2/JN!7"-UFBBKVS.^[ M@+AYEFWHA@"VN?&&5D\MXA+7Q]SX,[K!87:?,BNZZO''_UJW%QFX>8C]&Q&. M^YU@7D9'CDISK5-FDTZYMT:]O[&];0\V6R,\[DHQ[CD!PS(9JBE;12!.#7[T M,,LS3[6W7FA0"GTHFP,:,2L(;Y+-Q]RLJ0&4($W/'TCBTA:9N5Z?!<7#19(] MF4XJZU6\U +2@)=6!9+(@PFA%B#5E8)(@DR5$--"OS1Z_JL&D:!/@2WISM8( M1Y]W7TE&L$C;@$8OYW <*1F@B'''?=$1P>]^T@K8/@[&;I0U(,2>7S<-)"7Q;%5MGI"S7*H=XK8J4)A_1CX-K.)S75!;SS MLELF8WPI%# 54$86/O%9[\0B53%#?6753NCYY"O2HB16ZR.=5-)I!0LUU%X% M"U$,3,!28Q-262Z$$DP"%)B01)()6H0^J!8J;10!A%N)(Q81M:,%GW\*Q/*20Z"IM\SQ-HCI'>;LBKBFE%)='(?W M"M:/QV#ALES#H+$&;&GB1%\JD8LMU^GTO><=^C=,J0?>;XP_A[U6<8^(X>0'+W9(X0ZO^TAW46RJB>%YC##BMKCO:L5[U76MM M:%,6HY$+TQ0$U$/ SY6MXV=:'0K&K,3>LW/\B)-LN\K6Y5.0JU8A-/)^B*B M+>?=0!@NS>1 Q6C(#E/5>P4HMV):+#P-DF2'(FZ"GBZOK0 B6_T:+=*2^!/3 MN0_=+*^%GML"W5QJP(EWMEG(B].9:#FF"_++5_%:$F- M6SE:JN@^OSB59I1067L1IT$:'F"DI#4$@,46CEJP66,%^DC)#-TT4EHW%F"- ME/(LQ#@JZ!W/8RIR6.@YOG7$SHW!921Z)3"DM$4J+LYR/@P2S_6A-63'ZP2R-^G_H2/+R M&L.UD?ESF%01NW0Q9%LK;\A(8;Y>8V52X1J$TQOOO3S@[EOH%@&L-]F+[])H MP$3I^(#%!;K9HE.^C_[M=8>"8SS_5_2B'OR]@UBF]Q .24<9DK?A!-VUQ7Y) MNL<1>CI!#XP9 &O+',8A>VY@ND?3AA5. J?@ZL!!PY2*O;K+<#C6J2Z_;77! MC$]' K8E:GMTG1_.]%4!A,)3A2&HT40;%#P]QSY+S,2'^&P5"(=/^098;FIZ M02>^U[!"ZI10"IUA2L1#QMW2H1SIT=JI@^O=Q>(5"'AUMSE"Z+$+&\JT!_^L@]7'^_;IE&K73 ME8L2;XSK>O;Z3N>?Q[K5FWZV50;#T[&()44=3CE!(,XX+6+G87@$KO=&^EP/!("4TZZ@Z!)B6GW;^+(0,HM0:00^^SH MB0"BA@S7D!>-%..&=T;49Q7IM0Q9$H<6-0LU"DX+I1F!]XJC*:7!L,<(47', ME/9$C0:D6K^TW&=QO5Z2YT33N[KHUBJ^3^-U'-*MV8+#M_BY_)R(U[X=QJ1+ M=A["^2Y_7V(/#,,/X(1P;>%LM5BAZPNTO)FOYE>WL]O%]16:79VCU=I=6%%*65#I['19AD195C4U0>9P($.37.6?%4H@^?LFK0 M0_9>+/YK?HYFJ]7\=G6"KN:WWFGZ0Y9%3W&2$'^&1QWV;ADBYT@;+HDZR;TN M4T<9 $/5*:B'7&ULL!"[MX*X&;2W RGJJKTU!5LK3-A1LBDS1*P,AE1BKP;3Y;S;US[ 8_XK3"])R*K,"/<2>7 MI;;;70>C7.IO/K!2!<.]<7C%/2],FY\U:O31$S& VL)-@,*AP5E35+17!T16 M;8RTU7TM=#5%S+.OJ]OK+_,;=#:[.4<77Z_.%U<_H,O%[//B"\EL^ M#2%S*.22;'* 74KU)< 01PI+N,63"4&*6.(5L%=9B>T3N1'Z;J_V'.F6_O)> MA3(8\HU%+(2MZR]?KJ\0B5UG?_=.R7F0TR,F]*@7N^+)%*V4XD[CE@%T+X(I M9,'0R0!0B&JU."+RB"E BG!#9TP132/ODU#:B*44!DLIF_79,[8>>_'U\O)G M=+ZX_'H[/Z>S8.CR>K5"2YIDU6'KWVI]-[2F-^02#=89VPY&J=T,=IZ MI6&D#:=',:>XUSO9,L8 &-Y.02WTKGL;;+&A9P7H0H.5WZ90.M8(.#YK@^XX M"Z^+T38)X^+VR_SJ=L6"]-GUU2T9ZI M^="G2 Z :B*@ M31TE+IDWI^A4/%/,L!U%+0^99.8-*"3%FZ/;V7^AY7=GS^^8Y19SGY>_;K8; EOK]=GM"S;^^^79(B$-W%HVML_4M<%B2:Y0]DT M2M$[K::@%?C%U&G!F#/"KO/3]]^CQH3W /:Y*N(4%\4Y+L(\WC:WOH\_=3+> MCM.C)E/=[)TO&6O$.WM?BEPX3767524A[ZZ([],31&*M=P*307U!T$?LI SS M8V>>JM&IN)V8,8/O3\.HY<&0S0*D>!(D3L-XF^""1\$(]BRG)=BO,%A M$A0%.XC%WJ'H'U7!II_B7H]Z4+8F_3-WG/-F0MO9 M \[S44YHR@B:ZC:Z&JR$F.ZTI?G!35S\=I;C*"[I3^ID6JWA>*AB@CX8J:C$ MX1#.B%'N MWS1J^=Q*;=%+&E2\,VT<3O.&?>\TJ\_=W> PNR?1UGK=PD+/PUE)LQN20Y)J M)3!TLT6J.L;+JED];W%:8-0QXIU]]& \QOR8O!WOM!IN2Q<8H?>+%BC%P;#, MC''(KVLR0@A80\C2H8 M H[#*Y2FIX/-N+T==9J3 M_3M2Q]D 0]R)P"6KMD0EV:%%451T]J13,+AGU#NEE9-#DR?VH$WI39O,@T=- M:ZA". T?<%0E;-EXS2;S AB3>0VPZW5G@F@X=W0;D!^-112F6'):3F&ZJ[W" M"N/-@.'O=.PZ0L?[*4,@K&9I-\UVK)BKE'9>O4T-6:C9)HJ"89D>GXY)67\( MA)(XN(L3&)?,2 M_4;J3?N"RQKFSXMLD2XZ7A*>Z.E@J'FL&#(>G8]?Q.VR* MOT$B]KY3&$[$TBL+0N+P>9Q49/@X,@T8:[)MM MQ2^ZH+_B9KZ>Q'A4@)BOW_M.$ONH"LO.U7W,7>,S4^KY8;/!#3EO%4H &:I' MJN-BK8DZJN@7INS_J*GHU66<8G8KGWH8JM9P/. W01^,]%7B8-AFQBBY[43D M%E5"3,L_P>:;;9+M,*YG@2_WN<=9E>*?3*)C2 M(R48V$F2KV3,0$L]1+,-7;W1^"M(NF:2 NJ0/@,Q4)R18Q-V(T=QB&I!_R09 M[O4GPU?ZA^ >OU?/[6A4O)Z]D(#7'K[HR,,ADAFD]O@%.W-Q@O9:WCFF7/9K M3H!&7PO2AR=T.44S9AMC \2RKM1-ER?M">$(<5.(V3I2 MTFO\6 LA<8RBLS1^E"-M;F^EY9U\HZ$.&?=+R%8C/EG9\#_WT)N\4^R= ML)UIU:I[FW"U<$HY[ZK1]<[4B8!'W@4,9PY6[IHPGVG;B5QZFY&U=,2J Q_. M??JGHS74D42\!#1AJ_3QASPK1C.Q5@+!PIX#5@QD&O#9UX4Y,DEDJMXY-PO# M:E.Q&>1SO,UQ&+/!&/DYP4U9N4V6E_$_>?DOU8-0/+C#F7?)XT,_E"[C#V4; MS+MQ8(>$$H5[\ZAK_P2UW\#>K.YWG*#!NW?2?_ET;YV/\'B%I531R?_ZP2D! M'G%^EQ7XD\QJ(J!L ZTD( M902L<:XS]N@.+\8_):4A(!0U.&I)6H65UT!C/?2QQ.Z.6;OF/(T[A\Z24=7\ M.4PJ6J/IARR+GN(DD36UC1Z\<>@HU,8R:&P,BKYI+:#&Q!^]!ZY]+?.+++>( M3QIYIY-K)MB]V3*5,)B@8D(HS&=9Q@,G%&IKS_""-1=56>7X"XENFVJS#':L M3L)YA?7[Q<<:<4FV:0YV&3C. AA:3H(]Y"KE"_H&M[&O?,"HB)_1)DO+AP+A M-"(=W']49"CQ\=T)HM+^HZ*EXXOT]BG[&0>Y:G@QP0Y 8HMN3N#VWLAKH[> M7,+PCZ^(LN0+\6%(V[$$D[:"J].(VYIYA=0=8I>0]T^OA[P7Y"D>A+L=0R"I M*S@ZB;FME=='W"%T"6^_>T6\):/\P_!V;P@F;X>.3N-M8^45\G8 7<+;/[\6 MWMX^X!P'ZQ+G+WLJ73L 62NZ.8&T>R.OC;,"\B%E]P*OA;@O>R @2?H":CHE M9)F50:*;6AT'6N B-5]7^-K6TD@6(X>:4610.R M/=TBD7%#B>\Y)5)\SZH22$AAP#=L?2KY"=6RM'8@$P86E=H27U8O0$?:7]01 M(*NC3"L*M)L;XA,W"^*";MI_I*?964E5%H!&A!3WK6(]LSS4<+6P9G[11^*5 MO_@AET);NOK!*X/U:SWN8+7;%=$6M_. MXX+=UW%#LM&Z%,R41R0U X:]&B>MV2NQ\3K8JP8N' *J)1$QYO_T3]\I6N?> MRGLNZ(]Z7:!J1ACFE^CGF_UVDH]MKI G' M,QFZN# 5N;C)F^NC;Z+:TA]/4*H_:OQZWCBW[<7?N7FJG3FZIKF9&WPQR5 IM-EK)+0-E=(,6L*A^R7-W>2G%X$^ V8,4"I50' M,:43?MMX@?9Z_EMI&>37.KE:M#>O;X_8UX_.TWH+3CZ)11: M$N)[*/0-_/)@JSZ/B\)K-Q-0F[[NI+Y%&4#R/7#FNBJ+,F C!%O_>RJ.;Y\W M@M=2K",/*&DV@K1C6$?/.\V:"_!P1+#2HE.Z\]0J8:>5F[2 >U6:I))@Z*2% M)U1?HL*G=U0:U?M.T2S/B0BNZ\:1)T>O-9D?IG*88I530&GC/. _C E^OV=_YPG/!F3]X$ >QZ&SOZF%<;[>YOLR<=Q(?SHZL&6/8)R^,[).<:NEYAAE M&$2<@%A2EI.90-0&XD9XOXVX&43LU'^H+7GONX?WV-(9NS2,$UY$ MGI!\9C@"-#![O!F7A)[J9)?'8VV H>]$X$/6-F90P.W0:^'IX)^GL5HB VA9 M,A"-PY43_4B6B8ACT/Z M(^LRT#U[W6!ET*I.=$0.K3(!/XLV(C?ET>NJEQ\<+I]6S/.W4Q1+G'=8J\B" M[529;@F\G\ WRWLDU J0P]XE+E&1%@;8X[PVP?8VOAS.Y]9MA,T==B\+; M1V,"*EP.T'V9O6=Z M/73;[EZKPWR)G[NO#OF Y/=C'>(;O,>KH[JENV>K^S5H_SVH^2)$&Q9UOHHJ M-5^VWV((YD*N%SZV2\.E78R#>85/+!#PE45AWKA+@'= M-O;"9S;;T!/IQVF/QO8K>M_ZC^. +QLW_-_E3>MY(VRV:>:(>RD\PK]7\6.0 MT"D"A'MO7+C_*N^OTSX+N,%L6F\9Y.7N-@_2@HQ;Z)S?YUWO$ZLT$(0V!>AY>@UZ5XM0YB2JAK[P3=[08?0\GC%(_ E)^9U5P2V]:)+H=- M.F#H:@E4/-*K8".LC.82WP?)!19VE$L^=UM:;@"K7T&N_A ,1X:(Q'IPY'-$ M!;PW^)RM+Y-,A$\9W@;/M)82/<4>IQ5).^JR..(F[2D&G.YX'>U8;T;16AL, MZ49#%FID- 9H10%B 97!L[%^JV#*>Y,#7"+"R&?JZ989S M].B71E?;A1QS[,=N.-54J.X) %J'D^,2IB_J"UQK.:\/6?UTP3U6P_/T]!@O M][51-(05I0 ]7@TX(=G8B_KF;P>*X8G#?-0VS]C3H[VMMSVQ+5*L$(+L"8M2 M@!ZT!IQP_4NSR:L^_\VD/3WY[BF,^>^5HLZ:*/7KG\ \>0TXZ1:\6O0/B NC M[@XE6MJ:#')!!)GF@**Q=4PZ@-X2:ZB:&(6"-*K;SE,C_9!G1;',LW4L[7L[ M'P-Z]#)4PZ?,9! 7\GT+25VQ0'\'8R,$Z#FKL:F+]C:BOI_Y_KB>]JGOQ2 ^ M=PDZ]9/GPN@;*J[=;7W$Q\_?-]53WW\*Z&%+0,D&_+VG>T)_32I6RG19WY\S M['MIN1):!#)+$MXZYLO1CM@P]@=8ERA)-& M'%"0M$$I;HC?ZYP@\EN"6:"D.6_7 *OLM,VSJ I-NQ^.V&QB'?)9R"ZJ*&YP MB.-'U9J_C1Z@AAP%5UUCO5'_(ZUUW%A >Q-@&O&Z?,#Y'I?ZY))6"W0#*L%: M-A_3[[2=K]1=]&R9XVT01^=UL=%Z:$'B#X.LGH2?9@ET(X]RP++A:YO-D(T% M9DX&KZL"ZA"U#':4H+0#"L.\PI%A'GN:)= \&.7 V/A=&^4]-#>+_,^HDZS[ M+"@>R#CM,8YP]'GWM: 74[<#WQE=*U=RP%X;4+M/ "T;JU ;J#%"]]I]0^V0 M)O\CVD\;[&WYFC.H[WB^S6;A[U6<8X*8H"MW2^)024LLDK]N-XK507MM0.T[ M ;2PP;@V00>>M1'46#E!S,Y).[W,3'EOWG/\B)-LN\K6Y9.JGKI*&&3CJ3#J MVJK608V2]U:IR;-(R;#Y/J9]BC*O,BJ!;"435ILW:Z_L-S=2= P+5E=@:E\H MT0;4D!- C^P+6U/^^T*%LQ=Q&J3AU/:5:,-O7QWHD>W;FO+?OA0E_6>^/P=T MTY8"H1^0OK__AX[DDEW+-AP3\/-*;)$N?* %2.AN4[Z%5,81MP@ \XWD/SB7 2US M',:/8S'-$UN$)V!!"),.H'!D#54\P-1O*=IZ0)JL?\=S<5&558Z_Q&F\J39- M5GTNWQ!IJ0JH <!:ANH'8><.]]2R0Y'7.*B6-!#R30=XYL7 MNBVGD@'01$9HXCDP0?:_Q[W!@/HX*YSB[5+U-:I/1 TU>B?MK+1LVV3W3Y?D M)_+GYD_D7_2"(?*7_P]02P,$% @ (TT*52I3X-#4)P LG8" !4 !P M87ES+3(P,C(P-C,P7W!R92YX;6SM76USXS:2_GY5]Q]T?,>";)[F23 MVY+U,E&M1M)*\DSFOJ1H$K*YH0@M2-K6_OH#2$JB2 )H4*2:&MV-G_[VO/8ZCX0%+O5_?G7][9M7'>+;U'']^Y]?W2ZNNHO>:/2J$X26 M[U@>]'_^^F_KJXZ0Y=XSH^=/K6O1OZ*_K4SL=;DQ\X' MXA-FA93]M?/)\B+Q"1VZ'F&='EUO/!(2_H?DBW_L?/_M]7=6Y^H*T.XGXCN4 MW*/L]^-:F:UB#B] *HV#?VIOG-^G_DNH_ M>:[_^X_B/W=60#H<+S_X\3EP?WXEOC?]VJ=WWU)V__KMFS?7KW_].%[8#V1M M7;F^P,TFKW:U1"ME]:[?OW__.O[KKFBAY/,=\W;?\>[UKCO[EOE?747Y3$\" M]\<@[MZ8VE88TZ[]FHZTA/CM:E?L2GQT=?WVZMWUM\^!\VH'?HP@HQZ9DU5' M_,O9VW_KQMH&[KTO^'HM_O:Z1_EXY!V-:STPLOKYE2C#&W_[]LT/[]Z(IO_[ MJ%"XW?!Q&;AB6+WJO*[ZM;Y#_( X_(> >JYCA<2YL3P!V^*!D##0]PG:PIDZ M/+,8\<,'$KJVY9W>^]+FFA-%Z"59\V\,IJOI1LPE?+!6(T'=U'E$6(34_OV! M>@Z?\P;_BMQPVR 7M6\##TZ-/I%!5:JD6 &RMP>>,S1@+^ M-?$0Z/K.(EJO+;;E*/+"+H?-\L,9[Y3M$JT@U5NL1:"A^TR<;A!PU9P0[3 J M+UU+1T9<>/_>O?,(N#>**K5T:4R2U5'9B:-"]2A)%(1T35C/8LXP\L4V:NQ: M=Z['E5*K%H"Z-6GR>DW]>-;0JVJA:&VZ:'-=&4:>M^V[7L1G #X$QC0(9AR! MY%L?^'H#44&CAFI#T WCV8I_-Y_&0DX6WS<#Y@Q U5JZ.">>F%;YFJT?>65E M:YH8^(]D:3W/&'UTQ59?/R_(:B"M =QD&CI.J[:$(8[3^GM1P[29/9*8_[!417R'!+?(YK 8WX(<8HQH?_\EO\ M1=V[(&26O;=[>=8=\>+V?^-EGZ%7.R26O,7R3AV7R/!Z>Y)7C*YEZ*1(4$E'LT#QKS@/FEW^_8[H MP]"S[LOAS!4!XGF- 6BI-%B(]DE@,W<39JQ#$F"/2@+Q?8N*;XEL9X9YISMS M8,X526B0&NKX?6=Z<;"C3 ']<$HCW=YAXE\F& M!/,_(KZM(LS;0I N% :"_3TFV!()D?!>,LL/7($/!/!B:2#B/Z!N/"0R(D&^ M>"">)_RN+!\TRLO* V'_,R;LU\4?/[!!SLG'A+40S>P+2_IT9!_ M%JCA+BD.A1SES*D5$Q7V+\1B8- SA:&0HQQ#-2*>&?!>Q-A19Y2SBKPT%'*4 M ZA.R#-C/O!#-]P*1_U)M+X[&$Z/L2Z6@F*,UP>9GDCWR'/?R=;%="%HE"D40AHWU7$HHWXG&U7#A,G&+!527HN0V,">_":"%S)*+?X!!10E -HF3!GQG-,Q=W' _65]MAB*2BN*"=)F5#GGGB%'W$@5?W,G\$> M;"C3:EZ,,\/XF;DA[X'PHX_\U$8CN163%(7"BW+\4XIW9J@7<7R@"!G_R'>( MS#WD83G&N:P<%&24PYY]OKMW5)$S$AFF4(I*-8H1SZ9 M4&?&=D*7S!)1C(OM^HYZ\O"0TH)0A%$.> K1S@SR43_*X<:-;WS MW'M+'DFFK ".L\%$7"'JN>/WXI ?D7J5K>-^#/D/Y;!+BD(!QPF15(EW;J@C MQPV)DW1IZ/J6;_,CU2''H@1U;2TH 3@QE$"A4\1)1+2R2?UI(1)_=1]*W0BOMH0I_60TH_H@7BFIAT?SG68\O M//=4?6>>*PA%&]$5ME0T%) 7:\OS;J+ ]4F@G%MR!:$@(_J\EHJ& O)@3=@] MG]0^,/H4/J2QG2JP)16@H"-ZMBI%Q0'_^1!'GL2_*9$O*0W.3H (NU1(K+0; MMBT<*9*5W'6X M"A4:9VW-1/(KE]:C0DO$0H'W MQO)_9]$FM+%)7D.;[S,@R#EFR) =2@_ MJ!F%P#"4T/33ZX)<8_Y!^/'65!?=NYZNRMY"(-ZG32'TP6@[[X:3$= MC_K=)?_EICON3GJ#SN*7P6"YZ'QS.^G>]D?\+W\Z/67JR@KN8A*CX.K>LC;) MV"1>&.P^.0S2](/?]EV>KO;&_AE-SA&*W*II=5CMTQ6NBF1)RG6]#/ER6 E9 MC2 ]UC2)) W,?-6)2%=(*!^%XFAY7=7@EC$@$16="/$BG!SWY*]HZ5U!"-*2 M'K<$W#GA?75MOEBH8<2"WM8=R] MD(:6%Y?$TS6Z(2S2#2SPHO!&;^LP+K65*IJJ%EKJVDG;IY4=7JY+7 MN0;/MA<)L]$'2ITGURMS>D^KPVJC9;ZM0)H)'NCDI0^0^_?QRV%S]_Z!'YAO M@Z3KBKV%NAI>\MPJ.PT(!.A$)1+I5BW,)+J5UZL7L%#MWH!SB7A(.3:A/U"/ M(QV(*3O;EHSQ0E=[3(=!EO>5'7PLO]694!*8%O-<[MC_,S: MBI,CEY)_PB(^EQ3ZKK=J@!K!2S<,9Z7GB)C*NR M!T,"G; >]6,I/KOAP^[=5#AML-IXN9&KDF>""CJ%)E/F*3-C8]838WI $^"E M;4\E$\:$^G;%V3-;%2]M<\T3:!&/-BD@2/,PLS;7OL-\ 9HG?*K<,/;=X6"( MN9^/.L*/3"H^E97PDD+7PR\ $72MJW* K^'(WD!&Z7HXNX"#^FPW,<1]_61Y M45FNBL.M5;$P7OYI.,J%RS>9S.A\9)Q)-6042^*EI:[*A$Q:=!JZCA/;Y2QO M9KG.R.]9&S:)??;(2J23EQ$+JXN71 MKDHT'!%T+2S*9K+'PTS"7945QK*=S<).^Q&X0-E[K\/JJ\CLE@/.\RE-@9ED+22N3BOFB%KNSK8 M$3,U,W8,12O94L2A#VZ M-ND^NV6P\Z+E)2\!=&GG,W:1LR,>&Z>3S@1]NK;=;\L?IMY5K"V1KX3\3EP^Y%(,EF*LN5%T4X: M:K2.D95WOYZ]J@Q*1^!%10EU6 M$"\.RQ1AN9CH!Z^T5X#D8,62;;EA*>RL"IX,Y3*V!?PAEZPLI&0?S0(IRN1-R [72RHIS1"R>NTYII%1YI><'1N M/C :!'PR7ZD:R1(=^B6@7[!RTC_=)\Q0!5BQ%E=94\]$8;LK%W?%;T4+^BD_588/8#UL:])]$S02G*UA,8^X8#:;@PG M_]DC,:Z\UVN1UOO?LB.29MR%TBB3 M&RMP;<6Z9=H0>A*UJI16A Q/CR57+UP.(<'.OU*Q-1'%I:71\Z;IMR/*_K=$ M$7=!EKL.:M1-4APO#1H$8PH1H:5\]%TO"E5.H](*>-G-3N:6YHOEM/?W7Z;C_F"^Z S^<3M:?NE\TQ\,1[W1\D_XSN>9L()J M&6*B_>,D)4@RU_."P7*.-V@1[?*74AWONC%8JVQ@'2 M@ FIQ.@'0TFZ/ATOFFJM\7\K]]@ M5!.!DBN >,0E*2EN^3SQB03B6G:Z.KRR'9>07 . :[=FL9+R9R1.H[]R/&.SR+%3K.L13_;;J)?9(DOONABCM"K[OXI3,<3S^W(/%=YH9[+ZJ1RT%)+;2E M3/1EQNBCR_F_V=YR6D?^/ORL:X?N8_*X@CY$JT);;VF?ITW^6.B-F,&M#ZVN;M1$FDE2%HR K*))2KEV*B:6J,QV_D9N0: =]$+ M41R!+=XQYVAIYX+2PMCF]C,.!@58Z%K.I16>)J1/DG^Y?**W!R&#@,09)#./ MNW&00 G&3VL8VUA?VSZA)HA;.%2ZMDTCKD!ZHTEV24W2!.\)&": M#!A8>]B7#^<:1";HOK"!M9M>9]96Z(_8@=LVBT@6TBI+E;H]]!N1$'@O M^IA3 N@.R['X?2>OX@+4H GTE%!G6][4(+9PIUN6S[L2^9J&T+-(G6L(@ "] MZ+D#?GZLXQZO!=FJFADZYC!><#HZB; C_S'QX*WA#EC95GLR99U\"PS #'V= MX?NGG8^>_:_(980+P<=UN)UYEB\270J7HXTH(J?9I V\W%NG=8 M+'@UPN.K8$V"F,JM[?)@C]_*VD.E[S[5L(95MX64WJWT+"< ,?PO) MJ$V($XA'QPPCJ !5P;Y:9YX#(,P4LI;#<$)G%"YR'8H+Y_C<'J'F')LC=\'S MO)!4_+\XZ#Q:'HDODW?1O>(/_!!T_$&F9!+5E3?8[!\HY#\\\ T4F?.9=+!: M$=4:<>Y^0(?KN?U'S87RU)?U*&T>90;S= MV\9LL^T89R\F_K(@=%$EB<%*I/EG"2FT\+4=\D^4)H7T2;C1=#8WD[ M:$;^BK)UPHX^X!O: '00M,E\:8@.^D*9AL(<[.^^L]]$QGD<0&^00IL 1Q@V MQJ@A/8472LW 0J=W_Z @"43"(7YL4#K(%E)A,G%;P$SR1.J %IR M!:&<-)]6%#XM2J0M8>',25M$/H)@NIIE,?2=1;1>6VP[72UX87?EVI8?SJCG MVEE[]5'REC]WKCI]-[ ]&D2,\%]NNHM1G*%E-A\L!I-E=SF:3CK=2;^SN/WX ML3O_$C\F,_HP&0U'O>YDV9E-QZ/>:+# R=V2NI&+]':IG(";KSR9+%ILZ>UBIS+14]L3E7KP!!?KX?N,W$2CY/L?'.DLW_)Z^QP M].N@W^DN%H/EXG\ZD\$21Q>E_G-ZE0141;L;+^_8@0" )IJU@JQY8!J+U^/& M4.$K7-[/2ZIU[_-:-^*+X^3#Z&8\P%>]#Y0Z3Z[G<=CS AWZK%=#PV;0=J"2 MG@$T$50960$KD5G;DD?@1$1YS9=%ZD/M)8 -8 M=PG*[@%T#=X"LLH94EFX9# #J@4J><@!6:Z!;PL:./WX<3I)7MK%43?H<[EM M>13.#&JN%"(/&^;ON/-SU B]]F,KV>' MI\'+E>A=F?VQ%]L;A[?C\9=.?S2^%>FC^=&J,YXN%IV96.)23?NE.T?:"^[> M;N,RQM(!=$Y: ^F=UUQ_ -JFJ(*M71HZ\F^\ZF3'URNA.6Z26U!K[21 Z4S;0=;$ M2A27//QK#AV^SLZ))T(\9Q:3G=J^SROI?#".7T>8=>=X9[1#KY?,\@-.C AK M@AS.=#6Q3F7E_3+2.Z-&T,]F, H+AS)CG/"5;.\;$3N1!]ELR$>J]D/17L]7 MQ$%GV?VU,YM//XT6H^D$1^/V(I@L>LI*R%XZAB9X52UD30)0(_/5:;76F/N+ M*/U&KNOS&^E\L_LFI.=_6N%"(GF==K3>\#:GJYZ(E[E^/[,XXVO7ACB!B/KP MZA?C[6$FEE3]SNS?$P6N3X*@3P*;N9M=1O]*3CWF36$_UV/NRE,5+G2B#T^H M\3['W=R"CGBJ6MB/W1C3!P$!G:D9#('37_*"CB.S)ET-_9L:4H7)!T?$OCRB"3XRPZNCO MP!C/D":PM)1$7=A8(HTIM]!6L5]VJ8ER,Q#Q1P+U;2)N[^-GOMW@]QXCCAN* MGY2[&WDE[,=:JFQN=!"@TR3UQ 5/O/ 6L)]3J;"7,0,'G!O=H8')"AS: _BQ$A9V^$3;H7$[(4T9&1GW^HQW' MNZ==!I-JWA+ZJQ#&[%9%"_\J]SA$>'G\N./1):T^4+CS35(?Z>KU#Q4Q?,JQ MNSTWM;5'![=0PTIB@E5J!HP,1M:U/U*(\,)^($[DD>DJ8QW(=S=F Q)C4J6Q M%Q!"? *(^"H<;[L52ONV/+ 864\*H98I0FF MD<3(.O+20XI+^R3FVLRKEUNHQE5J#-V9_91 XQ/@PU=A<#"E2I\+<$06+71RT;*O]&'E2/4LWR:+!R(V1*GS M\;.KX$I>X[*)DLN5B>1H#TE]NK9*BL*0L=I2)?N1D'8^4 J/?Q!9\1&^V-\2W'_@F\'?U ME*6OV0Z-J#IUZ>7+C+.VD+?KH&XBT]=L!WG0X:GE+B_>B9-;72>* # 3'N]L M2VI@QY1 AV&.)!T$;9P;E_SKC*?%0Z5V*%6-,^)!M$P@8$O8$GTSG@>SE=K! M%F 4ZGC*"H4]\>VO?O*=U,U_VHJMFP:+ S!/% R+9B;"@(49OOAO!Z[X+[]] MM/Y)V:Z#@63.XP7+RK5#<8RG.8DTF0#:\\$_L=:\XT?=D2LZ=,QH8"CKH^%:==$*Z2LFC1LJ;8*F5% MW[LJ_*!NMHF$(C>">B]KU,B%3OI51,WH=^O8/?15C&;=_M>XH7:P7&%TP_DN M%[R91:CPW:H94U88/1*SXG \RI.E!**I^%BZWD0A80NZ"I^XH$KT98718RIK M0%\-!/IB-EAO/+HE) UMVOE&N23H14P@I'"WT5?%CU+0W>WF8V*A<#2D-G.R MBGSG8+:3*$RQ&'9V-P.HRP5HB3[D,J]TPY[%V-;U[S]97J3PXM#5P[Y8,U<% M&!*M(.S6=WWA$>5TU\+LK6:I4!@[#ULU:B0RX_.1-[C-"!,?6/?DVL!8?%0+ M.P];!88 **!3)0W&VV60DNSZL M2O5,5 ;6Q4ZJ9KB5,$($WS?X.&X[]<+==^_(W;?PEDM)X';:P-?([69<>27! MR@8>OS%6Z^Y3TLS"T&0W7<:J=?P-B%+G3C-KD 2WL)\2$! M57[99):XEN"Y"LM% [B8@"JW@TR#00M.F=$BUY-]IW2N)H6"+3!<00=@WE98 M+C/ZL6YG:>Z31^)1$"N**BVPCE3D1XL#.E/#B/&SB\C!X3O\7"!^DE]3[:XD M%'5:<+2NR)4>B8;.TY_)7<"/CW%*-^4=55E![+35%?"6B=(2C8C3:XBGCT?K M#:./228VG4HH*V%G-JZN$P LT/F22O>!T:#*-CRMAW]Q"#PM0C=K1WB@T]:U M[6@=Q5>B-6MZ!HP,8URN%6&,..,$(&GOXZX_$G9' Q*7;9>E6I.A MHO"RL=QDC9YYXB4:K[,3C;S[QZ7:NM9JK,]EHN)?[Y0D#57>\13>)Y:F#<6] MZ?F:-[0LY27D#DC?1CLLE.=-%MJ&.R%%'PNKOY%_][B]]T+0$0WWZ1ZWZ6[H M:VQ&_01+@S3P;HV^!FE<6I#&R90OF>40D?@@X M4_(OHG=8VJ*F&;5PX,< M)F2C!G2^;0^%HY;2>)XOA'VI5$-<1[G<3473I)&08S<(!<>[]+;J*PMM+>S[ MHCK":V#(-,3+V+6)'RAF(5$J7PC[UJ@&U,OE1C=0*B33W$?H:R);24S.*O"E MOEVW$HJ.9FSI69MY)4*E;;5X,W "QQKHT%DOL9@-GFTO$B\7[&P2R[YOD)M.-9<.?X:^O-26FX>OQM2OQM2OQM2OQM2OQM2OQM2OQE1L MNB_/F-J*C#?MM4Z@)+QI3V!NFPXQ=03HGMDUTOEG%(3"_V1(&TDKWFL+;U^G[GKC.-)?UP.=T0\1IV;]/NC.,1'3&1SZPUM%Z M9FUCM_1^1+3YHDS;N83G0*MA@S[) ;L]\I=/] NQF&)_7Z$I[$FQ3F:+$%T0 MN?P+26WT9AK#-K?63' !ILNA>$@C5A?#F;:P[^_K);@ T@7QRW=VM?%[: L[ MX5;-_.9!NA1^EP^$$6L5JAR<*C2%[?91)[M%B"Z%W),IQ<_452>1)]]AAC2T MO-P-9BT^/B0(1G$.7W&$YJ,M*#OCQ%XQ926QO7W4'$F[796,]PD9/KF/\^>> M0$?->KA_]1VJ=YD*0 [_TB(]*XC;LFEQWS]#LT&Q'G: _RGDR.T"+T;=)M2W M*U*B/\4FHL87+:G3M;NJO'->:\VP**[XER6*58LU90=C[(E8>OI:N?W MK)) 7_<23*YP#-"7O+*N3C?Q>SET$&N<&5WYNA=A2(6#@,[7<2<_$_?^07C- M\CG7NB=S(NZ;LR-.D<_9IK\AL:4L7:"R% M ]0R9D5.,RAW2=D+-'5FA<2_A-^_M&HQ9QCYPB]]O_%5WY/?&O9N%\OI MQ\&\T^O.^YWA[:0_FGSHC$?=F]%XM/R"?6L_)X_$C\B0,[C;:7QVPX>=_/H] M)+@!M)<["GT"6$TTU9"WE(:D%9_QT$-2^2S'E=JESB*T6(AZ]KHJ(@;^I+9A*+_]A9_"]N@K@OQ:M'V@9^WTK5ON5:;=-Y= M5UVWT8T]?^@5/.W[G-CTWG?_312V!]-V7NX:+P6M!?MNNEY3?Q%2^W>8WKXM MZ.WTX\?II,.5M_?W]BBIR/\7;O6ZF"^'I7)[%A8/?+ &W2A\H$RG7XI*R,I4 M#G]!9[12UWS#@<;JS&)3QO?H(7'BAR]GA,4B@]B55\;>^9K2K(/AHNF>[7IL MJ,>Z>M@;8A#),.%?$+_F&@VMCVWIK<#WB];KPC(U"H+(:&'>5<"V$E=;E8_% M?5E43J,P"*WX_&K YU$M;#_8:J26"(YN48I[=F,%Q.'=W1 _T$1,RLIC.[2" M&%$+VU!X<3P $GT>4O:)!&$Z@7>?+.:(S'>#9\)L-R#35?QY)&.FA G1 MZJF-8ONVJNFJ0\)&.9TQ:A/B!+QGZ[*N93LD8="L"6P_5CU?52#!-\7PR<"U MQ=M^ZXG7*DG)!S3(.#[J70&?XB?HE//RE MTQ^-;Y>#?IS+:CQ=+#HS87--C3B_=.?H<F9YF>-:T U#YMY%83HS6IZ7 MGCWY8>^SN"?W0T7FA9,:Q3:%U<5LBND.(^><3YQ"&C M:1O;*H)LT.7U(<+S3=!&NU1:]=V_-\[U)-AC.SKP#EIGZ+7'W< MY*2_[-0!IE\;VC%DFE&X M?"+PVD##?]+D1%ENMN4-J)] :?1+OP[$>G!$?X:EO'.0=U?T-=LQ2,Z@?* 1 MT_Q++%DW)>4K+&4%L9T(H .QX&=7*G!#5I9;_S%V#YOS_S+7/G844T(.JHE] M.5N% P-(T$_X)TX%W;5(1]/8BKMK'ME+J^[]<+W+Z3$'^$Z8%L6#6G;75<3VU @Z^'-]N@O4'N M47/MV!5!V94>_XUDQC_E2[H+.+WK:[:#T9-&=XYFO+;2:HVE9V7;09SYH%9PU>YK,?M/8>AJZ;*T\X2C*8Y\MY6,G>Y+1 M"HQ^?AF3>\L;DM+(NK1,I@AZ?AS8BEM(W)N3$7^/G]RF+JWG&:./;L ;A.WT M?\CO]$>3WO3CH+/L_MJ9S:>?1HO1=-*>#?]>3/E;\:6N8_)*2/?XJQ6Q!8[[ MOHD,LB+ADNM'_"R9IC4M#V_7-I9VY?97@S,3 Q M+FAT;>5946_;.!)^-^#_,#!P;0PH3=)N7A*O 2=Q;WW(MMG4+WVDI9'-BR2Z MI&3']^OW&U)RG-C=IMT<>@?G(8FDX7 X\\TW0[+WV_CWZWZ[U?MM.+C"7Y*? MWG@TOA[V>T?A+[X>U9][%Q^O/M.G\>?KX:^=U!3E&9T EW9I< M%5%X$=$GMCKM8""&WGSON'/*E9WJXHQ$]+C3[UWTA_!5S4;+M]%\5$S<__R]/@F5=#F_'H_>CR\%X]/'#__NZ M_EVY4J>K^J4N$A:EQV].=='ICR+Z7=D[41R;G&T$FZR(MUOE3)5G/\.FG^>- M@Y,NC6BF%DR6%YJ7G% YTXZ^5,HB4AG<8GEN;$FFH/?&YC#G\ ]*C84E&K1S,BVA4Q&]^ MRM)_HM/?=NE".7@,/LU7=%>89<;)E"/!()Q?>SPQF+TP)<4P2>F"5+&BJBAM MQ>1*57(.K>),!5,0+*TR2E6,5Y9,#I(J39#;$B@X9N>478E(KN[8!W.MT[5; MN4HX(LR)]0*C(-#(9$BK$PKP5#W4)0T*5VZS.^&_"(@BRPGA.]HV<)D\AUB3Y&F!?S?(M MI#V?'YX-.(!TH1.6_E4Y4RBA0N4 0FE>!%S*)DV< 3VM)CK3Y4HJU:YY!?<> M$C[: ;&/1#>:'\^X]_6*YI6= VY.P$XJCHU-O 6^#YIR@8J9 77XPG/!LXB@ MR0O( N[U'*2W;]B*NS1#*[?:"13&9[!5>-S=6W@0 M82"(QH4.9F*J$*CT=./(UZ MC]0,A]UZIN\XJ_=U3P9$?]M)^XC!TQ_IP?V)2M) -WI(:B&9#?1LY+>$_]F! MB+:;I->@184>J32U%?+9OX"V/-=ER1YBCQ8R,:B"\C;1,,@//0"FP%!.*!!_ MI3]K,H&_5!KVBMUI5<1^H]?=P\YZ@!VR]!\:,9=-ANQ78LV(D93YL+VJ]\]+ M5G=2-=@UJ1Y:%W]&T^R6OROT=2L:=GE-WM-#VJL$ QT+%X2TWZZ43:L#:40= M#4D4BI:#>UR5PS7Z/^PQ5->DG6<*^T@&Z'D'*#NI16)%B 3[(Q<#+O"G7'74 MH\#:NEB8;,%"W86:UJ=UMCZFX7R>F17CZW)F E^H1Z "!G84MM??9.OFP!90 M>?,_$)WQX.)Z2)?#Z^M/-X/+T8=__MHY[OCGF\'55?/\W=8M=5+.1/3X'^=@ M,8M=P&%LLDS-'9]1\U_'WRCUQK?-! MA;-3?9B6EF7?J6Z?>^*J1JI6?BNX= MZ^[T>^\_?AAO&GV8JEQGJ[-OF>UE';(KK++3OP)DSFA03:$:K\+9>>](],O] MU]6VR-^D?NZ/'52>]HU-\T%;]N M?\SA.YW< &G3"XXKV3/0Q] :O.@U7-I9VY?97@S,3 R+FAT;>59WU/;.!!^ MSTS^!TUF2LF,*;^.%T@S$R!;CV<=_N/$S52N3@^?'?4V3^'C7>OH_U,Y/28[\E$C?$J MI"PGT^KN9",[/?N7)\&R+OKWP\'5X*(W'-S>_-_7]4=AML5 3.2,A*&9HCE%<(.R MXDLA#:*4+)H-0U-MQ-I C,<7T.A($K9'X6&0DC@\"<71P M="1V^?M.$GTI])E7L6/<0UOH6-S)A85Y@1ADX;N?LO2?Z/2C-J!GX3'X-%V( MATS/$XK&%#0;SOFEQR.-V3.=BQ F294)F2U$D>6F(&%SF5,*K>Q,"5,0+"43 M$#)ULP%(1HHU!RQ2)) 1C0"Z>:S MSJ!0VHF($SVW%8 ,C97-C<1,DE]ZPV%F4,.!K:Q9,W?;H/!+6PR?>.VM]5%& M 'S1XHS2<:SPZ'T^$-*0"QNBH$8).:XF8&64*#MA>19+P2?,*?P<*1LFVA88 MQTQC=.)538T.*<)K*W81K8@0?Q^2_F,XD=F8FHT>DOB^2"!R>"SW#D]VJ>W& M'IY$_LD_*B[Y&?!43B XTVM0]>%E8[XRDUB;*'XR4=QN-QM55:JC#") 6@"JXZCC4SUE18+B\0^$:TU/XYQ'\L5 M30LS!=PL@UW(,-0FMF$K;(O^ M3":%RW!V.[9K:$/4#/ZR<.5:.X'"^ *V\H^;>PL'(@P$T5C?P8QTD:]/7K4R M+R)4N10G;M#B;W>[8E3U?BXQR'L!!IVQ\BV#002*\6Y>"U>SP;NALCEPG^IP MV#&6MYKV>XB%*Y,.P\)P4&I%8(/65-L<[_DD UT'+(2F:1D..S6$_5 2;FO>S8@ M^&$G;2,&3_Y)#^Y.5*(*NL$JJ9ED:NBIY3>'_\6!"-:;I+>@18D>*=>E%?S9 MO8"V-%5Y3@YB3Q8RTJB"_#92,,@-W06FP%"6*1!_N3^K,H&^% KVLMUQD85N MH]?>PLZZAQTR]Q\*,>=-!N]70D6($9=YO[TJ]\]SD@]<-Y;%W=&4^V6 MOROT92OJ=WE5WHM5VLL( RTQ%_BT7Z^45:L#:40=#4G@BY:%>VR1PC7J3W(8 M*FO2QC.%;20#]+P]E)W8(+$"1(+5L_?;=U<1?F$10_>G('%#'8!>Z%.$CFU="JJ_UKN M-JDSO*\FF#%CH_Y6*QGI/-=IJ[QTZ@PO*\%2_\G!FU:W3!3%XFI)C;>^!7C5.7;++2 ?W"\G8F*N[1++UJ/-$S\+SK[+ONYK M77Q685I=#?*U+%_'^OM9OL;]"U!+ P04 " C30I5F0_T':D" >"@ M$@ '!A>7-I9VY?97@S,C Q+FAT;=U6P6[:0!"](_$/(PX1D1RPH:D:<"T1 MXBA422#!.>2XV&/8QMYU=M<)_'UG;8B25CU4(JU2#B!V=]Z;>6^\'O\BNKH, MF@W_(AR=T2_8CQ]-HLLP\+OU+^UVM]O^Z?3L'N;1_67XM95*80;@N86!B.>H MX1J?X5;F3#CU@@-S5#QM42"%SOXT;@@Y4TLN!F"/NJW /PW"]8HON(%^K^/Y MW5/*<;8?]"$87)LCEO$E+<4H#*I6<" 6NAB^,PF5-0_'T61Z#5[_V(5Q>!M- MSB?CD5V:?_0JOY?:\'33"F:ETB43!HP$[PO<=>:=<8< 8L.EJ"IW@&E@B2P, M)LU&\>K\[M2)^QED"F:%,&=JP03JH^DZPPV,8F-W>J[;8+-$F MQ,S@O27_.\9Z'8BHSIN2*6JG; .W2*)1S0+.I0NB@03 M^%8*A#X9WW-[/7@E< VQU7=G^59U2,N,6,C9(N.4_#,WJVI?X6/)%>;4UMK& MZ)?>:C,"4> =MY,7-.JI4G%#",U&N(Y73"QQUT;>2?_3$)A(_@^'>K5#7) + M>=7-I)XPC OR@(M*CJUI*>-D(3U]"K75T;'[+,N(A\SE+".5=4'"ZOJA2KE@ M(K;KA)CP"IMTLZ?*K+9!DN<5J?[)R,X'4Y>NZDG@WP5=W7U[O]0\_^K;[][1 M&V*RO[=$*WA3W1YQ?W,%[Y&A72A._5A00^(+C:QI#O?(L_?6.J/G:P"C7-I9VY?97@S,C R+FAT;=U646_:,!!^1^(_G'BH MJ)2&$-9IA2P2T%1-U14*Z4,?3>* U\1.;6=3"^Q">8GQ>%T6W@>[WFB=;>SNQ-9I>/L(P>;X.OG51P M/82^4VB(6$X5W-$76(B<<*M9L&!))4L[Z(BN\S_U&T%.Y)KQ(9BM3L?W)GZP MW; 5TS!P;=?K33#'^7'01Z#I5I^1C*UQ*:9<4]GQ3_A*%:-W#H)E+8-I%,[N MH#\X=V :+*+P*IR.S=+RHU?YO52:I57'GY=2E81KT +Z7^#!7MI3&P%BS02O M*[> *"")*#1-VJWB8/]^UX7S&40*>D-A2>2*<*K.9MN,5C".M;&XCN-:$%IP M0],4)N2)2JO>/MTPFL(5XX3'C&0P2U,64VE\YJ12F"JZ\=C&'+#,'R0A$ M9 M"$E,X':K:T!.GDNA1U.1%X17S MN'C):+*F)B&BA^_-]]]1M6]#A'7>ET1B+V45+"B2AC5SN!(RQSAG]Y *6;-1 M(*Y :2E/: (W):5\5&OC=4E""*A?]Y-7M&PH4K)-"*T6\$VWA"^IOL>ZE\,/HV \.3_ M4,AM%&(<5_IWH'ATL3Y%_] M>[T'_#:$Q_L^=/RWTHX(^IO#]X@1NH5DB%T@^%M3FE8D<2Q*KAE?8__544^/ M&/;H/7:)@S:$<;G&+D;_YFS7-I9VY?:3$P<2TP-C,P,C(N:'1M['UK<]I* ML^[W5.4_Z/5^USY)E7!TX>ID>1?&."&QP3$X3O*%$M( BH5$=+&!7W]Z1A(( MD$" !,+6/F>]P2#-]/1MGN[IF?GT?Z.!0CTAW9 U]=\3]I0YH9 J:I*L]OX] MLNBW_:DZ?&@IC0^ZIIZ(V( \Q>9XY M(5:)! G^I?#_?3)E4T'GGS[8_\*O V0*%&XB@_Y:\M._)Q5--9%J9EHPDA-* MM/_Z]\1$(_.#;;P?\'L?G&8__2>3H:YDI$AG5!.9'ZFZ,$!GU$@:?:1JE^1# MF^$NVO?-?[C+S^7R+?R#R:,RF;!O\VP;C[3M&6';'>$&S63+]ELLPV[S>J[: M1J"50#[\_ZH*#!Q7@#.ZH-14"8V^H7&; <^5+>6S67Z3=DN>=LL#I$KPGWFE M"+UV5U ,M$E3C*>IBJ7KN"'9$ 7E%Q+TJBI="B9JL]P'GMVVU4M-M 9SS5[! M-T9[0Y'FBH%MWB)=UB2[U>^;M)G'2G;99MN..[4;AZ\V:8-K-_N"CF! ;3)[ MV(T8Y+M-VKG$M-PZ;?%+).W6>*E]:^FHG?6V,H1OG#8ZFC2F#'.LH']/NF"_ M9Q3+#$VJ)0^@FSIZINZT@:#2]A(I)/G)?4^2C:$BC,\H55,1^5$> MG6&31SKV)>0O69*02CP+_A,>K(,8=5FTG<;(O,,^^TK7!E@YL#]D6%.S/^>3LYG!O7IPUP7T?0Z9VTGY\3<8NDHR!9/SC,9EH/I,Y9> M VSUY!P_OH<>/99\AZ*9*E?T_ 5#@9&P@X?/C*4F7[6; ^F#^-,U568%;3+1""2YE+ M1@RDL;:Y?I>E/Y9AZW=+*TN2C)\!DQ9DJ:96A*%L"@J9W3":!_T?#)%JD*#@ M#N-(0S81S"M/LHAL+W"'1*VGDE9^"(J%-A0;-C=-7:E^I9?.@Q!&R$?H3A+* MA7 &S#-29Z&]Z%X !!!Q&?3Q3QH2RED"@/GYV. M!".8C4;")0M"!(PDI-URT=EM](-9IC8ZS'-H=QL@MO6.BXO.D!+*@U!&^'+@ MQVX&S$27^CCVEV(7@SI%2(;GZ+@OA0EA+=)!?%E)R=CF1CS)>D59#@D82TVR2M M@BP-9IG:!$.*[34J&T-*/^YAA5.O; PY^D/-CP&,6#O39"-,0R>4!Z%T_(5D MSW8V"3;Z[%FHN7MK_64/D5,*)G@CI)1E#X1+=[ 4=JM)[L-@8ZZ2$>J MB S["5R8>V:0BFMHFB)EU&=]4G6+RRXS;L'DZZ_GMBR(.A@NRJ M4*>K^<;M[@S-TMW>X#%2N7;FL(<,29Y-2D6)KFE;4?+)-:MP8R#28'+27GL4(:#1!NU;13 &0DV5X$]][.#$0TE@QE34P\&6YP?G)PF( M&0T5691-FU9*DN%)>R^AH9MGM[HF6:+9T)UXJSR2C9-SDC#R&^JG#[ZM>BGZ MX$_2J_)\J;8<7EL2Z\'G2B=3;4F&MB0O5 R:[U-M.;RV'"%NZ0OZ0!"193W"K1FQ9 /[6N.#<>DVI,8[3E"7)-J3V*TYPAQ3JH]B=&>X\,]#;./]#OT MA%0+O6B=61[HH?W,D6&<5%-2/!,.SZ2:DF*7<-@EU904I_@MUZ^H\3I2_9A5 MMP+/\/O5OQ8^5$H;##65'-1#E,5[@L_M+ONJ0 B0^^I2N=>A RMY\,KT MP:_Z\'5H@<_(7YGL ZJ37X?X_0?_PC5@_0%%KT/X24(!CDSV*O<4!207!1Q" M'U(4\'I]08H"DH0"]J@!1U:_NVPJ5D@N5#J$/*51Z MO;X@A4I)@DI[U(#CA4K[8-+ZDY9>AX4D"2JQ>X#(FQU8]3IT(*E0Z1#ZD$*E MU^L+4JB4)*BT1PTX7J@4*Y.VN"OD==C*P4%3))5^7L6)OR8T15U)1EW'KE I M;$N]T=;*D^*^@^.^(U6A(P..1\/ET!?'O X;31S>3.9NM6TO\'D=2I1HO'EL M"I7BS=0;;:T\*=Y,'-Y,I@IM9"&A;7=.Q@ZAM[V@YW4H47*1T!$J M5(J$4F^TM?*D2"A92.AX5.B8,V])YG+HZW5>AXTF#F\F\_2?;:\Y>AU*E&B\ M>6P*E>+-U!MMK3PIWDP#@X>]GY?9(H"DH8"V /(/44!R44!A]"'% 6\7E^0HH DH8 ]:L"1K3CM MF4G^I_Z+2'X2.LJ1'^?N:O^%H BJB)I]A,QK313P=+A\K/O\F%\\0K9/FTG% MGABQ[^F.>-:_MK4LBIH%\\8B0V8Q%-$4I%"_&%T@5^P-!?UQ V@$L7*]3.]+3&@_10N"W6EC14(1OR[@1_FBZVYOA MM:Y%/3CH>D5B+U6)WR#+JH8=76J4J5&>^>I":ICK"M<6#NE,9\K4*%_L3+EE MC>,<=#U2@TQGRM0HDSM3)M8P V^0K*D0P/9D4*2R82#SA61C&U]4@3#JTO^?$AAUT;*A#/;EHGTIM8UGP7]A:2H-ED ORP= <.NY!'^]$*"E(W4(9@-K\P[ MI/J07'W8IW]P0LX'U#$@.JMHQDO)7812 Q)F+H_]E?B"5/;)DOTA<,$U$@S4 MUQ2I-ACJVA.IKWQ-6N ^O((/K\0;I!IQ#!IQ"!_1T@4)X44T WA&_J@+@Y<" M%S=*2\^V&*S@R"OS%ZEV'(MV'""N $]K=C5]\ JU@>#+^?&_$L^0RCY9LC^ MW;O%)-S5#7I=G2+7C:+3C +[C6A:!HZ\201)E MF!__Z_(,J>P3(OL][=#+^A; D9W[C2&NA'TAFE"&=B59L4S0A282+5TV9614 M1Z)B24C"_+"+W4CU;Z/K[EV_17JS+^CH8NS?@$=SEGFV;^TYCOLJ JLN4Z5[ M"4J7L.K,=9[N7GU"AHFD._A?71;A$V%I^5G0I50+0VIA""8>6BV/S!>F:ODZ MU#*9WG+Y;.1TBGXI4W3R3E/VN[TC5;J7IG1;769R.$^73L"O8 (^/E^8JN7K M4,MD>LO */H.*="9= N$CJ^%YROYI2PZ>P?6T@75$$0RIUZ,O;]X="N0$X>. M-(XL $XU*O$:=62Q:ZI1R=:HXP-CJ48E7J,2@*,L5;;5Z;YYN:08 W)2.CJ7 M#2W+L84S>,9MS/UIO@O<6D#[!/X:@5TX3" /;=T'T'<;T(\D/X%&+O,6OUNW M!D@73,WGV*0->+!(HU^KGDXOD:H-9'5=M^OYLMBO7\/N[W-<",'06^AFCD]6SRC\*'-R_LD8"JJWE8PA M3] 951B:\*- ]774_??D?X0V^*Z3\Q8^YHO2NA0NKL)[.3Y]$,X_?HEU6R56]5FS'TUJY7[ MNUJK5FU2Y?HE5?U9^5*N?ZY2E<;-3:W9K#7J,1/P(!A]"+M-#5Z^/*V<4AR3 MRY9>@A@_=J?"&I;:(42W#,FR[ M33[E 1U,OA;*51Y]>R[_Z$!S8'^JIA)?)8N4,T7<8<.8CX%,;8:03RA5P& M.CSS]G=RSC*9[\2F9VW.;*CS(NQHD?'9!<9_MV >1[H"8&2HZ::_#,J:Q-Q> MZ[_%!W9K&>#:<<'\]T0>F6<=35.0H)JZA?R$LT 3YE2ID,U_#! 5]?V^?->J MWEW_HNZJMXV[%G5[?]>\+]=;5*M!@7&WP((IEG_[IG%'L;EWTGNJ<46UOE0I MC^%/C;Y<:>&?V1*??0GRO])TRNPCZJ_+4\H&6Q1@,20MV65I03UNR<-5&[?Y M*\>3_+M;^_;E@NEV(U$."=^+ N_U)6$\1@ D5#\=F2/LY/RKI2**9V@*MQIH MTL_9_E*EY_GP)8\?7^\D&SA-071EP MO&J1[$&0751)V'X%3];)@_[V<&OUU>S-]\_63Q0!4EKL$R=-V Q?S'-\(OTK M%Q5>711";DX(=Z@G&UAE3;P+UE\0#^6.^J,B%>Z9*""K7[]VIJCVN4Y3M7KE M]' 8]EUU)(@FH18'H_J42DHP*&.(1)Q2DR@9&&H:E-@G(.3]?C7%)*&RB!0% MN")"G/7O"3 8_ST4),G]>V-"GF7)[.-'F7\^4AU-EY">$35%$88&1.WN)SL= M\D&[*HJ"X1)O:T$U9?#(E]RFG\1QN>WF('RE/?@#3ZI<]Z H#61F? MK1M&0$LS_>?G]+^FBIH.LQ]9,"9WV%7PV>/ZN*)) >; %XV'/Y,;(SN2HIBG M,P822F7R>9R#)O+AN W_(^^G?/4'TN7#4DFN7WL"F6O I+'])Z@RA/R]_N5*K;OD=3N &4.AHHVAG',RY"J M:Z?O_>7S@?C5\^,&8HLF59PSJ;(DZ<@PG'^N916Q_N8D71?*9OU;J33H169/ M/IV?G'-YB!.:YBD,V$#4K: _/@OC +.B]\P[QH]W%?C8T%O:L^K/N;_5WT6N M>EWGY>TGAP#.S;H^.?^"TQVZH:E!O K,4,XU26R^H=_"Q /V'3#?=>5?7_1" M7BVU\ON;[_P)7#/1+0WZTF_0MQKTKOR6A\%3?+7Q%77DWI/8B%R*<[V?G!XL?/S?_RER;.&C <\I:(A)=+(/-(8LBH4#HK=O!. Y MC%M"QZ+-&0"%I*/I%QW--+6!\UVPCGLQEX1$!["=41:>,!28=5T:D_R_]0_E M))"Q^G_WI.I7,'4"CL7&2)-Y%/X0',\MJ)+[55."E%,$Q*)WG>8S&!=8FM6?FVDZ=!.@QW:.F&A1,VI@;-V>$+R[WKO'_[ M!N8YG* MB^;9_I=#CS%KX[3G>IZ.(HB/% M$&9HB2]/.^9QO[B#25$'GO"6; M=H4($L0^18[FL*6X(O(,.P#_Y$?4 ] %+&>J.1YT-"4RVO?"_+J3$"6\1R/; MMU!@6L]]&;Z9V=_BL*+,?\29>W*SXHY3&;-OOA0;14DO1H"N M%ONTUU. N63G"4W]ESEE&)8:"CKU)"@6PNM*%*E)VR;AMU^^NME61_EMW?=G MZG7YKJ+=7O_,3B+@Z5Q_]O+")LQR/\4S-;1@%EIDU,6" E8=(PM>EA$*/W]5 MZU\OY=[VRS*+<3DV[>60W(\F",4%0Q+^+G(5UQ$2AA+EI6X$_1&9U/5U!<^$ ML:7[XY+RF2CB?B*C.&& 6@F'B\V3!%R*2.L4@8[9R]/;- M._8]U1<,LC0J48*B.$ ,XY:_EHQ1"X"5#G(>@$:GP(7'F5:[QL=!+Q[4XXH# M(QK\,UY)IR3X%289_.A01R(B4P[+4:0$Q0!BH$&0.F58X+>-OH87L-R%:K,O MF O44\_"/)ED?9>\[ SB/4U@Z#O.'F0'= =^[_R!(>#GR:/P$B;#:8>O[/ZU2 M9#D<_^Y/SG_AZF#_,-ZI]:+J&C4MKXA7.Q-I U@U0"L&LFF"'D&H+IJZIF(4 MH(PI!(A@3-6P<\2;"9X0=2F8 H47ZQ=-9-:&%^C?6?!DELEA*[A#/4NQD_W- M3(MZA]E1^,CQW"D\X 0!,EF['>*UVS4&0^UJ+S;!4S- QOME'6<7EB2G?,!L M<'3.7\>-FXONW>2RRSY% 416];]*R=^^2;6<:#GHE0"AM@X^61 AML,[$$ - ML-QU["9]OZ6 H1G?'XP!F =TH[O^!F0Z (:/:3PM0'/@2O$8>E1/UY[-OOOS MZ=LW380(=1+JXF,.\08=;!PX6\8Q'X-()#^S']W'UCX03*#SX-LW>&YPG@Z@ MUFU35FT[!ABY9IXXQ9)\MYT>)ZJ^7] 7[9GUFZZ$*#**DJ!R& MELV#SQ@CH?)2\9M> ?)[FC[V]^T]O<\_?KXJ"C^V+VI8PO>D#Q#ZNB8V\SR/6LJ3HD[UU8AJPB(P X?AE\?RXQ6I]K;+]V M$F)[@ \]Z[8&[*CJMCO^ M&KSZ4>@,T[E7[ M\0O&EZ[M!!17:; RVT+6.GM&P*6Y.XB1L;! D!P)>H&D'PEF'C M%>C7WLGA4T8-F =WIHQQ[\\R](VU2X4A:=@//,D&P2FJH(JRH.#I"I?(D?4_ M?#ZRA$]PH7#1@2P%+13P[X3W?M!C365!=30KIK=WZN=/_\^>NW:_YK-9+"FS7:XJ4'3_EKY_>7H"I;3GXS'7O[!JN#L]\! ME,/>*DYIEDE<#O94[K*)HSJR85A(GY8MB'@A"Y'@3+2S_H:=]1<,]PU\?()A M@N?"0;E(@A*\J>QLR2G-ES;;BP@D#6OORF_,B&K+-4?GBDRN/7G0:J(F=(H] MZ\\)9>(UB']/[$:H^:4(NR'*T])4,Z]T^R"(Y:39"CI.YA1Y=N-$,5\,/X]J=6O3BB\R9TTX9X_D.-H-L?2)7Y:7.72-TM:.+*R M&5VV>J 45,[>B5/0J-99.V-I!ED/DA5!Z.0);"8SG/8*" MNN2-Q;"5Y_\Y\>)FGR>R00NP'F:Z;/Q(X9W:9U19%SJR^)'"*RDVJ^O:1\HY MD_.,^B)+$E(QPYVN/4U]<-O"/P?1Q"_0I,N]OCD_$(Q.763J'OVP)%P="8^9 M#@)#!#*'1".\]4FV-*?ZY]$JK[[/M>X="1ZWK57),H@#UK4L[(,Z_@&1XQ+P MP03.GM&]%7HZ!XLXCKQ6OZS^3"M^0J8/2[E(DW7SI[UP6,OO6E3ME+JJUJ.%:6,=Q"?SAW]LBJE&,[)[9XC\2N=B*2SN%C, T UT8!B@<73>)C4 MTI.UU_4<]AEI=+3R,:2QCDY$)4=$W"EU(Z@P$6+)3*."2]D0+7M#-5Y *:N" M,C9D E1G JUH@*%-]YD[9%B*21YI#)%=]GMH2;.Y5-00U3NBYD^I[SCC)./C MB9\0D1I\H;A_8Z$K&C[""X*2#H20;O7,G6P\'EB27!Q&FU!YL8Z\LJ?D-#)= M4^Q*ZUM=$Y&$Q?,2A7%T9C7%$0 D&JTOU;O-0$2*'/R8ZD$.UZ@'DPQ1>E(4 M":&IZ*IPD"" M(DX\L=P;I+C>,;54E$D09=X19?Z4JH[Z-C$I6 :Y%(X.<<)LG+K_@X? MI'I0@>1?Q$D2:8/'T."*E1DN79F)=V4&\Y=+UV#VO2C9F=(?^V;=N7/RG"2U MX]Q7YJKW0UKL;'!L;.D 5*$A5?ASRAK.,0UHWAE88E9_&R9!2#3VS>Y MO:'1J4E(JO>Y:1\XM+"0MW\-SDZ%4FG4+ZOU9O62@D_-QG7MLHS/HK\H7X-" M5ZGFEVJUU7PAFNQEA[>7<(MQ;BD-S[!MEF7;D[&>DS@3?='N.S#K60/H>4P> M.9OI-96A0G&8>G=?+]]?XGL WA]NW<^>[C?)S*X)(%R>94O,M';MQ ]_+\+7 M[?I;1T0.$\&R',_N1$28B&<'5F)Y8=O\]X1;1%,!&_ZGW<1F+^Z9XY\Z.O7! MZO"I8DFTAZ[W:YM3XDD+V72+3O5.+911:S>V-Q.32#YPQ@ M:EYXJZ)S$50F4S8,9!KE#BZD%/'^5;Z[EX:]KY62UU8 + _[W=,U2 M)>S&-!T 12 B'^E4LSYY%F13#Z(#RN MUAX(E0EJY-J3"UD0^K6G;USU3SP&ZZ"K#(XP; %-D4R^&&F1$1Y=F*HA]A]_ M9OH\%AUQ_PU%64#&(,)4JF^IMGNS'^9@4$'V\FZ"P()LQE..3:ZUR],YKD!G M"_F@4NRHY)6*=2.QLAF6RV"1CG+"=\5+('K!=C&=??R-NF40*FVW>_MV# MQI(A-"0>7U+(96EVFSDK%=<6XMK92W%9#@=JD7FI0E!2&ONC%C@DTW9(V#%) MX-,FC=%7H:..D2S&!S2XB-U12S,%96O/D]1I,7;G4&)HMK!!?O'XD4;L!ES( MTCQ7H-E2;D<+CA(3'&YM)1$K.>P<4-.&P-+QK2*H)KAUO*U@B&M1('2<(33B M"$WF.I=[J/W2*]ED+=-=R2-\&C9199I2D7G\KFZ56&(*L5@&0ODMYME7PN"= M@4P> YGB%C%LB'"KIIJ"VI,A5K0=.@RB.G*NK/JL:=*SK"@+UEP:]:N7TG=3 MV7PH\,FQC M:_IDK<=. J><>S$M MK?-S&QW83S;&W0VAS :3BGBI./%6&..:#3![^$:WD+0L^UF(SEY6VI-OO]BK MZ_[?VN^'*/+J>RY0'-K#)?4.@CW@+15D7Z A 05Z(70D#G"8HW.%',VRT1=$ MIK);*[L=$5^.+N1S=+807;G656!&T1W1V-]?M>XFA8?OEU*UUC_&4JW%Q*/K MK<;TM&""W .FJ<>_T+!:KK&D#G%8DHL\F'PUV<4=&B8(N45V+7!^3+C:X>_Q"Z,!Q M[<=*!1:+(XIALU=N9;Q)O$07F5W=S>XK;FF>>TW<6-=4<1$M M$E=]^S1I_FR5R@VQE-@TYXKX4-'@6Q/I@\TCQ!?N ]8J0DP;?$LYFBUN4?V0 M"FMC8>U!W* =?84V./S8O/[F$,F43T[G0%0TCTZDG_*([H%FGW':=DN/APW>Z[HB-$-U& M@.-K]:MYQ'A+6C9B)' S0!M,('/*,'Y;:(-0+OEG)H*/U*+<@^W0[K)LF7U- M!_V5PBJ90=ZCA.F+R\K&;]9I""7SZW0#62YV&[F2;:-@H8C:1;%O>G1L4I%'7WJMNV$>/,A+8[#-ZQFC]KNF0@-0[#\W F M262M8)2?+T@ HR(A"TA"8;S39OYKP9O91F2?73<;U%$$\QM(C:"5\#/!D:$&^Q"YDX35T,MJ:1%O]8ZG^6)@+2(!:8N\"9CDEG@34O.CYTT4^@6\ M84JYE;QQ<:Q)N3<1DNL'"<^\E^>1&_-H"IH=(FCA"2DQIJ7W5P\^CVYBV4E( M]/.UH-U0'-UU?Q_1ZLC@KC?I5 9DB1L3E%M!EFIJ11C*IJ LH%[C;^?A8:Q\ M0_(VN_H.M MY.C(*'TX-F)H2[<$=OQD'2"V6PS\+= G^RQ=?S55(FS!WUX,_ M\W0QSVRWZSI$"5]+1X)AZ>/Y:+9>:TMR>V XMCV\[?X<*&_VX#9L4$W)SP+Z8RB&_Q1U(1%(Z%=9XPD2"A@ MZO&ZV#MD"K**I*J@J^#\C;(H6@-+P0FK2]251=E<@)B?!>N^5RFQ$^GQ>"#F M;% @,S*J5U1=OL8>UFM -![,@-']>Y)9/F699UFZ&/HNGX,XLU0'HO&1 3K MTX5"ELZR8<_5WZ^[K*PLY/1L:,?^<;KGIF<8=X5\H5'O'B5:)[MQC)U*/H_> M:%;;S+(JQ(+T>#K'%&DVGQ[C'8MX=H5Y^#J0 EUD]GZ&:UIM'Y@K77=PJV>; M)''5P[N[PI!KUFSY^O:J7'@:<*$/DD$\U! MX1],?.0E?/XT]/+)'O8Z+@T$O2<#M_&CS+P IN=2?QA"X[$U[X[I^#MI(H1/ MV=4&(+DQ/J)$U4QHTM1 [((ER3A+ 4HDX3M:R2<"IG L]O9-5U8%590)-H=O MR!;.T\CHC9P!,3081U/_R62H*QDITAEU*_3 P31A*D6J"#Z!IS(9U[(D^2G M2UTL E^[I^GO>>)8B &"&BB*$[P16\=_@Q&+[M_S/0#(4(2A 92XGSY2S[)D M]O&(F7_\_%2+[3X ;\##39>-'JC4> M H%E'9RG^)&J@TNU65W7,']Y[TL?W+?P+T&]\__XS@*+CL]U>I\^@.S\Q*@C MX3'30>"7@: AD;TC.N"5*[>IIGGTQZO9S]KE.4[5ZY70_7JM)-:ZHQFWUKMRJP0/[(?;=?;U\?UD#0M[OIT-7*_=@JP8 [P5K][PDW8UJVQ+3)TCTNXV_/-JC=,>6>\/2Y M\.-O;CK8R),0 105,!WLE"+6IFC2X\I=\[/Z^U'<.T6P4*BT9_;4ZX%Q:?1U _@W\TC>H*D!YB?K4T:D/0+9; MS&K[G]W"]XV'/N5P;&ZU*8_FQCUSL_'V.\_6821IU]V=7U+T$?N22!4N66-C M7_#84KD%9/R9N2J6)Z1:R)B[DNUI4*X6?\G:V$SNY>@NX1LD[7UD&2\R2#N) M>JTN> U_"M^SV7\B/;!'$8R!0,FJ9(&%^*\1+>18V']6K_UZ'HM];6!:P5LL M+UO]E:X-_.Y/F%X2CZ_PA/\OM8214SX\'X.T#=W$!TMHDB6:#1UH>Y)%5![) M1KLMDL;@5\+ FL._&[+[J#UA/ANR,?@MWQ1FQWO8*W6Z8]@GB^QB_3-7^UJ_ MV()G\TL:^$U[32N;8=C9ZI;#J;8?H[8^ I-<8<[Y;F:-5(&3I^>Y"/1\,;+= M7L^'JF54?WRIM*37IN?L5,_9^/0\1Y>R!9IG0Z[OO20]9R/QYVQ$_GS8$HP.G65IGF?H;#[D/3>K-7BWX./@M<2W?4%?%WML$-#-3(K;T:2& M0V;(;!\1D&&)R")R6#2PS^7.Y=17WA0 MX/'FD?WL=YZIG4_B:4NUVPJ@KU2[Z_M*ZW;P5<[ENZ] [X+!>:QZE\^R-,-' M?EW&.KVK1NCNM@#,*_7NNWE3_,75AM6>] KT+A@LQZIW+)TKE.AB(?JKW]=H M7B%"C[<%@EVI>:/R7^GF>LAG)_E7H'G!Z#5NS>-XNIC?PN?M*W,>I2P;9A_I M>]KH%H>5;0-GR9B=;EW;TF_42^6J>O5WTEEG6PG>"18[REUF70065Z*YL-'C MGO;\1;<(LQL"]M/4F[Z8K5Y.\N/GM;CW%6AJ("Z.0U/Q'66A=^_O6U-W32_O MAIG]-'7TS6SVV5^_ORE\JJG!2#H.3>6+=*D0>;H@(DV].BC&]M-4]O'SPU>Q MKY>O4I^Z GG'H:D%?"?GKF![5BJUZ]H#/M3B MF5H$!]'DZ2($I5EVB_.-4UG& 4!V.;.&9^@"6SQT-N^UG%GSDGL+@)S%N5L, M#+/1_:QI$CDSPXX_C*:F2.1T8X(L^6^/[,WW2^6FBA);K(_'06G=%$ NGZT? M).!X<2)/EQB&+H4M)TNGI.WD%1D@67R%32ZUL+@M M+!ILEZ=+V3S-9W>]A"2%=FEO86ZN^*QKAG&K:UU\3GB+'*F(X1Q.&(Z&7]L3 MH5*69HOI*=$I[W%!&- M(=(%4U9[U=$0'R,Z?S#&7X/O:S]^-/1?R05ETQ%0R!E"?%R]) 5F6LOOAR5T>A\1'N),KX>["W%B/X;*M-9@=L3XJ>D:;Y M.4?QPZA%O/-J@>5I-OK;IE.Y^#1?(FC^5R: M*M^?S454,@ B7*S*]I +SLAB' 8$N,:*+,:QV=XE\_QEU"G* ML87)\93L:SMD@UZXIKPG! MO0OIRF8"CAK$&3"P?T\RBUZ-*[ ;%(M&QY#WJ? W%?X.T#! ^"4^3[.%L&5= MJ? /:_G; \X \>=*/(@_+.Q,Q7]8V]\6Q08Y?GP(-\TQ!W#]KK!FW:0 .>UM MEY*ANJ9J\Y;DQ(1S56_-AC0HU[E&^7&;9=$8P3$Y0(:2">%ID=OQ]Q:@L=[Z MS!J^3PT99EF5B/1MK9TNXY-@KM"]*W[^.>*O?VR3K3_X,KX[1$>Q:4I%Z>X: M=^+WEW_,Z_4,S7'I)H[8!!59[CY',VQ:5A&G0456;H=+'-/-['&:5&1'WK#; M[##<+3))-]^\O-X"P)VW8M/>4#:?IL>(#B.['UR_/2E^N_DSU'Z6L]?;I.GW ML_^&9.P[",P-.0B.,H41WB7])!L;%6(>KG1X3?9E)J=]9=L9%MQ0V!7$@V3< MCE58<63'05BA-SVGPMK,LJ+/9C-%.L^&K4I*Q;69;46??<[Q-%,*6YVTO^SS M;$;/SZ5K\ 38$D9.7O$"J8B<>(+S-88SJ_\<5+^TO@V_/Q@)RR_6=IJ^7WPT MXBO:>%,Q7)XNA?95:=RXN:0BR\44F303$ZM!196*X8IT,>S]V:FLMC.I:'(Q M')W=QJC21>*TMTVS,MXJRCHR9U46Y2=!5H2.@EI:11L,-+5I:N)C7U/ 4HT+ MP9#%6>J&@+MOOUN?C>N;YZ$0Q0D3$1HX#(M28$01 3KNE,N!:Y(T"YBSA_O1 M0]-RV$*=#95G7_DDF/08_@!!5*IL25>V>/)AI63GPU)E.YAGBSZ?QQ?H+'>\ MU:FINL7IVV+(1^;H; +SD6F@D_86KAK6OH=*9E1##5$H/.8[K00]OA["U$K415T559[4W6=QM[M29FY^*+_Z8VNN(A/ M*=U/_2L920HFX@03OLH3:>Q=JU\%@(9;TJ-QTA7K'@T5:^#^JTM(^MP"A:V)#;U7"].M;:-HL,I5O+VE8;#GY>R8IE(LA'H M9WVD2_G?N4+W\6B.%7<&D%K9/JW,87H*/5/5VJ=JI> S5;"X?5<*/U/EBLU[ MO2H FB[EI+V%.R;"7OPMP7ER]_G7S=7_60M MZ[@#H 1[!. &\!#L%9[T0J\7T%N $C.>$'M!B^O6H(/T1M?6XX9E&J:@XH#8 ML_3#,U\JFOA\V9UL4VWYDI=^=GO_H,7F&^E!]*'T%"BX("''TJ423S/\?J]3 M2 4:40"[+%"&+F2+=);?[R$WJ4 C"QA];93)TSP?%LZG(HW!1KY "I##C=8@T!1HO M3J0IU'B!0DTBV/A@XBT*\/G3T,M%FRGK>#@0])X,LL"/,O/B$1$^" ^XVIGV MVX%NA]!3;'VY'<7:21,A2A!%;0 <'N,[VU3-A"9-#20D6)*,$X(@>PGO.">? MR$9X ;Y^^Z8KJX(JRH("E,$W VC2.(V,WL@9$$.#43:%]2E"G=I'B__)9*@K M&2G2&74+7N0CO/;70JH(3BA+93*NL4KR4X!;O%@\7\'N[P$ OR(,#:#$_?21>I8ELX\'SOSCYS"#EWU,;3AO/3A. MP&],W;W3-,__,S\:E*-*ZKZ_;[6^K4?0M_= MU\OWES4@XGW$OBD^WQ[._;@Y#IXIM%DVVYXHCS4AZDG\\,NK1]U.']Y M$FYE/.Q!L0U]83_\]X::$K_%.6S0\S3Y=E-O3Y--4!-6_EFR.*P" -!4# MF/)(-F:/>;:ZWB",D=N38>77<_%K/E\<*7LAFMF8Z#)H*0;.@G(KR%)-K0A# MV104=P#9"FMHU[VO/U!V+P.XVG@ +9A>#$L?S_&=>2X^56ZZXW)I/\IRL3'9 M=\@49!5);F&-2WE?%F]5)CO@"L6]4)YK3QZ*6>&+_-R]NBELV67H:AB?=.JJ M:&8>E[B)5Q?PL4,S(*Z>#C6_"/4"P:0?&;9!4T2S-B5F-[IG6NOSLC^Q,T.F M/G5TZL,YA0TZ(ZN)I]RU8)?N(^&W*%H#2Q%(LC[AM-IWK7L/8?C?_RER;&%C MO.GPO]TOP33UV:$QYQ MQ7]P%9DBJ"*BJ4LD$M1'\2Q-X=1X0":&_2= HN/^26>%J3LLJI4O/*R97D! MO>G+R; X=V54]#?'WW_M&^AWHW-"F;*)QW"!()[&2!CXZ[#'+B8]61AER3\K MM7H)8\TB1=EH=,G2!,ME8)#.6^TETG=;M.!HII2C^:+?_IL N8<0:(2J\M^ M1K=C^9*EQS>F7HO_6%3'FZF&=HEO5;FCM&UJ_9&+,E[WVR M%CL?=L;F&)KQW3BZ =_?OUB6^V=<=N8Z3Q<*63KK>PG9D?$]2K;O<*%;J5B@ MBXS?D>];^H]([WJ;BV9EO-AMGE&Y93P=>D/&*G^W-@T7ML&4FI2:8Z]^1KVM_^%)_&BINQ**E,#+TO(>7YL\V8L.J,ER?"CT M=RB+WYW)>V*O#R19CT4.Q=4 J!PC6R.*&H-BF*UX_3YVY?66VF8,)&;D4:8O M2^#@SRCPG9P\ZN@*PY5XW&B18]F/<\<%'%Y10H\@>_0CR.TV G^84?)D2\O2 M'Y@E20EK2PNP!^*6.X*!)#S=(=40\$-W"&9 P**)M*?9!'=(EW6I#LD:CV5 MM/)#4"S4EMO#(3-D(MRT% T,H1"O'M_2F+\R,\1S9%I52FQ=K$R:H];5P\S M>RRD>O,E.N=[K%5")!1.QWB&3:R.A1T!E]@1'(&5'%;_UQ_X,7?'QPZ35-@ MVD/J+'R>6Q">79*V[2+V%@O7JS1ODW963XAKBWM6D7%,XP_M6];BNI1EBRS+ MIRS;E&6%E&7AEN'F9H,-86!<:W%,B>9#+/J'%.'2FMSKEEY"Q1/IZEZ"ES]2 M:E)JCI\:_[+-O+."E)VN(.5Y9GW9Y@C]ZK$3S1M#%OEN?R46] MWL:$*\&G+YMVKX5L\%9'DOELZ6THD'Z.IM5MDY"'+&Z-;'CP<_V**C[(T4^3I M(I-/&!.CY.'69LK37+9 E]A=2RC2>"2E)J7F6*B)KJBPCVH\]_W/M^^-M*8P MNIK"&&*?[[]^_WADI8+45(ZWIG#^(-.X:@J9W"NM*8R8OFV1P-<:: MP@"VQEQ3N!6ODU)3R'-'7Q7");>PUA9/[;K7TU2@\2 TN M+2Q,D&JM77!.UNQZZ)*I>*>0A7Q)$=!XT>\P\(1(**R.);=X->0(>.;H1[#C M-.X_A5P%EN=-='UP4VK\NKK@].MZ(NXT9]_0ZU2N?;541/',?-W>FI[Y7-*U9 M%&-7%_Y5XUO\8KC+UHU<^:FTLM/%KRKI-K#J;\.A1UL8&./J5HZC>8X/51CH MJS#;(\JX]"T<.ME5=*'+<>)9.K/%EHHL?I'%50Y9@O_RQ?7+RJ]+A)%5$L[) M\)"5F*'EMS:2>Y6BBZT(E&=9NIA-Y1>+]]RA_C3'%&DV']/4MGSM93*OTEIH M<*/[_ Y^D95?I.5_U86_+:RYXVI]4VG+1]_R+E>LA+X19M?,=WK#4GK#4GK# M4E)N6(ICZ.DU2LFD.+U&*;U&R8_D2*]1*I,$-#L]T9D-=XU2M=C]9GW-&<4\ M>\!KE)A%)L1ZC5(VS![^14Y&DLKO7N1_2:+Y6$92HJY18N*]1HFAN1Q+YYGU M99G'<<%,),F'J'B^G&W'[$YOK%K!ZGBRY%F:+Q;I8FG'ZWP2P_IH4J2+O$^O M4=H[RV/*2K,TD^-IIK"C5T\"WZ-D^RZG&?!YFLE'> ->>HU22DU*S=%3$WC. M\\8G'MRAP9?*PZ5^@9XQ&O2,]\H"=GD;* MQGI:7#:?I_/%]9>7'LKB8]J;'SU[ES=3YI.[D3*N(P^"V1KOD0?;\3HQ1Q[D MDKLG.NP(BD<_@AWW#/O#C,)B$MDVK$M+!YNR-X*3W=_DM\80*ZY1'2%=E TD MM>5;?KN)=6)\D\K"2'Q"A6($AQ^3SV89.AMB@V'29\7\CI<+)F $:^^$>55JOY-"YW?UTOX@*;O7 MV/)^G.?;X)[;"L=]< MS!>RB1W!$5C)8?5_X\.M?MX/\]UQMGCU6XKQ,,/T1*ND'9P3V?A#>Y7T/L"- M6;8V]YFR;)%E:Y.MKX9E.Y^.% P 8RM=RG,\G>/6+[DD^&"K!,LOL0+:J2!J MU?5SR2T>2:E)J3E^:OPWO126%OVO MGF2C7E@,N6UEGA?17+_R>]2]$>HE4<@>_NK)>%?R<@Q=@/^*^[]Z,LJD^_IB MY=@6Z0@#V=?%O'C6WW(TR^=HII!<9D:S76&1FR_C)LH#,S&N\X#I?"%/YYEM MLH?QUZI%R,BMK9:C^5PI@BMXTT@EI2:EY@BI\5\8V?Q.Q?;DX?;/PT./^S;0 MMMFL$6K[UO'LT+C8;8=&#%'1W6/MRW#\G!-_=(YWAT9VFK>+\=A>OK0M^CID M4!#%5H*(V;M<$AEBMWG"HH,8V1KO#HWM>)V8'1JEHR\7*26W7"3L"':L1?7' M%I7==FBTAT-FR$1;2+B_[18A!K]JNT5LZ$![S/V]ZXCF!<<=UX:)O2 "CLX= M'1Z(O*PY;G!PU"GL&!D<2[JV1.<+Z\^!3O@$!7[PR*?8+)/,XWNE97S/:_*^D5V@FRTN1N%T]DY?<^9[)Z56(?1>Q9-KW\ M>V.6K4U"IBQ;9-G17_X=&)8NA3B;*MTHL8WT$BJ>]!KP ME)J4FF.A)KJ]$=7V)#'N MJ_8G-Y&EQ^3? A[OXF&.I=EL>@OX5BL,H0J@8[H%G(@M%5G\(HMK/TJ^F*.Y M$,M"KTN$D6W@2&\!?QFBBRD2Y^D\4Z1S(?:#O1KY12F^[8\5I$N% EW,;AZ$ MOZ!;P%??61QK)TV$*$'$B^Z".L9X6-5,:-+40%""!3,A69+'&Q[LQ7F5)'CP M';5OWW1E%:"S+"A F8/,C=/C8@I806?:9N<\VG:C;M%MZC^9#'4E(T4ZHVZ% M'AAW$_VU$ 0Q9U2.RF1<+R/)3V'3=79/T]_SV&UM=A5]N!OF/U)X]!E#GB"; M!;B;P"R9J0W][-OC$YRF>?Z?(#CD/I']QU^?O,QTV?B1:HV'0&!9%SJR^)&J M@V.T65W7,']SWI<^N&_A7X)ZY_UOSEKT5*Z7^O0!9. M:E*-*ZI2;GZAKJX;#\W]$/ONOEZ^OZP!(>_WTV$,7CY8$MY>POE1-TO&,_DV MRW+MR6?A?@ S\L_)@P!>UAI SV/R"#@J=[JE,M2&PJ4\?#_9?/CAW/Q)N/6/ M39[(16E]L+E M$82*WY?#VM?KUN]BE]V6C-"K26N*5OR[\FI YAGA:0FWIT@!]2VK.9(/?:.W M3W^^Z%0>43?P:-^@JH!!)>I31Z<^G$_3W*$6ZI;ZVO*L@&!UC9:+X>]%#\E% M;!51<.H8!KIVT6-3E? _IKZ.S(I@]&]U[4D&O;P8WT-X5%,;0Z0+>#-F&6+8 M)]F4D5'N&"8.:=OR17LR&!7EI_J]7KG=YAC?KQV12745[-JBNK@THS261 M$J8TGB5Q82Y9U*R_WFFN@*'\),@*GO=;FF<)P$FG7 B&++9EF"H&0F6B"D_M MR9<_)>VB)N4-AHVPTM[O9 )GFLX7?>^_#:I?C/-:838@.MJD8&0]OWU+2CC[ M[$U3LS]'4E22XPMTEEM_HV)R[G4^H #F#C^-A/TB@^K."M8&;_-\25\OF""]^9%RKH(#8TM%/!QJK$8&N "]]YK=20)F:GW-$>2GN?UQRZX"]P=\F8S'SX%;L5%?-T,7^LAV.$ M95ADML.Q+)UE=KT(WM]RO/7($&S@DB=TB>Q_(;S 0YW%&(:!3 /.QSZVU);@\,Q^_R7VO/XG LW#]R>_2[.!25NV.(2AT2 M<3SJT!@W]]?D/L*P,6Y77,K217:;".+0IW)OS;SHW'*)IYG2-H!F95Z(6^^1 M9R,T7#-C9G8V^,4/N.:5U?V^3=P>00 Q-3E";)+M;9&;<5M;EL/!YC:'5!WX MZ/8M6;?&UB9(UR1 4>&2LM,-S'N'0;1Y( ^ $*$"38L6I[O M'J6O3:W+_%4&V;W'&0[%;H1APR"-F*-HP1A4T\%'B3/),+R.VTQS+ Y7$VFF M^^-G9/,DG\_3.6:;:&_E/,F& J2WPAB[)YSK$$7=0M[893XMT/WSX]>HF/^: MRW;PM2A3;F=>[-I]P8RB5.T,!S?V_HI6V+P+2!)M."]\34R RXP+)TK MQG,KO'?[H#'\X9[_TWEQW41?1?WOTXU)=#)Z+D&.DZ<>0:PPN0)=XG;@I+\E5E=:8@5&ACMZD,U^A=P"@O0 >\Q] M>U99L?*M]7>;2U,BFD@#:@E=TBE1T"6J:Y$-]"&J_1)[(,ZFJKM2CK'G_?$& M9IXN\?FH3LL)MWWY=0LPNC4\\."Y+)UG-]__&D)\Z[-AX>MEL4-JM0>F[9&P M9_IQ-6E/)-/Z.RC+;.%G?!EH;A-W5 ];!/5R-3R\4&/W3GF:+Y7H;'[SXQ5> MJ7?:4791.B:(3^A";O.S339T3%'"F00O 2:+&O^9X6K]S%!3G;O? G926.,G MZ4OE.S/2"K$>3;^X?4)VZ4K+7*.M_;D5QNZ9U^)?2]81: 0X(W-\JPBJ658E M? C%$#^"BQ6FZ?J?S/?VY*O0:I5_7O.%P3:[)R++_]U:NM@7[!N*NO((($$B M$O7A.1OW- T,9HO;W.U[Z#S"CBR,<+;DZ6QAA]SH)G9XB9Z0H@V;6M=\%G2T M;';-AX?ZWSNE]$/?)NV^6_;..97+*8#$%B?C/8"JH"ACX""A'%\5ZA"?&/U9 M8&K\1:]X.Q*SU8'\R3&Z,$R+L-R5R19I/K_#+>WK2\J7'$I--06U)^-5 G=- MFIT5AQ!SD[Z6JU=?K6;Y(GG).>_4)T^'LC#_O;PH:JT8M[/O>(HK7DWDN^ED M'DIHT:VIE^@"&UFTN]+C7&X59V'78V?@L-N99N":Y:^_K?Q%'W7CJ[W?+@-G MX:UFLNH;F[U@/0XOT?VM%-*Y0H[FF/4(-;WQ8%?YQ; Z27-YD& NLB6>*"Y$ M2+-P<65?V/6SPY5]PF-@%J[_4[QJ/7S/_9EL TFWS\)U7;K2+-SN>N ]E1\4 M0$1(,K"/";CQ'/1&8@@LN.3S[_? _,H)R8M*G-'82H/6W:I^C'/, M&JB[3IR1QB=I6+)W4467]> 8FLWNL3H@1&SB,_O8L0GV/Z;M?Z;A24W^_:/4 M&N<>E5["PA-O@8#?Q/5R=3J\7%,_]$)D=FP.*8U'$H-#O=N4L0KB__"ZVI.@ M(+(W% (/6321A'\HJ]+\%YXG[7N/%^OOJB-1L;"JP >RZ?Q.,%&UVT7V]G<[ MXT6FDKHE-4QS8AG74>[^6F8)F2$(*3A[1>8*O&-$GXZ+?!>W %>[@_T*(O;E ML"Q=Y+(T%R+%<2A[2KPXHO/P>3J;96B>WZ8B8+T[X:-R)]@[--N3QI^'._,[ M(_RHQ[3\%K8./L!/T%0']6057YJ#(]PA$?;+Q2D[B33@*AN6R_#LMNJ<+]+Y M DLSA9]6O_^X:=Z;W L>6^=YXHU MQ(>B*C)P;EM+'AZ0/@<@; 3PU'?71:]8]D1=Q9Y.EO*T3RW^=+:R[[^ M M+WGP :MPKU9=N1VI]:54^5XRO MOW/*]#[T"DFD[Y*8B&/FS-,YKD!G"X=.V,R87 A@\M+E3\VFU6"S@]^U/U+< M3-YQ6LO3>39'L\4HC]).6"G G7]2]7!!]4RARH$33:#]UAXN*GFA.%1*^:EJ M+8PP]-U*&VOA/(UQ&'TA3Y?R!;J8>W&IE)G4*VNEON10>ESU6]D0?CW>]!,I M]5V]4(XNY')T+L3ITH?.ONQ6'N#$9"W-%)2URSZ'"^S">*AE*!SHLW[U^#M1 M;3Q^E\2I]JYFP6IEWC&V7#>.- VPK;;P6VC+DJ^[NLB71M^^R-9]_FBUY24G M&[8*4Y,;]B6+FO7[!YO6<*B0*X %!:OBE:(]UU1;S_#](-Y\1%'J?,XR/UG] M1[SE#%Z:;"O%%=N4/",KS3]L*?JK*H65^F;]\MV!)&R+@59*F.B+#;$[:/ M)@6N9I;$?9];O7H]BAQH#6Z ,C')AP8@/)CZ$'#Z_??-IZ#;9A4'9-DJUY $RJ#IZ MINZT@:#2]A?2=-A/#)_=I@**AC MC%]5S43D\F-+%2Q))DD'397PA0SD$TFKXAM1W[YQ0"\$088)WY"S)DXCHS=R M!H =)+*IA6'^)Y.AKF2D2&?4K= #@VZBOQ92171&Y:E,QO4LDOP4-@5N]S?] M/8]=U2=B(Z &BN(8&S%6_+8&94A*$!E+B?/E+NY>(,\\]'"O,@ M8\@3Y"[^KDBYF-K0SZ(]7L!IFN?_"?+#[A/9?_RUV\M,EXT?J=9X" 26=:$C MBQ^I.CA#F]5U#?,W[WWI@_L6_B6H]X!;Y1=]D^N7/GT V?F)44?"8Z:#P+$" M04,B>T=TP"M7;E-]\VB15X?F6O>.!(_0UI^D&<"GSI3^3@3MVMPB8&Q!\Y< MVE1/.N>WY5_-VN*'+3V!I*@&S0IMABIBG^)OS>J-5;5*M M!E5IU"^K]6;U$G]J-JYKE^46_'%5JY?KE5KYFFJVX(N;:KW5/"3KWMW7R_>7 M-2#M_1X8=XBYUX8K=6L #8BAX2LR1&&(DR"ZA4X60->%8,A&HWL+P OG$9V[ MCIM A-P%+ZF:SI4JX(AOP8N+,C):T.>%HHF/Q NX,5"1\2ZP[M)L>Z*.[HR; M'X-2^?ID9Z-F3VT>!OVOK?S>-!&@1DVWTZ< /F"^4605G7BLA R7*[4GU=O> M3?^[QOQJ\"?G%^5FK4DUKJC;NVH33*'OH$?L6W7 MKFJ5AH&6 MTL-LP!O7<1M-)%HZR>&2=]S]8F_?5+3!0#8,_+9+;+-:<6D]I.4U4X7 ?<@**/L28 M$%4X0Y8H:,B5S#<[8PK/CI&@X_)]^/T2B6C00;IM-CQ+4SCX/*5JMA)I0UEU MSD,%2P%H@SNEW[[!O^TV^*ZEJ[+1AY\QR>2TM9F4! E;&GF0=L7VW)=%L *= MG+V\1/810 MT@7BWK[Q?X-Z5+5G%2#O^5 !T.KHQ MI*>&Y$>JCIZ0 M:MGC?/MF>I.F9!'%F[U%G#-1H%/POR*$8@+H%::1,!+8-R0"H)RY@=LWHZ,+"G#L M>58#%1/-1K>"SR-A2[>@4&@@BVO0?S;?AGD&7[&4R81MH3WY;'8;S7SI>\&4 M=D7Z ;S:%M[G^?:D-^AW>>8J.]2$DW-[4%A+*HT?M>>C+ M"G) KHZ=+LRGNC6TO>=P")20CHF'GN]] "[6!NB2A? S9%IX$F3%N5,,]_0$ MDPEHE#,5VO=(=X%H33=H&QLH]@2!9\=9X&# #*H[39#)S.$KC& X77A@82'E"-M"?F81FF21]2(D".21XJ C&0'#2 M&90;4= S^>#)TE(L?(6O^ CPV2 LMR&S!@KT[&((K!J$6 R_@4C)$AU= EP, MS6,7;H=HD@QN!V9J(D4)-!A8[="!'S!F55/Z^.T;F2Q-0\@D260"Q:$B#1UW M\*-]F(4)4< \IPG2(!::/29CKC*2L&Q(P!#ATPT +M =RGX%DV0'+1J,"?3R M238$^ZS$MV\Z"+^ HRJ 3H([V=B]8=!$>J=MK830@*B5;0U8'1VBB#@T8TX7 MG/"Y[PH;2W0ZH0&'O$J!GR3"@0 #U!$:<@S.P26+^,,?:%"-;A=PJ*,IF)P^ MJ-HS2 8L )F.^[%\0<.(NP8$P^VJVE 8T_ @9&*'"6Q#0B"8Q"X VT-I#_) M(I8*L59,.$S2D@YRAQZ]"H!7TVU-(B85(,&.@%75&CJ#E)WS6JAGFU&ZC!/O M$E85.Y"TR'0/8U8T03(PG@4G */OH<6V761J8.N2J+\6=HWD58)(,(LMPP'@ M.BC$P@.NKWI&KA< LX+F+4,!S<6':0Y C=4!O(L& M%H*=$Y9H9NJZ-,^-OZ"/=I^$7_ZBL$DXI3Y/?=K4ZX%C%$A9A.VL1B;VCO=V@KNIR\*-N'[2,9!I/\!)%U=# M SI2A-&T >"QB43B=P:@+L2O>7( ;]\X7"31 P040.@L.'##'=!UU;ZY7(0H M71#'E'>"M3'^G+%O9(DTJ0I]^\8^R!=;V#1>P/I(!O9"PH)[C.2<*!!@ISUY M3:.F&8XIR^!B[I BHZ[C8*KNQ.=DV\94&=C\#K_H8I[R7;6)OYV"GL4Y"A1_ M.C\1>[@(7\A+5 <-AHHV1MA'$-W'Y@3S(Q@KD/''":<=,X)?9!)Q.O.VTT&? M=$"F!-O[>U*I&+6/<1-X:S.@H8EM^SWP,+I*P ;$N."&[$1L'_L?.X#6M8XP M%T"[OT=CM(FQ%!$Q-F[*%XV29R&_.H#KX*<(!R4ZOSB(WA?@Q)_MP2EW. ML@^N8YT%AM0T+O22U@5W*\VQV*8#CUW'K_YW/DXHS:UZ5!U)W-F4>"Z=KUBZ M3FY2JSE[="ZO[]=O]=_WQNO/ M^131D#AH.@!G]@U44\!>Q%2Q5)PLZS1D5Z6E^'K!-K#J+@GE8A:,WA$IWA$= MP^HX+X*V9\5*P6K7["-D7FNBO60UDHUVVVVI@=WPK*$;0E5[4FZ:HOGK82 V MIS(D3SIZC1\-$A^)MQ<)7"4JAY:V+RG;W[_$E?)TUO>>."))VP26F'RUGLDL MR_%L%$R^FC2'(RE7[*#"[LQTSAV+A9G% K#2][1#PDK:37&"PR/I)P??SG3% M<&?X@+6"CLU"B$V AUX;L]W5WM-\,$Y$#C1$WGP0QU^V)S_%1]DTQJ)0$6+* M[GC+33R$K"2LU)Y,S%HA__?1* \+"2(LUY[(/<-BF<;OK\\HKGS86I)6U'T5 M%NJ^9K1S[4E/+9IZH5"V]$?'O2^5F8%*\^/UU5N@>P[@]SZ?CS.$IV+ /G%XU+>$B7ATYM M3>@ZG>QSO\#;F$N_KJNL<#')GYR7.YIE@@&- M<;Q&4S753=6?OJA<_1R_B*/K"@-9&9^M;OSDW.7,VS? FM/YF->&U[03\KI? MNV\L?/V,W"\@C BLO2%%LJY6@[7V[J M@@0D6]-PWA@/.II"872'W\)1:UTP).$O12[MH&X$_1& T/5UY=25]"F., 7W M&@C=3M8@LB5.%'0<5&H]71C@] B,4D=]'* _X90[1$PJ69;'Z_MV2O_M&PVO M\((MD)7W'KX$%T"8^HA#RUDF4K6+/'KV\(;VC8>X)[S6B!^%49&D@:-YWA(T M:FL! IUOWW0<&T9D0*J!78U-D2=&Q^5(LFDY"=HO2)"J:FC)T$2: =X MVI$5SH+BU1D;)L/4*>'LK:H]V>NE[AAA*K><]6U2%Z3(=O& J&N&06I39%6R M<'XP+ +!%9)&YE\8Y8L7L@X 0?-8,^[9AG/8CX;H+8#?P]LTFU51N\91=R"'Z55781HS+SJR.(4NR M@#7VE"J#!GN6 >TZ*-=&G&C,77#4!=40G&6@6=$B4G".6CA K53\J@NBTW3[ MG'L(H162W]2EY.'5L+R?BS(G;L&CG']VJ01_;='.\TRJE MI?GQQ1G-O8$:W:I;)[9@$MYC4.K M*S/!G=OU>._D]QN79[Z3G9>"ZC0#WJ2<91)2E.FN9V["!]P>=+Z"9*=,DSP9 MKDBS3(H><15Q<-6CYJUZ?'E3G/\!5!O M##OMR=,5?QK\%:OGHLK6[JU;6?; MD\G-?5\I&E]DY8_G]&/RP3.H%48^K17 >HS#,CLVZ,N]OC(&,X!&).="<5N; MAY8N]DEEAKV[ R_!0_BE"K@4R;3<6BE/U2=,4 AIW9$%MQQ[.HJ5NWYQ6O?%=+7XH/7'1)H^]@5^&J79L%(I7N&_VM^YA^YI'EL,&7I MEU*N-4;7TJTP=QJS?0ZZKY\N+VB7'=7Z+, OGGI/?+I!$GM=BBQ#4GT$. $O M=9+(!>^_PV[6CE#L'!PNWYCFXIP-,3I!?N0T-8N\-.N)1!<6KNOPNE\GKC>< M>_T(&%RDS@W2[8ED>ISEDG&1XI7I ?X.))K=\45 $ZGYQZ3@-*"+K)P:NP"L MYD%H\_/(R[-2C93BVOIY)QN/%5+@@3^MB/M7O-6>Z*/L8-RJ/MRVLDFSL5Q[ M\MC]498>-:O[NP"HR#L..Y-E5RSAD018W)6+XW%U*=XP:NL),89I*2.8P;22 MRZ/Z=K"]T*53)*5#EZY5NKMA24.N!OH: ,G +UC/-*M.X0)4G$0P2))L92M+ M)@@6@FLL-J<2(-;RYU M2<+%/[C&TE.F2^.-CY2D85> *T1-&0_=1'A] 7"FAO/D_IO-7)I.P_M!H,K$P+AEY(P:YW$@>N:L26A7F/1K(LCE62CSOX[8OQ!3BU/O#ST2Z3FS[J+-$;2Z5R*UO# M]24+#54<]BP][;9GZ&8FI=B#KW ?6L<2M&UP<=TCW4:M?31U(AO-X MD%MP "?G.;]3 XGK^(CANP*-<2;3,!W>A:3II[9B;4@2%OEB5?X5[2LX?D--=QSM\%"_?%Q:KB/ M@ZTQDB&9/^H/?Y1#:;?W*$Z[GOI8'*S?]0XK'&SAE:M?@(-%5XIB"E?W1;;_ MZG@[HSF^5?"A<:J$T[!D6W/X];>P3;0G M$O/8890\/VB(24LVX;L&QL_:^.>X5VIU3\ZOY!',E&6RD!R86\*/N&O-NK.> MA3>TF613F;-8)HK6P+*+020\"8OVU:6GH%VSO^P-?;,TTG0_G+-9!5^ @6O+ M,YAZ:H#,O@:_/3DUG.[BL(3SMUU+@;BVBZ9+_81"VCF^2O:>V+;*$P=*U:TX MD.Y)7]<0-!O^%V3QM8Y6:-9;#TKV9%O=#:FM?D2=G/,X]\0RY#@98\F8G%)E MRCZ*PS[&@I2Q.M6=)!^'5.(,9)( UWMV18^SM$_95;>X D&@#3CG+MCEEA.L,*I'$9!'BN0T!+N_<-\+28 'M'E20; ML[W;^#PT=TQDM[6MLC3#/B2=]4QU<.U57CY&9>\ MRA@0=^W=M+,=7O8Y$]0[1S;O7V :QZX9<59[T).@6*3 YKF/" ?(J1A.I:0H MZ\!Q>Z>O4TZFB;:FSDY>>A9T'5=T.TJ4*!V=;T>#\3A]CROKLX$2OS/ MW!NSXP9=XNVMP-.CP/ 6?)DHY/PBE&60.J+9[OZ%'4>8S)8RESU($FV><,."M3,MDUB)MP*M63LO,OVYX\_VEDFP\]6;GXDZ - M=H7VQ+HIY= 30M<>(MMI.A^/WD9&I.- MU%27)(+9A'>!?,;WO<:GG]?7Q?*ZN3^PN0_[1^6[G]6/O\]L BT2JYG@ W'3 M9O&L;)":O+A5?4U(AT/"VMW>NIYM7)DX"2;!X"=@DG:@/L(=:-IRK%'6AVP"1HDUG-\;F;BB M@:WRSS;$7'UT/@NPD:!4^NP;FP.>,36X8I<*DRA2 M+=FI7.'#J/E&["0/''+I;#8M8\+5S^@Q_+T>!P>QS",9&!Q\4D8&?Y6*I;N< M_SD7F#/XU<-=3M+'3S0KG6KMTM$NC'>TEU1=^%];\;J]C(\1K!:U-=0.N"L@ MMLETF\$#E>T#*<\M%F#02?QT TWU MR<=,;10C:C#TR*R:CZ=E>%SR^GZ'L( FIPHJ!U]ZXC[6T-8]NX99$O#V@R[* M;KFR3[5.C+H@)_I!^;KX$HBUENDU:$K43E#,CX?C9^2JT.L26\,L,/:-,6TMVFH]OI?5PTG$VB<(]?2//DJHCQ#D0#Z,YX9,>/.F7_SRS;EK6&9U;^U*[+*8ZMXX= Y^[?\\JKQY+]>" MU^<:K68$"R+25AW;I]/CVUO87==OL784>#'@XS9L;-)Q;PF<"=$G5C2)%7%V M7]@_'8J*(>OY"G]H=^ [6O09\DQ)IL>4X?;6@X6ZT&KLR-;(4=MD>+R-"AY? M][%E.-X#T($85M4X#5F+>H"+0(-NRDEH<@Y@'XR:!"^9YT/]9*),]@D3Y%GI ML<\%'L7G>V(D-@#0'(F&W]X:'C^V5[$[)EZ.N'QMBH!_$B6D,9H>==.I2WPI M5%^=P-Z1/+ YJDN*C$LN:[[D0,[D)BIQM.Z)[][T_WP).U[S9Z9W6EPWL6'< M]#O!Z>U!9?^ZV"ICG5=4X'TH;H%C2TN7(=C^"4QAO&OE.R@JA**>XNZ#JAFG M:TT1*1-\*DNU9&65S!]*QM> *S%?1O0Y=QWPW,B7 E;<\0.K"U\RG9YO^W]O M;V&]O=W LA?9[T*6SJ=]YQ^NM9=35\^++]+-N%MS1-=O?AR>%^VZXV!7L^_2Q .?5F_ M::.[20F3Z1_8$,J. M:;?]>$VMF@L'7MR#RT;] M=$D(K.)V.(5D?V"3E5E-30/405$M::+'&?E!H1+$]XLCM0(P@Q+PI.C#V(;6 M=6T!/(9=!N@(CY8!*#O!^6S:CL,AA=B2!YA&&^@C-DE":$&ORPD>VUN(@8/R&(B0RV@-LT<] M&_S0Y#8KHHL+"6Y*#O)C"(71%-H(A[-#SKH2\RG9%3@:&&)@$LGLLGA'>@1; M&$G3J.N)P'%3-RWR1D713DP0" $:*.B)FB2Z.]4(-/+>M>NB CE]J[>W@%A2 M<#VP-Z(NJYH[5M&/W/8-X$K'5(=9E4D:QRM0; MH,, O\CE)P%C.2,I1OKX)VQ?9K])G 0\(2B7R%_$EGFC[)3T0SUXN.##.-TZ MED1C?+=A2Z27V#WM (G4" M;?LU=VLAN5N5%>9N96_Z]Z>G7P(CL,Y+M?7-W2K<] _]/XYA?['WVZO 9%B" M4QL&MD/*2^3[ND%4**&" 7N"'I!%14@3 M>F?&>T.->>NF_[-_UF5Z(!QGD8B MV([1CS\VX_RJ4:@XQ]^EFP*RW01&7N0=1L@'&?Y(^G_T MC.O$LT^)I'P9(.M@^+MTS6FSYJ0 '#?5$3X<$R>*[. 5'(]M^P/1E&3ED?M4S,J_ M0E&*EC6=@ 9U_ K2S"^;<\/X_@>Q/%S/XQLIC.U'(6%.P^9*;]((,B-#AX-/ MI;/$''2:VBCR[4!!!/.,Z,8,'"NGEPCUL+DB&S^+OH@#\@'?35H1)2A5'0X$9ZN/&'IUW167F\?[ MV+QU5IW":D9YBJX%[")7ZS8U(SO4/5E$)P=+O!/ @SI'PA(LIHD^RKXEF3CF MA SGPF]O#41:HS)BJ1T?N^@-!HJ)^KUG6K MN79)#V!<.3!(_+6Q$: M(^T[B8D0S+)*?Q6>?VSHZ'L4X-NYJK=+O:=XOM-(%0 MG<2B'KMKDA0DK&X]2J'$F=%EP-CJ')R2>#)A;**%!\86.O'=Z%9C* ,EMB\C MZ*PEZ$OW*I3;DSK&H MIN7E>0*&2VU:_'/W+N:.*?@MMH+]NYVF9UE\^0*D@<,#^[YYV60PVQ@ H@?F M?"C,2B$EQTO;>!/^68<"K[']+?AP\-W*W2^J0/W18O?@IE_[?GW;ZN1=GUJ* MURDHQ@'@M?O/,=]$1^37DO0?H1S !:&,[FS&*+(#H5HTQ\>ZPBM1DN%[+D:. MW@K0PZ/JU9Y$/5Q3PH@K^NK55SY99ZX(.>&2=XR+EM\][=VFLRL2SZ)R1&K7GSJ?U(7JU-)'+M% DD2E%V7G8[; MT.;[8)#VF",998R('B)"K]5+3_U/O!,YUB?;(NE)U3R1 MYGX;Z1#'-3NBXS]7_TD4%TXBA=_O!.Z.0FUI6+4@EENN2^U&^0FHI->4+C&0 M=FS)3!V;B0MBI=CB'B&.YTZ6$AI_T&UT558-QM@30#[@M;,_R*1QF\V=)(B]."1@B1!8%E^Z#&691.3F MGT%/V0Q%ZNMK2ICD">%@?R"D"R75@*7G4).K6.]^IE($\'4;FFBT4Z+J55CS MZ0(YP/0OQ&W%1EIH]8'P+K.Z @T4D_%K2AE0.C3E':-"^F8_'H0^CC4(PQ.C M-(R>+JK3]%)?.I_XA(#ILL9PA@Y'@H-R@!-+"+FU^$I M9"%@D$!2:R>;T;5:R-B_EMF(];=*'BY[717S8.(5,T(YG]6YFQTE;R$"-&PR M5=^E' #!:FCZ9R>8-MDD"_V]IE2Y]MRPAKEI!ZA'"=DGK =4F,1ZY)M-/5.U M X4_Z*>>AAC<)Y8NL<86H(G,&0%_:DT)07:$EUQ_K2?$J$QXMCHM9*!&#(V1 MJR6 MVUW$$8R:>!NNRE.- @,GQ,,!Y-S;;87TJH0,@CS&AZ6P#)6:J>P(T35/E0"N MF@JI_\'^/G7R3LP&AG!HLMAJ)6;28_0E$A-7ZH;A'S3V+;#T=,P\;K@*>P;O M60-UGV@B0"'0#]Z57^NL,44&TU F HUN2-H)J([S>N"R]231?&+:@V=!-I30 M(<9.IDPZ9 ^#>GA9 K2KB;"?,U2GZ3^? M,LQ-_Y=CVQ\/#P]K>>OI],SNQI.RAO_WL3<\V=Q-_V?SX_EMX_I3];CUYOW1 M\;^'!Z"UKPZOKW3M[/ Z>6FR.)6VJ.9F\7[:$AU3]MJ6C0G^CBO69?%>G..F M$]YJU\H'TW!EC!?SO=]5Z_O^];>O;[!-*.;DTU!_QP(&&LB/PH75W!LIYU#X)GEX[^BF;U4?+HZ"ZN]^-JK'POQ\Q^S] M#88>H:[SB;-8%<2FO/HE3QZ?^[TTT?)I^2FJU,3_.:+CS15BQ:O#&/Q4_--G"28?:W'OBVC1W1%-"[K;T%,UL7_WT7 M8ZT!8ZI8AB.N9-((B\OXSPC2#CZ69F'^I095O1;+A6D$Y >L7(HA\-Y,?B45 M;TO]57133(+7RK%TC4;C/CWR#5VC2;P97.@("W0\F-;XA8Z#!%8860-+>3HZ M;E;/5,IZ(9L&P#:"%=+V>*R[,'?N*<_&/8.8;R^&>P8AV!;!/<627L[EY\<] M3Q)[HA=JI$9E2]/Q.CY%KZ>R=<2!Q67*+[F(@Z@U[M-Y<172:^1"YH#RG206]#SX=5"@C5[)TQFV5"CIQ>)DNVQ9$JVR3(GV?%ED M4*2M/XO,U>(:_"2O>?H_R2S=7%0JA&ZWGPY$"__^$%/)T5BQ6]7$[# MIU^-L)KJ6N")PNKY\H.44>O.#\NVMD8$%=-A>J>(\8T/>TR*02Z.W9]FOBER MQ)."G\[XLY!C6?;=F*7.(7B2K>BETF3MG1H\GC8$MTJN7*K%N,%<.6A2/E>N MG&]H;S&&PU0WMX.2=,W5O;H'?W(,1<^7*KI161^G]/ Q(F;-MTL<][EL5][0 M,YG)T?EG8H;Y_M^8P!JV0RX#:&!7^;HM.DNLC^*+CW)]HM3?_,BQV(%'=YK ;OF M)X>+GZUQMKSNP4\ O&D0&H0.FE% MXKV9CPZ]IS6HHF[:Y(.I0HUGUFB!/<'@@%?'L_;H23_-(J$/+U*J&GK>R.B5 M?&EFCJ4E/UZN+I,]I@K%2/9XA#VZ=NPQ1X%6S&?URA11PT>QAQ)IJBH@F=?^ MK-*FXWIIL-F?1FB[LH>@U6E@*S.5HJD@47'KM ?3U_X:!$+>C[%P_$/,J$*N MY1.PQ_V]WJ7_Y>Q[_>'24)R<-LE)[!=_Y\V(!.]\ L5X#HR7R^O90IH>Y49$ M2*TA(E4F$\E01#*82*JQ#O=/; MU<8RJ&__2;"G-IH[M[>&*'\PBO)I>-Q)V;HHCAPN.7BR!U+*Z-G4K,PQ/'DT MCC*&HHRQ+,H8"G%\;FR8+19T(YOFEZ6QX7,&71X$C9]<"Q5WZ:9X^Z9?W_]5 M*?9+7XS/3P9??O,^M\ 2J*,OX;>3T]^_/O\VWKP_/KNNGGTXWCLY7&(=U)S5 M.I:ZRPU:9?63++HY;QYA&V+K!,Y-8Y!WKM%>>DHY5+S;[2.^>-.O-B[_S9[^ MR-[^LL862&GIO/$\RJ2J-_V3_'['+WWW/]X6IBF3L@=Y:!ZU4BG%M/,IE9H\ M\&NEU&.+A=9^X9M1*97F8UZ8@6H72*T203C=#66'+*H4IAH3K6,$ZNC.&> *YYT,L%Q9 M*-,_Y6KFP)?+E7 M+N3T\A07ENN5CO+FO6QZICFV/]#);:&5#,L38G*%)[A 4$FJZ]NS8=X!J39A M0?.XK3)*)3V;R:R-E,NN1,H]?\X9$'O/AG,6DJ.1GGEGUPE,;IWRE_(KD9.2 M$G-@[KFG+3U7V&"+:LK; MAG&\]1CQ]VQY:VXRM*0;&+?-5IZ3F31S;<%0WLW:%1@4QJ1QG5G!X1\!#//! M=1L/MN.,%*5! M]3%\DR8JGSW?S$TDYO5,N:A7IFBQM+XE":D5!&E2]H&MU^44, RG/R)P581G M*A&_;4\+?:L9.MM;#N)*:AZ^)H'X)"26V]0&?&*89?%*$:_H/)TZ_O/?YYZ_O;Z;/'!X.UJ4/+U,\+ZH_KL;8&+&EOWF? MV]X*7,TH,([8, ($917N)NRB*:I.QJ3UCZ^GJ#:03[#HZ,CU$M;=F J4[+\_ MJW9P5?SI%B86>(X:?UD5)P7P52O9X3HX3"PG6J>F]Q_,2**A^I-ZMGCQ\_;' ME_#S[7Q)M(!ZDWP96Q>DY1"D)?IO;XWES1D*3H;)GIF*[*.+3^;-C/,O-C%T M(YN%_PY;_N,9,CLU9=*+3^;-@_,N-JGD\WHEL_1BDY5"\"VQPH4!8\^;)P16 M/;F^):XB)KY[T_=ZQ>/R_O>/7R]J3Z]NR2^JNJ4(YH#9^N1=')2ZM?*;]R>' MU:O#9P[J-=$7$+"Q*U9=6"6&(2@ MW6&I#=R587A8'@"&;R-W^C7U\TPA^Q'SION]E MKDH''R_/OM64:W2B/CG63D:_?P3P :-$W;I=!(<^DM!&^TZ+T9 MS-VD&)E,I^0$W[P/'ESQ>=/AK_OP;Q]Y36LB59AW/'@ /E9S>EK= M\@*3H'[-( &?B9ZO("E#Y=*H8*"3*Y0P;AA#U;/:,%!TZFAWT-H9QP=) G^G M^@NK407/S+RU+N6(BDN-E#.4[U2ZV:M_S<.JH_CC,F4NBSA-LT[_S?O2;F7\ MX:(:#R G EOK-^[3K5:+U?Q98MKL@ MA7<^H-2PQ[5 \&9<7]]R0/W?ZMJMU8%''1;'C3:PH!_@J_?6]I;P6OQT-V1O M)$-AX]YQGO'OT]K]7L&[O2Y';0?29CP;#^%7E]:AH9S7**3E&#+)DF$;)&"JD\SG)U(FR2X/8_E^ M>VLZQM?&\WUAVFT<"G=\ZQW<_W"SMU^:]C*V<0%!$,Q;RA1&2LITOI^!8$FG MO']GER^^]+H?OO9J2R+8O#WV?#8_(K-V)JZ7UI.QM'X2HX!_C\"/_57\=G'X MZV/_QQR0LJ//3@\^7+GI7];-@SW?^U+]L6#PX5%SV ,ZW-NF6\N?!S5GU8CA MQDC$\.I-WRTT\\7S[L/O:X$_W?)L<5C?T!N-"VUOFL"_[]_HZ M!F_>_P /$54(+B'>[6"!W5N4>GURAY;]P=#J\*@W_;-R]^#+R??VM_V[L5U8 M*(3Y/'JNY&_Z?^X^Y$JGY[V?'Z9IN3(8OI2!'-N:O?F*G$:^>)> 2; MC6WS_.3H]*+_ZPYF^O5^OWGG]KKWQXTWX[?@D4E=,JD"U0XSCMK_[?8G@GSZ"\PV]8LN ]VN:!7R@M"=XTX,S\[9QYWKA]<%+G^ M".9L7E]=7-\&Q]^&PV_LQ47"P?%4J&7BD^ MM2% .O/D'L4\Z/^-8Y^^W?AT_R?[\]+++T^VI7)2_KEPDB+I\^6EZF-XZ0C, MUW&L=/SE:^[ZJ%NW[FJKD$2%9\(_BHR+99^BD=4S3Z[M2F>?_4>QCWT_5A)5 M'YH7?C:;^W3KK%@2%9\+)TF*+IB3\AF].%=PG2?9ZN!T>Y;9!-]@!"/]*'PK M-+)NIGEI+U@.I98/1?-;?;71HDIZ9MZJ1B'%+LS/N MC7VM^#6(\6O9O_S]]?;*^[AG+$;P#:_OV@U,1WCV73'#9R'T%ET^4P:C*UN< M9W%MQ#*Q3'U,[#EN=\. TM7AD/C!C7UV+.M35E.0*R:$&6PTH^FY^4$;OQO';Z+R $YF5I33HL@3/!5 ;CK)V M;SHAQ1F;=-#76!0I6BT:%\F164"%0*89N&O9-W_O3O-VK MU:WPPV-TTUS$4ITGIG4Q+QXV"YAF(+=P P75!%Y<2E T5\CHI52XF/G+JM$> MI5KSF=NI#X3IER.U1I98G[CP.\HP?3QO+KYP=H&%JQ-W:N$PO94"F/ZSHU>N M3]7J"@!7+JU[JQ-:^+I,M_]N!RW9#W!454J\/&S:(6[Z_=Q>_?ZHM6_G2D]/ M9BDLJCCEX*;?^]>];]6#NWQ0>/-^_^O5]?GIX:6V7[T\T(Z^GAT\&N9W5-NZ'5 M3:_A:P_ &F#Q>;8;XI_<>YM+"S!)#9] B'?+TYH6O F_LOYT;=ZS74TPFLBJ M1.^$ZCYB;P'S=7P^]O[V%F:ZD?]2;YF=6XO'Q!*&6/G"0\OJQ*L,_N?_E;-& MZ1\?JZQ))&&*C5L#^G"1I0TS#9VF[3A68U?[VO&[:([43 &"=R!+?00 HLL]R8<(Q_7BW_@%L&.'?VA93GT>@UT MH&LV>"QZE%.&<$ZP36U,P^>5A4X HCZPG)XF*-M3$^<])JY($L 3?"&>%3LY MXZI@'D19U-X\K&J 3#/&%5$&A"IB<9EQ0 HW,).7VB.3;4?C"Y;0_)9E!;O/ M4SIP4I,+&X$KY^UU??RW8GC!6(+F_Y^O>D3'B>(]/0(=*/BHYIZJ8S5^4HL-6SM_97]1SOEW*5# MS%WZ[__62$YJB_MD!$@EOC4K>>>YE6N*7?5B0+HV Y!KSP*^[\14\V)S_J(& M7 <3-&$LO'PUKOS,./RW9_PY-:L/)56&,[2H^8 9C9WF8GMK%0T]6\[I%6.. MZ86+W^/'J\&BFC'R M?MRI8WF^-57/R&4V3O_Q) \L_O_CSGA&G0R;+4?4WC;$F.^( HOKC3KC M&I;8*JF@%U%JY29GD#W;#KP'3V2F\4CCSY.9%E"K:I3T8B&O%XV%I^;S$VN%0MZJ5#0"YO7 M-7>9_=/X*@ #@#*F'XOT-T(O5N^VO35-;TMJ(H4=-N)]:8)84'LHT-BCFZB! M.ZNT%AW5:8^,N+:Z5"N9POB\'%X^3%QFOV!?)ISB/5ZB.;W$XM(BIT\Z-T/3 M7V:+SGRYH&=&-Z-,[P52?MK.C+?DGMW.+,*(TS/9G)XIC&X2BAW=%ME"9.EY M$E>!6[\3-Y"'OT-*; FLR>T[#V.\./48-_UOMWOG'R\[E79M#ID2Q45E2AS= M]"N%WY>?PFNO=-%Z\W[__/3T_$R[NC[?_[R):1'5(*W-8'3W:89!R_5()@ G MV8'I;&_YN.FIS?*2MGD;U!DQR%7+A+-354-A@ENL*=[OLR^G1NFX\LW^-5EX MC!QT7IWNE%S@#V"H( ,"F_X[4FC[]"Q?\^$,-:*1CGTD12[PV$;IL65=F-ZY M=Q7@A?LW?/'"\F@B S2K?LZV"S]^MJW#Q@PT&S7XW&D',O5"TB^SF\FDN<9, MN:[E,?5TTGR#5(J7E%]X5M,"I=28AJGVOWX/[>OOV5M[8AOY\>,NC*^RA1G8 MJBOG. 5GY4;2;$KFNKT,OGW-=0[^_5&9C7;KR5\@L?#17>U.DV&<\M9( M/9R%<10Z#P,_,,E3'B"3;9D'U3- M5]S2AN[A9/9C5O40OX8R%'4-\\%- MOZ4=\AHG\73ZK);5@C5?+NO9\C!DR5CWLSB9J),# *NEXR)<^4RAI)?*(]O9 M#G99G7@XJ(?^+&TM)X=Q)AZ!H6ZKW7\O/E3^O?MP?5U;AZU;0#?60CZC5[*C M38;4(W X&U$'HLAGV8^?]X^KW]V\/5_:S#\.4BJ5=".WIF IH]J*'MST+WJ? M3FJ-7_M7-?NI\86)Q^J2_J9X]?N# MZ#9K:AL^[H0+3S/E[D/VE2 +BCWE(]?[9OF!"#Q4'_!6J]II'/ZQO+KM6^=- M^CVCR?CLV:6;_&?7IS\_N9F&_:>E[)VSD+J^@LLFG+=[^M0HU4UM%YXVM[F: M_R/BF)G"V" ]_KK0?R,'(^WO?/O_*F4>]QAK2_I$NPXAH7[8\1:@O:5WI M0P$&\A"8(.(WYH,L@!,% ZHVDXC:YR8X_SJ^ZML-=S+Y:_SMVJCY=@:#J[QZ.PC:3R^!A\0OQ"?&,L$ ML\QU6=[V^-.6YKD]F?(#1^RLWK\V^B?-7P_9M:;\_/WSD;1?J@NSC\(^?A3U)Z=5K2/!YQXNS&9T M(S\RE+HTV*7%9TL=FAYF5_KR2GM4=E3\UGCD.S?]7Z7SZU90_E _:RPH:%#: MU<;G2,TE7RI_T]_OY(O=?B%_5BR\>;]7O3K>W]ZJGF%E_\G)#^W@^.3K]>&! M=G9XK9V<7UUI%UCY+[*J/E8O%X61O/+$WP@XAR.,OL5WG$%+]-C %HU$8,*R MK9D^<"J*J&;H.#VM83O4K;)C!9KC^M2]12DG9*;9[TME"O'?2T8@7T#JHNBK M<-X#XO/$Q$Y/5"^C $4TC=Y-FU+7[K=[5Z=UAI?-K.=.HWJ0%%%JWA<-N M\^33Z6UM.=,XNDGS5*Y^M*R/'>O\OOUH:CRFX\58YEYDDXCI>YU,V22"<#X2 M;4J4NEC')AES7_]@DY:YKOY9L=9KHY55-UIY#@M]W=''"H!$B_R1SB'6/'7J MMF.3:5.M^50E=6/OS;<+\'NRP\T 'GM2<["4J_WY=!W;Q($G8VR<6<$Q=;H\ M 5^O>@\V/?D0;BP!6I19D:]Q8X,UQ ' OG/1_?'%^-UP8H553^^D(ER _&!& M"2>GG FO=+'M>@:>'GQ\NA;C,U)V<3>#(T 3Z&(X]\3F2Z\.53R%G%[QG@,OT\/_O?FO9R39O*D$I)W-W(_$X2..A'2' MLC?=QE+@Z[,C@%5C^H*NYOA"#^90#QURZ1>]#^,MC9GHN81LY (8VY4<>#Y/ M!2-\O@2=;S89HEGERWH^-]F#V52"SCMG&WDT4]1SJ=5P+X.D\\W* QXM %&S MEYW-W&TT8["I,)X:TQ$..O?."0+/KH6!<-V! M/T568K73^&YZU.V! MB-S$W_Z\6W;Q^.^E?AUU^+L=XFG[W2M- M.3AEH:\2Y[$3<>CUM+85M-S&N]7*^R=LR&-,OK[EN0W3;TT6_(1!9OSS3-7H MO,DZP?![)>NCN76\^?=*V$?SZS@C<-EDG6S\346 J-&&:&D2ZV@2Z:AHLTF"XD^Q2H)+D+RXM98?.]NE(IWD.%QZ_7 M2J^S6>BU4FIU]6*MY>$$N)%V,,UF57)W*/WX<2)W0E9RZ@;,WXI-S3E.P#K, M3\ .)8._U!U[DJ4Z<%3J97&CV)%7/;TA>_:JJ9_?GKWJZN>X:\]66V\L MP?+!SCCX!/;@+O#78"Q._+ M&[6'PLRT_0BF?8NEJ";2@<5AA51A) MTN?*JH<>(40?BO?Q].U'BQ]NJU>E6:5VE+^9US?V>ND#5/_8_LU-HM>RR)8[ MM3 $?=/_\+GPU3Z^_QS^LJ*>KS-0CQ@@MOF#S?&HD?9"2&FL&RDO[PO-7O5G MX_O!KWF1P[/*, M,G$(^0(TU7 C]L&&GBGF1T "399PX7B*-S,.1C)JP&=63Q8$6:%VM3/!&M[]V%$V&BK4P=VB !'KJUT!*/X MK?]L ]WT^ZWK/_:'XU*_8SX5UNC-^_)2$(RR-_U"Y4_WJ/CUZN?WYIOWB*]R M?'UZ>'9]15 L^^=GU\=G'P[/]H\/KQ8$5K2L:Y4C\JO@-?(,X?]U<%/@S9Y6 MLS"A6+,[]ZZ#B'5V1[LWP6T*P:5QS <_M .V%1SK%J2U +0CX)6'E@U^'#SL MX_OD,KD>_,GT>L#,H#7LF6'YX(5]=!\L\-ITS0'Y=,N^G>V#-UC[A6XF MS,SNH*,(/E?8J5M>8-H=%&0Z>'LP =@\LP'OP[!PK$,G$!_%SWB:BSXFK"@( MX E:&4^L.;AR>,4,Z $0-6UP'+UHBDN6!Z.PQ7,W_B[O]AGT?FWS^IE\\^52I MAJ=NP\Q/C;7 4U9_+V(:P93(6\DO3,"F$B@,OMVW9-?2,8 K@=M-NU./W<.+ MH7.Y_XQ*;9=/#';%E_ 1<3I+"O^C7?>Z,,&J9];L^C_:&:AJWH4S%REOY.)O M_:]\#?\TZO.Y]&;3@VGV47X ;&OZ#N_?],\.K-)#N7EO'4<=+FJ>9=[MU"A8 M][?6)8X1NPIDE%NJQ&.,1Y.G)/;=^!IQ\;R^:8\1S-._.\J<7Y9._^16<+P7 M"!0HT91;I@]JV&*K'O0MM;#=MOV[XOJ=+3,!"-T]W5SOD71IE_P?%IW#B>JMULLI%F=M@. M0M\ZZ&%Q-M( 'Q9S@"F@:P1+^N"Y85>S3* ]4\K1G^?G=)[ MX&TD)]AY8CBU=S6K93I-NH+@9R@<#R8>/O70P?HHETB+\1IX\BWLHX#L MANLW*KF\]A8?$GP9?R!Y8FA>IV#;>F" R]G07T;/(YMY:[XC;%+\1'QL7:OU M0+S=(1^ J0WBCFC0!$>>C'!@7]QT_+./THC\1QW_TC1MAUKGN5J#_4=+C0!_ MK <$R7UK>@W18&][:W SD:E L#CD*'NNH[F@Z(%3.B:XI?!KS^JZ'JZ)EF>3 ME)1_BV8SM)6^9=T)UF+NV]Y"W\-N@@F!/^HD=ZV.CPT0>EK#;(,.\YFZX&V MK+.B.38MB\]"W?7Q6W!N#ZPZA4.T;/SLLG".G;*&/%BP<#Y9/IQ56-2 ](BQ MQ4GD1M%DU,$;<]YAU,%C"7/\9'9"]-J,+/A:? %V$0D6(1Y D+;YKDQ13VJ@ MQ#J8BKNP<*'"U C:J9(O!RSKZ.VA88'WI%HP"O)&CKW-V+1<6"\*RWO;Q,G1 MCS:-7_-LJSD@_[5L1=WMN6*PV R!>1P;[Q7A>;H*9"%@(+N$/N^9D([@LG;< M!]$&@SYE-217X::B.@)(DJ=N)#43GPNY@D$SL6=?T<&.W MMQY:%HEQ.R"N[S1\G#29FN@4PXO TV!EA,C2.(R'&*EA5XS?-5%",@%VM2K) M3/P]SP'_;=-?85ZZ8I2ZV<%9WZ(TAF,'RL R4>##.C7@(+LM7G;L.]"9>.%* M@0/XN#@2R_:>EV29@6QSA\PS[HCB1&;:]A8>A0>7=0U#E]9M4;$\S MV9C-FK;G!\.#(V.2WG>0CZN=AM>W?FG7;KUOW>FQQW'SXHHU*5_ 7"$U=;D; M4U[(R6"QH)1!JT6=K"NK&[!P,TK25+E&YA(S8N4(#,TZAB@ 7U0*+P^*1DO7 M,QY9)BX>XT8(,AQ%;QB 7@T[N%6P4B!-"_E?E_,*+%US8(=QA4!G$$H=\:$' MF\&WM[=0#R'F,IDXGH=Q)SZ"+$<#J][JN(Y[VY-:QA^C9FAUR@P?81SJG/U0 M0VM,M8]5V@TG NH/4R"ZC 8]?C3F .4),'<*,L.KOHU\%WBL@V-4-V_A<2"; M"*O!H^"A 65-!^Q.)0:3"LLH#FLL4#*>>T_"',Y+5W3^0?W:DYUQQ=Z#70M2 M-WHS354,+A+85K*R'Z(F1<&&XPK!-J0_F!P^(B@VQI\([9/;ZFB?=T$/FKUI MCL/V5N(\2'-I]&$ YTE%"N:;/(HB K:SP?)(EB'YQ["'SHF;8?<1.?6V62 MD(('W\ #707&BMWFG)Y1QR2-_U-8>/0Y2QM 3!A%79+/1C-7)""%Q31T>MG^ MH.2;>%[Z--S&=O(3V$V;F=O2=2F(E?'*5%MW7;KXFZE+BYR,"S!Q>M>>">8T M:\3)UU*5V+74#*/<] O-'X'SZ>KGP9\YW$E5EG(G5;WI_[:_/]SN^RYX>_C#@8UZV 6+U1;FEDFF M,+C89%:9H-4?T.II#[G9($AN\;QP?HOEW=MUBVQES[JW8;+@4J+00,>-CRA[ M9_BTN.42%T=\NR6NCR(?$3]A=T!J>"CW^"'0U. -TOG]:UQNV@D^?00.X80$ M\5$\O=>+_R69=Q'_RXGY< 2TD=D6A4:YU3WI][Z7FY/R!M0,9\L('OGQZ?$' MDV"#>4//&&E-E?A&'W=LB-*%,90>E2X^9TI__^3#*ETU.1YT[I MLJ&7"KF1E&Z$GL(W&)\JRR(CJB7S++\;Q5.EO0V_YM 2'N<>'F-4E5X;DY2G M_9)*RDV<>WDHMJTP\6F M[]#I(B4Y/]MQ!68B][>[-O],M@L'^OZ/?.VF[U9,I]-R#^Q#Z^F&H)%9BB5X M>-,_,WY]ORK\>W7:-=Z\/S[;/S\]U*ZK_VH7E^??CJ^.S\\69!"N//S&=2?H M.P7F'_"+ UE/,:DN_*U-? "G ]Y#U]'V*0R%OEW7\O"R'B^@T?/"JAB^YM;X M)2WQSCOR[=\."K@XSQW*62KFNX29;1C?5!NQ_-B\^-7_5 MC;H?9<:J8>/S0AI,$F?3SVM M;M)U'H@Z#):[VUM#>Y-_TMX,V@(@-&Y/?QY4?^:<7RO?FZ=UA!FY-YG=M+8B M,VZ-P=Y2RIE-/4&'3SQ!2=N^7R]_^OKOG^R?YB=CY;OTU!XP(_>IL)O6#UKN M$UIB0V0N//$P)*VUOM4_J'KW=[\.^N65D_EI35N>>!C&]]3@^UN^98P;;:.. MB(]1B)ZR\[H>3!5S05ACB2Q7$7#$^T9XW E%462'@B@87R4_"(?$ +&,?&YO MD8/4";2>97JR"I,>JUD=JVD'RGP,7!J*;JYV:@C?$%UYJ\MEF)R%+Y/B%,%5 MF"^0A<;G4LM5ARUCYJ&1O>G_ZG^Q#EK%AZ/OB\H3XXU)2\P,I MJ:^)IXM(/,TO/?%TN>FES^BP#+2\HD\&& 9!G08>8A?]%I#)\%P-%EY;EK9#*5-W**QX'5UK)X?]HQ&01(YDE1KF,]]'VE7CJFT_-MGR\BY3TE MWHS:2@6Q.J1'7&4A["Z")-.O7C+#F![ ,SZ9(NLM$6 @*TX2L[7SAIL\%70D03AVFR MO14E 5(,31@QXFHVGI>2+56EU16[,HZ2+W/DC9JTND'_A4V M(ZG;7?A._+<\K?AO.,V.?X.IX/!_70=X5#Y"FP-SQ)1#72:&TQ_;9D\\17.D MS?#MMNV 50S? :GE<^87(G(!$P_1,9Z;>LP\V4%_Q@$37E71Q8F!M7N8G(Q9 MC^!3X Z""=^RG*YV9UE=-N:QCI;3T'QE_'?#FF/7HYS#B,Z10-6I-$Y5S8%: MWL'_W]ZB) F5XA%/[[5L3E;L: _([WB6/$I1Y-1ZD_)<\2W*>,3AU<_CN*[J M!"W*RWX YN*=I=$X]AWG+% -3[7;05*%"R#I0DG(U.BXQ M*^R.^)%6[B3M'NATZ#LM\H6R>D#"36Y90.WFQR MY:9*)^L8V%K=]W.RO<*OL-HHT+)Q!F8=)!5*T'LN_;&\=\9^D2(V= M7/D2+E0FJBN!*1*G1&& R%3':W M+H%RFIC.KI0K56(P]*WI5C2L^62A!W2^0$[Q?#$'>-Q6Q: 9D4:--"\=?@N MO 1GUGW0'L,!VUO$ BB8$B?/]"FI&B5>B^7?L#15%(#Q&A;.$X],/,$O!%;Y MX8:T6)@2#@VSQ70MF L(?3CY(6@9NEZS\=Q04G@PX6C(!'4.JL 7'8=2247)#?G^I/084D.G\ \%]^:.#M.B:&S M-%(XT$YQT;39#"POFB[FK[I-IIK?HKTD"493H6H'F#CGPXN\&WPUGE<+FR5$ M4\.MA\(&LRAW,DH6B!E,.*@RFJ@7 6G1#4DQ9T/^_![SE:R'S;+0D]GD\2(E M61D564]"/O(+XM>J#N_!&JZ_ XD0E3>U++/QFUT!%E&<(Z_3O0.&I+TN7K2* M&I#P%O-.LV!U&Y5*011'>28Z"G30^"CVVC77T2ZJ/Z[HT&/4]LST&^9OC=J; M4"HP2*"3DWU5U4=):YH,_5#J>6#=\H?I.K'!*6\@5;NF36>%_H YO\SHU%/! MI]1PE<*&\6:U ATMP8X?RM*M6TQ)[Y"0,[M=1Q0J8?8V2,PN0^]B9"P48A.. M'?S3L?LHE7MLH,NQ-PF>=>D@AM1129>]TG6MGE? M:=CX/D5#,Y/@ V+?X3B5P.BO@:U(13;;6R#0D-2FV@*QL4*/#S( \$@;/HRQ M$8^L4,I)Y[5Y**1#T;W"9'\/TQR%$DD,!3K:JO?JCK4ATO&[)<\-UGP*8LD# M OHY0+5"B=W 6.38T^ERP6*R LQ?]WL^J#W!9VXS>*!=B1V4R%=%8H8=&ZPK MK6-9#5^Z6G7'5KQ!!CY,E!UU9A$U'^6@ULVN6;,=6]J]7%(JGE93DS)#+@-- M;GXR7K,G_TI<$=$",U;1]H(Y*CD1LT2CW*G8!%%T E%09+5\5S'X:(9O$JR MX$Q3"K^NQ9XRZW5J?-E6<3L]7C) "E_*!#$1ON :G#])XEIHXR56!ZN+8700 M I[K^SOJ&2SSLP,X\&@=F%3&@8-8LIZX9=^VT"EPK#\V^6MXA4=&;301D!'P M"YZ$'#BJR:0W<6MZ?#]'D@N(J-XEFG&M%YBL\.70%\Z9##LH&851R=A.HS@% MXQ]_,MF@#LE(]D@-N,!4#T*V)&).4O: [.J:(ZG7 /L3^]V0V(P$&<="63X@ M<6GWL?K1"_!*T^8$:):0E$2]*95Y\BPV8/$.[$BZ2!W0G:2LT&VYMP3EJ -8 M='!T(&) YK]CMVV^#]4UI6\]JT87M;%W=3!B._2-Z))41Y'1H5A;@$Z,3_:) M$[3J'&ZPVZ256&')[6>U@&V(@ E"LA^4[C!]%&]HF<>%$#)D)(2H;,A%YXDR MVUEI8XA/A1\HB"XU?40(:7YPZ*UAM?G_J(!6'G_T$4F(U*2-CETI:O 4EN% MJMBL)TG%OAI5M(4>MR&(3M#P=.F D-<-%(EO9/2(C.X!45!PT9^Q&-<#:JB? M\ LR_S=!:'Z K2+Z)X1,>$K[J J=6YA M$*C^BDK^@_=MX5?(4F(73$\S6HC$_&A<]XCJM)B.Y&=(&UM!X/"+G#.RJUW& M+9V8$J*7\/!./0EAT4^8B$9AG#K>]C; ";>$0+8\GOK:G#ZB<%$90JPHBW,76&MQ:>](6RU25^9*B^A\)J7L(2\A,)K7L*:'Q9I MBF"K _"FK%O7LT6X(NX\1X:"__?VUEOC7/Q,9.([%"NQX8_B,>U M;NAU^?Y$?4E>@WRXN%3W'L) NHB;5_19NNPC"PGO&-M=Q^WQA94)?ISXF5H5 MD'2B/S@<[;P//$P1;^JK8(D>0N"S[E" M*A8Z&)@!?IM)C.6A[= )["[>MA"+")M9?D+YHX(8>CR,)YP[X'XP4AJTA=2P MG=IO8;*HU0SISDN M*&8W& M0$D-TJ'>$D&06]=M4'!4A912>$=<\E!/@YH8"&LPP/:U> I^:T-D\QX"Q\3$ M)JX\316)YLFP%_+88 @ ;XO%#]B5274?I]^!)SIPQ(0($?34XN3$;:A>G\;V M (3QQ?$978>H#92[M[VEMH\?HQV%E9D<5DO9TGO;PXM8Y-Y.[P'#]U%UO1 H M'-S6WE8IO1KF>LAWPSHVQ*B[U,OY%/ON>'AZ=.V;[9O@LUE!??<=78N ].\& MV(-J/Z),;.ET=N3Z25QCRCQV7M/:[/4%*+421$RA'&9I8&-I+. 7KZ'KB&%W MS(^W,99X2]W/@-^C)U1T >/KZM<#\_!;;K?+[>X<9T-8_'KP!D'5+M7 MNQ0-Q: *6'<@:$"C(#-13SS05D#,![Z!1XX5)0:@+4)+MHX,VS+O*"*LU09V M0O<&LM%#N>@E7P\%MT%0R:V M*I\-53(1Z',=V:"R0[D10F:;#MT'<5F&RRUM1.0, T)1-(RBBC+[R;H5\5MY M(>/*YC0Z=W&KPX\>"6,TP] 4<,. A (VK>1\")2FG&/1P]%1^==;5OU.9%#Y MYCTWK. 9; CST64;1F[HV)E4(S/A7DL7^2#TGNP:0(_P58'L?@B;+#O4^[XT MP&0\CP6Y,)2H!Z!@*[%G]3L:6\<+1$Z<$=E;#9$S POAFX+=[:WO@J]<:D=/ MW?.!';#+"$>Y*(\A:B&&UR<=ZX&BP@[&\OD&U'4P:8P/8'33PH%FRD/A_DC? MR4P&DQJ-0TJR +NP"68BA<=V@+'BE[1"#^ KL'(R+CG51%R=@H*@1BB8@S/T M$GP7Y#M6R>)Y\/$2'TZ'."G?\/2A.,8 JB6:\@,]=QY $X*<] (X[+Y/H&QB M//Y9MN1$?@"Z80^K#6'F?4YSI:I\MAJ;;IV;O*$WS'(5?^(T39^2"M("\O$8 M=GJB0(3+(,6UC.K$+P&'KS*42QA]5GP(=C!Q1<'%8/*V*AJS[NYT$4Y!74@, MW77PM5W*G8C(&(@N3J@SZX#ENAFL4/5)U*@+9%7-&-WGT6V('[N?U2EGP.*B M/DLE31,SP+%D62=5I RS"&]47&B*FS[0@;YJ?2LRK=35=^RRV>4\1DQUIAL; MZIXD.DI(]FK!KO"5>?S^' 1<@UHT=>2$181;OF9WFA[8@E[(-[G(". X\24Z M697):I 4!%.DON1D4/8G?1+HE-UQ-)(M@O'#T_X%#1B\P'G2>LUD@C MD%(5R8Z4"\G6:@/#!&B^,#@:FQX=V#)QT&,#X.;@R#!!LSV8Q:22"0:SP:+< ME :U78N-*')Z!_MNQS\BN+2-N2SB:Z3QT-LCU8:OR@3.=MBAV@N1*B$RWZE= M.S:;CU+ &D/3I-.HM(:X@]=3+L?U6.ZVNE:/@H8RMTU744EDZUMU^4XO^F#1 M7:/W;7)&KB\I29468H$D<(@20I?C>@4)J9P!_I\,3GPP<7QEIW#J@UDG9SR2 MF5S-HOQ-2O1KACB5_Q[U%D7&,#ND M),D]P"@-NFQL]HCVW/QSY)**H*S8TPY8**1C03N#$O!4_I=8Z(;8)IOTE:EN M:XNOM[5+N*TMOM[6KOEA.>Z(YDD/Y 5(9!?T3"Q.%T-PB%BV&-AVXN8BW@I= MQ.M$G4ND4I3IH(,$-L,&^X&VWPU)6P^&%V1L0[5DI>LVFW/[/S';/]8FA52=D,T"C>A]X!E[FTOC&KL]L^_'1_L M&!5UPTP)BVV[CKM)3A.8;9ZHYZ-"*4+@8;X \TL 821="'0Y*9C*S>@E [-M M'86E'6)4LR[2L. QM]V3D<7$B")T11T4?=5@Y\'UG 8ZJUB41"XGFU# T%[8 MY38$W2Y%NF799_+K;<9C@<^(2#BU)[\'%TQZZ^0NU^OH3W(JE[V/P@%$7-=(E)9P,8R6Y:;-#!"VW?PF[WHI.RX IL=$ZRFTL! M"84&_$NAA331UD#B?7)MG-T.G= 7 5H@F\@-IX.''2]%RUI"]<*WJ%,L5Y\T M1!F:##=Q^8TCO@ ( M1BS0%&8V1]=$O(*_QC$F^+K.7"FS;_DT6 TU*=H.O(^(\8*X)FG)S18EH%QT M.Z N\$G:' 7$*@ZFFBL=63\67A^\7*JZ"*;3JNX]6EX]CV+YH@!L(\D+*' =5?LD,I[5#9D(?W1"V>0<+XQ]=.%!",#J;ZW!L67$1.!7B&(V?)6: MB2&)0P:,8,B7@0>DK'J0\&RBG#7T,5W(!9'51@^K3E1A>85EZG%M3BD\47T# MT$?M&;47,&]O$94+>8'<1%DMC_H3K2^\_&BY#^Q&V0RK2R6K,7;@*M& +LY@ M1W>4Z(H^ZB _\C>)7NE;P5/8U3XHF195FR/<+S8$%2FX@8RC(@VXN0?U1.LJ MV'D9)"4YQ]AE"DT+GE8B"P>1; LAZA(-^[@?Y/IH[ A2 Y$30KP#A"T0;VGQ14L5[OCACOO++"9\.**:R^CU4:]!)=18@O?EHM' MZ?T.6>-R$?/")R2I.\>/L3';=#%_D502'3@_;&,K1KPO%=@FO7[U/LX#>VG] MWYOBU*#3J?&,^;*@&K:6=B3D8=<6]U5YZI;PJ;=A!UQY]);>R:_-NIVQ1RG0 M]6!AG ?9Q8']6B@SI'PO;9W?2*/7K2E6EC+F<,1J3N=D/M3*SIM:*.KG0:GG ML%#C12STKQ>QRO\L]7C_HPWC$GBWM;?97%D7_WT7$P$C:8?U(5RP*:<_-=TF MQ-:'Y,[KP//8Y.\,/C&TLY+;\+Z&-;2RKO*#%S%\IW/!?J^\%AYQC6+\9\1) M&GPL[1-#)U\^/?BX(%I)+V>*>C8S)!?'?F7L+=12YU_0*_F2GC-RSW3^AEXN ME/5RN;PF\Q\_\HA%Y(S=W) PGOHSBY; :>T_*+65!KF1>[_+?YG%XL%1^Y_G?/ M>NG%RFY^.L=FY,J7JU"SF50O*VU^UVY 4=5IW)^G2^VR7JB4]=(P'ZU,R>K% M@J%G*T,'>V5JEHSG?'EM*)2MI!B2*U"TTP8\]EW.+QEDZ>7)Z)9/1*\7" MBU4[.3V/ B,[Y$N^& KD,V!WYZ<+!F_B^@UCM_!8Y;O2H.+PA$9(K _8G1.S M%YIV\)QW*J\7*R6]/.Q!OQA>S>E&(:L7BD-.^XNA@*$7\@605R_73\Q7=C,K MEU?312MFWZHF,_G!=9_-HO3P&B_Y M=3;/93;+\ER'9W&N,G-%KXB%QV*>_VZ]SF;=;_"N+,>A8C79$H72N6,()??6 MHHF7U[.%@EY9GY!C3L^7\N D#+GTJYI0J6SH>6-];O:R*0[_RFWE= X?X=$? M8%.GNAW5DIEMA/+@9E;/V;DI&>#BEE_N+5C1R,/Z7VXPKE+6*Y6AO)@7LWRC MJ!LK]^T7=QLX0IKQ%:$[TD!]CCN9URO%BFX4'GNA_?QY.:]GRF6]]((C=>5R M!NR>ERO,L^MPL_($IWF$N#K!2"6CV<8J$9>^34-9IX_)/,F6##V7?^SU[RJR M;N:R[$H.%&WIL;+^=>KCQZ6S(>?W6RX#RK-8[TO,[FNZS]^ERU!"A' YR7EZ8<2YF<7LF]W#2PMZ7"XZWU=4]" M/N/.K4O)+7B;W2U-$5Y^M_!Y&/D4:V<%$]D@O2J:6#[_9G^;])6IVL>67MO' M)CE^(>UC2Z_M8]?\L%S'V]UAK[I$>0[6-?RE*D08HP![CP74(:?-'7*LE*91 MU"7>B^#P?. ,;/MFNPW9$:\+/W@$*\7HEGY :._8>-YVJ FFB=\6I=&)27(- M/6+3,; TW7C"PUPQFGR42WK%DSK"1?B@_!'U4ON+2\RTAA4]3U63\G%N;3G\ M9?EW[0%1.N64M[=$3U"SDR1IHF-@HA^F@E61W=I,1.U EX\U7'##NP%M'N5+Q5=Q'. M1N!Q^V+3M[<$^H&%3261O:)=$>])C WY)D]K)'^,GA4BAM]V;-DI< @47,SZ?Y;7MCBEZZ(YL'VEL2*?AP0HJ:@4Z1LQL;RDY(SFF 8>9ZU9F M$SV[VM#';9^&\&P<%9M*QO#F!Q'OX&_=BP&^V!X,/XM'REY>ZDKR$4^ MK00]Q_^,PT#)#(XNS NU3!W^/[71MN28&+ 8'/@()H=$P:WH+PP,&';U&* ( M(S0K@ @QR31R* J+-KQCNID.B\)@X%3'9%9(,&("(Z6G#SV*@A*L'%P[2L! MI7-)RD@X*_A,V(7C1# 9/K;P]'T7DV%0\E"7390,B.%I$]8>K[QK!38C5"$8 MH>>+DUK,CFH2.SQ#N9]RA^,S(FB-F#"*0(:BALL)P@SBM$5L$U=9((H(KQ@! M"FD?HSU,?%XVOF:H)M$>E9J]PHGBYJ3B+*2WG=T,P1(O=)HD5-!VV=X:%"JJ MO&1&BX:[1BKID?+\T_!_89<1"K8'BC;B(<:49JDDTB$7= M1@UMR2_!$QV!=IE85=%13<;%3.)"3APB! 038Q"S")Q9;O%N,F;GO=U@"'&" ME^*VY!8CU( -XMU2YWYNKNP.&D*Q3PK@(+=.\&@)29-F'M!T;N-[BWHX.B;4 M-GB$1!#MM^$)..DH%T:UA!;@ )X$;(K-21R6J(7Y5 >9CR>-P1SD$IZM(Z%6 M!2R-%!/#%M%MO"2&&0P[E5+O<&I#C\Y.Q":BX_R&'.4I$GLC2DNH@JL/_V.V MN_]4)50!6%V3A<"082'25;%[,J6*SB@*6-\,.3CRA"=X)X:LR"ARC!G/?EBY MDM$SF8S.:D"]!.Q6!U>7YIH8 -\I9/7B\"MN&/@V0H6'Q0V+N [Y1'/J0 40= ML"W:1)V_LKE2VHH] E$EF"P4-[H *D%[IQ-],*\;:1_TS'N+N8<..G86EW@) M?Q5*>I;?:<3?(WG#7>B'D]+HQ:Q!6\-GEANU-X24(Y")IL#[0N,R\A=B^GJ0 M$1BM!-$)(R3#6$=_]*C\C8%8'9N]K#!3Q=$E<+NISR[GC\[J$PQ*WL:X"6YO MR1FF>H,27*$1;:HZGJA_(H1+9,G?H=V-,(*C=ZU."SE;8=\1@)G$_-P,+CB: M5C0_L'OM-="^-^E&>3#]B@\EYS)%B,#9=XJT61>! M$L/VIFSQ]^@TB:U!&H/>5V2ALU34*T9Q>OM)XN>"0*-MY7VW0 \R7@:.3T#5 M,/A_L:^K"MP/W0,_V1.(@S*S&A"G7C(COB9,,0PZ)YS\D>87!Z6["-#[AX54 M0M-(QV8Z^I+49'9!?-(*=0 M8?\ELGK84HQP6CH M0+SB#KWB#KWB#FT"4,TK[M!&K?(5=VA<@O;KP"OH%?/L<(>, EVW%8;;33\7 MX!Y#SX'EE!]&J7@F"\CIY5)&-]8&^6G\R*,6D=_-OB(/S=CTOU"JP-Y7UJ4* M!R:4!68*Z67VU>\5-1SY9?; M5/QMKJ3GC9>)/?24=N+K7O:[7.PAHZB7C0HPTI!YNS(MF]4K8*^6C*&.>BM3 M;%C;A3 .:S.AS.YPQ[WUZ+*Q\>A#)=T (S!7>+GH0T6]DB\^H0'7\Z> 42J! MX?UR&[ZF]2)>PX:?K^!#%=!:X",67RZK%O1*.:_G2B^W1TX.3"E#+[Y@3ZF8 M?04?>G*HJ;1.X$/%F=$W%S>9Q_3F6:_9O+:'?)W-VL[F%7SH.>W6ZVS6_1)O M#<"'RGH9O))R>6T"?"4]EZOHA?S:3,C0"P685'YM -BS1LKU]5&9 U#DJ\81!-W,J-GRQ6@ MWU#:SXMAYC*8(F".E%XPI)A> H.L6'RY BV;20EQK4O,\A6&",9X6ZCD=&,X M.W&-$W#F S"!N=!Z-O/2\)<,O5+*ZIGLRP7'>ULJ[E;6-.UJC>,^K[-Y+K-9 M,V7YW*&("IBAFGV)"K)0T/.5EX;!!,K1*.N9X4*I%Z0@-S@O>:EP1+FIPLU+ M@".J[);782(;I%LW!HYH"E02E3D>H9+X]I]E8)*HHLEI,$FXCFQZ2!*N/'F% M)'F%))D/)(EGPZ]E4_21J"38X9A[?(Y!)>$S-0D%8N-!25*E3#HDB4AF?X4D M608D2;0M0W D>#A!1:PNA"7!YO*C04E*QB28@F@/I@4I M(7H,HI1HJP4I&4:]>*D@)2--F>$.RRH)_45"E$@0$J%)%XI"HC-XB"GZ1\,O M=P8G13VG'?RF)S[B#WYEV*[X\%0H$Y /*5 F8.-,QC)1C#;8\WB.F"81]M$L MH":OK6^?TU>F:GU;>6U]F_3K%]+ZMO+:^G;-#XO$)8KZZ4\(7201R3A_E?"( M,'=T57A$AIZMY 5@SO2(1(91T7.+AB3*Y@MZ.07]AX:(^;TBE%3(IX(3*IY)E7 M */AKZ0"&,W@7 -E\X7L*WS1VF[PE/!%9;ULY*:]*5H >%%AM_2?=W@6T;+7 M!/9.3(VN LIH$*XX9K;Q]"@EE=\S^?$G'A&:USQ%=.U?42AJ=MZ\%/7)RV+;P< MIBUO64YW>PLO@=V.'0B6ZL:(1CXOZ.@&LD2S![X5=6<"DOD[QK(= MVT(ED,!U49?,: <+R0A+Z6%'7[$KY$3B<.(:P^D)'ZT3QG(;YH?VL@:7&@>4 M)Z!]#ZK)PYV8-S#+1[?A=(UPQQ9Z*4 M PPS"XK*.W)Y:2DNRL_A3QQ?3@[FJ(E0V@)+KURIJ+5MQR%_"#?FKVRQQ,02 MOYX6X"T"+M)1I7?9:G!Z**S I$N;$'6T^BUL-F"F\.+:#8E2_[$D#^ MJ;B7;%64.W73J8?B:[).?H#+4)(A8]5)=CB W[ MWL:XN[RF2IGK]M;@9&D<$+9N&[P3&&E7JV)B#OP*$U428ASG/02&Q9[R4)H1 MC$#!-.9B8'&I _!['8R:-60*@K"N!UF6,'RKE]W-5O[#^/05O.C$$)UK8Z3E M+7)B-O-/K>O3OXQ_WE%H$.RVW;QX)P_O=/W!'9^.^UC(\JH2JY]A:=M;X]9F M@!B@>1K9 L\3_V[L&F7^K5%^ZNRC34*W9SX[\C:SFRF^HQF^+;Z+Y@V_SQ7$ M[^$?Z5/?WIJ1\A/Y:4I](;DI;^ ,@4?R1C3U[&ZNQ R3*RV386#NVUM33][8 MS3%;&[E*@ETR@ETR3YC[]E:27^9$<&26LF"*_A'RL3)IIQFYIMA M5<8,?U"KKK+^[T" QZWZR.@&"LF\TG0QK4=A5^!(=2-">DJ&:V*Y9[PQ,?U# MR29UNTLC[((3AAJ$,BQ)*]%%&SR'N1AT4:-UI%_V%K;U?_Y?+O^/V< %6@WZ MX5WD2H!JJ9'!U@P=_*$=6SVEU=Y;/KE[EH@2"64?7?#$::)B7QRMP?63T6TU M=!$MHD0:6':D= /7=8BE![_0N77IWRIBK6N._3L$>T!D&\;FBBX6QJDH^1L?78]#N1U)@T ^(KHN](8N%CID@/!EIQ!Z; DE<6M(J& MU77%[_ M.<#'<)YOT3ZI"PO2"1$+4EJ@==-O):Y"\,*#$S)MBH>#E+/ +J%#+W M&K0PV@1<%WDYY)0,M+;-GL1$3 ^1)[G/#:I)P!E&M5 "3$W4L7UCJL3L?:5&-S4]0%T/X![*2 MJE(ERPG [T!#-1VPC'WV[^D)TL4@B_DQ^!>F.M2=$.RRV"UIZB;'G)B+AS)\,@=OD":/ 8..R5\=DK5/8K5/;K MCLYW1U<,:Z/DQN6083!H#(!](&V%O\?W#%A?Y.HI!E[@ZPOI&!3'R)YVLT?U M"EH%8//;;+:L9W*SX4T/=;U9R*$[!P4MH@975#6/(,%YW@?S2 M0"!*1DXWRB\7 *%HY&']TSFJF[C^5Q"0>8* K*(1K-*^[)PO6J[G\X9>SJT- MZOO;7!8\K\H4\UFXQBM5*KI1&A(E*Z.,@6CC,*/I:;/>.OAJQ*76TQM"QD: QK%&>E_H=EEG9W0*2?2!V/FF5 MXJV9-XO>TQIN6'.LQS?J'CV*!(;/971C\KT.C?-X?EUS(F2-,@BMB7@>FTT$ ML (+1;TR&6IIL\GPUBB5];9YGIIV86U]R>)#.E]D9A\:?EN MZ-4WJ3[W.I%TRWE)F ".2=BB3T';_.6" N*5<\)S*#H181;PLM-C-R!W2EZU M/]7<>42"4&K>YWPW3@U;&\HSBF48\0'2%O?MMV''#.$(6XUW\FNS4GIZ"VPT M!-,8NVM-LCU>TUK6*:U%")M2-O6Z]TR67JCL5:QH2*G 6([@))>*!MZJ3!T S7U A;BPXWA"ZI8HEY76#"5SA,+#-$52HB) M..3^K^3"3L\6L0'G%(D!2XH7#GYX#-[9T!F/.H2-/N//*4XBNBZ\W#A1-J,; M^7E$"I%6E'ZK6?N%QMYO9S-Z]EA:?*RX@.@ MTO/YC)[+303EGHH.RT3#^J\]4(MC+]R%AT_N4XFJ[7/F\4A_B%H-L&_-ANI2 M)K<\2ARD@K^,:+= C>H,JLEGM8?=$:)B>49_ #%VV^+&FAUJ]2++R!O5WTL<2>%K8IA4E"+4] =8M\]T0RIF;.F VCIEKC-BG/E6;)NH3PIM(9W+&-I0LM=D MK/7C]E9:5V75B'*P)?L@%TQN8I\OIC59'QPG7MG*PCA1VDJC88_OC0%.VZ2O M3-43P'CM"9 :R)AO3P#CM2? FA^6_4FQH@1JF9'3BX7<]"TM4^R)*5H#BX[ M-2MXL*R.ZGV4Q#DP U!>M5!J]12LU&'@@YB1*# MXC 7IB^:/Q'Z 4Z8Z<%( M)[!@B1G2VS00A"';,BW(1/3O6Y[[V.V?*I3%NI5C(E.B=P+73+< P1?4PTV8 MM!&FCKC$C#K]*S@SZX_EU6UN<:Z,1[(TP$XA(T6TB,3/R;DOB3.6I%'M]U=\ MZXLT4%?B&^><)CI%"R '\]ZT'5;PR!Z(_T#@RMR2A.SX@0@7&*G!P$E IB[J MA6Q)SY>*\'?'!58A&YLZI8&2JB/41ZQEET!6C=FEXBP,H?Q(?"@^EO"YG,[= M3VO I6$3(1Q%0Q4?UFD*81:SL.7('2")!B+7N9<],S=$O/VWAFQTWFSN[#%, MAW;5LL#AJ'H>*AI#V6GPR!\\ESM*+_R:P=<.E5FDM$_OU$DIGIV@/][X.+>60XUZN-AE'L,_-,,"024X38D[$74S0XA MIT5_Q5@\(/7O$5Z\IR".N(,FM1+&'L-I#0QUU320WH%?<4\]3_W>DSD[FEH< M(DEXW#,QZF2X44R_[]GD*6C5"'OM ER9NL0].Q2 &AM] + !K ^_LD$8FMA( M,B)&5Q&#@,[\.AB5:%(">YZY@:494LSB3]1!:A^!?< 9I#C)D6+A*\0C8:0L MI"OR?Y51 BZIYR >BB,P&6%1.Y^5S&W:/NX.R7 V;0[ _J!(2\Y@H(Y-"3%< M4^C0PCZ-TAZOQTD920-?D9+V 9Y"6QMS\$AE,&-)"(7++2.WM[C]N!\U1QT,6(H& MF7[=<;'?I%@B3HO:EXYXAS_3$-A$Y+E,IHN$!E(-+6.3DYVE"=I--L>-P0?S M.Z+7+($ 5>M!&.O77J<&HPP?*.U@UX\1;4-8$N5"C!%@QQ3@-)Y?I)UG6Z)M M[?86_HY<2 )5DDR,767+# )3\]M@:]+=LK2:N&5X#_,2P! 3;=R%L4F13MF6 M/R! 7]4Y'[%^L!TY&O^$OV/[&N[.@O6U^"4&C7#0S&[![BBBKG0+GL#?1I*_ M\[OHEP6>Z["!?>&Y=:N!W/R2>!<*5V)] MJR'2+85#B+ZR[&AMMR,($70PP'N(LERB#S-=U-?WW7;;]K%Q&R7IEOZ!&82. M<'.1"J(/^ "5XA2*DZ9F*>K0'4TH;F1FI,SI%X 2M(_C\% F%A4MO%?A\YU"Y&QRT/EL& N#[Z_P+[ <<30!+; M6\VP4Q<11P29Z0+Y83STV!G3T'T@&G.2$@-_H MH>C0M180H-,"(2O66;35C M\Q3SX= __6UHKMM; M;%8O]? 1R3_R@0V!J3#\1;,^K[#KMP2?MJY,P=H_#6 M>L?X2X6&^"F-2;>WTKCT'=('_IVX_MC5]J1;30QB*8!DG:;["#)P"!K[N6)? M^(8(6$^Y=LI+BI"A4V:LQW.?(OP=&/&>D%:D]OZB4$$YR$=H@C+*]V7AW>,7 MF*T:1>F/Q:6YU">$W!L%/K>W+J5AM'F*)8J9"?S7]+Q)5"1@"A)/UC!EH>/& M[SE4W*C#5QT1%>-0B=*Z)$ZFH>3U!$8ZB5M1W".0XZA[F>@%D)STAC[;Q^?/ ML:\#O@[X.N!S'W"J\%SN-3RWA/!<[C4\M_(&(6H#'QN]R*KHQ47U\GI[Z_@8 M'(+KCX>7VO'9T?GE:?7Z^/QL$8&+)Z]#TG714XL,OL?2.)>($&UO&;O:";AD M#H="+!0JBPH.+<=,/Z*+673M,;?61E#'!XLN"FL6]5ZW._>N<\\.WKT)#DP( M7IMC/OBA+>^AB2#=B" *F-R.0A@N>K&FU\-K88_3(.6%Y:[V4<)9XM7G+3O] MX!CY8>T77:!C8@U:QYT O$@!ITJU/:*L J%7$8W7$C>=XJ,^!4DX0@-6+7 I M7X'RQ)J#*V>C&1_ VI3$G>I&)6)B#L4^1Y]AI;YP-D!%-"1(>Q,<%+,CR.A9 M_W][5_J;.++$OX\T_X/UI/4IEJ-8EJA_MSE^_7"W>=/$NQ,.[SGQVKYT3,KP>.J._1$< MG(QT='4Z)^@ '?D/TI=_?OY4=-=XD_22J?)+2]6X.-GHX?$AL#A<0 T,\F;T MF>S=JTDCL\1JR;A3Z(9>D#2C"L&R55E66&?C&(HGW^!.UPSLXK4\"O&0V8!(J. MXRJ6Z2XY">%%I4Q"G&X2K0>$]P&W$L"JPJ869B4':)$U1C29YB4/)Q*DU$S8 MI8))0N+G3SZ%M"/@P%ZR^5VZK&HU)?STAO-7;2(I2)-IWQK]"?[3R^]M%!._ MX:4E#PKEYS@AWV@:%.'-^M%\*<:,C.7\IE/Z.!'S^$LRD38F[(SJ &8)\W86 MR"?S7C$)ZFU<+PP& JPWZ_4C3_,.P1#A%5JK)NWF$R3RT=BR?)E\];)4P8P< M2\W"-"UL!BW[,#+Y/]Z8W-F0\>@7],20DQV@IPCH.9":F+MSY-39RMB2 MM#B2(PZ\%('7,,"JUT=H8A&"@X]1&K$\=PX6@JDYMH4Z37[YS/,;;8*?09D8QM_-7!&PA5F*EF\IBM1J MD=?/QSWXC91'$(U+ F29^'O!ZJU5!,21_R008FYBT93QL0EG'BA&KGFFHQU( M!.'15/I[DMN+'?J17)LN&3-S.+@QS TGNR#Y9"I)](0*UA3<,M2#H=45<8J$ M2 J1HOL,NC9T)*(7M%;"#!%IE87\M"*1P$=UB-0;HDU++ Z[C=[$E@3;P9FK M,_0U5&5P+&RR_FP$IHXRX#!P/GW@'D"\<#H/L0$_CR+@ DEEB<6,:+!/J*ZILWZH!LSY=X3=:^ M0TD^;?TMXO?)/?6BBPTK&$07L/>N 4N%OQ2S1J%5.4:7@W25I*>'XUU+?KFBT@G8S-^E5UJ;U''&. ZFN&?8[:Q;1&Y M:7Z-.0M%%5^(3[Q(+'WN1D@]W\[PI6WO 2&N!-R\9\-./ MQ&+KB;)-^I+ W)!J*WWYS*A3=MB BQ6?UPBN;BH&UPACYX1V+U&'SY^.],&+ M89Y6!HA_I@&UD(9KARH<)7(\K4YSYFV2W?O(C?GLLWV^%ROZGDIDZ MD4QL? <&WM]!JS7P54#LA)X29C2V;@%+ %9I0+.,+%'[)G*<"F?@A+-?S^.7 M8@PV$K6+ /YR+1O O!P]]T#:2K1WB24K*)]9EU6P*=X+\2#"^Q+W@[P \P]( MG@0SD-/B[2&U#/VZ7@S M9#"8&NQ*V;$ S$N)*D1^)J"QP$NXFH.\9CJOZ_[U+/Z[+_]MPI=V>21O9>1W M*",G;V7DCZU"OQ![GS[&WJ?#7&FKJ!/5N4ZP_<$(!)7^U"C\,(U'-N%)V_'= M>R*PT ?O##CZ5&)I9*2KVNZ/[Y%S9I42L7#,9T7P^-A7G.,OQ"F6),.AKV2# M_K>T3<2BL;#BZ/_Z!IAB"BF&@"-"X,0DN<0'$^SV7Q'T+4CG2\XQ?DNFQ7\- MT^(?F&GQ7R-I<4_2_-QE(A6]]+UIHPZ"1AB<$G.ZWT7F)5:6[C( MOI.9<]%_OV1#^U/DU Q-Q?NSAT*OR=4,VR$GZ13-*:W)?*'9 O98]!Z+ID2+ M0PC[+&1Y23&"L$>T&:&('(2#&0V Y#1Y 95,,HV#9K3\#9E@43QN\0G2X\WW M]6H$'Q9/X*O/+MX[+E@?;>',AAV.6QS)@'8=3I@JDH[\%;PJSO'YYA5SCD?: MU,L$-U5C 4=H7"Z8HYV+$D M&W/L"8WF7BE(@/M&_@L;,DR686XLM'S=:"'YUH$63VK0)-]PV8%_H<4"AYVM M"^RF13>5=2W"8XGNG/&8L:_ARZSUK\1X(_3W!V@_N09\^HV,&QDW,FYDW,BX MD7$CXXK)>*ZXF+H5%]^AN)BZ%1=?NP!WO>KVRUM2CXN3&;\X*=0J[7Q_T"L) MUT?VN\+@.@&\$&W+(O V>ECU&0CH\L$^=^Q-"BTR:)^#Z&H404T:&,@!5>2H M:]K3Q<[0 D"G8WM@7H*5D^B)0MXA6P#%=@UH#8+QD.LH)CG/ZKWQG1^I4'QB M0%/1EUV'G7K=HDPG/P8MN^-J;3[\DYFAB^3_Z 6W/S'D.<\NWY[[FOPK(@?\ MJ#L#$':,8?V>30V>1"J3TTCE(D->L;JH?HO8$8J^]UI1Z$E,K[_T[*^?=W,% M_*%'%-]Q/#E6K.0?.79/CQ6CIN"5IOURZ2@Z=G[95QIGW!3E-U>4NB3+7 $M M/HB6',CU5.1PP<4;J\BA'89=J^I=Z/",QKQ>9OPC9,%O ]X&O UX&_#W&/"Y M+%WZ3^Z>WL;S!]>$B_%N2;NW3]JEWS5I]Y9IM2M6 F^H'_WGK\C$%'<0Z404 M1]>^'2N0(#G>@F[%[9];@.F[*8O"?5=]K0*=\G]_EN)-\, M;21SGUS6ID)Y+W<7O9XX+E>4:;VNYN6'>$]H;FOI;'_%RV(UEZKL9"5=TP?# MLEA&6K,S;\M6%@G]G5Q="'9N430G.5>;5S+Y=*/E3D?Q0FW7:N1+);Z!(JG- M+J1E^-ZJ%GLH&XEXH37O]S:SO:/7Y>QRN2F5+?6Q<*\_R*$Y2L[&Y>2F.$T] M3N?1%++')Q9#2&5W%D:/ZQH4<2G1I-)P]EOV^E8U'X8]A/C=F$EC@8A M093N([M)X3$IVP5'S,9$YV%9+$_[W=2]@60SJP^CPX?'?OE>B75'F7VC,G,G MO!:Q8M/&M*XLY^)LG(R/9TTMEYI->''2%L9=8R9ERXE]1.X45HM.K2AWRDYC M4[!;B6XG:CK5VDJJ*:V%T;)#Y9V6JZCQ6(RW-Y-N=J1;9E%NFTNSUEPU-H-. M)\2O-XYN+^[WV^TDDJL9H59HJ?G! M0.VFM6B-3]B5R7JJ9I++[:C=V ]'LVUK6XJF5[%>0^OK8F906O&;42[:F8V4 MJ)D8)5K);++9FV:4G(9M?@07^PF8UM9)^1\2'U(%EIHT%34 ME3:M\M7'E1JOVI&=XA;5;D08R'*G-# +?*7>=)2(V,CSC=1RU^SL'T>:4NHE MG&HLXM3:1GS>K63FF\EZ67?T^5!>FZ5>N:XW]YUXJ,$GM.HXG6C?CXQ\2>VE M:NM.KAA:N>8J4KIQ MOM.1ALM^W$UO['%&:@Q73E:)U%8%,6.YK5QB6*N(J86XVPP?JOR@$.OEF]%9 M.C.PN[6*&]KKE59Q8BXR@C&OIYQZ;SS=:M9H7QU.)X+<[9:D36,U3F8UQ4BZ M"7NWJ.XRF7QG%,_LM9T\T8>Z-'*-;3X[<,R(5EGP?3%>B70>]-ZFI:8RV4*V MD%-[K?]15?T_4$L! A0#% @ (TT*53R?@-WN"0 _ED !$ M ( ! '!A>7,M,C R,C V,S N>'-D4$L! A0#% @ (TT*53:W ML('2# 0YL !4 ( !'0H '!A>7,M,C R,C V,S!?8V%L M+GAM;%!+ 0(4 Q0 ( "--"E6$6[(3%Q, !$* 0 5 " M 2(7 !P87ES+3(P,C(P-C,P7V1E9BYX;6Q02P$"% ,4 " C30I5U<6% M9;(W !($P, %0 @ %L*@ <&%Y&UL4$L! A0#% @ (TT*52I3X-#4)P LG8" !4 ( ! M46( '!A>7,M,C R,C V,S!?<')E+GAM;%!+ 0(4 Q0 ( "--"E6AQ,*U MS 8 -H= 2 " 5B* !P87ES:6=N7V5X,S$P,2YH=&U0 M2P$"% ,4 " C30I5EL'3R,D& #-'0 $@ @ %4D0 M<&%Y#,Q,#(N:'1M4$L! A0#% @ (TT*59D/]!VI @ '@H M !( ( !39@ '!A>7-I9VY?97@S,C Q+FAT;5!+ 0(4 Q0 M ( "--"E7(?AENHP( +\) 2 " 2:; !P87ES:6=N M7V5X,S(P,BYH=&U02P$"% ,4 " C30I5):9RJGW< !7:P@ %P M @ 'YG0 <&%Y